<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <atom:link href="https://feeds.megaphone.fm/HRALC9149152947" rel="self" type="application/rss+xml"/>
    <title>Pharmacy to Dose: The Critical Care Podcast</title>
    <link>https://pharmacytodose.com</link>
    <language>en</language>
    <copyright>Copyright 2019 All rights reserved.</copyright>
    <description>Pharmacy to Dose: The Critical Care Podcast discusses critical care and its pharmacotherapy in a fun and entertaining manner. Each episode features a special guest, a subject matter expert, talking with host Nick Peters.</description>
    <image>
      <url>https://megaphone.imgix.net/podcasts/ae36d0a2-a883-11ed-8a3d-a3194a5be589/image/fbbea96a4d0526df37c2584da54a009f.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress</url>
      <title>Pharmacy to Dose: The Critical Care Podcast</title>
      <link>https://pharmacytodose.com</link>
    </image>
    <itunes:explicit>no</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <itunes:subtitle></itunes:subtitle>
    <itunes:author>Nick Peters</itunes:author>
    <itunes:summary>Pharmacy to Dose: The Critical Care Podcast discusses critical care and its pharmacotherapy in a fun and entertaining manner. Each episode features a special guest, a subject matter expert, talking with host Nick Peters.</itunes:summary>
    <content:encoded>
      <![CDATA[<p>Pharmacy to Dose: The Critical Care Podcast discusses critical care and its pharmacotherapy in a fun and entertaining manner. Each episode features a special guest, a subject matter expert, talking with host Nick Peters.</p>]]>
    </content:encoded>
    <itunes:owner>
      <itunes:name>Nick Peters</itunes:name>
      <itunes:email>pharmacytodose@gmail.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://megaphone.imgix.net/podcasts/ae36d0a2-a883-11ed-8a3d-a3194a5be589/image/fbbea96a4d0526df37c2584da54a009f.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <title>NSU Symposium Critical Care Clinical Pearls</title>
      <description>Highlighting PharmD speakers as they discuss pearls from their upcoming talks at the NSU Critical Care Symposium. 

NSU Critical Care Symposium Registration Link: https://pharmacy.nova.edu/ce/programs/critical-care-symposium.html



Conference overview with Co-Chairs Karen Berger, PharmD and Melissa Santibanez, PharmD

ECMO with Amy Dzierba, PharmD

PADIS with Patricia Louzon, PharmD

AI in the ICU with Scott Nelson, PharmD

ICU Drugs with Limited Data with Justin Muir, PharmD

Antimicrobial Therapy Duration Controversies with Tim Gauthier, PharmD


Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 17 Feb 2026 11:00:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Highlighting PharmD speakers as they discuss pearls from their upcoming talks at the NSU Critical Care Symposium. 

NSU Critical Care Symposium Registration Link: https://pharmacy.nova.edu/ce/programs/critical-care-symposium.html



Conference overview with Co-Chairs Karen Berger, PharmD and Melissa Santibanez, PharmD

ECMO with Amy Dzierba, PharmD

PADIS with Patricia Louzon, PharmD

AI in the ICU with Scott Nelson, PharmD

ICU Drugs with Limited Data with Justin Muir, PharmD

Antimicrobial Therapy Duration Controversies with Tim Gauthier, PharmD


Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Highlighting PharmD speakers as they discuss pearls from their upcoming talks at the NSU Critical Care Symposium. </p>
<p>NSU Critical Care Symposium Registration Link: https://pharmacy.nova.edu/ce/programs/critical-care-symposium.html</p>
<p><br></p>
<p>Conference overview with Co-Chairs Karen Berger, PharmD and Melissa Santibanez, PharmD</p>
<p>ECMO with Amy Dzierba, PharmD</p>
<p>PADIS with Patricia Louzon, PharmD</p>
<p>AI in the ICU with Scott Nelson, PharmD</p>
<p>ICU Drugs with Limited Data with Justin Muir, PharmD</p>
<p>Antimicrobial Therapy Duration Controversies with Tim Gauthier, PharmD</p>
<p><br></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4412</itunes:duration>
      <guid isPermaLink="false"><![CDATA[906c9eb4-0bc0-11f1-a829-9faafd1757e1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1654003627.mp3?updated=1771307114" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>RSI Trial Bonus Episode</title>
      <description>Special Guest: Kristen Sherlin, PharmD, BCEMP



Pharmacist author on the RSI trial joins to give a behind-the-scenes look at completing a large RCT and so much more. 



@PharmacyToDose

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 27 Jan 2026 11:00:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Special Guest: Kristen Sherlin, PharmD, BCEMP



Pharmacist author on the RSI trial joins to give a behind-the-scenes look at completing a large RCT and so much more. 



@PharmacyToDose

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Special Guest: Kristen Sherlin, PharmD, BCEMP</p>
<p><br></p>
<p>Pharmacist author on the RSI trial joins to give a behind-the-scenes look at completing a large RCT and so much more. </p>
<p><br></p>
<p>@PharmacyToDose</p>
<p>PharmacyToDose@Gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1891</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1656db60-fb4b-11f0-b863-677b68b81941]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7677069806.mp3?updated=1769496773" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>RSI Trial Deep Dive</title>
      <description>Special Guests: Matthew Semler, MD &amp;

Nicole Acquisto, PharmD, FASHP, FCCM, FCCP



Join us as we do a deep dive into the RSI trial, published in NEJM in Dec 2025.



Previous RCTs, study development timeline, guideline recommendations, study methodology and findings, answering listener questions, clearing up internet rumors, how to apply these findings, significant secondary outcome?, next steps, fun facts, and so much more.



RSI Trial: https://pubmed.ncbi.nlm.nih.gov/41369227/

Episode Reference List: https://pharmacytodose.wordpress.com/wp-content/uploads/2026/01/rsi-trial-deep-dive-references.pdf 



@PharmacyToDose

Pharmacytodose@gmail.com

Pharmacytodose.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 21 Jan 2026 11:00:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Special Guests: Matthew Semler, MD &amp;

Nicole Acquisto, PharmD, FASHP, FCCM, FCCP



Join us as we do a deep dive into the RSI trial, published in NEJM in Dec 2025.



Previous RCTs, study development timeline, guideline recommendations, study methodology and findings, answering listener questions, clearing up internet rumors, how to apply these findings, significant secondary outcome?, next steps, fun facts, and so much more.



RSI Trial: https://pubmed.ncbi.nlm.nih.gov/41369227/

Episode Reference List: https://pharmacytodose.wordpress.com/wp-content/uploads/2026/01/rsi-trial-deep-dive-references.pdf 



@PharmacyToDose

Pharmacytodose@gmail.com

Pharmacytodose.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Special Guests: Matthew Semler, MD &amp;</p>
<p>Nicole Acquisto, PharmD, FASHP, FCCM, FCCP</p>
<p><br></p>
<p>Join us as we do a deep dive into the RSI trial, published in NEJM in Dec 2025.</p>
<p><br></p>
<p>Previous RCTs, study development timeline, guideline recommendations, study methodology and findings, answering listener questions, clearing up internet rumors, how to apply these findings, significant secondary outcome?, next steps, fun facts, and so much more.</p>
<p><br></p>
<p>RSI Trial: https://pubmed.ncbi.nlm.nih.gov/41369227/</p>
<p>Episode Reference List: https://pharmacytodose.wordpress.com/wp-content/uploads/2026/01/rsi-trial-deep-dive-references.pdf </p>
<p><br></p>
<p>@PharmacyToDose</p>
<p>Pharmacytodose@gmail.com</p>
<p>Pharmacytodose.com </p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5688</itunes:duration>
      <guid isPermaLink="false"><![CDATA[61c05214-f698-11f0-a997-3b72b4595ec0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8543283970.mp3?updated=1769003378" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 ACCP Annual Meeting Recap</title>
      <description>2025 ACCP Annual Meeting Recap

 

Reliving the 2025 ACCP Annual Meeting as Conference
Correspondent Anthony Hawkins and I recap everything that happened in
Minneapolis, MN

 

Special guest: Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 23 Oct 2025 02:24:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 ACCP Annual Meeting Recap

 

Reliving the 2025 ACCP Annual Meeting as Conference
Correspondent Anthony Hawkins and I recap everything that happened in
Minneapolis, MN

 

Special guest: Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 ACCP Annual Meeting Recap</p>
<p> </p>
<p>Reliving the 2025 ACCP Annual Meeting as Conference
Correspondent Anthony Hawkins and I recap everything that happened in
Minneapolis, MN</p>
<p> </p>
<p>Special guest: Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP</p>
<p> </p>
<p>@Pharmacytodose</p>
<p>Pharmacytodose@gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5547</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6d098488-afb7-11f0-81db-7fc506ed377c]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5656556649.mp3?updated=1761187591" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 ACCP Annual Meeting Highlights: FCCP Roundtable</title>
      <description>Three new Fellows of ACCP (FCCP) join to discuss their journey, the application, things they learned, advice, a hearty congratulations, and so much more!



Special guests:

Christine Groth, PharmD, FCCM, FCCP, BCCCP

Philip King, PharmD, BCPS, FCCP

Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP



https://www.accp.com/meetings/am25/index.aspx



@PharmacyToDose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 21 Oct 2025 20:57:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Three new Fellows of ACCP (FCCP) join to discuss their journey, the application, things they learned, advice, a hearty congratulations, and so much more!



Special guests:

Christine Groth, PharmD, FCCM, FCCP, BCCCP

Philip King, PharmD, BCPS, FCCP

Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP



https://www.accp.com/meetings/am25/index.aspx



@PharmacyToDose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Three new Fellows of ACCP (FCCP) join to discuss their journey, the application, things they learned, advice, a hearty congratulations, and so much more!</p>
<p><br></p>
<p>Special guests:</p>
<p>Christine Groth, PharmD, FCCM, FCCP, BCCCP</p>
<p>Philip King, PharmD, BCPS, FCCP</p>
<p>Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP</p>
<p><br></p>
<p>https://www.accp.com/meetings/am25/index.aspx</p>
<p><br></p>
<p>@PharmacyToDose</p>
<p>Pharmacytodose@gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2345</itunes:duration>
      <guid isPermaLink="false"><![CDATA[47110180-ac73-11f0-8f60-67b7e9f1003a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8580122612.mp3?updated=1760828194" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 ACCP Annual Meeting Highlights: Elevating Clinical Pharmacy in the ICU</title>
      <description>2025 ACCP Annual Meeting Highlights: Elevating Clinical
Pharmacy in the ICU

 

Highlighting a 2025 ACCP Annual Meeting educational session
as well as a financial opportunity available to all Critical Care PRN members.  

 

01:30 – Highlighting the Consensus Recommendations for
Integrating Critical Care Pharmacists on ICU Teams 

Featuring: Mojdeh Heavner, PharmD, FCCP, FCCM, BCCCP

Susan Smith, PharmD, FCCM

Brian Murray, PharmD, BCCCP

Andrea Sikora, PharmD, FCCP, FCCM, BCCCP

 

https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70084

 

39:40 – Critical Care PRN Multicenter Research Network (MRN) Grant

Featuring: Julie Farrar, PharmD, BCCCP

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 21 Oct 2025 20:53:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 ACCP Annual Meeting Highlights: Elevating Clinical
Pharmacy in the ICU

 

Highlighting a 2025 ACCP Annual Meeting educational session
as well as a financial opportunity available to all Critical Care PRN members.  

 

01:30 – Highlighting the Consensus Recommendations for
Integrating Critical Care Pharmacists on ICU Teams 

Featuring: Mojdeh Heavner, PharmD, FCCP, FCCM, BCCCP

Susan Smith, PharmD, FCCM

Brian Murray, PharmD, BCCCP

Andrea Sikora, PharmD, FCCP, FCCM, BCCCP

 

https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70084

 

39:40 – Critical Care PRN Multicenter Research Network (MRN) Grant

Featuring: Julie Farrar, PharmD, BCCCP

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 ACCP Annual Meeting Highlights: Elevating Clinical
Pharmacy in the ICU</p>
<p> </p>
<p>Highlighting a 2025 ACCP Annual Meeting educational session
as well as a financial opportunity available to all Critical Care PRN members.  </p>
<p> </p>
<p>01:30 – Highlighting the Consensus Recommendations for
Integrating Critical Care Pharmacists on ICU Teams </p>
<p>Featuring: Mojdeh Heavner, PharmD, FCCP, FCCM, BCCCP</p>
<p>Susan Smith, PharmD, FCCM</p>
<p>Brian Murray, PharmD, BCCCP</p>
<p>Andrea Sikora, PharmD, FCCP, FCCM, BCCCP</p>
<p> </p>
<p><a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70084">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70084</a></p>
<p> </p>
<p>39:40 – Critical Care PRN Multicenter Research Network (MRN) Grant</p>
<p>Featuring: Julie Farrar, PharmD, BCCCP</p>
<p> </p>
<p>@Pharmacytodose</p>
<p>Pharmacytodose@gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3312</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fe596ffa-aebf-11f0-947a-fb69e9eda383]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4590736740.mp3?updated=1761080990" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 ACCP Annual Meeting Highlights: NMBA &amp; Ketamine</title>
      <description>2025 ACCP Annual Meeting Highlights: Neuromuscular Blocking Agents &amp; Ketamine

 

Highlighting two education sessions from the 2025 ACCP Annual Meeting in today’s daily recap. 

 

01:25 – Neuromuscular Blocking Agents in the Critical Care Setting 

Featuring: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCCCP, BCPS

Megan Rech, PharmD, Masters in Research, FCCP, FCCM, BCCCP

Julie DiBridge Clarkson, PharmD, BCCCP, BCCP, BCPS

Eric Johnson, PharmD, MBA, BCCCP

 

39:50 – Use of Ketamine Across Multiple Practice Areas

Featuring: Leslie Hamilton, PharmD, FCCP, BCCCP, BCPS

David Zimmerman, PharmD, FASHP, FCCP, BCCCP, BCEMP



https://www.accp.com/meetings/am25/index.aspx

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 20 Oct 2025 23:31:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 ACCP Annual Meeting Highlights: Neuromuscular Blocking Agents &amp; Ketamine

 

Highlighting two education sessions from the 2025 ACCP Annual Meeting in today’s daily recap. 

 

01:25 – Neuromuscular Blocking Agents in the Critical Care Setting 

Featuring: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCCCP, BCPS

Megan Rech, PharmD, Masters in Research, FCCP, FCCM, BCCCP

Julie DiBridge Clarkson, PharmD, BCCCP, BCCP, BCPS

Eric Johnson, PharmD, MBA, BCCCP

 

39:50 – Use of Ketamine Across Multiple Practice Areas

Featuring: Leslie Hamilton, PharmD, FCCP, BCCCP, BCPS

David Zimmerman, PharmD, FASHP, FCCP, BCCCP, BCEMP



https://www.accp.com/meetings/am25/index.aspx

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 ACCP Annual Meeting Highlights: Neuromuscular Blocking Agents &amp; Ketamine</p>
<p> </p>
<p>Highlighting two education sessions from the 2025 ACCP Annual Meeting in today’s daily recap. </p>
<p> </p>
<p>01:25 – Neuromuscular Blocking Agents in the Critical Care Setting </p>
<p>Featuring: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCCCP, BCPS</p>
<p>Megan Rech, PharmD, Masters in Research, FCCP, FCCM, BCCCP</p>
<p>Julie DiBridge Clarkson, PharmD, BCCCP, BCCP, BCPS</p>
<p>Eric Johnson, PharmD, MBA, BCCCP</p>
<p> </p>
<p>39:50 – Use of Ketamine Across Multiple Practice Areas</p>
<p>Featuring: Leslie Hamilton, PharmD, FCCP, BCCCP, BCPS</p>
<p>David Zimmerman, PharmD, FASHP, FCCP, BCCCP, BCEMP</p>
<p><br></p>
<p><a href="https://www.accp.com/meetings/am25/index.aspx">https://www.accp.com/meetings/am25/index.aspx</a></p>
<p> </p>
<p>@Pharmacytodose</p>
<p>Pharmacytodose@gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3884</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f6362c4a-ae0c-11f0-a742-0fd7ed26c336]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7697086351.mp3?updated=1761004226" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 ACCP Annual Meeting Highlights: Hyperthermia &amp; Artificial Intelligence</title>
      <description>2025 ACCP Annual Meeting Highlights: AI and Hyperthermia

 

Today’s daily episode from the 2025 ACCP Annual Meeting
highlights two different educational sessions. 

 

01:40 – Management of Drug-Induced Hyperthermia 

Featuring: Megan Musselman, PharmD, FCCP, FASHP, BCCCP,
BCEMP

Ruben Santiago, PharmD, BCCCP, BCEMP, BCPS

 

22:00 – Artificial Intelligence as Your Co-Pilot

Featuring: Zac Noel, PharmD, PhD, BCCP

Abby Krauter, PharmD, BCPS

Scott Nei, PharmD, BCPS, BCCCP, FCCM, FMSHP

Kaitlin Alexander, PharmD, BCCCP

 

https://www.accp.com/meetings/am25/index.aspx

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sun, 19 Oct 2025 23:28:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 ACCP Annual Meeting Highlights: AI and Hyperthermia

 

Today’s daily episode from the 2025 ACCP Annual Meeting
highlights two different educational sessions. 

 

01:40 – Management of Drug-Induced Hyperthermia 

Featuring: Megan Musselman, PharmD, FCCP, FASHP, BCCCP,
BCEMP

Ruben Santiago, PharmD, BCCCP, BCEMP, BCPS

 

22:00 – Artificial Intelligence as Your Co-Pilot

Featuring: Zac Noel, PharmD, PhD, BCCP

Abby Krauter, PharmD, BCPS

Scott Nei, PharmD, BCPS, BCCCP, FCCM, FMSHP

Kaitlin Alexander, PharmD, BCCCP

 

https://www.accp.com/meetings/am25/index.aspx

 

@Pharmacytodose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 ACCP Annual Meeting Highlights: AI and Hyperthermia</p>
<p> </p>
<p>Today’s daily episode from the 2025 ACCP Annual Meeting
highlights two different educational sessions. </p>
<p> </p>
<p>01:40 – Management of Drug-Induced Hyperthermia </p>
<p>Featuring: Megan Musselman, PharmD, FCCP, FASHP, BCCCP,
BCEMP</p>
<p>Ruben Santiago, PharmD, BCCCP, BCEMP, BCPS</p>
<p> </p>
<p>22:00 – Artificial Intelligence as Your Co-Pilot</p>
<p>Featuring: Zac Noel, PharmD, PhD, BCCP</p>
<p>Abby Krauter, PharmD, BCPS</p>
<p>Scott Nei, PharmD, BCPS, BCCCP, FCCM, FMSHP</p>
<p>Kaitlin Alexander, PharmD, BCCCP</p>
<p> </p>
<p><a href="https://www.accp.com/meetings/am25/index.aspx">https://www.accp.com/meetings/am25/index.aspx</a></p>
<p> </p>
<p>@Pharmacytodose</p>
<p>Pharmacytodose@gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3461</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4ff0fc58-ad43-11f0-a4dd-2be92543c4d0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2868113902.mp3?updated=1760917431" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 ACCP Annual Meeting Pre-Cap</title>
      <description>Conference Correspondent, Anthony Hawkins, returns to the podcast to preview the 2025 ACCP Annual Meeting in Minneapolis, MN. Session highlights, conference advice, Minneapolis review, and much more!



https://www.accp.com/meetings/am25/index.aspx



@PharmacyToDose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 17 Oct 2025 23:54:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Conference Correspondent, Anthony Hawkins, returns to the podcast to preview the 2025 ACCP Annual Meeting in Minneapolis, MN. Session highlights, conference advice, Minneapolis review, and much more!



https://www.accp.com/meetings/am25/index.aspx



@PharmacyToDose

Pharmacytodose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Conference Correspondent, Anthony Hawkins, returns to the podcast to preview the 2025 ACCP Annual Meeting in Minneapolis, MN. Session highlights, conference advice, Minneapolis review, and much more!</p>
<p><br></p>
<p>https://www.accp.com/meetings/am25/index.aspx</p>
<p><br></p>
<p>@PharmacyToDose</p>
<p>Pharmacytodose@gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1854</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ac57d77c-abb4-11f0-9d2c-470749f3e0b5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6449931073.mp3?updated=1760745997" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dexmedetomidine ICU Clinical Pearls</title>
      <description>Dexmedetomidine ICU Clinical Pearls

 

00:50 – Dexmedetomidine for Sleep with Natalia Smith, PharmD

20:00 – Dexmedetomidine in Alcohol Withdrawal Syndrome with Alyson
DeRosa, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/10/dexmedetomidine-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 17 Oct 2025 20:59:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Dexmedetomidine ICU Clinical Pearls

 

00:50 – Dexmedetomidine for Sleep with Natalia Smith, PharmD

20:00 – Dexmedetomidine in Alcohol Withdrawal Syndrome with Alyson
DeRosa, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/10/dexmedetomidine-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Dexmedetomidine ICU Clinical Pearls</p>
<p> </p>
<p>00:50 – Dexmedetomidine for Sleep with Natalia Smith, PharmD</p>
<p>20:00 – Dexmedetomidine in Alcohol Withdrawal Syndrome with Alyson
DeRosa, PharmD</p>
<p> </p>
<p>Reference list: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/10/dexmedetomidine-clinical-pearls-references.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/10/dexmedetomidine-clinical-pearls-references.pdf</a></p>
<p> </p>
<p>PharmacyToDose.Com </p>
<p>@PharmacyToDose </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3002</itunes:duration>
      <guid isPermaLink="false"><![CDATA[40a2c13a-ab9c-11f0-b697-4791b6b0e21d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1581568977.mp3?updated=1760735719" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Vasopressor Clinical Pearls</title>
      <description>Vasopressor Clinical Pearls

 

01:20 – Post-arrest Vasopressors with Sean Chi, PharmD

18:00 – Midodrine for Vasopressor Weaning with Eric Pham,
PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/08/vasopressor-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 20 Aug 2025 10:33:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Vasopressor Clinical Pearls

 

01:20 – Post-arrest Vasopressors with Sean Chi, PharmD

18:00 – Midodrine for Vasopressor Weaning with Eric Pham,
PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/08/vasopressor-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Vasopressor Clinical Pearls</p>
<p> </p>
<p>01:20 – Post-arrest Vasopressors with Sean Chi, PharmD</p>
<p>18:00 – Midodrine for Vasopressor Weaning with Eric Pham,
PharmD</p>
<p> </p>
<p>Reference list: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/08/vasopressor-clinical-pearls-references.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/08/vasopressor-clinical-pearls-references.pdf</a></p>
<p> </p>
<p>PharmacyToDose.Com </p>
<p>@PharmacyToDose </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2320</itunes:duration>
      <guid isPermaLink="false"><![CDATA[30324ca8-7db1-11f0-806a-c7b3408392e2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2576409282.mp3?updated=1755686793" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Toxicology Clinical Pearls</title>
      <description>Toxicology Clinical Pearls

 

01:10 – Naloxone-Induced Pulmonary Edema with Natalie Pettit,
PharmD

20:40 – Lipid Rescue with Paige Hanke, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/tox-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 11 Jul 2025 03:09:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Toxicology Clinical Pearls

 

01:10 – Naloxone-Induced Pulmonary Edema with Natalie Pettit,
PharmD

20:40 – Lipid Rescue with Paige Hanke, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/tox-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Toxicology Clinical Pearls</p>
<p> </p>
<p>01:10 – Naloxone-Induced Pulmonary Edema with Natalie Pettit,
PharmD</p>
<p>20:40 – Lipid Rescue with Paige Hanke, PharmD</p>
<p> </p>
<p>Reference list: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/tox-clinical-pearls-references.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/tox-clinical-pearls-references.pdf</a></p>
<p> </p>
<p>PharmacyToDose.Com </p>
<p>@PharmacyToDose </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2454</itunes:duration>
      <guid isPermaLink="false"><![CDATA[673b27c8-5e04-11f0-93bf-1baac50f6fd3]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1026425837.mp3?updated=1752204051" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Emergency Medicine Clinical Pearls: Part I</title>
      <description>Emergency Medicine Clinical Pearls: Part I

 

01:05 – SCAPE Management with Caylee Brown, PharmD

23:45 – Frostbite Management with Christine Hancock, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/em-cp-part-i-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 10 Jul 2025 00:14:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Emergency Medicine Clinical Pearls: Part I

 

01:05 – SCAPE Management with Caylee Brown, PharmD

23:45 – Frostbite Management with Christine Hancock, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/em-cp-part-i-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Emergency Medicine Clinical Pearls: Part I</p>
<p> </p>
<p>01:05 – SCAPE Management with Caylee Brown, PharmD</p>
<p>23:45 – Frostbite Management with Christine Hancock, PharmD</p>
<p> </p>
<p>Reference list: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/em-cp-part-i-references.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/em-cp-part-i-references.pdf</a></p>
<p> </p>
<p>PharmacyToDose.Com </p>
<p>@PharmacyToDose </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2718</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d92ce6c4-5d22-11f0-bfe2-fb17d31f2ca6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8648637757.mp3?updated=1752107303" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ARDS Clinical Pearls</title>
      <description>ARDS Clinical Pearls

 

01:35 – Corticosteroids in ARDS with Dixie Pyles, PharmD

20:10 – Inhaled Prostacyclins in ARDS with Nick Kim, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/ards-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 03 Jul 2025 20:54:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>ARDS Clinical Pearls

 

01:35 – Corticosteroids in ARDS with Dixie Pyles, PharmD

20:10 – Inhaled Prostacyclins in ARDS with Nick Kim, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/ards-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ARDS Clinical Pearls</p>
<p> </p>
<p>01:35 – Corticosteroids in ARDS with Dixie Pyles, PharmD</p>
<p>20:10 – Inhaled Prostacyclins in ARDS with Nick Kim, PharmD</p>
<p> </p>
<p>Reference list: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/ards-clinical-pearls-references.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/07/ards-clinical-pearls-references.pdf</a></p>
<p> </p>
<p>PharmacyToDose.Com </p>
<p>@PharmacyToDose </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2563</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d92a9e96-584f-11f0-ae6a-9b9c1350b8d7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6928890779.mp3?updated=1751577059" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>N-Acetylcysteine Clinical Pearls</title>
      <description>N-Acetylcysteine Clinical Pearls

 

02:04 – N-Acetylcysteine in Acute Liver Failure with Meg
Smith, PharmD

22:10 – Alternate N-Acetylcysteine Dosing Strategies in
Acetaminophen Toxicity with Tanner Smith, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/06/nac-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 30 Jun 2025 19:10:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>N-Acetylcysteine Clinical Pearls

 

02:04 – N-Acetylcysteine in Acute Liver Failure with Meg
Smith, PharmD

22:10 – Alternate N-Acetylcysteine Dosing Strategies in
Acetaminophen Toxicity with Tanner Smith, PharmD

 

Reference list: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/06/nac-clinical-pearls-references.pdf

 

PharmacyToDose.Com 

@PharmacyToDose 

PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>N-Acetylcysteine Clinical Pearls</p>
<p> </p>
<p>02:04 – N-Acetylcysteine in Acute Liver Failure with Meg
Smith, PharmD</p>
<p>22:10 – Alternate N-Acetylcysteine Dosing Strategies in
Acetaminophen Toxicity with Tanner Smith, PharmD</p>
<p> </p>
<p>Reference list: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/06/nac-clinical-pearls-references.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/06/nac-clinical-pearls-references.pdf</a></p>
<p> </p>
<p>PharmacyToDose.Com </p>
<p>@PharmacyToDose </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2630</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ce07f70a-55e5-11f0-87f5-97ed58177542]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7246453867.mp3?updated=1751311451" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 March Madness Eras Bracket Recap &amp; Final Four Preview </title>
      <description>2025 Critical Care Trials March Madness Eras Bracket Recap
&amp; Final Four Preview 
 
Featuring Bracketologists: 
Trisha Branan, PharmD, BCCCP, FCCM
Rob Maclaren, BSc, PharmD, MPH, MCCM, FCCP
Nick Servati, PharmD, BCCP
Clay Small, PharmD, BCCCP
 
I’m joined by the 4 Bracketologists for the 2025 Critical Care Trials Eras Bracket to recap what happened in the first four rounds and preview the Final Four. Who was the most accurate? Best prediction? Worst prediction? Toughest region? Did the listeners get it wrong? And so much more!
 
2025 Final Four Ballot: https://forms.gle/A7XFTTeCGgxdjwc9A
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf 
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 04 Apr 2025 17:00:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 Critical Care Trials March Madness Eras Bracket Recap
&amp; Final Four Preview 
 
Featuring Bracketologists: 
Trisha Branan, PharmD, BCCCP, FCCM
Rob Maclaren, BSc, PharmD, MPH, MCCM, FCCP
Nick Servati, PharmD, BCCP
Clay Small, PharmD, BCCCP
 
I’m joined by the 4 Bracketologists for the 2025 Critical Care Trials Eras Bracket to recap what happened in the first four rounds and preview the Final Four. Who was the most accurate? Best prediction? Worst prediction? Toughest region? Did the listeners get it wrong? And so much more!
 
2025 Final Four Ballot: https://forms.gle/A7XFTTeCGgxdjwc9A
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf 
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 Critical Care Trials March Madness Eras Bracket Recap</p><p>&amp; Final Four Preview </p><p> </p><p>Featuring Bracketologists: </p><p>Trisha Branan, PharmD, BCCCP, FCCM</p><p>Rob Maclaren, BSc, PharmD, MPH, MCCM, FCCP</p><p>Nick Servati, PharmD, BCCP</p><p>Clay Small, PharmD, BCCCP</p><p> </p><p>I’m joined by the 4 Bracketologists for the 2025 Critical Care Trials Eras Bracket to recap what happened in the first four rounds and preview the Final Four. Who was the most accurate? Best prediction? Worst prediction? Toughest region? Did the listeners get it wrong? And so much more!</p><p> </p><p>2025 Final Four Ballot: <a href="https://forms.gle/A7XFTTeCGgxdjwc9A">https://forms.gle/A7XFTTeCGgxdjwc9A</a></p><p> </p><p>PubMed links for all 68 Critical Care March Madness trials: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf</a> </p><p> </p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2929</itunes:duration>
      <guid isPermaLink="false"><![CDATA[444efb3e-1176-11f0-8ce6-4fc994d50a29]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3706768099.mp3?updated=1743786951" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>NSU Critical Care Symposium Recap &amp; March Madness Bracket Bonus </title>
      <description>NSU Critical Care Symposium Recap &amp; Bonus Discussion on March Madness Bracket 
 
04:45 – “From Scan to Script: How Imaging Drives Pharmacologic Decisions in Neurocritical Care” ft. Nina Massad, MD
 
10:50 – “Mechanical Ventilation for Pharmacists: Optimzing Care, One Breath at a Time” ft. Deontae Johnson, PharmD, RRT, BCPS, BCCCP
 
18:30 – “Glycemic Control for Critically Ill Children and Adults Remains Important: Guideline Update” ft. Judi Jacobi, PharmD, FCCP, MCCM, BCCCP
 
32:40 – “Guideline Updates: Rapid Sequence Intubation” ft. Kelly McKinley
 
41:45 – “Periprocedural Management” ft. Rachel Wolfe, PharmD, MHA, BCCCP, FCCP
 
54:15 – Conference Recap with NSU Critical Care Symposium Co-Chairs: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP &amp; Melissa Santibañez, PharmD, FCCM, BCCCP
 
64:45 – First Round Recap/Second Round Preview 2025 Critical
Care Trials March Madness: Eras Bracket
 
2025 March Madness 2nd Round Voting: https://forms.gle/5AmRmE9n5CRMG5aRA
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sun, 23 Mar 2025 21:05:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>NSU Critical Care Symposium Recap &amp; Bonus Discussion on March Madness Bracket 
 
04:45 – “From Scan to Script: How Imaging Drives Pharmacologic Decisions in Neurocritical Care” ft. Nina Massad, MD
 
10:50 – “Mechanical Ventilation for Pharmacists: Optimzing Care, One Breath at a Time” ft. Deontae Johnson, PharmD, RRT, BCPS, BCCCP
 
18:30 – “Glycemic Control for Critically Ill Children and Adults Remains Important: Guideline Update” ft. Judi Jacobi, PharmD, FCCP, MCCM, BCCCP
 
32:40 – “Guideline Updates: Rapid Sequence Intubation” ft. Kelly McKinley
 
41:45 – “Periprocedural Management” ft. Rachel Wolfe, PharmD, MHA, BCCCP, FCCP
 
54:15 – Conference Recap with NSU Critical Care Symposium Co-Chairs: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP &amp; Melissa Santibañez, PharmD, FCCM, BCCCP
 
64:45 – First Round Recap/Second Round Preview 2025 Critical
Care Trials March Madness: Eras Bracket
 
2025 March Madness 2nd Round Voting: https://forms.gle/5AmRmE9n5CRMG5aRA
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>NSU Critical Care Symposium Recap &amp; Bonus Discussion on March Madness Bracket </p><p> </p><p>04:45 – “From Scan to Script: How Imaging Drives Pharmacologic Decisions in Neurocritical Care” ft. Nina Massad, MD</p><p> </p><p>10:50 – “Mechanical Ventilation for Pharmacists: Optimzing Care, One Breath at a Time” ft. Deontae Johnson, PharmD, RRT, BCPS, BCCCP</p><p> </p><p>18:30 – “Glycemic Control for Critically Ill Children and Adults Remains Important: Guideline Update” ft. Judi Jacobi, PharmD, FCCP, MCCM, BCCCP</p><p> </p><p>32:40 – “Guideline Updates: Rapid Sequence Intubation” ft. Kelly McKinley</p><p> </p><p>41:45 – “Periprocedural Management” ft. Rachel Wolfe, PharmD, MHA, BCCCP, FCCP</p><p> </p><p>54:15 – Conference Recap with NSU Critical Care Symposium Co-Chairs: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP &amp; Melissa Santibañez, PharmD, FCCM, BCCCP</p><p> </p><p>64:45 – First Round Recap/Second Round Preview 2025 Critical</p><p>Care Trials March Madness: Eras Bracket</p><p> </p><p>2025 March Madness 2nd Round Voting: <a href="https://forms.gle/5AmRmE9n5CRMG5aRA">https://forms.gle/5AmRmE9n5CRMG5aRA</a></p><p> </p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5032</itunes:duration>
      <guid isPermaLink="false"><![CDATA[835ba35e-082a-11f0-973d-aff1c7ac11af]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9342296804.mp3?updated=1742764982" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 Critical Care Trials March Madness Eras Bracket Preview: Part II </title>
      <description>2025 Critical Care Trials March Madness Eras Bracket Preview: Part II 
2010’s &amp; 2020’s Regions
 
Featuring Bracketologists: 
Nick Servati, PharmD, BCCP &amp; Clay Small, PharmD, BCCCP
 
02:40 – 2010’s Region breakdown
59:40 – 2020’s Region breakdown
 
2025 March Madness Bracket &amp; Voting Ballot: https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 20 Mar 2025 02:50:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 Critical Care Trials March Madness Eras Bracket Preview: Part II 
2010’s &amp; 2020’s Regions
 
Featuring Bracketologists: 
Nick Servati, PharmD, BCCP &amp; Clay Small, PharmD, BCCCP
 
02:40 – 2010’s Region breakdown
59:40 – 2020’s Region breakdown
 
2025 March Madness Bracket &amp; Voting Ballot: https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 Critical Care Trials March Madness Eras Bracket Preview: Part II </p><p>2010’s &amp; 2020’s Regions</p><p> </p><p>Featuring Bracketologists: </p><p>Nick Servati, PharmD, BCCP &amp; Clay Small, PharmD, BCCCP</p><p> </p><p>02:40 – 2010’s Region breakdown</p><p>59:40 – 2020’s Region breakdown</p><p> </p><p>2025 March Madness Bracket &amp; Voting Ballot: <a href="https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/">https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/</a></p><p> </p><p>PubMed links for all 68 Critical Care March Madness trials: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf</a></p><p> </p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>7146</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2344d2ca-0536-11f0-8b5e-93cf9e1d6ccf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2310932036.mp3?updated=1742440658" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 Critical Care Trials March Madness Eras Bracket Preview: Part I </title>
      <description>2025 Critical Care Trials March Madness Eras Bracket Preview: Part I 
1900’s &amp; 2000’s Regions
 
Featuring Bracketologists: Trisha Branan, PharmD, BCCCP, FCCM &amp;
Rob Maclaren, BSc, PharmD, MPH, MCCM, FCCP
 
04:00 – 1900’s Region breakdown
37:00 – 2000’s Region breakdown
 
2025 March Madness Bracket &amp; Voting Ballot: https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/
 
PubMed links for all trials in the 2025 Eras bracket: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 20 Mar 2025 02:15:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 Critical Care Trials March Madness Eras Bracket Preview: Part I 
1900’s &amp; 2000’s Regions
 
Featuring Bracketologists: Trisha Branan, PharmD, BCCCP, FCCM &amp;
Rob Maclaren, BSc, PharmD, MPH, MCCM, FCCP
 
04:00 – 1900’s Region breakdown
37:00 – 2000’s Region breakdown
 
2025 March Madness Bracket &amp; Voting Ballot: https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/
 
PubMed links for all trials in the 2025 Eras bracket: https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 Critical Care Trials March Madness Eras Bracket Preview: Part I </p><p>1900’s &amp; 2000’s Regions</p><p> </p><p>Featuring Bracketologists: Trisha Branan, PharmD, BCCCP, FCCM &amp;</p><p>Rob Maclaren, BSc, PharmD, MPH, MCCM, FCCP</p><p> </p><p>04:00 – 1900’s Region breakdown</p><p>37:00 – 2000’s Region breakdown</p><p> </p><p>2025 March Madness Bracket &amp; Voting Ballot: <a href="https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/">https://pharmacytodose.com/2025/03/17/2025-march-madness-bracket-critical-care-trials-eras-version/</a></p><p> </p><p>PubMed links for all trials in the 2025 Eras bracket: <a href="https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf">https://pharmacytodose.wordpress.com/wp-content/uploads/2025/03/68-trials-in-2025-march-madness-bracket-with-pubmed-links.pdf</a></p><p> </p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5799</itunes:duration>
      <guid isPermaLink="false"><![CDATA[44d96400-0531-11f0-a315-772557117731]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5538755751.mp3?updated=1742438494" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 SCCM Congress PharmD Research Highlights &amp; NSU Critical Care Symposium Spotlight</title>
      <description>2025 SCCM Congress PharmD Research Highlights Plus NSU
Critical Care Symposium Spotlight
 
03:20 – Focus on NSU Critical Care Symposium with co-chairs Karen
Berger, PharmD, FASHP, FCCM, BCPS, BCCCP &amp; Melissa Santibañez, PharmD,
FCCM, BCCCP
 
Symposium Registration: https://www.nova.edu/webforms/pharmacy/inaugural-critical-care-symposium/index.html
 
17:00 – “Buprenorphine Microinduction vs. Methadone for
Opioid Weaning in Ventilated Critically Ill Patients” ft. Krista Wahby, PharmD,
BCCCP
 
26:40 – “The Impact of Extending Beta-Lactam Infusions on
Intravenous Access Requirements” ft. Kirstin Kooda, PharmD, BCCCP, BCPS, BCIDP,
FCCM
 
34:10 – “Safety of Intravenous Push Administration of
High-Dose Levetiracetam” 
ft. May Zhang, PharmD, BCPS, BCCCP
 
41:20 – “Effect of Discordance Between Cystatin C and Serum
Creatinine-Based GFRs on Medications in the ICU” ft. Abigail Cochran, PharmD
 
48:55 – “Safety Evaluation of Thiamine 500mg Intravenous
Push Administration Among Critically Ill Patients” ft. Victoria Harmon, PharmD
 
56:20 – “Evaluation of Efficacy of Levocarnitine for
Propofol-induced Hypertriglyceridemia” ft. Sylvia Karpio, PharmD
 
64:55 – “Implementing a Cardiopulmonary Bypass Vasoplegia
Protocol: A Step-Wise Approach with Angiotensin II” ft. Ryan Rivosecchi,
PharmD, BCCCP
 
More info on research highlighted: https://pharmacytodose.com/2025/03/13/2025-sccm-congress-pharmd-research-highlights/ 
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 14 Mar 2025 02:48:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2025 SCCM Congress PharmD Research Highlights Plus NSU
Critical Care Symposium Spotlight
 
03:20 – Focus on NSU Critical Care Symposium with co-chairs Karen
Berger, PharmD, FASHP, FCCM, BCPS, BCCCP &amp; Melissa Santibañez, PharmD,
FCCM, BCCCP
 
Symposium Registration: https://www.nova.edu/webforms/pharmacy/inaugural-critical-care-symposium/index.html
 
17:00 – “Buprenorphine Microinduction vs. Methadone for
Opioid Weaning in Ventilated Critically Ill Patients” ft. Krista Wahby, PharmD,
BCCCP
 
26:40 – “The Impact of Extending Beta-Lactam Infusions on
Intravenous Access Requirements” ft. Kirstin Kooda, PharmD, BCCCP, BCPS, BCIDP,
FCCM
 
34:10 – “Safety of Intravenous Push Administration of
High-Dose Levetiracetam” 
ft. May Zhang, PharmD, BCPS, BCCCP
 
41:20 – “Effect of Discordance Between Cystatin C and Serum
Creatinine-Based GFRs on Medications in the ICU” ft. Abigail Cochran, PharmD
 
48:55 – “Safety Evaluation of Thiamine 500mg Intravenous
Push Administration Among Critically Ill Patients” ft. Victoria Harmon, PharmD
 
56:20 – “Evaluation of Efficacy of Levocarnitine for
Propofol-induced Hypertriglyceridemia” ft. Sylvia Karpio, PharmD
 
64:55 – “Implementing a Cardiopulmonary Bypass Vasoplegia
Protocol: A Step-Wise Approach with Angiotensin II” ft. Ryan Rivosecchi,
PharmD, BCCCP
 
More info on research highlighted: https://pharmacytodose.com/2025/03/13/2025-sccm-congress-pharmd-research-highlights/ 
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 SCCM Congress PharmD Research Highlights Plus NSU</p><p>Critical Care Symposium Spotlight</p><p> </p><p>03:20 – Focus on NSU Critical Care Symposium with co-chairs Karen</p><p>Berger, PharmD, FASHP, FCCM, BCPS, BCCCP &amp; Melissa Santibañez, PharmD,</p><p>FCCM, BCCCP</p><p> </p><p>Symposium Registration: <a href="https://www.nova.edu/webforms/pharmacy/inaugural-critical-care-symposium/index.html">https://www.nova.edu/webforms/pharmacy/inaugural-critical-care-symposium/index.html</a></p><p> </p><p>17:00 – “Buprenorphine Microinduction vs. Methadone for</p><p>Opioid Weaning in Ventilated Critically Ill Patients” ft. Krista Wahby, PharmD,</p><p>BCCCP</p><p> </p><p>26:40 – “The Impact of Extending Beta-Lactam Infusions on</p><p>Intravenous Access Requirements” ft. Kirstin Kooda, PharmD, BCCCP, BCPS, BCIDP,</p><p>FCCM</p><p> </p><p>34:10 – “Safety of Intravenous Push Administration of</p><p>High-Dose Levetiracetam” </p><p>ft. May Zhang, PharmD, BCPS, BCCCP</p><p> </p><p>41:20 – “Effect of Discordance Between Cystatin C and Serum</p><p>Creatinine-Based GFRs on Medications in the ICU” ft. Abigail Cochran, PharmD</p><p> </p><p>48:55 – “Safety Evaluation of Thiamine 500mg Intravenous</p><p>Push Administration Among Critically Ill Patients” ft. Victoria Harmon, PharmD</p><p> </p><p>56:20 – “Evaluation of Efficacy of Levocarnitine for</p><p>Propofol-induced Hypertriglyceridemia” ft. Sylvia Karpio, PharmD</p><p> </p><p>64:55 – “Implementing a Cardiopulmonary Bypass Vasoplegia</p><p>Protocol: A Step-Wise Approach with Angiotensin II” ft. Ryan Rivosecchi,</p><p>PharmD, BCCCP</p><p> </p><p>More info on research highlighted: https://pharmacytodose.com/2025/03/13/2025-sccm-congress-pharmd-research-highlights/ </p><p> </p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4632</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[d76271ac-007e-11f0-ac13-dfb5ecc2368c]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9462334780.mp3?updated=1741921713" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 SCCM Congress Recap</title>
      <description>2025 SCCM Congress Recap
Special Guests: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Andy Webb, PharmD, BCCCP
 
Full review of the 2025 SCCM Congress in Orlando, FL discussing things such as the convention center, Select Lounge, clinical sessions, lobby bar review, Disney highlights, looking to next year, &amp; so much more.
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 26 Feb 2025 00:25:15 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brian Gilbert and Andy Webb join to help give a full recap of the 2025 SCCM Congress in Orlando, FL. </itunes:subtitle>
      <itunes:summary>2025 SCCM Congress Recap
Special Guests: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Andy Webb, PharmD, BCCCP
 
Full review of the 2025 SCCM Congress in Orlando, FL discussing things such as the convention center, Select Lounge, clinical sessions, lobby bar review, Disney highlights, looking to next year, &amp; so much more.
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 SCCM Congress Recap</p><p>Special Guests: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS</p><p>Andy Webb, PharmD, BCCCP</p><p> </p><p>Full review of the 2025 SCCM Congress in Orlando, FL discussing things such as the convention center, Select Lounge, clinical sessions, lobby bar review, Disney highlights, looking to next year, &amp; so much more.</p><p> </p><p>2025 SCCM Congress: <a href="https://sccm.org/annual-congress/critical-care-conference">https://sccm.org/annual-congress/critical-care-conference</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5725</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1a62af7a-f3d8-11ef-8c66-d70b238e9f69]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3336306223.mp3?updated=1740531047" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 SCCM Congress: Monday Mini-Recap</title>
      <description>2025 SCCM Congress: Monday Mini-Recap

Special Guests: Christopher Buckley, PharmD, MS, BCCCP
Megan Rech, PharmD, MS, FCCM, FCCP, BCCCP
Alicia Sacco, PharmD, BCCCP, FCCM
Susan Smith, PharmD, BCCCP, FCCM
Laura Blackburn, PharmD, BCPS, BCCCP, FCCM
Caitlin Brown, PharmD, BCCCP, FCCM
Kaitlin Landolf, PharmD, BCCCP
 
03:35 – CPP year-in-review
29:35 – Going green in the ICU
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 25 Feb 2025 00:26:43 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>This Monday mini-recap from the 2025 SCCM Congress highlights two CPP sessions: the Year-In-Review &amp; Going Green in the ICU. </itunes:subtitle>
      <itunes:summary>2025 SCCM Congress: Monday Mini-Recap

Special Guests: Christopher Buckley, PharmD, MS, BCCCP
Megan Rech, PharmD, MS, FCCM, FCCP, BCCCP
Alicia Sacco, PharmD, BCCCP, FCCM
Susan Smith, PharmD, BCCCP, FCCM
Laura Blackburn, PharmD, BCPS, BCCCP, FCCM
Caitlin Brown, PharmD, BCCCP, FCCM
Kaitlin Landolf, PharmD, BCCCP
 
03:35 – CPP year-in-review
29:35 – Going green in the ICU
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 SCCM Congress: Monday Mini-Recap</p><p><br></p><p>Special Guests: Christopher Buckley, PharmD, MS, BCCCP</p><p>Megan Rech, PharmD, MS, FCCM, FCCP, BCCCP</p><p>Alicia Sacco, PharmD, BCCCP, FCCM</p><p>Susan Smith, PharmD, BCCCP, FCCM</p><p>Laura Blackburn, PharmD, BCPS, BCCCP, FCCM</p><p>Caitlin Brown, PharmD, BCCCP, FCCM</p><p>Kaitlin Landolf, PharmD, BCCCP</p><p> </p><p>03:35 – CPP year-in-review</p><p>29:35 – Going green in the ICU</p><p> </p><p>2025 SCCM Congress: <a href="https://sccm.org/annual-congress/critical-care-conference">https://sccm.org/annual-congress/critical-care-conference</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3214</itunes:duration>
      <guid isPermaLink="false"><![CDATA[891bed10-f30f-11ef-8c9b-bbcb72d0ad61]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2998223391.mp3?updated=1740444321" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 SCCM Congress: Sunday Mini-Recap</title>
      <description>2025 SCCM Congress: Sunday Mini-Recap
Special Guest: Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP
 
01:35 – BZD v. PHB for alcohol withdrawal
09:36 – 2025 PAD-IS focused guideline update
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
2025 PAD-IS Focused Guideline Update: https://journals.lww.com/ccmjournal/fulltext/9900/a_focused_update_to_the_clinical_practice.448.aspx
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sun, 23 Feb 2025 23:44:31 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick highlights his talk, debating alcohol withdrawal treatment strategies, before Joanna Stollings joins to review the 2025 Focused Update to the PAD-IS guidelines. </itunes:subtitle>
      <itunes:summary>2025 SCCM Congress: Sunday Mini-Recap
Special Guest: Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP
 
01:35 – BZD v. PHB for alcohol withdrawal
09:36 – 2025 PAD-IS focused guideline update
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
2025 PAD-IS Focused Guideline Update: https://journals.lww.com/ccmjournal/fulltext/9900/a_focused_update_to_the_clinical_practice.448.aspx
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 SCCM Congress: Sunday Mini-Recap</p><p>Special Guest: Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP</p><p> </p><p>01:35 – BZD v. PHB for alcohol withdrawal</p><p>09:36 – 2025 PAD-IS focused guideline update</p><p> </p><p>2025 SCCM Congress: <a href="https://sccm.org/annual-congress/critical-care-conference">https://sccm.org/annual-congress/critical-care-conference</a></p><p> </p><p>2025 PAD-IS Focused Guideline Update: <a href="https://journals.lww.com/ccmjournal/fulltext/9900/a_focused_update_to_the_clinical_practice.448.aspx">https://journals.lww.com/ccmjournal/fulltext/9900/a_focused_update_to_the_clinical_practice.448.aspx</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2351</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7ea19bac-f240-11ef-8961-1302c7cf5c9f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2398723810.mp3?updated=1740364288" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2025 SCCM Congress: Saturday Mini-Recap</title>
      <description>2025 SCCM Congress: Saturday Mini-Recap
Special Guests: Seth Bauer, PharmD, FCCM, FCCP, BCPS, BCCCP
Kevin Betthauser, PharmD, BCCCP
Sandra Kane-Gill, PharmD, MSc, FCCP, FCCM
 
00:00 – Intro/Podcast updates
05:30 – CPP Pre-Congress Forum discussion
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sat, 22 Feb 2025 22:13:27 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Pharmacists from the CPP Pre-Congress Forum highlight how their Critical Care Pharmacist background helped them succeed in their new role within pharmacy or critical care. </itunes:subtitle>
      <itunes:summary>2025 SCCM Congress: Saturday Mini-Recap
Special Guests: Seth Bauer, PharmD, FCCM, FCCP, BCPS, BCCCP
Kevin Betthauser, PharmD, BCCCP
Sandra Kane-Gill, PharmD, MSc, FCCP, FCCM
 
00:00 – Intro/Podcast updates
05:30 – CPP Pre-Congress Forum discussion
 
2025 SCCM Congress: https://sccm.org/annual-congress/critical-care-conference
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2025 SCCM Congress: Saturday Mini-Recap</p><p>Special Guests: Seth Bauer, PharmD, FCCM, FCCP, BCPS, BCCCP</p><p>Kevin Betthauser, PharmD, BCCCP</p><p>Sandra Kane-Gill, PharmD, MSc, FCCP, FCCM</p><p> </p><p>00:00 – Intro/Podcast updates</p><p>05:30 – CPP Pre-Congress Forum discussion</p><p> </p><p>2025 SCCM Congress: <a href="https://sccm.org/annual-congress/critical-care-conference">https://sccm.org/annual-congress/critical-care-conference</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2266</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4985b2cc-f16a-11ef-a2db-97a02829ac1f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2886417155.mp3?updated=1740263447" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ASHP Midyear Clinical Meeting Recap</title>
      <description>2024 ASHP Midyear Clinical Meeting Recap 
 
Nick gives a recap of the 2024 ASHP Midyear Clinical Meeting highlighting the convention center, clinical sessions, Bourbon St. adventures, food/drink review, New Orleans, and so much more.
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 12 Dec 2024 17:11:46 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick recaps and discusses highlights from the 2024 ASHP Midyear Clinical Meeting in New Orleans, LA. </itunes:subtitle>
      <itunes:summary>2024 ASHP Midyear Clinical Meeting Recap 
 
Nick gives a recap of the 2024 ASHP Midyear Clinical Meeting highlighting the convention center, clinical sessions, Bourbon St. adventures, food/drink review, New Orleans, and so much more.
 
PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ASHP Midyear Clinical Meeting Recap </p><p> </p><p>Nick gives a recap of the 2024 ASHP Midyear Clinical Meeting highlighting the convention center, clinical sessions, Bourbon St. adventures, food/drink review, New Orleans, and so much more.</p><p> </p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2973</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2ec8bc46-b8ac-11ef-bc93-b3b32859d795]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9010799844.mp3?updated=1734024762" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ASHP Midyear Clinical Meeting: Tuesday Mini-Recap</title>
      <description>2024 ASHP Midyear Clinical Meeting: Tuesday Mini-Recap
Special Guests: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Lance Ray, PharmD, BCEMP, BCPS
Ruben Santiago, PharmD, BCCCP, BCPS
 
Nick is joined by the 3 presenters to dive into their presentation from the ASHP 2024 Midyear Clinical Session:
“When the Good Times Roll Too Far: Overview of ‘Party Drug’ Management.”
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 11 Dec 2024 00:37:34 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brian Gilbert, Lance Ray, &amp; Ruben Santiago join to highlight their clinical session from the 2024 ASHP Midyear Clinical Meeting: "When the Good Times Roll Too Far: Overview of ‘Party Drug’ Management.” </itunes:subtitle>
      <itunes:summary>2024 ASHP Midyear Clinical Meeting: Tuesday Mini-Recap
Special Guests: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Lance Ray, PharmD, BCEMP, BCPS
Ruben Santiago, PharmD, BCCCP, BCPS
 
Nick is joined by the 3 presenters to dive into their presentation from the ASHP 2024 Midyear Clinical Session:
“When the Good Times Roll Too Far: Overview of ‘Party Drug’ Management.”
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ASHP Midyear Clinical Meeting: Tuesday Mini-Recap</p><p>Special Guests: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS</p><p>Lance Ray, PharmD, BCEMP, BCPS</p><p>Ruben Santiago, PharmD, BCCCP, BCPS</p><p> </p><p>Nick is joined by the 3 presenters to dive into their presentation from the ASHP 2024 Midyear Clinical Session:</p><p>“When the Good Times Roll Too Far: Overview of ‘Party Drug’ Management.”</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2812</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1e6b1588-b758-11ef-9243-03c1dc9637e5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5622501420.mp3?updated=1733878325" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ASHP Midyear Clinical Meeting: Monday Mini-Recap</title>
      <description>2024 ASHP Midyear Clinical Meeting: Monday Mini-Recap
 
Nick highlights the Residency Showcase from the 2024 ASHP Midyear Clinical Meeting.
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 10 Dec 2024 01:29:49 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>A review of the Residency Showcase from the 2024 ASHP Midyear Clinical Meeting.</itunes:subtitle>
      <itunes:summary>2024 ASHP Midyear Clinical Meeting: Monday Mini-Recap
 
Nick highlights the Residency Showcase from the 2024 ASHP Midyear Clinical Meeting.
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ASHP Midyear Clinical Meeting: Monday Mini-Recap</p><p> </p><p>Nick highlights the Residency Showcase from the 2024 ASHP Midyear Clinical Meeting.</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2005</itunes:duration>
      <guid isPermaLink="false"><![CDATA[425e97d4-b696-11ef-b47a-2bfb816cfa0f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2663895048.mp3?updated=1733794953" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ASHP Midyear Clinical Meeting: Sunday Mini-Recap</title>
      <description>2024 ASHP Midyear Clinical Meeting: Sunday Mini-Recap
Special Guests: Angela Antoniello, PharmD, BCCCP, BCEMP, BCPS @CodeTripleA
Kyle Weant, PharmD, BCPS, BCCCP, FCCP @KyleWeant
Anne Rose, PharmD
 
02:25 – “Optimization of antidote stocking, availability, and administration practices for a large multihospital organization” with Angela Antoniello
https://pubmed.ncbi.nlm.nih.gov/35861156/
 
14:05 – “Improving inpatient discharge workflows through pharmacist pending discharge medication orders” with Anne Rose
https://pubmed.ncbi.nlm.nih.gov/37343297/
 
26:35 – “Development of an emergency medicine pharmacy intensity score tool” with Kyle Weant
https://pubmed.ncbi.nlm.nih.gov/36322132/

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 09 Dec 2024 00:29:43 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Mini-recap from the 2024 ASHP Midyear Clinical Meeting highlights 3 Pharmacist speakers from the “Practice Enhancing Interventions about the Medication-Use Process from 2023: Gems from AJHP” clinical session. </itunes:subtitle>
      <itunes:summary>2024 ASHP Midyear Clinical Meeting: Sunday Mini-Recap
Special Guests: Angela Antoniello, PharmD, BCCCP, BCEMP, BCPS @CodeTripleA
Kyle Weant, PharmD, BCPS, BCCCP, FCCP @KyleWeant
Anne Rose, PharmD
 
02:25 – “Optimization of antidote stocking, availability, and administration practices for a large multihospital organization” with Angela Antoniello
https://pubmed.ncbi.nlm.nih.gov/35861156/
 
14:05 – “Improving inpatient discharge workflows through pharmacist pending discharge medication orders” with Anne Rose
https://pubmed.ncbi.nlm.nih.gov/37343297/
 
26:35 – “Development of an emergency medicine pharmacy intensity score tool” with Kyle Weant
https://pubmed.ncbi.nlm.nih.gov/36322132/

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ASHP Midyear Clinical Meeting: Sunday Mini-Recap</p><p>Special Guests: Angela Antoniello, PharmD, BCCCP, BCEMP, BCPS @CodeTripleA</p><p>Kyle Weant, PharmD, BCPS, BCCCP, FCCP @KyleWeant</p><p>Anne Rose, PharmD</p><p> </p><p>02:25 – “Optimization of antidote stocking, availability, and administration practices for a large multihospital organization” with Angela Antoniello</p><p><a href="https://pubmed.ncbi.nlm.nih.gov/35861156/">https://pubmed.ncbi.nlm.nih.gov/35861156/</a></p><p> </p><p>14:05 – “Improving inpatient discharge workflows through pharmacist pending discharge medication orders” with Anne Rose</p><p><a href="https://pubmed.ncbi.nlm.nih.gov/37343297/">https://pubmed.ncbi.nlm.nih.gov/37343297/</a></p><p> </p><p>26:35 – “Development of an emergency medicine pharmacy intensity score tool” with Kyle Weant</p><p><a href="https://pubmed.ncbi.nlm.nih.gov/36322132/">https://pubmed.ncbi.nlm.nih.gov/36322132/</a></p><p><br></p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2886</itunes:duration>
      <guid isPermaLink="false"><![CDATA[201c1bfa-b5c5-11ef-9b02-7756dd66afcb]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4054770990.mp3?updated=1733705206" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>October 2024 ICU Clinical Pearls</title>
      <description>October 2024 ICU Clinical Pearls
 
01:25 – AVP-D &amp; AVP-R (formerly known as Diabetes Insipidus) with Michelle Tsai, PharmD
16:10 – NMBA use in ARDS with Maggie Schmidt, PharmD
40:20 – Nimodipine for aSAH management with Libby Powell, PharmD
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-cc-clinical-pearl-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 05 Dec 2024 17:55:28 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Three Critical Care PGY2 pharmacy residents, Michelle Tsai, Maggie Schmidt, and Libby Powell, join to highlight their October 2024 Critical Care clinical pearls. </itunes:subtitle>
      <itunes:summary>October 2024 ICU Clinical Pearls
 
01:25 – AVP-D &amp; AVP-R (formerly known as Diabetes Insipidus) with Michelle Tsai, PharmD
16:10 – NMBA use in ARDS with Maggie Schmidt, PharmD
40:20 – Nimodipine for aSAH management with Libby Powell, PharmD
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-cc-clinical-pearl-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>October 2024 ICU Clinical Pearls</p><p> </p><p>01:25 – AVP-D &amp; AVP-R (formerly known as Diabetes Insipidus) with Michelle Tsai, PharmD</p><p>16:10 – NMBA use in ARDS with Maggie Schmidt, PharmD</p><p>40:20 – Nimodipine for aSAH management with Libby Powell, PharmD</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-cc-clinical-pearl-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-cc-clinical-pearl-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3636</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3bffbb6e-b332-11ef-a3b5-9f471a31b46b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9591835793.mp3?updated=1733422950" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>October 2024 EM Clinical Pearls</title>
      <description>October 2024 EM Clinical Pearls
 
02:10 – Esmolol for Refractory VF/VT with Mallory McGee, PharmD
21:00 – Fomepizole with Seth Carroll, PharmD
36:00 – Sugammadex in the ED with Cecilia Schowe, PharmD, MS, BCPS
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-em-clinical-pearl-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 03 Dec 2024 23:24:30 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Mallory McGee, Seth Carroll, and Cecilia Schowe join to highlight Emergency Medicine clinical pearls for October 2024. </itunes:subtitle>
      <itunes:summary>October 2024 EM Clinical Pearls
 
02:10 – Esmolol for Refractory VF/VT with Mallory McGee, PharmD
21:00 – Fomepizole with Seth Carroll, PharmD
36:00 – Sugammadex in the ED with Cecilia Schowe, PharmD, MS, BCPS
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-em-clinical-pearl-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>October 2024 EM Clinical Pearls</p><p> </p><p>02:10 – Esmolol for Refractory VF/VT with Mallory McGee, PharmD</p><p>21:00 – Fomepizole with Seth Carroll, PharmD</p><p>36:00 – Sugammadex in the ED with Cecilia Schowe, PharmD, MS, BCPS</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-em-clinical-pearl-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/12/october-2024-em-clinical-pearl-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3454</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d2d23cb2-b1cd-11ef-928d-2334246eb5d4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4249982937.mp3?updated=1733269195" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>InteGREAT: A Guidebook for Creating Great Healthcare Teams</title>
      <description>InteGREAT: A Guidebook for Creating Great Healthcare Teams
Special Guests: UGAC3 @ugac3
Chris Bland, PharmD, FCCP, FIDSA, BCPS @blandman19
Trisha Branan, PharmD, BCCCP, FCCM @TrishaBranan
Anthony Hawkins, PharmD, BCCCP, FCCM @iamahawkins
Andrea Sikora, PharmD, MSCR, BCCCP, FCCM, FCCP @AndreaSikora
Susan Smith, PharmD, BCCCP, FCCM @SESmithPharmD
 
03:30 – UGAC3 background
07:00 – InteGREAT introduction/foundation
14:05 – InteGREAT exercises
25:00 – Building your team
37:30 – Activities for team growth
48:50 – Why InteGREAT is so essential
 
Critical Care Collaborative website: https://www.critcarecollab.com/integreat
 
Buy InteGREAT on Amazon: https://www.amazon.com/InteGREAT-Guidebook-Creating-Great-Healthcare-ebook/dp/B0CXGM616P/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 02 Dec 2024 13:17:01 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick is joined by all 5 members of the UGAC3 to highlight their book, InteGREAT, and talk about this book's role in creating and building high-quality healthcare teams. </itunes:subtitle>
      <itunes:summary>InteGREAT: A Guidebook for Creating Great Healthcare Teams
Special Guests: UGAC3 @ugac3
Chris Bland, PharmD, FCCP, FIDSA, BCPS @blandman19
Trisha Branan, PharmD, BCCCP, FCCM @TrishaBranan
Anthony Hawkins, PharmD, BCCCP, FCCM @iamahawkins
Andrea Sikora, PharmD, MSCR, BCCCP, FCCM, FCCP @AndreaSikora
Susan Smith, PharmD, BCCCP, FCCM @SESmithPharmD
 
03:30 – UGAC3 background
07:00 – InteGREAT introduction/foundation
14:05 – InteGREAT exercises
25:00 – Building your team
37:30 – Activities for team growth
48:50 – Why InteGREAT is so essential
 
Critical Care Collaborative website: https://www.critcarecollab.com/integreat
 
Buy InteGREAT on Amazon: https://www.amazon.com/InteGREAT-Guidebook-Creating-Great-Healthcare-ebook/dp/B0CXGM616P/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>InteGREAT: A Guidebook for Creating Great Healthcare Teams</p><p>Special Guests: UGAC3 @ugac3</p><p>Chris Bland, PharmD, FCCP, FIDSA, BCPS @blandman19</p><p>Trisha Branan, PharmD, BCCCP, FCCM @TrishaBranan</p><p>Anthony Hawkins, PharmD, BCCCP, FCCM @iamahawkins</p><p>Andrea Sikora, PharmD, MSCR, BCCCP, FCCM, FCCP @AndreaSikora</p><p>Susan Smith, PharmD, BCCCP, FCCM @SESmithPharmD</p><p> </p><p>03:30 – UGAC3 background</p><p>07:00 – InteGREAT introduction/foundation</p><p>14:05 – InteGREAT exercises</p><p>25:00 – Building your team</p><p>37:30 – Activities for team growth</p><p>48:50 – Why InteGREAT is so essential</p><p> </p><p>Critical Care Collaborative website: <a href="https://www.critcarecollab.com/integreat">https://www.critcarecollab.com/integreat</a></p><p> </p><p>Buy InteGREAT on Amazon: <a href="https://www.amazon.com/InteGREAT-Guidebook-Creating-Great-Healthcare-ebook/dp/B0CXGM616P/">https://www.amazon.com/InteGREAT-Guidebook-Creating-Great-Healthcare-ebook/dp/B0CXGM616P/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3451</itunes:duration>
      <guid isPermaLink="false"><![CDATA[e47ed3d6-b0af-11ef-982e-2bf73b08bd41]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5872384186.mp3?updated=1733146340" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Andexanet Alfa FDA Committee Meeting Recap</title>
      <description>Andexanet Alfa FDA Committee Meeting Recap
 
03:08 – Purpose/Background
13:30 – Thromboembolism
25:45 – Efficacy/Patient-centered outcomes
34:55 – Discussion questions
 
Advisory Committee Meeting Link: https://www.youtube.com/live/xztpe5-d9eY
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 28 Nov 2024 01:11:34 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick Peters recaps and discusses the FDA hearing regarding andexanet alfa and their supplemental Biologics Licensing Application.  </itunes:subtitle>
      <itunes:summary>Andexanet Alfa FDA Committee Meeting Recap
 
03:08 – Purpose/Background
13:30 – Thromboembolism
25:45 – Efficacy/Patient-centered outcomes
34:55 – Discussion questions
 
Advisory Committee Meeting Link: https://www.youtube.com/live/xztpe5-d9eY
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Andexanet Alfa FDA Committee Meeting Recap</p><p> </p><p>03:08 – Purpose/Background</p><p>13:30 – Thromboembolism</p><p>25:45 – Efficacy/Patient-centered outcomes</p><p>34:55 – Discussion questions</p><p> </p><p>Advisory Committee Meeting Link: <a href="https://www.youtube.com/live/xztpe5-d9eY">https://www.youtube.com/live/xztpe5-d9eY</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3242</itunes:duration>
      <guid isPermaLink="false"><![CDATA[edf57902-ad25-11ef-a2e1-6baa703ddc53]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7578967222.mp3?updated=1732757200" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>July 2024 Literature Review Series</title>
      <description>Literature Review Series
July 2024
Special Guests: Camille Casillas, PharmD &amp; Sarah Sindelar, BS, PharmD
 
06:00 – TRACE III
13:30 – CONVINCE
16:10 – PharmD anticoag prescribing protocol
20:05 – Levetiracetam seizure prophylaxis in TBI
28:25 – AHA/ASA sICH quality measures
29:05 – Early BP lowering in ICH
31:35 – DecatSepsis
37:40 – Analgesia/sedation use with NIPPV
40:05 – ANTHARTIC post-hoc study
41:50 – Harms with inappropriate anaerobic coverage
43:00 – HASFLAIR II
52:10 – DEPOSITION
54:40 – AHA CYP2C19 genetic testing scientific statement
55:20 – DOT-HM3
62:35 – DOAC:ASM interactions
64:00 – Naloxegol v. methylnaltrexone
70:25 – Acute abdomen review
70:40 – UOP for AKI prediction SR
72:10 – Fluid timing in trauma
79:40 – Calcium MOA in hyperkalemia treatment
80:50 – ICI ADE in the ED
86:00 – Front of the Fridge (PharmD-featured studies)
89:35 – Sweet Emotion (Non-clinical articles)
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/11/july-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 26 Nov 2024 13:52:06 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/a1dfba10-abfd-11ef-9897-a75e53a66694/image/636e37615e7b021ee4d6d22960c4d3b4.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Sarah Sindelar and Camille Casillas join to help highlight the most notable articles from July 2024 in this Literature Review Series episode.</itunes:subtitle>
      <itunes:summary>Literature Review Series
July 2024
Special Guests: Camille Casillas, PharmD &amp; Sarah Sindelar, BS, PharmD
 
06:00 – TRACE III
13:30 – CONVINCE
16:10 – PharmD anticoag prescribing protocol
20:05 – Levetiracetam seizure prophylaxis in TBI
28:25 – AHA/ASA sICH quality measures
29:05 – Early BP lowering in ICH
31:35 – DecatSepsis
37:40 – Analgesia/sedation use with NIPPV
40:05 – ANTHARTIC post-hoc study
41:50 – Harms with inappropriate anaerobic coverage
43:00 – HASFLAIR II
52:10 – DEPOSITION
54:40 – AHA CYP2C19 genetic testing scientific statement
55:20 – DOT-HM3
62:35 – DOAC:ASM interactions
64:00 – Naloxegol v. methylnaltrexone
70:25 – Acute abdomen review
70:40 – UOP for AKI prediction SR
72:10 – Fluid timing in trauma
79:40 – Calcium MOA in hyperkalemia treatment
80:50 – ICI ADE in the ED
86:00 – Front of the Fridge (PharmD-featured studies)
89:35 – Sweet Emotion (Non-clinical articles)
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/11/july-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>July 2024</p><p>Special Guests: Camille Casillas, PharmD &amp; Sarah Sindelar, BS, PharmD</p><p> </p><p>06:00 – TRACE III</p><p>13:30 – CONVINCE</p><p>16:10 – PharmD anticoag prescribing protocol</p><p>20:05 – Levetiracetam seizure prophylaxis in TBI</p><p>28:25 – AHA/ASA sICH quality measures</p><p>29:05 – Early BP lowering in ICH</p><p>31:35 – DecatSepsis</p><p>37:40 – Analgesia/sedation use with NIPPV</p><p>40:05 – ANTHARTIC post-hoc study</p><p>41:50 – Harms with inappropriate anaerobic coverage</p><p>43:00 – HASFLAIR II</p><p>52:10 – DEPOSITION</p><p>54:40 – AHA CYP2C19 genetic testing scientific statement</p><p>55:20 – DOT-HM3</p><p>62:35 – DOAC:ASM interactions</p><p>64:00 – Naloxegol v. methylnaltrexone</p><p>70:25 – Acute abdomen review</p><p>70:40 – UOP for AKI prediction SR</p><p>72:10 – Fluid timing in trauma</p><p>79:40 – Calcium MOA in hyperkalemia treatment</p><p>80:50 – ICI ADE in the ED</p><p>86:00 – Front of the Fridge (PharmD-featured studies)</p><p>89:35 – Sweet Emotion (Non-clinical articles)</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/11/july-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/11/july-2024-lrs-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5733</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a1dfba10-abfd-11ef-9897-a75e53a66694]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2202752196.mp3?updated=1732630258" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>June 2024 Literature Review Series</title>
      <description>Literature Review Series
June 2024
Special Guests: Aliya Abdulla, PharmD @aliya_abdulla &amp; Sam Halleck, PharmD @sam_halleck
 
04:25 – TEMPO-2
11:15 – PROTECTION
18:55 – HEMOTION
22:00 – TBI seizure prophylaxis guidelines
22:50 – STOP-MSU
29:05 – ULTRA post-hoc
30:20 – PREOXI
37:20 – Pulmonary edema post-naloxone use SR
37:50 – Serotonin syndrome controversies
38:40 – ED boarding and agitation/delirium
44:10 – Emergent ICU chemotherapy review
45:05 – GLP-1 use in anesthesia
46:30 – Cangrelor post-PCI with MCS
52:05 – ACLS epinephrine dose and patient outcomes
53:25 – Epinephrine use pre-defibrillation
54:35 – PELS-1
60:05 – Prolonged VV ECMO outcomes
61:10 – Vasodilators in ADHF SRMA
66:50 – Front of the Fridge (PharmD-featured studies)
69:15 – Sweet Emotion (Non-clinical articles)
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/11/june-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 26 Nov 2024 01:42:32 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/f928ad6a-ab97-11ef-8037-cb4384e7941e/image/a73a798596954b2ad684b2513ae1df8b.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Aliya Abdulla and Sam Halleck join to help highlight the most notable articles from June 2024 in this Literature Review Series episode.</itunes:subtitle>
      <itunes:summary>Literature Review Series
June 2024
Special Guests: Aliya Abdulla, PharmD @aliya_abdulla &amp; Sam Halleck, PharmD @sam_halleck
 
04:25 – TEMPO-2
11:15 – PROTECTION
18:55 – HEMOTION
22:00 – TBI seizure prophylaxis guidelines
22:50 – STOP-MSU
29:05 – ULTRA post-hoc
30:20 – PREOXI
37:20 – Pulmonary edema post-naloxone use SR
37:50 – Serotonin syndrome controversies
38:40 – ED boarding and agitation/delirium
44:10 – Emergent ICU chemotherapy review
45:05 – GLP-1 use in anesthesia
46:30 – Cangrelor post-PCI with MCS
52:05 – ACLS epinephrine dose and patient outcomes
53:25 – Epinephrine use pre-defibrillation
54:35 – PELS-1
60:05 – Prolonged VV ECMO outcomes
61:10 – Vasodilators in ADHF SRMA
66:50 – Front of the Fridge (PharmD-featured studies)
69:15 – Sweet Emotion (Non-clinical articles)
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/11/june-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>June 2024</p><p>Special Guests: Aliya Abdulla, PharmD @aliya_abdulla &amp; Sam Halleck, PharmD @sam_halleck</p><p> </p><p>04:25 – TEMPO-2</p><p>11:15 – PROTECTION</p><p>18:55 – HEMOTION</p><p>22:00 – TBI seizure prophylaxis guidelines</p><p>22:50 – STOP-MSU</p><p>29:05 – ULTRA post-hoc</p><p>30:20 – PREOXI</p><p>37:20 – Pulmonary edema post-naloxone use SR</p><p>37:50 – Serotonin syndrome controversies</p><p>38:40 – ED boarding and agitation/delirium</p><p>44:10 – Emergent ICU chemotherapy review</p><p>45:05 – GLP-1 use in anesthesia</p><p>46:30 – Cangrelor post-PCI with MCS</p><p>52:05 – ACLS epinephrine dose and patient outcomes</p><p>53:25 – Epinephrine use pre-defibrillation</p><p>54:35 – PELS-1</p><p>60:05 – Prolonged VV ECMO outcomes</p><p>61:10 – Vasodilators in ADHF SRMA</p><p>66:50 – Front of the Fridge (PharmD-featured studies)</p><p>69:15 – Sweet Emotion (Non-clinical articles)</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/11/june-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/11/june-2024-lrs-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4508</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f928ad6a-ab97-11ef-8037-cb4384e7941e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1867388857.mp3?updated=1732586568" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 Pharmacy to Dose Awards</title>
      <description>2024 Pharmacy to Dose Awards
Special Guests: 12 Award Winners
 
02:15 – Research Article of the Year: "BLING III" ft. Jason Roberts, BPharm, PhD, FSHP et al
09:23 – Non-Research Publication of the Year: “Caring for Two in the ICU” ft. Mojdeh Heavner, PharmD, BCCCP, FCCM, FCCP et al
14:55 – Mentor of the Year: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
24:00 – Conference Speaker of the Year: Gretchen Sacha, PharmD, BCCCP, FCCM
29:05 – Preceptor of the Year: Grace Benanti, PharmD, BCCCP
36:40 – Black Cloud Award: Haley Peters, PharmD, BCCCP
45:35 – Tag Team Tandem of the Year: 
Christian Kressin, PharmD, BCCCP &amp; Kat Spezzano, PharmD, MBA, BCCCP
56:45 – People’s Choice Award: Andy Webb, PharmD, BCCCP
62:30 – Unsung Hero Award: Caitlin Brown, PharmD, BCCCP, FCCM
68:10 – Living Legend Award: Nicole Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP
76:20 – MVP Award: Anthony Hawkins, PharmD, FCCM
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 19 Nov 2024 04:09:03 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick is joined by the 12 winners as they highlight the 2024 Pharmacy to Dose Awards. </itunes:subtitle>
      <itunes:summary>2024 Pharmacy to Dose Awards
Special Guests: 12 Award Winners
 
02:15 – Research Article of the Year: "BLING III" ft. Jason Roberts, BPharm, PhD, FSHP et al
09:23 – Non-Research Publication of the Year: “Caring for Two in the ICU” ft. Mojdeh Heavner, PharmD, BCCCP, FCCM, FCCP et al
14:55 – Mentor of the Year: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
24:00 – Conference Speaker of the Year: Gretchen Sacha, PharmD, BCCCP, FCCM
29:05 – Preceptor of the Year: Grace Benanti, PharmD, BCCCP
36:40 – Black Cloud Award: Haley Peters, PharmD, BCCCP
45:35 – Tag Team Tandem of the Year: 
Christian Kressin, PharmD, BCCCP &amp; Kat Spezzano, PharmD, MBA, BCCCP
56:45 – People’s Choice Award: Andy Webb, PharmD, BCCCP
62:30 – Unsung Hero Award: Caitlin Brown, PharmD, BCCCP, FCCM
68:10 – Living Legend Award: Nicole Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP
76:20 – MVP Award: Anthony Hawkins, PharmD, FCCM
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 Pharmacy to Dose Awards</p><p>Special Guests: 12 Award Winners</p><p> </p><p>02:15 – Research Article of the Year: "BLING III" ft. Jason Roberts, BPharm, PhD, FSHP et al</p><p>09:23 – Non-Research Publication of the Year: “Caring for Two in the ICU” ft. Mojdeh Heavner, PharmD, BCCCP, FCCM, FCCP et al</p><p>14:55 – Mentor of the Year: Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS</p><p>24:00 – Conference Speaker of the Year: Gretchen Sacha, PharmD, BCCCP, FCCM</p><p>29:05 – Preceptor of the Year: Grace Benanti, PharmD, BCCCP</p><p>36:40 – Black Cloud Award: Haley Peters, PharmD, BCCCP</p><p>45:35 – Tag Team Tandem of the Year: </p><p>Christian Kressin, PharmD, BCCCP &amp; Kat Spezzano, PharmD, MBA, BCCCP</p><p>56:45 – People’s Choice Award: Andy Webb, PharmD, BCCCP</p><p>62:30 – Unsung Hero Award: Caitlin Brown, PharmD, BCCCP, FCCM</p><p>68:10 – Living Legend Award: Nicole Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP</p><p>76:20 – MVP Award: Anthony Hawkins, PharmD, FCCM</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5422</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1c3a5978-a62c-11ef-aef0-171cab77f924]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8148724398.mp3?updated=1731990854" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>May 2024 Literature Review Series</title>
      <description>Literature Review Series
May 2024
Special Guest: Brandon Carron, PharmD
 
04:05 – BICS
11:00 – ASTER
13:55 – INTERACT4
17:30 – Na in aSAH
24:50 – ATAMIS
30:10 – ELAN post-hoc
31:35 – ARiE
33:45 – AASLD guidelines
35:00 – Antibiotic effect on mortality
41:45 – EUROBACT-2 secondary analysis
43:15 – REGARD-VAP
46:00 – Leaving clinical practice
47:00 – Front of the Fridge
50:30 – Sweet Emotion
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/11/may-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 01 Nov 2024 16:52:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/d8275a14-9871-11ef-8584-7ba9b3ab1e42/image/cda6b4fd493df3b6f0422d88a33eeeeb.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Brandon Carron joins to help highlight the most notable articles from May 2024 in this Literature Review Series episode.</itunes:subtitle>
      <itunes:summary>Literature Review Series
May 2024
Special Guest: Brandon Carron, PharmD
 
04:05 – BICS
11:00 – ASTER
13:55 – INTERACT4
17:30 – Na in aSAH
24:50 – ATAMIS
30:10 – ELAN post-hoc
31:35 – ARiE
33:45 – AASLD guidelines
35:00 – Antibiotic effect on mortality
41:45 – EUROBACT-2 secondary analysis
43:15 – REGARD-VAP
46:00 – Leaving clinical practice
47:00 – Front of the Fridge
50:30 – Sweet Emotion
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/11/may-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>May 2024</p><p>Special Guest: Brandon Carron, PharmD</p><p> </p><p>04:05 – BICS</p><p>11:00 – ASTER</p><p>13:55 – INTERACT4</p><p>17:30 – Na in aSAH</p><p>24:50 – ATAMIS</p><p>30:10 – ELAN post-hoc</p><p>31:35 – ARiE</p><p>33:45 – AASLD guidelines</p><p>35:00 – Antibiotic effect on mortality</p><p>41:45 – EUROBACT-2 secondary analysis</p><p>43:15 – REGARD-VAP</p><p>46:00 – Leaving clinical practice</p><p>47:00 – Front of the Fridge</p><p>50:30 – Sweet Emotion</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/11/may-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/11/may-2024-lrs-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3358</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d8275a14-9871-11ef-8584-7ba9b3ab1e42]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7976031992.mp3?updated=1730481327" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: ECASS III</title>
      <description>Trial of the Week: ECASS III
Special Guest: Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP
 
03:10 – Setting the scene
06:50 – ECASS III trial of the week discussion
20:20 – Where are we now?
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/10/ecass-iii-tow-references.pdf
ECASS III trial: https://pubmed.ncbi.nlm.nih.gov/18815396/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 31 Oct 2024 16:39:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/d5274070-97a6-11ef-b00a-17200632d5fe/image/c69725edfc111e5770c4d3615d0c261a.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Leslie Hamilton highlights the landmark ECASS III study, in this October Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: ECASS III
Special Guest: Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP
 
03:10 – Setting the scene
06:50 – ECASS III trial of the week discussion
20:20 – Where are we now?
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/10/ecass-iii-tow-references.pdf
ECASS III trial: https://pubmed.ncbi.nlm.nih.gov/18815396/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: ECASS III</p><p>Special Guest: Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP</p><p> </p><p>03:10 – Setting the scene</p><p>06:50 – ECASS III trial of the week discussion</p><p>20:20 – Where are we now?</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/10/ecass-iii-tow-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/10/ecass-iii-tow-references.pdf</a></p><p>ECASS III trial: <a href="https://pubmed.ncbi.nlm.nih.gov/18815396/">https://pubmed.ncbi.nlm.nih.gov/18815396/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1829</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d5274070-97a6-11ef-b00a-17200632d5fe]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5067709724.mp3?updated=1730393776" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Stress Ulcer Prophylaxis</title>
      <description>Stress Ulcer Prophylaxis
Special Guest: Rob MacLaren, BSc, PharmD, MPH, MCCM, FCCP
 
02:05 – Guideline history and timeline
08:05 – Landmark SUP literature
13:30 – PICO question “categories”
22:30 – REVISE study
27:30 – Guideline recommendation: H2RA or PPI?
30:55 – Research priorities
43:00 – Take-home points
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/10/stress-ulcer-prophylaxis-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 30 Oct 2024 16:14:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/468c14ca-96da-11ef-a617-973693da1c4d/image/620a77e0b613b7597def7bb581b78829.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Rob MacLaren, first author on the 2024 SCCM/ASHP guidelines, discusses stress ulcer prophylaxis highlighting the new guidelines, the recently published REVISE trial, and much more. </itunes:subtitle>
      <itunes:summary>Stress Ulcer Prophylaxis
Special Guest: Rob MacLaren, BSc, PharmD, MPH, MCCM, FCCP
 
02:05 – Guideline history and timeline
08:05 – Landmark SUP literature
13:30 – PICO question “categories”
22:30 – REVISE study
27:30 – Guideline recommendation: H2RA or PPI?
30:55 – Research priorities
43:00 – Take-home points
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/10/stress-ulcer-prophylaxis-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Stress Ulcer Prophylaxis</p><p>Special Guest: Rob MacLaren, BSc, PharmD, MPH, MCCM, FCCP</p><p> </p><p>02:05 – Guideline history and timeline</p><p>08:05 – Landmark SUP literature</p><p>13:30 – PICO question “categories”</p><p>22:30 – REVISE study</p><p>27:30 – Guideline recommendation: H2RA or PPI?</p><p>30:55 – Research priorities</p><p>43:00 – Take-home points</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/10/stress-ulcer-prophylaxis-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/10/stress-ulcer-prophylaxis-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2914</itunes:duration>
      <guid isPermaLink="false"><![CDATA[468c14ca-96da-11ef-a617-973693da1c4d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8850296931.mp3?updated=1732577901" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 NCS Annual Meeting Recap</title>
      <description>2024 NCS Annual Meeting Recap
Special Guests: Andy Webb, PharmD, BCCCP
Keaton Smetana, PharmD, MBA, FNCS, FCCM
 
Recapping the 2024 Neurocritical Care Society Annual Meeting with Keaton Smetana and Andy Webb.
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 18 Oct 2024 17:16:50 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Andy Webb and Keaton Smetana join to help recap the 2024 Neurocritical Care Society Annual Meeting from San Diego, CA. </itunes:subtitle>
      <itunes:summary>2024 NCS Annual Meeting Recap
Special Guests: Andy Webb, PharmD, BCCCP
Keaton Smetana, PharmD, MBA, FNCS, FCCM
 
Recapping the 2024 Neurocritical Care Society Annual Meeting with Keaton Smetana and Andy Webb.
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 NCS Annual Meeting Recap</p><p>Special Guests: Andy Webb, PharmD, BCCCP</p><p>Keaton Smetana, PharmD, MBA, FNCS, FCCM</p><p> </p><p>Recapping the 2024 Neurocritical Care Society Annual Meeting with Keaton Smetana and Andy Webb.</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4945</itunes:duration>
      <guid isPermaLink="false"><![CDATA[e12fb2da-8d74-11ef-9681-c3f4afec25ce]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8131654593.mp3?updated=1729273090" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 NCS Annual Meeting: Thursday Mini-Recap</title>
      <description>2024 NCS Annual Meeting: Thursday Mini-Recap
 
03:00 – Highlighting 16 research posters presented at 2024 NCS Annual Meeting
 
Link to see the 16 research posters: https://pharmacytodose.com/2024/10/17/2024-ncs-annual-meeting-thursday-mini-recap/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 18 Oct 2024 01:49:02 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Thursday’s mini-recap from the 2024 NCS Annual Meeting features a discussion on 16 research posters presented at the conference.</itunes:subtitle>
      <itunes:summary>2024 NCS Annual Meeting: Thursday Mini-Recap
 
03:00 – Highlighting 16 research posters presented at 2024 NCS Annual Meeting
 
Link to see the 16 research posters: https://pharmacytodose.com/2024/10/17/2024-ncs-annual-meeting-thursday-mini-recap/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 NCS Annual Meeting: Thursday Mini-Recap</p><p> </p><p>03:00 – Highlighting 16 research posters presented at 2024 NCS Annual Meeting</p><p> </p><p>Link to see the 16 research posters: <a href="https://pharmacytodose.com/2024/10/17/2024-ncs-annual-meeting-thursday-mini-recap/">https://pharmacytodose.com/2024/10/17/2024-ncs-annual-meeting-thursday-mini-recap/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2385</itunes:duration>
      <guid isPermaLink="false"><![CDATA[35a1c9d4-8cf3-11ef-a84d-6764a6bf64f9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3152050999.mp3?updated=1729216920" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 NCS Annual Meeting: Wednesday Mini-Recap</title>
      <description>2024 NCS Annual Meeting: Wednesday Mini-Recap
Special Guests: Colleen Barthol, PharmD, BCCCP, FNCS @colleen_barthol
Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP
Sherif Mahmoud, PharmD, BSc(Pharm), MSc, PhD, FNCS @sherifelezaby
 
01:40 – FNCS discussion with Colleen Barthol
21:15 – Conference co-chairs Sherif Mahmoud and Leslie Hamilton highlight their role
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 17 Oct 2024 00:32:09 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Mini-recap from the 2024 NCS Annual Meeting features highlights from Wednesday:  FNCS discussion with new recipient Colleen Barthol and Conference co-chairs Sherif Mahmoud and Leslie Hamilton highlight their experiences. </itunes:subtitle>
      <itunes:summary>2024 NCS Annual Meeting: Wednesday Mini-Recap
Special Guests: Colleen Barthol, PharmD, BCCCP, FNCS @colleen_barthol
Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP
Sherif Mahmoud, PharmD, BSc(Pharm), MSc, PhD, FNCS @sherifelezaby
 
01:40 – FNCS discussion with Colleen Barthol
21:15 – Conference co-chairs Sherif Mahmoud and Leslie Hamilton highlight their role
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 NCS Annual Meeting: Wednesday Mini-Recap</p><p>Special Guests: Colleen Barthol, PharmD, BCCCP, FNCS @colleen_barthol</p><p>Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP</p><p>Sherif Mahmoud, PharmD, BSc(Pharm), MSc, PhD, FNCS @sherifelezaby</p><p> </p><p>01:40 – FNCS discussion with Colleen Barthol</p><p>21:15 – Conference co-chairs Sherif Mahmoud and Leslie Hamilton highlight their role</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2760</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4224c0b4-8c1f-11ef-9bd5-0366b2310158]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8156991467.mp3?updated=1729125985" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ACCP Annual Meeting Recap</title>
      <description>2024 ACCP Annual Meeting Recap
Special Guest: Anthony Hawkins, PharmD, BCCCP, FCCM
 
02:00 – Anthony Hawkins helps review the 2024 ACCP Annual Meeting including: Phoenix highlights, reviews of the conference/clinical sessions, favorite presentation titles, reception/business meeting highlights, and more. 
52:10 – Nick highlights things we missed and Tuesday’s events
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 16 Oct 2024 06:09:09 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>2024 ACCP Annual Meeting recap featuring Conference Correspondent Anthony Hawkins reviews the conference including: Phoenix highlights, reviews of the conference/clinical sessions, favorite presentation titles, reception/business meeting highlights, and so much more. </itunes:subtitle>
      <itunes:summary>2024 ACCP Annual Meeting Recap
Special Guest: Anthony Hawkins, PharmD, BCCCP, FCCM
 
02:00 – Anthony Hawkins helps review the 2024 ACCP Annual Meeting including: Phoenix highlights, reviews of the conference/clinical sessions, favorite presentation titles, reception/business meeting highlights, and more. 
52:10 – Nick highlights things we missed and Tuesday’s events
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ACCP Annual Meeting Recap</p><p>Special Guest: Anthony Hawkins, PharmD, BCCCP, FCCM</p><p> </p><p>02:00 – Anthony Hawkins helps review the 2024 ACCP Annual Meeting including: Phoenix highlights, reviews of the conference/clinical sessions, favorite presentation titles, reception/business meeting highlights, and more. </p><p>52:10 – Nick highlights things we missed and Tuesday’s events</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3995</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2d1c53de-8b85-11ef-ab0d-77e1fe434ed2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6322122182.mp3?updated=1729060478" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ACCP Annual Meeting: Tuesday Mini-Recap</title>
      <description>2024 ACCP Annual Meeting: Tuesday Mini-Recap
Special Guests: Katie Dane, PharmD, BCPS @kdane_pharmd
Jessica Elefritz, PharmD, FCCM, BCCCP @jesselefritz
Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD
Zach Smith, PharmD, FCCP, BCCCP, BCPS @ZRSmith16
 
02:35 – Pre-session roundtable discussion
26:10 – Focus session highlights
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 16 Oct 2024 00:53:15 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Mini-recap from the 2024 ACCP Annual Meeting features highlights from Tuesday: Roundtable discussion with the Critical Care PRN Focus Session speakers and moderator with a brief discussion afterwards of highlights from their session.</itunes:subtitle>
      <itunes:summary>2024 ACCP Annual Meeting: Tuesday Mini-Recap
Special Guests: Katie Dane, PharmD, BCPS @kdane_pharmd
Jessica Elefritz, PharmD, FCCM, BCCCP @jesselefritz
Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD
Zach Smith, PharmD, FCCP, BCCCP, BCPS @ZRSmith16
 
02:35 – Pre-session roundtable discussion
26:10 – Focus session highlights
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ACCP Annual Meeting: Tuesday Mini-Recap</p><p>Special Guests: Katie Dane, PharmD, BCPS @kdane_pharmd</p><p>Jessica Elefritz, PharmD, FCCM, BCCCP @jesselefritz</p><p>Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD</p><p>Zach Smith, PharmD, FCCP, BCCCP, BCPS @ZRSmith16</p><p> </p><p>02:35 – Pre-session roundtable discussion</p><p>26:10 – Focus session highlights</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2243</itunes:duration>
      <guid isPermaLink="false"><![CDATA[565f3738-8b59-11ef-8c96-67c7e85d4091]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9634789274.mp3?updated=1729041516" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ACCP Annual Meeting: Sunday Mini-Recap</title>
      <description>2024 ACCP Annual Meeting: Sunday Mini-Recap
Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP
Jimmi Hatton Kolpek, PharmD, FCCM, FCCP, FNAP
 
Judi and Jimmi join to highlight their experience as award winners, what went into these, people to thank, and so, so much more.

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 14 Oct 2024 00:40:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Mini-recap from the 2024 ACCP Annual Meeting features highlights from Sunday: Robert M. Elenbaas Service Award winner Jimmi Hatton Kolpek and Paul F. Parker Medal Award winner Judi Jacobi talking about winning these prestigious awards.  </itunes:subtitle>
      <itunes:summary>2024 ACCP Annual Meeting: Sunday Mini-Recap
Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP
Jimmi Hatton Kolpek, PharmD, FCCM, FCCP, FNAP
 
Judi and Jimmi join to highlight their experience as award winners, what went into these, people to thank, and so, so much more.

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ACCP Annual Meeting: Sunday Mini-Recap</p><p>Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP</p><p>Jimmi Hatton Kolpek, PharmD, FCCM, FCCP, FNAP</p><p> </p><p>Judi and Jimmi join to highlight their experience as award winners, what went into these, people to thank, and so, so much more.</p><p><br></p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1775</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f0e21d84-89c4-11ef-84a6-3ba082b33ee4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8756722694.mp3?updated=1728867079" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 ACCP Annual Meeting: Saturday Mini-Recap</title>
      <description>2024 ACCP Annual Meeting: Saturday Mini-Recap

Special Guests: Deepali Dixit, PharmD, FCCM, FCCP, BCCCP, BCPS
Sara J. Hyland, PharmD, FCCP, BCCCP
Rachel Wolfe, PharmD, FCCP, MHA, BCCCP
Kierra Cooney, PharmD candidate
Katie Gordon, PharmD candidate
Anna Madding, PharmD candidate
 
01:45 – FCCP roundtable discussion
24:15 Butler University Clinical Pharmacy Challenge team

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sun, 13 Oct 2024 02:18:57 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Mini-recap from the 2024 ACCP Annual Meeting features highlights from Saturday: FCCP roundtable discussion with new inductees Deepali Dixit, Sara Hyland, &amp; Rachel Wolfe then meeting the Butler University Clinical Pharmacy Challenge team featuring Kierra Cooney, Katie Gordon, and Anna Madding. </itunes:subtitle>
      <itunes:summary>2024 ACCP Annual Meeting: Saturday Mini-Recap

Special Guests: Deepali Dixit, PharmD, FCCM, FCCP, BCCCP, BCPS
Sara J. Hyland, PharmD, FCCP, BCCCP
Rachel Wolfe, PharmD, FCCP, MHA, BCCCP
Kierra Cooney, PharmD candidate
Katie Gordon, PharmD candidate
Anna Madding, PharmD candidate
 
01:45 – FCCP roundtable discussion
24:15 Butler University Clinical Pharmacy Challenge team

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 ACCP Annual Meeting: Saturday Mini-Recap</p><p><br></p><p>Special Guests: Deepali Dixit, PharmD, FCCM, FCCP, BCCCP, BCPS</p><p>Sara J. Hyland, PharmD, FCCP, BCCCP</p><p>Rachel Wolfe, PharmD, FCCP, MHA, BCCCP</p><p>Kierra Cooney, PharmD candidate</p><p>Katie Gordon, PharmD candidate</p><p>Anna Madding, PharmD candidate</p><p> </p><p>01:45 – FCCP roundtable discussion</p><p>24:15 Butler University Clinical Pharmacy Challenge team</p><p><br></p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2678</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a2deac9e-8909-11ef-9c1b-5fa79b7af971]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1743728964.mp3?updated=1728786781" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Peripheral Vasopressors</title>
      <description>Peripheral Vasopressors
Special Guest: Andrew Faust, PharmD, BCPS, BCCCP
 
04:10 – Different types of IV access: PIV, CVC, midline
10:55 – Medication properties limiting peripheral administration
16:45 – CVC/Peripheral vasopressor complications
28:40 – Safety considerations
34:30 – Vasopressor selection
44:45 – Creating protocols/Highlighting Andrew’s research article
51:35 – Extravasation treatment
56:30 – Research/Guidelines related to peripheral vasopressors
60:55 – Remaining questions/Take-home points
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/10/peripheral-vasopressors-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 10 Oct 2024 01:45:59 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/6ab90ce0-86a9-11ef-b87d-bbcf7d4046b9/image/b1dad1c4cd1d20ddc9189a6d453a781e.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Andrew Faust joins to help do a deep-dive into peripheral vasopressors highlighting safety considerations, his protocol experience, extravasation treatment and much more. </itunes:subtitle>
      <itunes:summary>Peripheral Vasopressors
Special Guest: Andrew Faust, PharmD, BCPS, BCCCP
 
04:10 – Different types of IV access: PIV, CVC, midline
10:55 – Medication properties limiting peripheral administration
16:45 – CVC/Peripheral vasopressor complications
28:40 – Safety considerations
34:30 – Vasopressor selection
44:45 – Creating protocols/Highlighting Andrew’s research article
51:35 – Extravasation treatment
56:30 – Research/Guidelines related to peripheral vasopressors
60:55 – Remaining questions/Take-home points
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/10/peripheral-vasopressors-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Peripheral Vasopressors</p><p>Special Guest: Andrew Faust, PharmD, BCPS, BCCCP</p><p> </p><p>04:10 – Different types of IV access: PIV, CVC, midline</p><p>10:55 – Medication properties limiting peripheral administration</p><p>16:45 – CVC/Peripheral vasopressor complications</p><p>28:40 – Safety considerations</p><p>34:30 – Vasopressor selection</p><p>44:45 – Creating protocols/Highlighting Andrew’s research article</p><p>51:35 – Extravasation treatment</p><p>56:30 – Research/Guidelines related to peripheral vasopressors</p><p>60:55 – Remaining questions/Take-home points</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/10/peripheral-vasopressors-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/10/peripheral-vasopressors-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4156</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6ab90ce0-86a9-11ef-b87d-bbcf7d4046b9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1469611357.mp3?updated=1728525840" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: REDUCE</title>
      <description>Trial of the Week: REDUCE
Special Guest: Jolie Gallagher, PharmD, BCCCP
 
03:00 – Setting the scene
11:20 – REDUCE trial of the week discussion
27:30 – Where are we now?
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/10/reduce-tow-references.pdf
REDUCE trial: https://pubmed.ncbi.nlm.nih.gov/23695200/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 08 Oct 2024 20:08:57 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/2e7377c8-85b1-11ef-86d9-c742d73a53fd/image/7d2d98d7eedb759471c2538bafa2c40d.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Jolie Gallagher highlights the landmark REDUCE study, in this October Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: REDUCE
Special Guest: Jolie Gallagher, PharmD, BCCCP
 
03:00 – Setting the scene
11:20 – REDUCE trial of the week discussion
27:30 – Where are we now?
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/10/reduce-tow-references.pdf
REDUCE trial: https://pubmed.ncbi.nlm.nih.gov/23695200/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: REDUCE</p><p>Special Guest: Jolie Gallagher, PharmD, BCCCP</p><p> </p><p>03:00 – Setting the scene</p><p>11:20 – REDUCE trial of the week discussion</p><p>27:30 – Where are we now?</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/10/reduce-tow-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/10/reduce-tow-references.pdf</a></p><p>REDUCE trial: <a href="https://pubmed.ncbi.nlm.nih.gov/23695200/">https://pubmed.ncbi.nlm.nih.gov/23695200/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2289</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2e7377c8-85b1-11ef-86d9-c742d73a53fd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2137196321.mp3?updated=1728419414" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Acid-Base Disorders in the Critically Ill</title>
      <description>Acid-Base Disorders in the Critically Ill
Special Guests: Justin Muir, PharmD, BCCCP
Judah Brown, PharmD, BCCCP, BCEMP

04:15 – Creating this review article
07:05 – Approaches to interpreting and analyzing acid-base status
12:30 – Step-wise approach to ABG assessment
23:35 – Acid-base homeostasis &amp; compensation
26:30 – Metabolic acidosis and buffer treatment
44:35 – Acetazolamide
46:30 – Respiratory acid-base disorders
49:05 – Favorite tables/figures and fun facts from this review article
54:10 – Take-home points
 
Systematic approach to understanding acid-base disorders in the critically ill review article: https://pubmed.ncbi.nlm.nih.gov/37125739/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 07 Oct 2024 19:14:11 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/6500710a-84e0-11ef-9770-e7b493f8d5d6/image/b28fada24b84122c865feb8fed029b51.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Judah Brown and Justin Muir highlight strategies, pitfalls, and tips/tricks when interpreting and analyzing acid-base disorders in critically ill patients. </itunes:subtitle>
      <itunes:summary>Acid-Base Disorders in the Critically Ill
Special Guests: Justin Muir, PharmD, BCCCP
Judah Brown, PharmD, BCCCP, BCEMP

04:15 – Creating this review article
07:05 – Approaches to interpreting and analyzing acid-base status
12:30 – Step-wise approach to ABG assessment
23:35 – Acid-base homeostasis &amp; compensation
26:30 – Metabolic acidosis and buffer treatment
44:35 – Acetazolamide
46:30 – Respiratory acid-base disorders
49:05 – Favorite tables/figures and fun facts from this review article
54:10 – Take-home points
 
Systematic approach to understanding acid-base disorders in the critically ill review article: https://pubmed.ncbi.nlm.nih.gov/37125739/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Acid-Base Disorders in the Critically Ill</p><p>Special Guests: Justin Muir, PharmD, BCCCP</p><p>Judah Brown, PharmD, BCCCP, BCEMP</p><p><br></p><p>04:15 – Creating this review article</p><p>07:05 – Approaches to interpreting and analyzing acid-base status</p><p>12:30 – Step-wise approach to ABG assessment</p><p>23:35 – Acid-base homeostasis &amp; compensation</p><p>26:30 – Metabolic acidosis and buffer treatment</p><p>44:35 – Acetazolamide</p><p>46:30 – Respiratory acid-base disorders</p><p>49:05 – Favorite tables/figures and fun facts from this review article</p><p>54:10 – Take-home points</p><p> </p><p>Systematic approach to understanding acid-base disorders in the critically ill review article: <a href="https://pubmed.ncbi.nlm.nih.gov/37125739/">https://pubmed.ncbi.nlm.nih.gov/37125739/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3607</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6500710a-84e0-11ef-9770-e7b493f8d5d6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3875436495.mp3?updated=1728329740" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Status Epilepticus: Part II</title>
      <description>Status Epilepticus: Part II
Special Guest: Jason Vilar, PharmD, BCCCP @TheBrainPharmD
 
03:40 – Definitions/Terminology
14:30 – Landmark status epilepticus (SE) literature
21:30 – Emergent ASM SE pharmacotherapy
26:00 – DDI management/TDM
33:55 – Refractory status epilepticus (RSE) treatment
48:15 – Medication safety considerations and weaning
58:00 – EEGs for PharmD’s
68:10 – Inhaled anesthetics
74:30 – Studies on the horizon/take-home points
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/08/status-epilepticus-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 26 Aug 2024 20:54:29 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/73e7a2ba-63ed-11ef-b4b4-1f1845d16a06/image/804b1d16b6fe420e00a738b93a787532.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Jason Vilar highlights updates in the management of status epilepticus before focusing on refractory and super refractory status epilepticus in Part II of this episode series. </itunes:subtitle>
      <itunes:summary>Status Epilepticus: Part II
Special Guest: Jason Vilar, PharmD, BCCCP @TheBrainPharmD
 
03:40 – Definitions/Terminology
14:30 – Landmark status epilepticus (SE) literature
21:30 – Emergent ASM SE pharmacotherapy
26:00 – DDI management/TDM
33:55 – Refractory status epilepticus (RSE) treatment
48:15 – Medication safety considerations and weaning
58:00 – EEGs for PharmD’s
68:10 – Inhaled anesthetics
74:30 – Studies on the horizon/take-home points
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/08/status-epilepticus-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Status Epilepticus: Part II</p><p>Special Guest: Jason Vilar, PharmD, BCCCP @TheBrainPharmD</p><p> </p><p>03:40 – Definitions/Terminology</p><p>14:30 – Landmark status epilepticus (SE) literature</p><p>21:30 – Emergent ASM SE pharmacotherapy</p><p>26:00 – DDI management/TDM</p><p>33:55 – Refractory status epilepticus (RSE) treatment</p><p>48:15 – Medication safety considerations and weaning</p><p>58:00 – EEGs for PharmD’s</p><p>68:10 – Inhaled anesthetics</p><p>74:30 – Studies on the horizon/take-home points</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/08/status-epilepticus-part-ii-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/08/status-epilepticus-part-ii-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4980</itunes:duration>
      <guid isPermaLink="false"><![CDATA[73e7a2ba-63ed-11ef-b4b4-1f1845d16a06]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2118642694.mp3?updated=1724708076" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>April 2024 Literature Review Series</title>
      <description>Literature Review Series
April 2024
Special Guests: Katherine Kessel, PharmD
Ming May Zhang, PharmD, BCPS
 
04:05 – RCT’s
21:28 – Reviews/Prospective observational
35:25 – Guidelines/Post-hoc
43:00 – Retrospective/ SRMA
64:54 – PharmD-featured/Sweet Emotion
 
2024 Award Nomination Ballot: https://forms.gle/HG1ytSHjrcRCW3SA9
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/08/april-2024-lrs-references.pdf

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 16 Aug 2024 12:09:37 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/78dea8ea-5bc8-11ef-9f19-1b26560ad332/image/1872de02c13a8404ff74aaa2287626cf.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Ming May Zhang and Katherine Kessel join to help highlight the most notable articles from April 2024 in this Literature Review Series episode.</itunes:subtitle>
      <itunes:summary>Literature Review Series
April 2024
Special Guests: Katherine Kessel, PharmD
Ming May Zhang, PharmD, BCPS
 
04:05 – RCT’s
21:28 – Reviews/Prospective observational
35:25 – Guidelines/Post-hoc
43:00 – Retrospective/ SRMA
64:54 – PharmD-featured/Sweet Emotion
 
2024 Award Nomination Ballot: https://forms.gle/HG1ytSHjrcRCW3SA9
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/08/april-2024-lrs-references.pdf

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>April 2024</p><p>Special Guests: Katherine Kessel, PharmD</p><p>Ming May Zhang, PharmD, BCPS</p><p> </p><p>04:05 – RCT’s</p><p>21:28 – Reviews/Prospective observational</p><p>35:25 – Guidelines/Post-hoc</p><p>43:00 – Retrospective/ SRMA</p><p>64:54 – PharmD-featured/Sweet Emotion</p><p> </p><p>2024 Award Nomination Ballot: <a href="https://forms.gle/HG1ytSHjrcRCW3SA9">https://forms.gle/HG1ytSHjrcRCW3SA9</a></p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/08/april-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/08/april-2024-lrs-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4760</itunes:duration>
      <guid isPermaLink="false"><![CDATA[78dea8ea-5bc8-11ef-9f19-1b26560ad332]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9613048481.mp3?updated=1723812677" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: PARAMEDIC2</title>
      <description>Trial of the Week: PARAMEDIC2
Special Guest: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCPS
 
06:20 – C4 conference preview 
12:50 – PARAMEDIC2 trial of the week
 
C4 conference registration link: https://c4conference.uic.edu/ 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/08/paramedic2-tow-references.pdf
2024 Pharmacy to Dose Award nominations: https://forms.gle/BTgirsv8uoFj7Rux5
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 15 Aug 2024 15:56:55 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/07eead6e-5b1f-11ef-95e7-83bb339a418d/image/1ca55fa8b9f359b6956d565dce839496.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Trial of the Week: PARAMEDIC2
Special Guest: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCPS
 
06:20 – C4 conference preview 
12:50 – PARAMEDIC2 trial of the week
 
C4 conference registration link: https://c4conference.uic.edu/ 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/08/paramedic2-tow-references.pdf
2024 Pharmacy to Dose Award nominations: https://forms.gle/BTgirsv8uoFj7Rux5
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: PARAMEDIC2</p><p>Special Guest: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCPS</p><p> </p><p>06:20 – C4 conference preview </p><p>12:50 – PARAMEDIC2 trial of the week</p><p> </p><p>C4 conference registration link: <a href="https://c4conference.uic.edu/">https://c4conference.uic.edu/</a> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/08/paramedic2-tow-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/08/paramedic2-tow-references.pdf</a></p><p>2024 Pharmacy to Dose Award nominations: <a href="https://forms.gle/BTgirsv8uoFj7Rux5">https://forms.gle/BTgirsv8uoFj7Rux5</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2948</itunes:duration>
      <guid isPermaLink="false"><![CDATA[07eead6e-5b1f-11ef-95e7-83bb339a418d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8020636684.mp3?updated=1723738948" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>March 2024 Literature Review Series</title>
      <description>Literature Review Series
March 2024
 
02:40 – RCT’s
13:20 – Prospective observational/Post-hoc
20:30 – Reviews &amp; SR/MA
27:05 – Retrospective
32:00 – PharmD-featured/Sweet Emotion
 
2024 Award nomination ballot: https://forms.gle/HG1ytSHjrcRCW3SA9
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/08/march-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 08 Aug 2024 03:37:30 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick Peters reviews the most notable and practice-changing articles in March 2024. </itunes:subtitle>
      <itunes:summary>Literature Review Series
March 2024
 
02:40 – RCT’s
13:20 – Prospective observational/Post-hoc
20:30 – Reviews &amp; SR/MA
27:05 – Retrospective
32:00 – PharmD-featured/Sweet Emotion
 
2024 Award nomination ballot: https://forms.gle/HG1ytSHjrcRCW3SA9
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/08/march-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>March 2024</p><p> </p><p>02:40 – RCT’s</p><p>13:20 – Prospective observational/Post-hoc</p><p>20:30 – Reviews &amp; SR/MA</p><p>27:05 – Retrospective</p><p>32:00 – PharmD-featured/Sweet Emotion</p><p> </p><p>2024 Award nomination ballot: <a href="https://forms.gle/HG1ytSHjrcRCW3SA9">https://forms.gle/HG1ytSHjrcRCW3SA9</a></p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/08/march-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/08/march-2024-lrs-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2460</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a3872f14-5537-11ef-bc57-a31fa0c0bd92]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1035207377.mp3?updated=1723089898" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>February 2024 Literature Review Series</title>
      <description>Literature Review Series
February 2024
Special Guests: Taylor Law, PharmD
Meaghan Rettele, PharmD 
 
08:05 – RCT’s
30:00 – Prospective observational studies/Guidelines
50:10 – Post-hoc/Reviews
58:55 – Retrospective
75:20 – PharmD-featured/Sweet emotion
 
2024 Award Nomination Ballot: https://forms.gle/HG1ytSHjrcRCW3SA9
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/08/feb-2024-lrs-references.pdf
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 06 Aug 2024 21:14:47 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/f6df6f1e-5438-11ef-9c9d-a750797c9e26/image/153fc62ba907bfc527037ddf6a88824b.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Meaghan Rettele and Taylor Law join to help highlight the most notable articles from February 2024 in this Literature Review Series episode.</itunes:subtitle>
      <itunes:summary>Literature Review Series
February 2024
Special Guests: Taylor Law, PharmD
Meaghan Rettele, PharmD 
 
08:05 – RCT’s
30:00 – Prospective observational studies/Guidelines
50:10 – Post-hoc/Reviews
58:55 – Retrospective
75:20 – PharmD-featured/Sweet emotion
 
2024 Award Nomination Ballot: https://forms.gle/HG1ytSHjrcRCW3SA9
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/08/feb-2024-lrs-references.pdf
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>February 2024</p><p>Special Guests: Taylor Law, PharmD</p><p>Meaghan Rettele, PharmD </p><p> </p><p>08:05 – RCT’s</p><p>30:00 – Prospective observational studies/Guidelines</p><p>50:10 – Post-hoc/Reviews</p><p>58:55 – Retrospective</p><p>75:20 – PharmD-featured/Sweet emotion</p><p> </p><p>2024 Award Nomination Ballot: <a href="https://forms.gle/HG1ytSHjrcRCW3SA9">https://forms.gle/HG1ytSHjrcRCW3SA9</a></p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/08/feb-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/08/feb-2024-lrs-references.pdf</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5334</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f6df6f1e-5438-11ef-9c9d-a750797c9e26]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6493883908.mp3?updated=1722981620" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: ROSE</title>
      <description>Trial of the Week: ROSE
Special Guest: Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD
 
05:40 – Pathophysiology/ACURASYS trial 
13:45 – ROSE trial discussion
38:40 – Current role of NMBA in ARDS
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/07/rose-tow-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 10 Jul 2024 14:19:45 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/e37d6dda-3ec7-11ef-a7b6-330d5f6e90e6/image/5ac660531e2b8997b63c23a1a126fb16.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Christina Rose highlights the landmark ROSE study, in this July Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: ROSE
Special Guest: Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD
 
05:40 – Pathophysiology/ACURASYS trial 
13:45 – ROSE trial discussion
38:40 – Current role of NMBA in ARDS
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/07/rose-tow-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: ROSE</p><p>Special Guest: Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD</p><p> </p><p>05:40 – Pathophysiology/ACURASYS trial </p><p>13:45 – ROSE trial discussion</p><p>38:40 – Current role of NMBA in ARDS</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/07/rose-tow-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/07/rose-tow-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3093</itunes:duration>
      <guid isPermaLink="false"><![CDATA[e37d6dda-3ec7-11ef-a7b6-330d5f6e90e6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6176041123.mp3?updated=1720623304" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>HRS-AKI &amp; Terlipressin</title>
      <description>HRS-AKI &amp; Terlipressin
Special Guest: Stephanie Bass, PharmD, FCCP, BCPS, BCCCP
 
05:45 – HRS and HRS-AKI diagnosis
17:00 – Albumin and volume status
23:55 – Terlipressin/vasoconstrictor treatment
52:00 – Medication safety considerations
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/hrsaki-terlipressin-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 05 Jul 2024 18:11:30 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/04e38b0c-3afa-11ef-a320-7b992485b010/image/46e641c161f5a80ece5ac672878a611c.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Stephanie Bass returns to review the management of HRS, focusing on HRS-AKI, then discussing the novel vasopressor, terlipressin.</itunes:subtitle>
      <itunes:summary>HRS-AKI &amp; Terlipressin
Special Guest: Stephanie Bass, PharmD, FCCP, BCPS, BCCCP
 
05:45 – HRS and HRS-AKI diagnosis
17:00 – Albumin and volume status
23:55 – Terlipressin/vasoconstrictor treatment
52:00 – Medication safety considerations
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/hrsaki-terlipressin-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>HRS-AKI &amp; Terlipressin</p><p>Special Guest: Stephanie Bass, PharmD, FCCP, BCPS, BCCCP</p><p> </p><p>05:45 – HRS and HRS-AKI diagnosis</p><p>17:00 – Albumin and volume status</p><p>23:55 – Terlipressin/vasoconstrictor treatment</p><p>52:00 – Medication safety considerations</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/07/hrsaki-terlipressin-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/07/hrsaki-terlipressin-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3693</itunes:duration>
      <guid isPermaLink="false"><![CDATA[04e38b0c-3afa-11ef-a320-7b992485b010]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7688903282.mp3?updated=1720205103" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: BLING III</title>
      <description>Rapid Reaction: BLING III
Special Guest: Jason Roberts, BPharm, PhD, FSHP
 
05:10 – BLING research background
17:30 – BLING III methodology/results
53:50 – Practical application/future directions
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/bling-iii-rapid-reaction-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 03 Jul 2024 16:35:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/3f58700a-395a-11ef-9952-bf8a59c716a7/image/896e237f74f240f3dffb0bd52f2f76a7.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Jason Roberts (Pharmacist and study author) joins from Australia to highlight the recently published “Continuous v. Intermittent Beta-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis,” the BLING III study.</itunes:subtitle>
      <itunes:summary>Rapid Reaction: BLING III
Special Guest: Jason Roberts, BPharm, PhD, FSHP
 
05:10 – BLING research background
17:30 – BLING III methodology/results
53:50 – Practical application/future directions
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/bling-iii-rapid-reaction-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: BLING III</p><p>Special Guest: Jason Roberts, BPharm, PhD, FSHP</p><p> </p><p>05:10 – BLING research background</p><p>17:30 – BLING III methodology/results</p><p>53:50 – Practical application/future directions</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/07/bling-iii-rapid-reaction-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/07/bling-iii-rapid-reaction-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3871</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3f58700a-395a-11ef-9952-bf8a59c716a7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6683311017.mp3?updated=1720026611" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ANNEXa-I Deep Dive: Part II</title>
      <description>﻿ANNEXa-I Deep Dive Part II
Special Guests: Scott Dietrich, PharmD, BCCCP
Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Todd Miano, PharmD, PhD, FCCM
 
03:13 – Safety/thrombotic findings
21:50 – Questions that remain
26:50 – Practical considerations
41:40 – P&amp;T elevator pitch
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 28 Jun 2024 16:22:26 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/a62192f6-356a-11ef-b183-53a5bc2605b7/image/300c918cb86d84b0b2d58e0567faa0f8.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Scott Dietrich, Brian Gilbert, and Todd Miano join to help review the ANNEXa-I trial, focusing on the safety/thrombotic outcomes and practical application/considerations in Part 2 of this 2-part episode series.</itunes:subtitle>
      <itunes:summary>﻿ANNEXa-I Deep Dive Part II
Special Guests: Scott Dietrich, PharmD, BCCCP
Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Todd Miano, PharmD, PhD, FCCM
 
03:13 – Safety/thrombotic findings
21:50 – Questions that remain
26:50 – Practical considerations
41:40 – P&amp;T elevator pitch
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>﻿ANNEXa-I Deep Dive Part II</p><p>Special Guests: Scott Dietrich, PharmD, BCCCP</p><p>Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS</p><p>Todd Miano, PharmD, PhD, FCCM</p><p> </p><p>03:13 – Safety/thrombotic findings</p><p>21:50 – Questions that remain</p><p>26:50 – Practical considerations</p><p>41:40 – P&amp;T elevator pitch</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-ii-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-ii-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3020</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a62192f6-356a-11ef-b183-53a5bc2605b7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1019814903.mp3?updated=1719597686" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ANNEXa-I Deep Dive: Part I</title>
      <description>ANNEXa-I Deep Dive Part I
Special Guests: Scott Dietrich, PharmD, BCCCP
Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Todd Miano, PharmD, PhD, FCCM
 
05:40 – Brief ANNEXa-I study overview
20:40 –Primary composite outcome
26:40 – Anti-FXa levels
30:45 – Statistics/methodology questions
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-i-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 28 Jun 2024 02:51:50 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/700e1fac-34f9-11ef-b72c-cf693ec62fcf/image/300c918cb86d84b0b2d58e0567faa0f8.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Brian Gilbert, Scott Dietrich, and Todd Miano review the ANNEXa-I study focusing on efficacy and statistics in Part 1 of this 2-part episode series.</itunes:subtitle>
      <itunes:summary>ANNEXa-I Deep Dive Part I
Special Guests: Scott Dietrich, PharmD, BCCCP
Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS
Todd Miano, PharmD, PhD, FCCM
 
05:40 – Brief ANNEXa-I study overview
20:40 –Primary composite outcome
26:40 – Anti-FXa levels
30:45 – Statistics/methodology questions
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-i-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ANNEXa-I Deep Dive Part I</p><p>Special Guests: Scott Dietrich, PharmD, BCCCP</p><p>Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS</p><p>Todd Miano, PharmD, PhD, FCCM</p><p> </p><p>05:40 – Brief ANNEXa-I study overview</p><p>20:40 –Primary composite outcome</p><p>26:40 – Anti-FXa levels</p><p>30:45 – Statistics/methodology questions</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-i-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-i-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3139</itunes:duration>
      <guid isPermaLink="false"><![CDATA[700e1fac-34f9-11ef-b72c-cf693ec62fcf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4486809359.mp3?updated=1719544685" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>January 2024 Literature Review Series</title>
      <description>Literature Review Series
January 2024
Special Guests: Haley Torr, PharmD
Nick Tran, PharmD
 
06:55 – Featured Articles
32:55 – PAD-IS articles
37:10 – Cardiology articles
46:00 – Heme articles
51:40 – Potpourri articles
60:05 – Pharmacist-featured articles
67:30 – Sweet Emotion articles
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/jan-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 25 Jun 2024 19:22:08 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/4c6e487e-3328-11ef-9b8d-0f6a84ab6137/image/dea978f0a6ea047a60255896264548b6.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Nick Tran and Haley Torr join to help highlight the most notable articles from January 2024 in this Literature Review Series episode.</itunes:subtitle>
      <itunes:summary>Literature Review Series
January 2024
Special Guests: Haley Torr, PharmD
Nick Tran, PharmD
 
06:55 – Featured Articles
32:55 – PAD-IS articles
37:10 – Cardiology articles
46:00 – Heme articles
51:40 – Potpourri articles
60:05 – Pharmacist-featured articles
67:30 – Sweet Emotion articles
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/jan-2024-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>January 2024</p><p>Special Guests: Haley Torr, PharmD</p><p>Nick Tran, PharmD</p><p> </p><p>06:55 – Featured Articles</p><p>32:55 – PAD-IS articles</p><p>37:10 – Cardiology articles</p><p>46:00 – Heme articles</p><p>51:40 – Potpourri articles</p><p>60:05 – Pharmacist-featured articles</p><p>67:30 – Sweet Emotion articles</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/06/jan-2024-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/06/jan-2024-lrs-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4425</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4c6e487e-3328-11ef-9b8d-0f6a84ab6137]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9306640985.mp3?updated=1719346489" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: PROWESS-SHOCK</title>
      <description>Trial of the Week: PROWESS-SHOCK
Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita
 
03:30 – Background studies/Setting the scene
30:25 – PROWESS-SHOCK discussion/Where are we now
 
Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (activated) in adults with septic shock” published in the New England Journal of Medicine in 2012. 
To fully understand the discussion regarding drotrecogin alfa, Paul and I review the mechanism of action and its proposed action in the treatment of sepsis. Then we review earlier studies and the controversy behind the FDA approval process. Finally, we go into detail on what Clinical Pharmacists were tasked with doing at the time based on treatment protocols or hospital restrictions.
Then we dive into the Trial of the Week, discussing the study design and results. What was the mood in ICUs and Pharmacy Departments after this publication? How much did our sepsis care improve from PROWESS to PROWESS-SHOCK? What lessons did we learn with the Xigris FDA approval process? Is there a patient population that could still benefit from drotrecogin alfa treatment? Plus, trial fun facts, issues with calculating APACHE II scores, and so much more. 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 21 Jun 2024 02:50:22 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/7a8dd0a6-2f79-11ef-83a1-7bf6847b345d/image/d06d0d9e67790fff0d96d8696c826d38.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Paul Szumita highlights the landmark 2012 PROWESS-SHOCK study, in this June Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: PROWESS-SHOCK
Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita
 
03:30 – Background studies/Setting the scene
30:25 – PROWESS-SHOCK discussion/Where are we now
 
Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (activated) in adults with septic shock” published in the New England Journal of Medicine in 2012. 
To fully understand the discussion regarding drotrecogin alfa, Paul and I review the mechanism of action and its proposed action in the treatment of sepsis. Then we review earlier studies and the controversy behind the FDA approval process. Finally, we go into detail on what Clinical Pharmacists were tasked with doing at the time based on treatment protocols or hospital restrictions.
Then we dive into the Trial of the Week, discussing the study design and results. What was the mood in ICUs and Pharmacy Departments after this publication? How much did our sepsis care improve from PROWESS to PROWESS-SHOCK? What lessons did we learn with the Xigris FDA approval process? Is there a patient population that could still benefit from drotrecogin alfa treatment? Plus, trial fun facts, issues with calculating APACHE II scores, and so much more. 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: PROWESS-SHOCK</p><p>Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita</p><p> </p><p>03:30 – Background studies/Setting the scene</p><p>30:25 – PROWESS-SHOCK discussion/Where are we now</p><p> </p><p>Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (activated) in adults with septic shock” published in the New England Journal of Medicine in 2012. </p><p>To fully understand the discussion regarding drotrecogin alfa, Paul and I review the mechanism of action and its proposed action in the treatment of sepsis. Then we review earlier studies and the controversy behind the FDA approval process. Finally, we go into detail on what Clinical Pharmacists were tasked with doing at the time based on treatment protocols or hospital restrictions.</p><p>Then we dive into the Trial of the Week, discussing the study design and results. What was the mood in ICUs and Pharmacy Departments after this publication? How much did our sepsis care improve from PROWESS to PROWESS-SHOCK? What lessons did we learn with the Xigris FDA approval process? Is there a patient population that could still benefit from drotrecogin alfa treatment? Plus, trial fun facts, issues with calculating APACHE II scores, and so much more. </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3484</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7a8dd0a6-2f79-11ef-83a1-7bf6847b345d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5601772603.mp3?updated=1718940373" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 Year-In-Review Literature Review Series</title>
      <description>Literature Review Series
2023 Year-In-Review
Special Guests: Jacquelyn Crawford, PharmD @jacuronium
Kathleen Hartman, PharmD @HartKate8
 
04:30 – Neurology
11:05 – Cardiology
18:50 – Cardiac Arrest
26:30 – Pulmonary
35:00 – Sepsis
44:05 – Endocrine/Renal
52:30 – Trauma
61:05 – Infectious Diseases
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/yir-2023-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 06 Jun 2024 12:47:54 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/5a674dce-2403-11ef-9119-0f1f30c55cb5/image/a57cf4c264e31aea807f6081dc190b51.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Jac Crawford and Kate Hartman join to help highlight the 16 most notable articles from 2023 in this Year-In-Review Literature Review Series episode. </itunes:subtitle>
      <itunes:summary>Literature Review Series
2023 Year-In-Review
Special Guests: Jacquelyn Crawford, PharmD @jacuronium
Kathleen Hartman, PharmD @HartKate8
 
04:30 – Neurology
11:05 – Cardiology
18:50 – Cardiac Arrest
26:30 – Pulmonary
35:00 – Sepsis
44:05 – Endocrine/Renal
52:30 – Trauma
61:05 – Infectious Diseases
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/yir-2023-lrs-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>2023 Year-In-Review</p><p>Special Guests: Jacquelyn Crawford, PharmD @jacuronium</p><p>Kathleen Hartman, PharmD @HartKate8</p><p> </p><p>04:30 – Neurology</p><p>11:05 – Cardiology</p><p>18:50 – Cardiac Arrest</p><p>26:30 – Pulmonary</p><p>35:00 – Sepsis</p><p>44:05 – Endocrine/Renal</p><p>52:30 – Trauma</p><p>61:05 – Infectious Diseases</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/06/yir-2023-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/06/yir-2023-lrs-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4391</itunes:duration>
      <guid isPermaLink="false"><![CDATA[5a674dce-2403-11ef-9119-0f1f30c55cb5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8748212721.mp3?updated=1717680302" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Ketamine for EM Agitation</title>
      <description>Trial of the Week: Ketamine for EM Agitation
Special Guest: Justin Lin, PharmD, BCPS, BCCCP @jjlinpharmd 
 
Justin Lin joins to review the May Trial of the Week “Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study” published in the American Journal of Emergency Medicine in 2021. 
We set the scene by discussing how this research idea started, review the classic agitation presentation at his institution, and highlight evidence comparing pharmacotherapy treatment options prior to this study. Then we dive into the Trial of the Week, discussing the study design and results. What was the biggest pushback from providers or the IRB? Any unique education strategies? Would results stay the same with increased IV push administration? What would the comparator arm be if this study was replicated today? Plus, the most challenging part of this project, Justin’s favorite agent, and so much more. 
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/05/ketamine-for-em-agitation-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 30 May 2024 15:13:39 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/783894aa-1e97-11ef-8912-3bd5b6621048/image/11cf9a6c84c067140f64589a3a7808da.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Justin Lin highlights his research study, Efficacy of Ketamine for Acute Agitation in the Emergency Department, in this May Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: Ketamine for EM Agitation
Special Guest: Justin Lin, PharmD, BCPS, BCCCP @jjlinpharmd 
 
Justin Lin joins to review the May Trial of the Week “Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study” published in the American Journal of Emergency Medicine in 2021. 
We set the scene by discussing how this research idea started, review the classic agitation presentation at his institution, and highlight evidence comparing pharmacotherapy treatment options prior to this study. Then we dive into the Trial of the Week, discussing the study design and results. What was the biggest pushback from providers or the IRB? Any unique education strategies? Would results stay the same with increased IV push administration? What would the comparator arm be if this study was replicated today? Plus, the most challenging part of this project, Justin’s favorite agent, and so much more. 
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/05/ketamine-for-em-agitation-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Ketamine for EM Agitation</p><p>Special Guest: Justin Lin, PharmD, BCPS, BCCCP @jjlinpharmd </p><p> </p><p>Justin Lin joins to review the May Trial of the Week “Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study” published in the American Journal of Emergency Medicine in 2021. </p><p>We set the scene by discussing how this research idea started, review the classic agitation presentation at his institution, and highlight evidence comparing pharmacotherapy treatment options prior to this study. Then we dive into the Trial of the Week, discussing the study design and results. What was the biggest pushback from providers or the IRB? Any unique education strategies? Would results stay the same with increased IV push administration? What would the comparator arm be if this study was replicated today? Plus, the most challenging part of this project, Justin’s favorite agent, and so much more. </p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/05/ketamine-for-em-agitation-trial-of-the-week-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/05/ketamine-for-em-agitation-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2638</itunes:duration>
      <guid isPermaLink="false"><![CDATA[783894aa-1e97-11ef-8912-3bd5b6621048]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6657126425.mp3?updated=1717083537" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Sanford Guide Q&amp;A</title>
      <description>Sanford Guide Q&amp;A
Special Guest: Doug Black, PharmD
 
04:40 – Doug’s background/Sanford guide introduction
14:20 – Print v. digital guide/included content
34:35 – Tables/tools highlights
41:55 – Doug’s favorites/conclusions
 
Sanford Guide Website: https://web.sanfordguide.com/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 28 May 2024 09:36:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/77154c36-1cd9-11ef-b3b3-f7b9ab510ee3/image/d5b9931a7a9dc1824bb065c0c0edf17c.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Doug Black, Pharmacist contributing editor to the Sanford Guide, joins to take a deep dive into this tremendous infectious diseases resource. </itunes:subtitle>
      <itunes:summary>Sanford Guide Q&amp;A
Special Guest: Doug Black, PharmD
 
04:40 – Doug’s background/Sanford guide introduction
14:20 – Print v. digital guide/included content
34:35 – Tables/tools highlights
41:55 – Doug’s favorites/conclusions
 
Sanford Guide Website: https://web.sanfordguide.com/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Sanford Guide Q&amp;A</p><p>Special Guest: Doug Black, PharmD</p><p> </p><p>04:40 – Doug’s background/Sanford guide introduction</p><p>14:20 – Print v. digital guide/included content</p><p>34:35 – Tables/tools highlights</p><p>41:55 – Doug’s favorites/conclusions</p><p> </p><p>Sanford Guide Website: <a href="https://web.sanfordguide.com/">https://web.sanfordguide.com/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3713</itunes:duration>
      <guid isPermaLink="false"><![CDATA[77154c36-1cd9-11ef-b3b3-f7b9ab510ee3]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6575867378.mp3?updated=1716892119" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Code ICH</title>
      <description>Code ICH
Special Guest: Gabe Fontaine, PharmD, MBA, BCPS, BCCCP, FNCS, FCCM @gabe_fontaine
 
04:00 – Code ICH and history of ICU bundled care
15:15 – BP control
22:50 – Hemostasis
33:15 – Challenges &amp; future directions
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/05/code-ich-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 23 May 2024 04:55:25 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/e18ed708-18c4-11ef-88e6-7ba7053a3ddf/image/39741e788f72376f19f20f573486ad52.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Gabe Fontaine joins to highlight Code ICH, a new bundle-based approach for ICH patients. </itunes:subtitle>
      <itunes:summary>Code ICH
Special Guest: Gabe Fontaine, PharmD, MBA, BCPS, BCCCP, FNCS, FCCM @gabe_fontaine
 
04:00 – Code ICH and history of ICU bundled care
15:15 – BP control
22:50 – Hemostasis
33:15 – Challenges &amp; future directions
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/05/code-ich-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Code ICH</p><p>Special Guest: Gabe Fontaine, PharmD, MBA, BCPS, BCCCP, FNCS, FCCM @gabe_fontaine</p><p> </p><p>04:00 – Code ICH and history of ICU bundled care</p><p>15:15 – BP control</p><p>22:50 – Hemostasis</p><p>33:15 – Challenges &amp; future directions</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/05/code-ich-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/05/code-ich-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2768</itunes:duration>
      <guid isPermaLink="false"><![CDATA[e18ed708-18c4-11ef-88e6-7ba7053a3ddf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4728433372.mp3?updated=1716443655" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: MENDS2</title>
      <description>Trial of the Week: MENDS2
Special Guest: John Devlin, PharmD, BCCCP, MCCM, FCCP @devlinpharmd
 
03:20 – PADIS background and research introduction
35:25 – MENDS2 discussion
 
John Devlin joins to review the May Trial of the Week “Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis” the MENDS2 study, published in NEJM in 2021.
We set the scene by discussing how John developed an interest with PADIS research, discussing PK/PD sedative properties and considerations, landmark trials prior to MENDS2, and how much background work is required for a large RCT.
Then we dive into the MENDS2 trial itself. Any significant findings? Biggest methodologic differences from MENDS2 and previous studies? Most challenging process of blinding? Any potential safety concerns? How to avoid unblinding study patients (and why that’s so important)? Plus, trial fun facts, seeing your name in a NEJM research article, applying MENDS2 findings into daily practice, and so much more.
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/05/mends2-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 21 May 2024 12:37:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/6867f9e8-1772-11ef-b1f4-af7187b42b3a/image/74c5bd584b8d62c7dee5b05c44a93e69.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>John Devlin highlights the MENDS2 study in this May Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: MENDS2
Special Guest: John Devlin, PharmD, BCCCP, MCCM, FCCP @devlinpharmd
 
03:20 – PADIS background and research introduction
35:25 – MENDS2 discussion
 
John Devlin joins to review the May Trial of the Week “Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis” the MENDS2 study, published in NEJM in 2021.
We set the scene by discussing how John developed an interest with PADIS research, discussing PK/PD sedative properties and considerations, landmark trials prior to MENDS2, and how much background work is required for a large RCT.
Then we dive into the MENDS2 trial itself. Any significant findings? Biggest methodologic differences from MENDS2 and previous studies? Most challenging process of blinding? Any potential safety concerns? How to avoid unblinding study patients (and why that’s so important)? Plus, trial fun facts, seeing your name in a NEJM research article, applying MENDS2 findings into daily practice, and so much more.
 
Reference list: https://pharmacytodose.com/wp-content/uploads/2024/05/mends2-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: MENDS2</p><p>Special Guest: John Devlin, PharmD, BCCCP, MCCM, FCCP @devlinpharmd</p><p> </p><p>03:20 – PADIS background and research introduction</p><p>35:25 – MENDS2 discussion</p><p> </p><p>John Devlin joins to review the May Trial of the Week “Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis” the MENDS2 study, published in NEJM in 2021.</p><p>We set the scene by discussing how John developed an interest with PADIS research, discussing PK/PD sedative properties and considerations, landmark trials prior to MENDS2, and how much background work is required for a large RCT.</p><p>Then we dive into the MENDS2 trial itself. Any significant findings? Biggest methodologic differences from MENDS2 and previous studies? Most challenging process of blinding? Any potential safety concerns? How to avoid unblinding study patients (and why that’s so important)? Plus, trial fun facts, seeing your name in a NEJM research article, applying MENDS2 findings into daily practice, and so much more.</p><p> </p><p>Reference list: <a href="https://pharmacytodose.com/wp-content/uploads/2024/05/mends2-trial-of-the-week-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/05/mends2-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4539</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6867f9e8-1772-11ef-b1f4-af7187b42b3a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3795980019.mp3?updated=1716298606" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: ANNEXA-I</title>
      <description>Rapid Reaction: ANNEXA-I
 
02:35 – Study design/results
18:30 – Considerations/questions
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/annexa-i-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 16 May 2024 21:21:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick reviews the recently released ANNEXA-I study, researching andexanet alfa use in ICH patients, for this rapid reaction episode.</itunes:subtitle>
      <itunes:summary>Rapid Reaction: ANNEXA-I
 
02:35 – Study design/results
18:30 – Considerations/questions
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/annexa-i-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: ANNEXA-I</p><p> </p><p>02:35 – Study design/results</p><p>18:30 – Considerations/questions</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/05/annexa-i-references.pdf">https://pharmacytodose.files.wordpress.com/2024/05/annexa-i-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1970</itunes:duration>
      <guid isPermaLink="false"><![CDATA[539d3e74-13cb-11ef-95cd-9f4f11f556bd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2547681047.mp3?updated=1715895248" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: DESIRE &amp; In-Flight Medical Emergencies</title>
      <description>Trial of the Week: DESIRE &amp; In-Flight Medical Emergencies References
Special Guests: Jim Miller, PharmD, BCCCP @millerjtm
Michael Liu, PharmD, MBA, BCCCP, BCNSP, BCPS
 
04:05 – DESIRE trial
31:15 – In-flight medical emergencies
 
The episode starts off with special guest, Jim Miller, helping review the DESIRE study as a Trial of the Week.
We set the scene reviewing dexmedetomidine pharmacokinetic advantages and landmark dexmedetomidine research. Then we highlight the DESIRE trial itself discussing the study methodology and results. What was considered usual care with regards to sedation? What is the external validity in this trial? What was the effect of changing the primary outcome measure mid-study? Are there anti-inflammatory properties with dexmedetomidine? What did Jim’s novel research show? What would Jim and I want for sedation if mechanically ventilated? And much more.
 
Then the episode closes with Michael Liu highlighting his experience assisting with an in-flight medical emergency.
We review his AJHP article describing his experience. Was this his first time in this situation? Biggest difference between in-hospital and out-of-hospital emergency response? What advice would he give others? And so much more.
 
Reference list: https://pharmacytodose.files.wordpress.com/2024/05/desire-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 14 May 2024 08:27:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/f7f8e6c8-11cb-11ef-a46e-37bf80194384/image/8ba991860865724fd232027952fb1b9d.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Jim Miller highlights the DESIRE study as a Trial of the Week, before Michael Liu highlights his experience and advice with in-flight medical emergencies.  </itunes:subtitle>
      <itunes:summary>Trial of the Week: DESIRE &amp; In-Flight Medical Emergencies References
Special Guests: Jim Miller, PharmD, BCCCP @millerjtm
Michael Liu, PharmD, MBA, BCCCP, BCNSP, BCPS
 
04:05 – DESIRE trial
31:15 – In-flight medical emergencies
 
The episode starts off with special guest, Jim Miller, helping review the DESIRE study as a Trial of the Week.
We set the scene reviewing dexmedetomidine pharmacokinetic advantages and landmark dexmedetomidine research. Then we highlight the DESIRE trial itself discussing the study methodology and results. What was considered usual care with regards to sedation? What is the external validity in this trial? What was the effect of changing the primary outcome measure mid-study? Are there anti-inflammatory properties with dexmedetomidine? What did Jim’s novel research show? What would Jim and I want for sedation if mechanically ventilated? And much more.
 
Then the episode closes with Michael Liu highlighting his experience assisting with an in-flight medical emergency.
We review his AJHP article describing his experience. Was this his first time in this situation? Biggest difference between in-hospital and out-of-hospital emergency response? What advice would he give others? And so much more.
 
Reference list: https://pharmacytodose.files.wordpress.com/2024/05/desire-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: DESIRE &amp; In-Flight Medical Emergencies References</p><p>Special Guests: Jim Miller, PharmD, BCCCP @millerjtm</p><p>Michael Liu, PharmD, MBA, BCCCP, BCNSP, BCPS</p><p> </p><p>04:05 – DESIRE trial</p><p>31:15 – In-flight medical emergencies</p><p> </p><p>The episode starts off with special guest, Jim Miller, helping review the DESIRE study as a Trial of the Week.</p><p>We set the scene reviewing dexmedetomidine pharmacokinetic advantages and landmark dexmedetomidine research. Then we highlight the DESIRE trial itself discussing the study methodology and results. What was considered usual care with regards to sedation? What is the external validity in this trial? What was the effect of changing the primary outcome measure mid-study? Are there anti-inflammatory properties with dexmedetomidine? What did Jim’s novel research show? What would Jim and I want for sedation if mechanically ventilated? And much more.</p><p> </p><p>Then the episode closes with Michael Liu highlighting his experience assisting with an in-flight medical emergency.</p><p>We review his AJHP article describing his experience. Was this his first time in this situation? Biggest difference between in-hospital and out-of-hospital emergency response? What advice would he give others? And so much more.</p><p> </p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2024/05/desire-trial-of-the-week-references.pdf">https://pharmacytodose.files.wordpress.com/2024/05/desire-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3194</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f7f8e6c8-11cb-11ef-a46e-37bf80194384]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3642813892.mp3?updated=1715676930" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>December 2023 Literature Review Series</title>
      <description>December 2023 Literature Review Series
Special Guests: Jenna Self, PharmD
Hannah Millard, PharmD
 
04:30 – Featured Articles
38:45 – Cardiology
49:30 – Potpourri
53:20 – Sepsis
60:00 – PharmD
65:00 – Sweet Emotion
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/05/december-2023-lrs-references.pdf

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 09 May 2024 18:38:01 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Jenna Self and Hannah Millard help highlight some of the best and most notable articles published in December 2023. </itunes:subtitle>
      <itunes:summary>December 2023 Literature Review Series
Special Guests: Jenna Self, PharmD
Hannah Millard, PharmD
 
04:30 – Featured Articles
38:45 – Cardiology
49:30 – Potpourri
53:20 – Sepsis
60:00 – PharmD
65:00 – Sweet Emotion
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/05/december-2023-lrs-references.pdf

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>December 2023 Literature Review Series</p><p>Special Guests: Jenna Self, PharmD</p><p>Hannah Millard, PharmD</p><p> </p><p>04:30 – Featured Articles</p><p>38:45 – Cardiology</p><p>49:30 – Potpourri</p><p>53:20 – Sepsis</p><p>60:00 – PharmD</p><p>65:00 – Sweet Emotion</p><p> </p><p>Reference List: <a href="https://pharmacytodose.com/wp-content/uploads/2024/05/december-2023-lrs-references.pdf">https://pharmacytodose.com/wp-content/uploads/2024/05/december-2023-lrs-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4292</itunes:duration>
      <guid isPermaLink="false"><![CDATA[469a30bc-0e33-11ef-a3b3-ab68150ac181]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7464235915.mp3?updated=1715282072" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ACC 2024 Rapid Reaction: Part II</title>
      <description>ACC 2024 Rapid Reaction: Part II
Special Guest: Snehal Bhatt, PharmD, BCPS, FASHP, AACC @SnayCardsPharmD
 
04:05 – EMPACT-MI
29:35 – ULTIMATE-DAPT
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 08 May 2024 01:55:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Snehal Bhatt helps review EMPACT-MI and ULTIMATE-DAPT in Part 2 of the 2-part ACC 2024 rapid reaction episode series. </itunes:subtitle>
      <itunes:summary>ACC 2024 Rapid Reaction: Part II
Special Guest: Snehal Bhatt, PharmD, BCPS, FASHP, AACC @SnayCardsPharmD
 
04:05 – EMPACT-MI
29:35 – ULTIMATE-DAPT
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ACC 2024 Rapid Reaction: Part II</p><p>Special Guest: Snehal Bhatt, PharmD, BCPS, FASHP, AACC @SnayCardsPharmD</p><p> </p><p>04:05 – EMPACT-MI</p><p>29:35 – ULTIMATE-DAPT</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3756</itunes:duration>
      <guid isPermaLink="false"><![CDATA[192647f2-0cde-11ef-91e0-3f3b8c92f2e5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1929152435.mp3?updated=1715135552" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ACC 2024 Rapid Reaction: Part I</title>
      <description>ACC 2024 Rapid Reaction: Part I
Special Guest: Ryan Caputo, PharmD, BCCP @RyanCaputo1
 
04:05 – DanGer Shock
29:15 – REDUCE-AMI
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-i-references-1.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 06 May 2024 22:20:06 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Ryan Caputo joins me to highlight 2 of the most practice-changing research studies, DanGer Shock and REDUCE-AMI, published during ACC 2024 in Part 1 of the 2-part rapid reaction episode series. </itunes:subtitle>
      <itunes:summary>ACC 2024 Rapid Reaction: Part I
Special Guest: Ryan Caputo, PharmD, BCCP @RyanCaputo1
 
04:05 – DanGer Shock
29:15 – REDUCE-AMI
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-i-references-1.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ACC 2024 Rapid Reaction: Part I</p><p>Special Guest: Ryan Caputo, PharmD, BCCP @RyanCaputo1</p><p> </p><p>04:05 – DanGer Shock</p><p>29:15 – REDUCE-AMI</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-i-references-1.pdf">https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-i-references-1.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2814</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d808ba1c-0bf6-11ef-bb12-9b60db106c4e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7621650364.mp3?updated=1715034763" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>RSI: Part II</title>
      <description>Rapid Sequence Intubation (RSI): Part II
Special Guest: Christine Groth, PharmD, FCCM, BCCCP @GrothChristine
Angela Slampak-Cindric, PharmD, BCPS, BCCCP, FCCM @AngelaSlampak
Kevin Kaucher, PharmD, BCCCP
 
04:05 – Guideline development/involvement
12:50 – 2024 guideline overview
25:10 – Pharmacotherapy recommendations/considerations
42:40 – Non-pharmacologic recommendations/guideline insights
70:30 – Research ideas/conclusions
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/rsi-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 03 May 2024 02:46:28 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Kevin Kaucher, Angela Slampak-Cindric, and Christine Groth join me to help highlight the 2024 SCCM RSI guidelines and share their insight as panel members.</itunes:subtitle>
      <itunes:summary>Rapid Sequence Intubation (RSI): Part II
Special Guest: Christine Groth, PharmD, FCCM, BCCCP @GrothChristine
Angela Slampak-Cindric, PharmD, BCPS, BCCCP, FCCM @AngelaSlampak
Kevin Kaucher, PharmD, BCCCP
 
04:05 – Guideline development/involvement
12:50 – 2024 guideline overview
25:10 – Pharmacotherapy recommendations/considerations
42:40 – Non-pharmacologic recommendations/guideline insights
70:30 – Research ideas/conclusions
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/rsi-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Sequence Intubation (RSI): Part II</p><p>Special Guest: Christine Groth, PharmD, FCCM, BCCCP @GrothChristine</p><p>Angela Slampak-Cindric, PharmD, BCPS, BCCCP, FCCM @AngelaSlampak</p><p>Kevin Kaucher, PharmD, BCCCP</p><p> </p><p>04:05 – Guideline development/involvement</p><p>12:50 – 2024 guideline overview</p><p>25:10 – Pharmacotherapy recommendations/considerations</p><p>42:40 – Non-pharmacologic recommendations/guideline insights</p><p>70:30 – Research ideas/conclusions</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/05/rsi-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2024/05/rsi-part-ii-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5168</itunes:duration>
      <guid isPermaLink="false"><![CDATA[5b21da12-08f7-11ef-b0de-cbafdefee6b2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4292822747.mp3?updated=1714705383" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: ESETT</title>
      <description>Trial of the Week: ESETT
Special Guest: Ashley McCormick, PharmD, BCPS, BCCCP 
 
Ashley McCormick joins to discuss the April Trial of the Week “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus” the ESETT study, published in NEJM in 2019. 
We set the scene by reviewing ASM PK/PD properties and discussing if there was a standard of care first-line treatment. Then we do a deep dive into the ESETT trial of the week. Did the 75kg dose cap influence results? How appropriate was the BZD dosing? How does this % of seizure cessation compare to other studies? Where did this dosing scheme come from? Trial fun facts, medication safety considerations, and much, much more. 
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/esett-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 30 Apr 2024 20:41:35 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Ashley McCormick highlights the ESETT study in this April Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: ESETT
Special Guest: Ashley McCormick, PharmD, BCPS, BCCCP 
 
Ashley McCormick joins to discuss the April Trial of the Week “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus” the ESETT study, published in NEJM in 2019. 
We set the scene by reviewing ASM PK/PD properties and discussing if there was a standard of care first-line treatment. Then we do a deep dive into the ESETT trial of the week. Did the 75kg dose cap influence results? How appropriate was the BZD dosing? How does this % of seizure cessation compare to other studies? Where did this dosing scheme come from? Trial fun facts, medication safety considerations, and much, much more. 
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/esett-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: ESETT</p><p>Special Guest: Ashley McCormick, PharmD, BCPS, BCCCP </p><p> </p><p>Ashley McCormick joins to discuss the April Trial of the Week “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus” the ESETT study, published in NEJM in 2019. </p><p>We set the scene by reviewing ASM PK/PD properties and discussing if there was a standard of care first-line treatment. Then we do a deep dive into the ESETT trial of the week. Did the 75kg dose cap influence results? How appropriate was the BZD dosing? How does this % of seizure cessation compare to other studies? Where did this dosing scheme come from? Trial fun facts, medication safety considerations, and much, much more. </p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2024/04/esett-trial-of-the-week-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/esett-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3226</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2cca381a-0732-11ef-a47b-2b2663d4d6e0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4028686472.mp3?updated=1714510560" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Thrombolytic Dosing in PE: Versus Series</title>
      <description>Thrombolytic Dosing in PE: Versus Series
Special Guest: Lauren Igneri, PharmD, BCPS, BCCCP, FCCM
 
05:20 – High-risk PE
23:00 – Intermediate-risk
37:10 – Cardiac arrest
52:30 – Closing arguments
57:15 – Bonus: TNK v. tPA
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/thrombolytic-dosing-in-pe-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 25 Apr 2024 11:10:28 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Lauren Igneri and I debate “Thrombolytic Dosing in PE,” as part of the Versus series.</itunes:subtitle>
      <itunes:summary>Thrombolytic Dosing in PE: Versus Series
Special Guest: Lauren Igneri, PharmD, BCPS, BCCCP, FCCM
 
05:20 – High-risk PE
23:00 – Intermediate-risk
37:10 – Cardiac arrest
52:30 – Closing arguments
57:15 – Bonus: TNK v. tPA
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/thrombolytic-dosing-in-pe-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Thrombolytic Dosing in PE: Versus Series</p><p>Special Guest: Lauren Igneri, PharmD, BCPS, BCCCP, FCCM</p><p> </p><p>05:20 – High-risk PE</p><p>23:00 – Intermediate-risk</p><p>37:10 – Cardiac arrest</p><p>52:30 – Closing arguments</p><p>57:15 – Bonus: TNK v. tPA</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/04/thrombolytic-dosing-in-pe-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/thrombolytic-dosing-in-pe-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4247</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6f6bb1ae-02f4-11ef-8aee-8f9f2ca0d259]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5250744042.mp3?updated=1714044401" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: SEPSISPAM</title>
      <description>Trial of the Week: SEPSISPAM
Special Guest: Katherine Spezzano, PharmD, MBA, BCCCP @KatSpazPharmD
 
Katherine Spezzano joins to discuss the April Trial of the Week “High versus Low Blood-Pressure Target in Patients with Septic Shock” the SEPSISPAM study, published in NEJM in 2014. 
We set the scene by reviewing the concept of autoregulation, guideline recommendations, and pre-SEPSISPAM research assessing BP goals in sepsis. Then we do a deep dive into the SEPSISPAM trial of the week. Would we see these same results with other vasopressors? Did each group meet their BP goal range? How do we balance AKI prevention and longer ICU LOS? What do our guidelines recommend now? Trial fun facts, alternate trial acronym ideas, and much more! 
 
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/sepsispam-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 23 Apr 2024 16:11:03 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Katherine Spezzano highlights the SEPSISPAM study in this April Trial of the Week.</itunes:subtitle>
      <itunes:summary>Trial of the Week: SEPSISPAM
Special Guest: Katherine Spezzano, PharmD, MBA, BCCCP @KatSpazPharmD
 
Katherine Spezzano joins to discuss the April Trial of the Week “High versus Low Blood-Pressure Target in Patients with Septic Shock” the SEPSISPAM study, published in NEJM in 2014. 
We set the scene by reviewing the concept of autoregulation, guideline recommendations, and pre-SEPSISPAM research assessing BP goals in sepsis. Then we do a deep dive into the SEPSISPAM trial of the week. Would we see these same results with other vasopressors? Did each group meet their BP goal range? How do we balance AKI prevention and longer ICU LOS? What do our guidelines recommend now? Trial fun facts, alternate trial acronym ideas, and much more! 
 
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/sepsispam-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: SEPSISPAM</p><p>Special Guest: Katherine Spezzano, PharmD, MBA, BCCCP @KatSpazPharmD</p><p> </p><p>Katherine Spezzano joins to discuss the April Trial of the Week “High versus Low Blood-Pressure Target in Patients with Septic Shock” the SEPSISPAM study, published in NEJM in 2014. </p><p>We set the scene by reviewing the concept of autoregulation, guideline recommendations, and pre-SEPSISPAM research assessing BP goals in sepsis. Then we do a deep dive into the SEPSISPAM trial of the week. Would we see these same results with other vasopressors? Did each group meet their BP goal range? How do we balance AKI prevention and longer ICU LOS? What do our guidelines recommend now? Trial fun facts, alternate trial acronym ideas, and much more! </p><p> </p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2024/04/sepsispam-trial-of-the-week-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/sepsispam-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2411</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1ab02320-018c-11ef-9cca-1b21a4ecccfc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7955020389.mp3?updated=1713889294" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Glycemic Control in the Critically Ill: Part II</title>
      <description>Glycemic Control in the Critically Ill: Part II
Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP @JudiJacobi
Michael Sirimaturos, PharmD, BCNSP, BCCCP, FCCM @MSirimaturos
 
04:10 – Becoming panel members
11:50 – Guideline scope and PICO questions
21:35 – 2012 v. 2024 guidelines
28:05 – Effect of TGC-FAST
30:40 – 2024 guideline deep-dive
42:00 – Clinical decision support tools
50:00 – Pediatric recommendations
54:40 – Important future research topics
66:05 – Guideline manuscript writing
76:10 – Take-home points
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/glycemic-control-in-the-icu-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 19 Apr 2024 04:21:10 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Judi Jacobi and Michael Sirimaturos, 2 Pharmacist panel members, review the 2024 SCCM Glycemic Control for Critically Ill Children and Adult Guidelines.  </itunes:subtitle>
      <itunes:summary>Glycemic Control in the Critically Ill: Part II
Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP @JudiJacobi
Michael Sirimaturos, PharmD, BCNSP, BCCCP, FCCM @MSirimaturos
 
04:10 – Becoming panel members
11:50 – Guideline scope and PICO questions
21:35 – 2012 v. 2024 guidelines
28:05 – Effect of TGC-FAST
30:40 – 2024 guideline deep-dive
42:00 – Clinical decision support tools
50:00 – Pediatric recommendations
54:40 – Important future research topics
66:05 – Guideline manuscript writing
76:10 – Take-home points
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/glycemic-control-in-the-icu-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Glycemic Control in the Critically Ill: Part II</p><p>Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP @JudiJacobi</p><p>Michael Sirimaturos, PharmD, BCNSP, BCCCP, FCCM @MSirimaturos</p><p> </p><p>04:10 – Becoming panel members</p><p>11:50 – Guideline scope and PICO questions</p><p>21:35 – 2012 v. 2024 guidelines</p><p>28:05 – Effect of TGC-FAST</p><p>30:40 – 2024 guideline deep-dive</p><p>42:00 – Clinical decision support tools</p><p>50:00 – Pediatric recommendations</p><p>54:40 – Important future research topics</p><p>66:05 – Guideline manuscript writing</p><p>76:10 – Take-home points</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/04/glycemic-control-in-the-icu-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/glycemic-control-in-the-icu-part-ii-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5145</itunes:duration>
      <guid isPermaLink="false"><![CDATA[0328d2f0-fe04-11ee-91bc-0f0e257d9dfc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1199166479.mp3?updated=1713501324" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>November 2023 Literature Review Series</title>
      <description>Literature Review Series
November 2023
Special Guests: Arjay Mendoza, PharmD, BCPS, AAHIVP
Brock Townsend, PharmD @Townsend_PharmD
 
04:30 – Featured Articles
35:25 – Cardiology
48:05 – Precision-based medicine potpourri
58:50 – Infectious Diseases
69:10 – PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/november-lrs-2023-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 17 Apr 2024 05:52:11 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brock Townsend and Arjay Mendoza join me to highlight some of the most pertinent articles and research published in November 2023. </itunes:subtitle>
      <itunes:summary>Literature Review Series
November 2023
Special Guests: Arjay Mendoza, PharmD, BCPS, AAHIVP
Brock Townsend, PharmD @Townsend_PharmD
 
04:30 – Featured Articles
35:25 – Cardiology
48:05 – Precision-based medicine potpourri
58:50 – Infectious Diseases
69:10 – PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/november-lrs-2023-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>November 2023</p><p>Special Guests: Arjay Mendoza, PharmD, BCPS, AAHIVP</p><p>Brock Townsend, PharmD @Townsend_PharmD</p><p> </p><p>04:30 – Featured Articles</p><p>35:25 – Cardiology</p><p>48:05 – Precision-based medicine potpourri</p><p>58:50 – Infectious Diseases</p><p>69:10 – PharmD</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/04/november-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/november-lrs-2023-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4847</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a7a62bf2-fc7e-11ee-bfe9-bf800958b1b7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6191819994.mp3?updated=1713334076" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: SOAP II</title>
      <description>Trial of the Week: SOAP II
Special Guest: Jessica Casey, PharmD, BCPS, BCCP @jmc_cardspharmd
 
Jessica Casey joins to discuss the April Trial of the Week “Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” the SOAP II study, published in NEJM in 2010. 
We set the scene by reviewing catecholamine vasopressor receptor physiology, guideline recommendations, and pre-SOAP II research. Then we do a deep dive into the SOAP II trial of the week. Did including all forms of shock help or hurt? How does the mortality in this study compare with others? Would this have been as positive of a study in 2024? What do the guidelines recommend now? Is dopamine dead? Will anyone take norepinephrine’s throne? Jessica and I review trial fun facts, stand-out supplementary materials, and much, much more. 
 
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/soap-ii-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 09 Apr 2024 16:33:31 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Jessica Casey discusses the April Trial of the Week, SOAP II.</itunes:subtitle>
      <itunes:summary>Trial of the Week: SOAP II
Special Guest: Jessica Casey, PharmD, BCPS, BCCP @jmc_cardspharmd
 
Jessica Casey joins to discuss the April Trial of the Week “Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” the SOAP II study, published in NEJM in 2010. 
We set the scene by reviewing catecholamine vasopressor receptor physiology, guideline recommendations, and pre-SOAP II research. Then we do a deep dive into the SOAP II trial of the week. Did including all forms of shock help or hurt? How does the mortality in this study compare with others? Would this have been as positive of a study in 2024? What do the guidelines recommend now? Is dopamine dead? Will anyone take norepinephrine’s throne? Jessica and I review trial fun facts, stand-out supplementary materials, and much, much more. 
 
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/soap-ii-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: SOAP II</p><p>Special Guest: Jessica Casey, PharmD, BCPS, BCCP @jmc_cardspharmd</p><p> </p><p>Jessica Casey joins to discuss the April Trial of the Week “Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” the SOAP II study, published in NEJM in 2010. </p><p>We set the scene by reviewing catecholamine vasopressor receptor physiology, guideline recommendations, and pre-SOAP II research. Then we do a deep dive into the SOAP II trial of the week. Did including all forms of shock help or hurt? How does the mortality in this study compare with others? Would this have been as positive of a study in 2024? What do the guidelines recommend now? Is dopamine dead? Will anyone take norepinephrine’s throne? Jessica and I review trial fun facts, stand-out supplementary materials, and much, much more. </p><p> </p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2024/04/soap-ii-trial-of-the-week-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/soap-ii-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3572</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1fc3ef5c-f68f-11ee-bb29-53d85a1c298e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1341001685.mp3?updated=1712682278" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trials of the Week: Nimodipine Landmark Studies</title>
      <description>Trials of the Week: Landmark Nimodipine Studies
Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS @salia_farrokh
 
Salia Farrokh joins to highlight two landmark studies with nimodipine, “Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage” published in NEJM in 1983 and “Effect of Oral Nimodipine on Cerebral Infarction and Outcome after Subarachnoid Hemorrhage: British Aneurysm Nimodipine Trial” published in 1989 in BMJ.
We review aSAH treatments in the 1970’s and 1980’s and what evidence existed for nimodipine use before highlighting our two trials of the week. How does the study methodology compare from then to now? Where did our nimodipine dosing regimen come from? Is the term cerebral artery vasospasm out of date? Is it still appropriate to use evidence from the 1980’s in the 2020’s? Is there more to research with respect to nimodipine? What to do with missed nimodipine doses? We do a deep dive into all things nimodipine for aSAH, discussing the above and much more. 
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/04/nimodipine-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 05 Apr 2024 17:46:08 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Salia Farrokh joins to highlight two landmark articles researching the use of nimoodipine in aneurysmal subarachnoid hemorrhage.</itunes:subtitle>
      <itunes:summary>Trials of the Week: Landmark Nimodipine Studies
Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS @salia_farrokh
 
Salia Farrokh joins to highlight two landmark studies with nimodipine, “Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage” published in NEJM in 1983 and “Effect of Oral Nimodipine on Cerebral Infarction and Outcome after Subarachnoid Hemorrhage: British Aneurysm Nimodipine Trial” published in 1989 in BMJ.
We review aSAH treatments in the 1970’s and 1980’s and what evidence existed for nimodipine use before highlighting our two trials of the week. How does the study methodology compare from then to now? Where did our nimodipine dosing regimen come from? Is the term cerebral artery vasospasm out of date? Is it still appropriate to use evidence from the 1980’s in the 2020’s? Is there more to research with respect to nimodipine? What to do with missed nimodipine doses? We do a deep dive into all things nimodipine for aSAH, discussing the above and much more. 
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/04/nimodipine-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trials of the Week: Landmark Nimodipine Studies</p><p>Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS @salia_farrokh</p><p> </p><p>Salia Farrokh joins to highlight two landmark studies with nimodipine, “Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage” published in NEJM in 1983 and “Effect of Oral Nimodipine on Cerebral Infarction and Outcome after Subarachnoid Hemorrhage: British Aneurysm Nimodipine Trial” published in 1989 in BMJ.</p><p>We review aSAH treatments in the 1970’s and 1980’s and what evidence existed for nimodipine use before highlighting our two trials of the week. How does the study methodology compare from then to now? Where did our nimodipine dosing regimen come from? Is the term cerebral artery vasospasm out of date? Is it still appropriate to use evidence from the 1980’s in the 2020’s? Is there more to research with respect to nimodipine? What to do with missed nimodipine doses? We do a deep dive into all things nimodipine for aSAH, discussing the above and much more. </p><p> </p><p>Reference list:  <a href="https://pharmacytodose.files.wordpress.com/2024/04/nimodipine-trial-of-the-week-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/nimodipine-trial-of-the-week-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2815</itunes:duration>
      <guid isPermaLink="false"><![CDATA[902274da-f374-11ee-8a12-6fea9d10e1e1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4639155669.mp3?updated=1712340093" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Norepinephrine Position Paper and Sepsis Research Priorities</title>
      <description>Norepinephrine Position Paper and Sepsis Research Priorities
Special Guests: Brittany Bissell Turpin, PharmD, PhD, FCCM, BCCCP @BissellBrittany
Patrick Wieruszewski, PharmD, BCCCP @pwierusz
Seth Bauer, PharmD, FCCM, FCCP, BCCCP @SethRBauer
 
07:30 – Norepinephrine position paper introduction
11:35 – When did we realize this and what are the implications?
36:00 – Key task force take-aways
51:00 – SSC Research Committee history
56:00 – Submitting and ranking research questions
27:00 – Top 5 clinical sepsis research priorities
62:00 – Basic science priorities
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/norepi-position-paper-and-sepsis-research-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 03 Apr 2024 04:27:39 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brittany Bissell Turpin and Patrick Wieruszewski highlight their Task Force work on the Norepinephrine Position Paper and Seth Bauer reviews the 2023 Surviving Sepsis Campaign research priorities. </itunes:subtitle>
      <itunes:summary>Norepinephrine Position Paper and Sepsis Research Priorities
Special Guests: Brittany Bissell Turpin, PharmD, PhD, FCCM, BCCCP @BissellBrittany
Patrick Wieruszewski, PharmD, BCCCP @pwierusz
Seth Bauer, PharmD, FCCM, FCCP, BCCCP @SethRBauer
 
07:30 – Norepinephrine position paper introduction
11:35 – When did we realize this and what are the implications?
36:00 – Key task force take-aways
51:00 – SSC Research Committee history
56:00 – Submitting and ranking research questions
27:00 – Top 5 clinical sepsis research priorities
62:00 – Basic science priorities
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/norepi-position-paper-and-sepsis-research-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Norepinephrine Position Paper and Sepsis Research Priorities</p><p>Special Guests: Brittany Bissell Turpin, PharmD, PhD, FCCM, BCCCP @BissellBrittany</p><p>Patrick Wieruszewski, PharmD, BCCCP @pwierusz</p><p>Seth Bauer, PharmD, FCCM, FCCP, BCCCP @SethRBauer</p><p> </p><p>07:30 – Norepinephrine position paper introduction</p><p>11:35 – When did we realize this and what are the implications?</p><p>36:00 – Key task force take-aways</p><p>51:00 – SSC Research Committee history</p><p>56:00 – Submitting and ranking research questions</p><p>27:00 – Top 5 clinical sepsis research priorities</p><p>62:00 – Basic science priorities</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/04/norepi-position-paper-and-sepsis-research-references.pdf">https://pharmacytodose.files.wordpress.com/2024/04/norepi-position-paper-and-sepsis-research-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5043</itunes:duration>
      <guid isPermaLink="false"><![CDATA[8e49315c-f172-11ee-9ee2-4f6065e3adbe]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4940782302.mp3?updated=1712119333" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket</title>
      <description>Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket
 
Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP
CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP
Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM
Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP
 
06:10 – Region recaps 
32:10 – Final Four preview and predictions
45:30 – Revisiting pre-tournament predictions
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
Listener Bracket: https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/ 
 
2024 Critical Care Trials March Madness blank bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 01 Apr 2024 23:59:27 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>All 4 Bracketologists return to recap the 2024 Critical Care Trials March Madness bracket, make Final Four predictions, and much more.</itunes:subtitle>
      <itunes:summary>Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket
 
Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP
CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP
Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM
Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP
 
06:10 – Region recaps 
32:10 – Final Four preview and predictions
45:30 – Revisiting pre-tournament predictions
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
Listener Bracket: https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/ 
 
2024 Critical Care Trials March Madness blank bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket</p><p> </p><p>Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP</p><p>CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP</p><p>Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM</p><p>Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP</p><p> </p><p>06:10 – Region recaps </p><p>32:10 – Final Four preview and predictions</p><p>45:30 – Revisiting pre-tournament predictions</p><p> </p><p>PubMed links for all 68 Critical Care March Madness trials: <a href="https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf">https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf</a> </p><p> </p><p>Listener Bracket: <a href="https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/">https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/</a> </p><p> </p><p>2024 Critical Care Trials March Madness blank bracket: <a href="https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/">https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3940</itunes:duration>
      <guid isPermaLink="false"><![CDATA[adac9d2a-f084-11ee-9005-075185f7bd21]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3869550427.mp3?updated=1712017191" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>October 2023 Literature Review Series</title>
      <description>Literature Review Series
October 2023
Special Guests: Hailey Burns, PharmD @Hailey_rx36
Caitlyn Simonson, PharmD
 
03:45 – Featured Articles
38:15 – Neuro
50:10 – EM/Tox/Trauma
61:50 – Renal/Endocrine
66:38 – PharmD
70:10 – Sweet Emotion
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/03/october-lrs-2023-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 29 Mar 2024 04:55:02 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Caitlin Simonson and Hailey Burns join me to highlight some of the best peer-reviewed publications from October 2023. </itunes:subtitle>
      <itunes:summary>Literature Review Series
October 2023
Special Guests: Hailey Burns, PharmD @Hailey_rx36
Caitlyn Simonson, PharmD
 
03:45 – Featured Articles
38:15 – Neuro
50:10 – EM/Tox/Trauma
61:50 – Renal/Endocrine
66:38 – PharmD
70:10 – Sweet Emotion
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/03/october-lrs-2023-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>October 2023</p><p>Special Guests: Hailey Burns, PharmD @Hailey_rx36</p><p>Caitlyn Simonson, PharmD</p><p> </p><p>03:45 – Featured Articles</p><p>38:15 – Neuro</p><p>50:10 – EM/Tox/Trauma</p><p>61:50 – Renal/Endocrine</p><p>66:38 – PharmD</p><p>70:10 – Sweet Emotion</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/03/october-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2024/03/october-lrs-2023-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4576</itunes:duration>
      <guid isPermaLink="false"><![CDATA[8d15112c-ed88-11ee-b86d-233221248ff6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2161529863.mp3?updated=1711689087" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Sweet 16 Preview and Recap: 2024 Critical Care Trials March Madness Bracket</title>
      <description>Sweet 16 Preview and Recap: 2024 Critical Care Trials March Madness Bracket Preview
 
04:06 – First round recap
13:25 – Second round recap
19:05 – Sweet 16 preview
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/ 
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 27 Mar 2024 04:25:05 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick reviews all the action from the first and second round of voting before previewing the Sweet 16 trials and matchups in the 2024 Critical Care Trials March Madness Bracket. </itunes:subtitle>
      <itunes:summary>Sweet 16 Preview and Recap: 2024 Critical Care Trials March Madness Bracket Preview
 
04:06 – First round recap
13:25 – Second round recap
19:05 – Sweet 16 preview
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/ 
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Sweet 16 Preview and Recap: 2024 Critical Care Trials March Madness Bracket Preview</p><p> </p><p>04:06 – First round recap</p><p>13:25 – Second round recap</p><p>19:05 – Sweet 16 preview</p><p> </p><p>PubMed links for all 68 Critical Care March Madness trials: <a href="https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf">https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf</a> </p><p> </p><p>2024 March Madness Bracket: <a href="https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/">https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/</a> </p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1897</itunes:duration>
      <guid isPermaLink="false"><![CDATA[05a0294e-ebf2-11ee-95eb-334c144d7de7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7825765251.mp3?updated=1711514237" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pharmacotherapy in the Critically Ill Pregnant Patient: Part II</title>
      <description>Pharmacotherapy in the Critically Ill Pregnant Patient: Part II
Special Guests: Allison Lankford, MD
Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM, FCCP @mtbastin
 
04:50 – Obstetric hemorrhage
18:20 – Ectopic pregnancy
22:30 – Hypertensive emergency
28:45 – Pre-eclampsia/eclampsia
35:00 – Lactation considerations
39:35 – Take-home points
 
Pharmacotherapy “Caring for two in the ICU” articles:
Part I: https://pubmed.ncbi.nlm.nih.gov/36938691/
Part II: https://pubmed.ncbi.nlm.nih.gov/37323102/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 21 Mar 2024 16:41:48 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Melissa Thompson Bastin and Allison Lankford join me to review pregnancy-related complications in the critically ill pregnant patient.</itunes:subtitle>
      <itunes:summary>Pharmacotherapy in the Critically Ill Pregnant Patient: Part II
Special Guests: Allison Lankford, MD
Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM, FCCP @mtbastin
 
04:50 – Obstetric hemorrhage
18:20 – Ectopic pregnancy
22:30 – Hypertensive emergency
28:45 – Pre-eclampsia/eclampsia
35:00 – Lactation considerations
39:35 – Take-home points
 
Pharmacotherapy “Caring for two in the ICU” articles:
Part I: https://pubmed.ncbi.nlm.nih.gov/36938691/
Part II: https://pubmed.ncbi.nlm.nih.gov/37323102/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Pharmacotherapy in the Critically Ill Pregnant Patient: Part II</p><p>Special Guests: Allison Lankford, MD</p><p>Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM, FCCP @mtbastin</p><p> </p><p>04:50 – Obstetric hemorrhage</p><p>18:20 – Ectopic pregnancy</p><p>22:30 – Hypertensive emergency</p><p>28:45 – Pre-eclampsia/eclampsia</p><p>35:00 – Lactation considerations</p><p>39:35 – Take-home points</p><p> </p><p>Pharmacotherapy “Caring for two in the ICU” articles:</p><p>Part I: <a href="https://pubmed.ncbi.nlm.nih.gov/36938691/">https://pubmed.ncbi.nlm.nih.gov/36938691/</a></p><p>Part II: <a href="https://pubmed.ncbi.nlm.nih.gov/37323102/">https://pubmed.ncbi.nlm.nih.gov/37323102/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2791</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fce5775e-e7a1-11ee-a6fd-9f6bab0c97ed]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7890502661.mp3?updated=1711040225" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 Critical Care Trials March Madness Bracket Preview: Part II</title>
      <description>2024 Critical Care Trials March Madness Bracket Preview: Part II
Cardiac/Pulmonary and Sepsis/Fluids Regions
 
CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP
Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 18 Mar 2024 04:23:13 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Jolie Gallagher and Clay Small, 2 Bracketologists, breakdown and preview the Cardiac/Pulmonary and Sepsis/Fluids regions of the 2024 Critical Care Trials March Madness Bracket. </itunes:subtitle>
      <itunes:summary>2024 Critical Care Trials March Madness Bracket Preview: Part II
Cardiac/Pulmonary and Sepsis/Fluids Regions
 
CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP
Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 Critical Care Trials March Madness Bracket Preview: Part II</p><p>Cardiac/Pulmonary and Sepsis/Fluids Regions</p><p> </p><p>CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP</p><p>Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP</p><p> </p><p>PubMed links for all 68 Critical Care March Madness trials: <a href="https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf">https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf</a> </p><p> </p><p>2024 March Madness Bracket: <a href="https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/">https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5363</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4e9e172e-e4df-11ee-80d7-cfc9bd2dbce0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3672059757.mp3?updated=1710736987" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 Critical Care Trials March Madness Bracket Preview: Part I</title>
      <description>2024 Critical Care Trials March Madness Bracket Preview: Part I
Bleeding/Blood Glucose and Neuro/PADIS Regions
 
Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM
Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP @karenccrx 
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/ 
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 18 Mar 2024 03:40:08 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Jason Hecht and Karen Berger, 2 Bracketologists, breakdown and preview the Bleeding/BG and Neuro/PADIS regions of the 2024 Critical Care Trials March Madness Bracket. </itunes:subtitle>
      <itunes:summary>2024 Critical Care Trials March Madness Bracket Preview: Part I
Bleeding/Blood Glucose and Neuro/PADIS Regions
 
Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM
Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP @karenccrx 
 
PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf 
 
2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/ 
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 Critical Care Trials March Madness Bracket Preview: Part I</p><p>Bleeding/Blood Glucose and Neuro/PADIS Regions</p><p> </p><p>Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM</p><p>Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP @karenccrx </p><p> </p><p>PubMed links for all 68 Critical Care March Madness trials: <a href="https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf">https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf</a> </p><p> </p><p>2024 March Madness Bracket: <a href="https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/">https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/</a> </p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5381</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3cb5ac30-e4d9-11ee-95bf-ab6e60f47d6c]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7792288200.mp3?updated=1710734950" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: CHAMPION PHOENIX</title>
      <description>Trial of the Week: CHAMPION PHOENIX
Special Guest: Jack Pluenneke, PharmD, BCCP @JackPluenneke
 
Jack Pluenneke joins to discuss a March 2024 Trial of the Week, “Effect of platelet inhibition with cangrelor during PCI on ischemic events” the CHAMPION PHOENIX trial, published in 2013 in NEJM. 
We review PK/PD advantages with cangrelor, go over the CHAMPION trials, and then highlight why the CHAMPION PHOENIX trial was necessary. Then we dive into the Trial of the Week: CHAMPION PHOENIX trial and discuss its findings as well as study design. Are these patients we’d see in our ICU? How does cangrelor compare to glycoprotein 2b/3a inhibitors? Is it a weakness that the comparator group uses clopidogrel? The episode closes with medication safety considerations, cangrelor’s place in therapy, and much more.
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/champion-phoenix-trial-of-the-week-references-1.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 15 Mar 2024 01:22:22 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Jack Pluenneke joins to discuss a March 2024 Trial of the Week, “Effect of platelet inhibition with cangrelor during PCI on ischemic events” the CHAMPION PHOENIX trial, published in 2013 in NEJM.</itunes:subtitle>
      <itunes:summary>Trial of the Week: CHAMPION PHOENIX
Special Guest: Jack Pluenneke, PharmD, BCCP @JackPluenneke
 
Jack Pluenneke joins to discuss a March 2024 Trial of the Week, “Effect of platelet inhibition with cangrelor during PCI on ischemic events” the CHAMPION PHOENIX trial, published in 2013 in NEJM. 
We review PK/PD advantages with cangrelor, go over the CHAMPION trials, and then highlight why the CHAMPION PHOENIX trial was necessary. Then we dive into the Trial of the Week: CHAMPION PHOENIX trial and discuss its findings as well as study design. Are these patients we’d see in our ICU? How does cangrelor compare to glycoprotein 2b/3a inhibitors? Is it a weakness that the comparator group uses clopidogrel? The episode closes with medication safety considerations, cangrelor’s place in therapy, and much more.
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/champion-phoenix-trial-of-the-week-references-1.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: CHAMPION PHOENIX</p><p>Special Guest: Jack Pluenneke, PharmD, BCCP @JackPluenneke</p><p> </p><p>Jack Pluenneke joins to discuss a March 2024 Trial of the Week, “Effect of platelet inhibition with cangrelor during PCI on ischemic events” the CHAMPION PHOENIX trial, published in 2013 in NEJM. </p><p>We review PK/PD advantages with cangrelor, go over the CHAMPION trials, and then highlight why the CHAMPION PHOENIX trial was necessary. Then we dive into the Trial of the Week: CHAMPION PHOENIX trial and discuss its findings as well as study design. Are these patients we’d see in our ICU? How does cangrelor compare to glycoprotein 2b/3a inhibitors? Is it a weakness that the comparator group uses clopidogrel? The episode closes with medication safety considerations, cangrelor’s place in therapy, and much more.</p><p> </p><p>Reference list:  <a href="https://pharmacytodose.files.wordpress.com/2024/03/champion-phoenix-trial-of-the-week-references-1.pdf">https://pharmacytodose.files.wordpress.com/2024/03/champion-phoenix-trial-of-the-week-references-1.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3635</itunes:duration>
      <guid isPermaLink="false"><![CDATA[84f442b6-e26a-11ee-a008-1f3d2524cb9b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7328043063.mp3?updated=1710466528" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Corticosteroids in the Critically Ill</title>
      <description>Corticosteroids in the Critically Ill
Special Guest: Andrea Nei, PharmD, BCPS, BCCCP, FCCM @Dre_pharmd
 
04:40 – Guideline introduction/background
08:35 – Scope/authorship
13:35 – PICO questions/recommendations
14:22 – Sepsis
17:20 – CAP
19:10 – ARDS
21:55 – Research priorities/Take-home points
28:50 – Working with your spouse
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 13 Mar 2024 03:47:09 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Andrea Nei joins the podcast to review the 2024 SCCM Guidelines on the Use of Corticosteroids in Sepsis, ARDS, and CAP</itunes:subtitle>
      <itunes:summary>Corticosteroids in the Critically Ill
Special Guest: Andrea Nei, PharmD, BCPS, BCCCP, FCCM @Dre_pharmd
 
04:40 – Guideline introduction/background
08:35 – Scope/authorship
13:35 – PICO questions/recommendations
14:22 – Sepsis
17:20 – CAP
19:10 – ARDS
21:55 – Research priorities/Take-home points
28:50 – Working with your spouse
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Corticosteroids in the Critically Ill</p><p>Special Guest: Andrea Nei, PharmD, BCPS, BCCCP, FCCM @Dre_pharmd</p><p> </p><p>04:40 – Guideline introduction/background</p><p>08:35 – Scope/authorship</p><p>13:35 – PICO questions/recommendations</p><p>14:22 – Sepsis</p><p>17:20 – CAP</p><p>19:10 – ARDS</p><p>21:55 – Research priorities/Take-home points</p><p>28:50 – Working with your spouse</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2148</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7e425b3a-e0ec-11ee-9ecb-ef13c09e3e40]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9462938278.mp3?updated=1710302376" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: REDUCE</title>
      <description>Trial of the Week: REDUCE
Special Guest: Matt Duprey, PharmD, PhD, BCCCP
 
Matt Duprey joins to discuss the March Trial of the Week, published in 2018 in JAMA: “The Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: the REDUCE Randomized Clinical Trial.”
 
We review the history of antipsychotic pharmacotherapy treatment and prophylaxis in delirium, reviewing guideline recommendations from that time. Then we dive into the Trial of the Week: REDUCE trial and discuss its findings as well as study design. Would results be the same with another medication? Why is delirium research so challenging? Prevalent v. incident delirium? What’s the best outcome to measure? What questions still need answered? These questions and so much more are answered in today's episode.
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/reduce-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 08 Mar 2024 16:04:06 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Matt Duprey joins to discuss the 2018 JAMA article "The Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: the REDUCE Randomized Clinical Trial."</itunes:subtitle>
      <itunes:summary>Trial of the Week: REDUCE
Special Guest: Matt Duprey, PharmD, PhD, BCCCP
 
Matt Duprey joins to discuss the March Trial of the Week, published in 2018 in JAMA: “The Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: the REDUCE Randomized Clinical Trial.”
 
We review the history of antipsychotic pharmacotherapy treatment and prophylaxis in delirium, reviewing guideline recommendations from that time. Then we dive into the Trial of the Week: REDUCE trial and discuss its findings as well as study design. Would results be the same with another medication? Why is delirium research so challenging? Prevalent v. incident delirium? What’s the best outcome to measure? What questions still need answered? These questions and so much more are answered in today's episode.
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/reduce-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: REDUCE</p><p>Special Guest: Matt Duprey, PharmD, PhD, BCCCP</p><p> </p><p>Matt Duprey joins to discuss the March Trial of the Week, published in 2018 in JAMA: “The Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: the REDUCE Randomized Clinical Trial.”</p><p> </p><p>We review the history of antipsychotic pharmacotherapy treatment and prophylaxis in delirium, reviewing guideline recommendations from that time. Then we dive into the Trial of the Week: REDUCE trial and discuss its findings as well as study design. Would results be the same with another medication? Why is delirium research so challenging? Prevalent v. incident delirium? What’s the best outcome to measure? What questions still need answered? These questions and so much more are answered in today's episode.</p><p> </p><p>Reference list:  <a href="https://pharmacytodose.files.wordpress.com/2024/03/reduce-references.pdf">https://pharmacytodose.files.wordpress.com/2024/03/reduce-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2937</itunes:duration>
      <guid isPermaLink="false"><![CDATA[92d666f2-dd65-11ee-94a8-6bfb2b15eac5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4471059138.mp3?updated=1709914705" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pharmacotherapy in the Critically Ill Pregnant Patient: Part I</title>
      <description>Pharmacotherapy in the Critically Ill Pregnant Patient: Part I
Special Guests: Allison Lankford, MD
Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM, FCCP @mtbastin
 
08:05 – PK/PD changes
12:50 – Medication safety/Drug information resources
20:15 – Maternal sepsis
33:15 – ARDS
43:15 – PADIS
48:45 – Cardiogenic shock &amp; cardiac arrest
59:00 – VTE
 
Pharmacotherapy “Caring for two in the ICU” articles:
Part I: https://pubmed.ncbi.nlm.nih.gov/36938691/
Part II: https://pubmed.ncbi.nlm.nih.gov/37323102/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 05 Mar 2024 12:09:59 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Melissa Thompson Bastin, PharmD and Allison Lankford, MD join me to highlight their 2-part article series in Pharmacotherapy called "Caring for two in the ICU" detailing pharmacotherapy considerations in the critically ill pregnant patient. This is Part I in a 2-part episode series. </itunes:subtitle>
      <itunes:summary>Pharmacotherapy in the Critically Ill Pregnant Patient: Part I
Special Guests: Allison Lankford, MD
Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM, FCCP @mtbastin
 
08:05 – PK/PD changes
12:50 – Medication safety/Drug information resources
20:15 – Maternal sepsis
33:15 – ARDS
43:15 – PADIS
48:45 – Cardiogenic shock &amp; cardiac arrest
59:00 – VTE
 
Pharmacotherapy “Caring for two in the ICU” articles:
Part I: https://pubmed.ncbi.nlm.nih.gov/36938691/
Part II: https://pubmed.ncbi.nlm.nih.gov/37323102/
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Pharmacotherapy in the Critically Ill Pregnant Patient: Part I</p><p>Special Guests: Allison Lankford, MD</p><p>Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM, FCCP @mtbastin</p><p> </p><p>08:05 – PK/PD changes</p><p>12:50 – Medication safety/Drug information resources</p><p>20:15 – Maternal sepsis</p><p>33:15 – ARDS</p><p>43:15 – PADIS</p><p>48:45 – Cardiogenic shock &amp; cardiac arrest</p><p>59:00 – VTE</p><p> </p><p>Pharmacotherapy “Caring for two in the ICU” articles:</p><p>Part I: <a href="https://pubmed.ncbi.nlm.nih.gov/36938691/">https://pubmed.ncbi.nlm.nih.gov/36938691/</a></p><p>Part II: <a href="https://pubmed.ncbi.nlm.nih.gov/37323102/">https://pubmed.ncbi.nlm.nih.gov/37323102/</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4213</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4cb1e0c6-dae9-11ee-b830-2f7965b35e5e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2661604549.mp3?updated=1709641415" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Levetiracetam Rapid IV Push</title>
      <description>Trial of the Week: Levetiracetam Rapid IV Push
Special Guest: Olivia Morgan, PharmD, BCCCP, BCGP
 
I’m joined by Olivia Morgan to discuss her first author 2020 Neurocritical Care article entitled “Safety and Tolerability of Rapid Administration Undiluted Levetiracetam.”
We review previous administration techniques and discussing how this study came to be before highlighting all the findings from this Trial of the Week. Then we discuss how the protocol has changed since this study, administering other ASM via rapid IV push, and much, much more. 
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/keppra-rapid-ivp-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 01 Mar 2024 14:07:20 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Olivia Morgan joins us to highlight her 2020 Neurocritical Care article "Safety and Tolerability of Rapid Administration Undiluted Levetiracetam."</itunes:subtitle>
      <itunes:summary>Trial of the Week: Levetiracetam Rapid IV Push
Special Guest: Olivia Morgan, PharmD, BCCCP, BCGP
 
I’m joined by Olivia Morgan to discuss her first author 2020 Neurocritical Care article entitled “Safety and Tolerability of Rapid Administration Undiluted Levetiracetam.”
We review previous administration techniques and discussing how this study came to be before highlighting all the findings from this Trial of the Week. Then we discuss how the protocol has changed since this study, administering other ASM via rapid IV push, and much, much more. 
 
Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/keppra-rapid-ivp-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Levetiracetam Rapid IV Push</p><p>Special Guest: Olivia Morgan, PharmD, BCCCP, BCGP</p><p> </p><p>I’m joined by Olivia Morgan to discuss her first author 2020 Neurocritical Care article entitled “Safety and Tolerability of Rapid Administration Undiluted Levetiracetam.”</p><p>We review previous administration techniques and discussing how this study came to be before highlighting all the findings from this Trial of the Week. Then we discuss how the protocol has changed since this study, administering other ASM via rapid IV push, and much, much more. </p><p> </p><p>Reference list:  https://pharmacytodose.files.wordpress.com/2024/03/keppra-rapid-ivp-references.pdf</p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1683</itunes:duration>
      <guid isPermaLink="false"><![CDATA[0954dd7c-d7d5-11ee-b10c-3fa5b1699ae6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2374939102.mp3?updated=1709302732" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Glycemic Control in the Critically Ill: Part I</title>
      <description>Glycemic Control in the Critically Ill: Part I
Special Guest: Traci Grucz, PharmD, BCCCP @tmgrucz
 
04:50 – ICU hyperglycemia mechanism
09:52 – Background/landmark research
27:00 – Current recommendations
30:25 – Hyperglycemia and hypoglycemia tips/tricks
46:30 – Treatment considerations
54:50 – Take-home points
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/02/glycemic-control-in-the-icu-part-i-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 16 Feb 2024 15:18:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Traci Grucz joins me to highlight the history of glycemic control in the ICU and discuss considerations and tips/tricks on management of hyper- and hypoglycemia in the ICU.</itunes:subtitle>
      <itunes:summary>Glycemic Control in the Critically Ill: Part I
Special Guest: Traci Grucz, PharmD, BCCCP @tmgrucz
 
04:50 – ICU hyperglycemia mechanism
09:52 – Background/landmark research
27:00 – Current recommendations
30:25 – Hyperglycemia and hypoglycemia tips/tricks
46:30 – Treatment considerations
54:50 – Take-home points
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/02/glycemic-control-in-the-icu-part-i-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Glycemic Control in the Critically Ill: Part I</p><p>Special Guest: Traci Grucz, PharmD, BCCCP @tmgrucz</p><p> </p><p>04:50 – ICU hyperglycemia mechanism</p><p>09:52 – Background/landmark research</p><p>27:00 – Current recommendations</p><p>30:25 – Hyperglycemia and hypoglycemia tips/tricks</p><p>46:30 – Treatment considerations</p><p>54:50 – Take-home points</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/02/glycemic-control-in-the-icu-part-i-references.pdf">https://pharmacytodose.files.wordpress.com/2024/02/glycemic-control-in-the-icu-part-i-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3682</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ac35a6e0-ccde-11ee-a9e4-63edd1d8efa0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3670373018.mp3?updated=1708099102" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>September 2023 Literature Review Series</title>
      <description>Literature Review Series
September 2023
Special Guests: Garrett Terhune, PharmD
Caroline Blankemeier, PharmD
 
04:35 – Featured Articles
32:28 – Pulm
38:35 – PADIS
46:50 – Neuro
53:40 – Trauma
62:00 – PharmD
68:10 – Grab Bag
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/02/september-lrs-2023-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 13 Feb 2024 20:47:19 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Caroline Blankemeier and Garrett Terhune join me to highlight some of the best articles published in September 2023. </itunes:subtitle>
      <itunes:summary>Literature Review Series
September 2023
Special Guests: Garrett Terhune, PharmD
Caroline Blankemeier, PharmD
 
04:35 – Featured Articles
32:28 – Pulm
38:35 – PADIS
46:50 – Neuro
53:40 – Trauma
62:00 – PharmD
68:10 – Grab Bag
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/02/september-lrs-2023-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>September 2023</p><p>Special Guests: Garrett Terhune, PharmD</p><p>Caroline Blankemeier, PharmD</p><p> </p><p>04:35 – Featured Articles</p><p>32:28 – Pulm</p><p>38:35 – PADIS</p><p>46:50 – Neuro</p><p>53:40 – Trauma</p><p>62:00 – PharmD</p><p>68:10 – Grab Bag</p><p> </p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/02/september-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2024/02/september-lrs-2023-references.pdf</a></p><p> </p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4485</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2a131a0a-cab1-11ee-851f-877dbc0bd105]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7189000684.mp3?updated=1707858197" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Immunotherapy Part II</title>
      <description>Immunotherapy Part II
Special Guest: Matt McKenzie, PharmD, BCCCP @mgm485

04:40 – What is and when do we use immunotherapy?
09:00 – CAR-T cell therapy
15:20 – Standard ICU work-up
21:00 – Cytokine release syndrome (CRS)
35:00 – Immune effector cell-associated neurotoxicity syndrome (ICANS)
51:00 – Immune checkpoint inhibitors
64:30 – Summary and take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2024/02/immunotherapy-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 09 Feb 2024 03:55:59 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Matt McKenzie joins me to highlight immunotherapy and the management of its adverse effects in the critically ill</itunes:subtitle>
      <itunes:summary>Immunotherapy Part II
Special Guest: Matt McKenzie, PharmD, BCCCP @mgm485

04:40 – What is and when do we use immunotherapy?
09:00 – CAR-T cell therapy
15:20 – Standard ICU work-up
21:00 – Cytokine release syndrome (CRS)
35:00 – Immune effector cell-associated neurotoxicity syndrome (ICANS)
51:00 – Immune checkpoint inhibitors
64:30 – Summary and take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2024/02/immunotherapy-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Immunotherapy Part II</p><p>Special Guest: Matt McKenzie, PharmD, BCCCP @mgm485</p><p><br></p><p>04:40 – What is and when do we use immunotherapy?</p><p>09:00 – CAR-T cell therapy</p><p>15:20 – Standard ICU work-up</p><p>21:00 – Cytokine release syndrome (CRS)</p><p>35:00 – Immune effector cell-associated neurotoxicity syndrome (ICANS)</p><p>51:00 – Immune checkpoint inhibitors</p><p>64:30 – Summary and take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/02/immunotherapy-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2024/02/immunotherapy-part-ii-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4816</itunes:duration>
      <guid isPermaLink="false"><![CDATA[28ed9e4e-c6ff-11ee-b08f-a7f551ae2639]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2635262778.mp3?updated=1707452054" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Burnout and Well-being</title>
      <description>Burnout and Well-being
Special Guest: Brent Reed, PharmD, MS, PhD Candidate

07:25 – How did we get here?
09:05 – Defining and drivers of burnout
18:45 – Is it too late if we're already experiencing?
20:15 – Relationship between well-being and burnout
22:00 – Work:life balance
29:00 – Precepting and teaching
35:25 – Foundation of burnout prevention
38:30 – 5 step process for work design change
50:50 – Being proactive and short-/long-term fixes

Reference List: https://pharmacytodose.files.wordpress.com/2024/02/burnout-and-well-being-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 02 Feb 2024 02:50:34 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brent Reed joins me to discuss burnout and well-being with a focus on Pharmacists and those in healthcare.</itunes:subtitle>
      <itunes:summary>Burnout and Well-being
Special Guest: Brent Reed, PharmD, MS, PhD Candidate

07:25 – How did we get here?
09:05 – Defining and drivers of burnout
18:45 – Is it too late if we're already experiencing?
20:15 – Relationship between well-being and burnout
22:00 – Work:life balance
29:00 – Precepting and teaching
35:25 – Foundation of burnout prevention
38:30 – 5 step process for work design change
50:50 – Being proactive and short-/long-term fixes

Reference List: https://pharmacytodose.files.wordpress.com/2024/02/burnout-and-well-being-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Burnout and Well-being</p><p>Special Guest: Brent Reed, PharmD, MS, PhD Candidate</p><p><br></p><p>07:25 – How did we get here?</p><p>09:05 – Defining and drivers of burnout</p><p>18:45 – Is it too late if we're already experiencing?</p><p>20:15 – Relationship between well-being and burnout</p><p>22:00 – Work:life balance</p><p>29:00 – Precepting and teaching</p><p>35:25 – Foundation of burnout prevention</p><p>38:30 – 5 step process for work design change</p><p>50:50 – Being proactive and short-/long-term fixes</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/02/burnout-and-well-being-references.pdf">https://pharmacytodose.files.wordpress.com/2024/02/burnout-and-well-being-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3829</itunes:duration>
      <guid isPermaLink="false"><![CDATA[dee4b1f4-c175-11ee-89e0-6faf41bc2803]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5883178305.mp3?updated=1706843050" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>August 2023 Literature Review Series</title>
      <description>Literature Review Series
August 2023
Special Guests: Katie Rogers, PharmD
Eric Johnston, PharmD

04:35 – Featured Articles
39:00 – Sepsis
47:35 – Potpourri
52:45 – Infectious Diseases
61:45 – PharmD
68:15 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2024/01/august-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 30 Jan 2024 20:53:23 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Eric Johnston and Katie Rogers join to highlight some of the most noteworthy articles published in August 2023.</itunes:subtitle>
      <itunes:summary>Literature Review Series
August 2023
Special Guests: Katie Rogers, PharmD
Eric Johnston, PharmD

04:35 – Featured Articles
39:00 – Sepsis
47:35 – Potpourri
52:45 – Infectious Diseases
61:45 – PharmD
68:15 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2024/01/august-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>August 2023</p><p>Special Guests: Katie Rogers, PharmD</p><p>Eric Johnston, PharmD</p><p><br></p><p>04:35 – Featured Articles</p><p>39:00 – Sepsis</p><p>47:35 – Potpourri</p><p>52:45 – Infectious Diseases</p><p>61:45 – PharmD</p><p>68:15 – Grab Bag</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/01/august-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2024/01/august-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4546</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a1a16668-bfb1-11ee-8c58-8bd7616b6d89]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7890005396.mp3?updated=1706648961" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 SCCM Annual Congress Recap</title>
      <description>2024 SCCM Congress Recap
Special Guest: Anthony Hawkins, PharmD, FCCM, BCCCP

Conference correspondent Anthony Hawkins returns to recap all the happenings from the 2024 SCCM Congress. We review Phoenix, likes and dislikes from the Convention Center, session highlights, exhibit hall review, favorite session titles, PharmD award winners, and much, more.

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 24 Jan 2024 22:41:33 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Conference correspondent Anthony Hawkins joins me to recap the entire 2024 SCCM Annual Congress recorded live in Phoenix, AZ. </itunes:subtitle>
      <itunes:summary>2024 SCCM Congress Recap
Special Guest: Anthony Hawkins, PharmD, FCCM, BCCCP

Conference correspondent Anthony Hawkins returns to recap all the happenings from the 2024 SCCM Congress. We review Phoenix, likes and dislikes from the Convention Center, session highlights, exhibit hall review, favorite session titles, PharmD award winners, and much, more.

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 SCCM Congress Recap</p><p>Special Guest: Anthony Hawkins, PharmD, FCCM, BCCCP</p><p><br></p><p>Conference correspondent Anthony Hawkins returns to recap all the happenings from the 2024 SCCM Congress. We review Phoenix, likes and dislikes from the Convention Center, session highlights, exhibit hall review, favorite session titles, PharmD award winners, and much, more.</p><p><br></p><p>2024 SCCM Congress website: <a href="https://congress2024.sccm.org/">https://congress2024.sccm.org</a></p><p><br></p><p>PharmacyToDose.com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4648</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c6aa0854-bb09-11ee-bfa4-ab10d5c8a7d0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9503588274.mp3?updated=1706137241" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 SCCM Congress: Tuesday</title>
      <description>2024 SCCM Congress: Tuesday
Special Guests: Karen Berger, PharmD, FASHP, FCCM, BCCCP, BCPS
Melanie Smith Condeni, PharmD, FCCM, BCPS, BCCCP
Julie Farrar, PharmD, BCCCP
Lama Nazer, PharmD, BCPS
Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP
Andy Webb, PharmD, BCCCP

03:05: Star Research Presentation: “Effect of Antipsychotics on Agitation in ICU Delirium: Secondary Analysis of a Randomized Trial” featuring Joanna Stollings
10:43: Star Research Presentations: “Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (PRO-CAN)” &amp; “Diagnostic and Prognostic Value of Procalcitonin in Critically Ill Cancer Patients with Sepsis” featuring Lama Nazer
25:32: Clinical Pharmacy and Pharmacology (CPP) Year in Review presenter and moderator roundtable discussion featuring Karen Berger, Melanie Smith Condeni, Julie Farrar, and Andy Webb

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 24 Jan 2024 18:39:40 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Joanna Stollings and Lama Nazer highlight their star research abstracts. Then the presenters and moderator of the CPP year in review session join for a roundtable discussion.</itunes:subtitle>
      <itunes:summary>2024 SCCM Congress: Tuesday
Special Guests: Karen Berger, PharmD, FASHP, FCCM, BCCCP, BCPS
Melanie Smith Condeni, PharmD, FCCM, BCPS, BCCCP
Julie Farrar, PharmD, BCCCP
Lama Nazer, PharmD, BCPS
Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP
Andy Webb, PharmD, BCCCP

03:05: Star Research Presentation: “Effect of Antipsychotics on Agitation in ICU Delirium: Secondary Analysis of a Randomized Trial” featuring Joanna Stollings
10:43: Star Research Presentations: “Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (PRO-CAN)” &amp; “Diagnostic and Prognostic Value of Procalcitonin in Critically Ill Cancer Patients with Sepsis” featuring Lama Nazer
25:32: Clinical Pharmacy and Pharmacology (CPP) Year in Review presenter and moderator roundtable discussion featuring Karen Berger, Melanie Smith Condeni, Julie Farrar, and Andy Webb

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 SCCM Congress: Tuesday</p><p>Special Guests: Karen Berger, PharmD, FASHP, FCCM, BCCCP, BCPS</p><p>Melanie Smith Condeni, PharmD, FCCM, BCPS, BCCCP</p><p>Julie Farrar, PharmD, BCCCP</p><p>Lama Nazer, PharmD, BCPS</p><p>Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP</p><p>Andy Webb, PharmD, BCCCP</p><p><br></p><p>03:05: Star Research Presentation: “Effect of Antipsychotics on Agitation in ICU Delirium: Secondary Analysis of a Randomized Trial” featuring Joanna Stollings</p><p>10:43: Star Research Presentations: “Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (PRO-CAN)” &amp; “Diagnostic and Prognostic Value of Procalcitonin in Critically Ill Cancer Patients with Sepsis” featuring Lama Nazer</p><p>25:32: Clinical Pharmacy and Pharmacology (CPP) Year in Review presenter and moderator roundtable discussion featuring Karen Berger, Melanie Smith Condeni, Julie Farrar, and Andy Webb</p><p><br></p><p>2024 SCCM Congress website: <a href="https://congress2024.sccm.org/">https://congress2024.sccm.org</a></p><p><br></p><p>PharmacyToDose.com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2726</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f2522c24-bae7-11ee-8274-93ab099649c8]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5761692706.mp3?updated=1706122442" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 SCCM Congress: Monday</title>
      <description>2024 SCCM Congress: Monday
Special Guests: Caitlin Brown, PharmD, BCCCP, FCCM
Marilyn Bulloch, PharmD, BCPS, FCCM
Kayla Kotch, PharmD, BCCCP

02:55: Marilyn Bulloch discusses her role and experience as a 2024 SCCM Congress co-chair
28:30: Star Research Presentation: “Impact of Early Initiation of Phenobarbital for Alcohol Withdrawal Syndrome in the Critically Ill” featuring Kayla Kotch
39:00: Star Research Presentation: “A Multicenter Study of Pulmonary Embolism Patients Treated with Reduced- or Full-Dose Alteplase” featuring Caitlin Brown

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 23 Jan 2024 00:09:38 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Marilyn Bulloch joins to discuss her role and experience as 2024 Congress co-chair. Then 2 star abstract winners, Kayla Kotch and Caitlin Brown, join to highlight their  research.</itunes:subtitle>
      <itunes:summary>2024 SCCM Congress: Monday
Special Guests: Caitlin Brown, PharmD, BCCCP, FCCM
Marilyn Bulloch, PharmD, BCPS, FCCM
Kayla Kotch, PharmD, BCCCP

02:55: Marilyn Bulloch discusses her role and experience as a 2024 SCCM Congress co-chair
28:30: Star Research Presentation: “Impact of Early Initiation of Phenobarbital for Alcohol Withdrawal Syndrome in the Critically Ill” featuring Kayla Kotch
39:00: Star Research Presentation: “A Multicenter Study of Pulmonary Embolism Patients Treated with Reduced- or Full-Dose Alteplase” featuring Caitlin Brown

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 SCCM Congress: Monday</p><p>Special Guests: Caitlin Brown, PharmD, BCCCP, FCCM</p><p>Marilyn Bulloch, PharmD, BCPS, FCCM</p><p>Kayla Kotch, PharmD, BCCCP</p><p><br></p><p>02:55: Marilyn Bulloch discusses her role and experience as a 2024 SCCM Congress co-chair</p><p>28:30: Star Research Presentation: “Impact of Early Initiation of Phenobarbital for Alcohol Withdrawal Syndrome in the Critically Ill” featuring Kayla Kotch</p><p>39:00: Star Research Presentation: “A Multicenter Study of Pulmonary Embolism Patients Treated with Reduced- or Full-Dose Alteplase” featuring Caitlin Brown</p><p><br></p><p>2024 SCCM Congress website: <a href="https://congress2024.sccm.org/">https://congress2024.sccm.org</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3070</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fe9e7f06-b983-11ee-b445-3f125fb24380]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2566761952.mp3?updated=1705969352" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 SCCM Congress: Sunday</title>
      <description>2024 SCCM Congress: Sunday
Special Guests: Judi Jacobi, PharmD, BCCCP, MCCM
Blake Robbins, PharmD, MBA, BCCCP

02:45: Quick review of the happenings on Sunday, January 21st from 2024 SCCM Congress

07:20: Star Research Presentation: “Standard vs. Augmented Corticosteroid Dosing in Mechanically Ventilated Patients due to COVID-19” featuring Blake Robbins

22:05: Discussion about the SCCM Glycemic Control in the ICU featuring Judi Jacobi

Glycemic control guidelines: https://journals.lww.com/ccmjournal/fulltext/9900/society_of_critical_care_medicine_guidelines_on.277.aspx
Star research presentation: https://journals.lww.com/ccmjournal/pages/articleviewer.aspx?year=2024&amp;issue=01001&amp;article=00030&amp;type=Fulltext
PROPHY-VAP: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00471-X/fulltext

2024 SCCM Congress website: https://congress2024.sccm.org

﻿PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 22 Jan 2024 02:20:33 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick Peters reviews the first day, Sunday, from 2024 SCCM Congress. Then Blake Robbins highlights his star research and Judi Jacobi discusses the new Glycemic Control in the ICU guidelines. </itunes:subtitle>
      <itunes:summary>2024 SCCM Congress: Sunday
Special Guests: Judi Jacobi, PharmD, BCCCP, MCCM
Blake Robbins, PharmD, MBA, BCCCP

02:45: Quick review of the happenings on Sunday, January 21st from 2024 SCCM Congress

07:20: Star Research Presentation: “Standard vs. Augmented Corticosteroid Dosing in Mechanically Ventilated Patients due to COVID-19” featuring Blake Robbins

22:05: Discussion about the SCCM Glycemic Control in the ICU featuring Judi Jacobi

Glycemic control guidelines: https://journals.lww.com/ccmjournal/fulltext/9900/society_of_critical_care_medicine_guidelines_on.277.aspx
Star research presentation: https://journals.lww.com/ccmjournal/pages/articleviewer.aspx?year=2024&amp;issue=01001&amp;article=00030&amp;type=Fulltext
PROPHY-VAP: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00471-X/fulltext

2024 SCCM Congress website: https://congress2024.sccm.org

﻿PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 SCCM Congress: Sunday</p><p>Special Guests: Judi Jacobi, PharmD, BCCCP, MCCM</p><p>Blake Robbins, PharmD, MBA, BCCCP</p><p><br></p><p>02:45: Quick review of the happenings on Sunday, January 21st from 2024 SCCM Congress</p><p><br></p><p>07:20: Star Research Presentation: “Standard vs. Augmented Corticosteroid Dosing in Mechanically Ventilated Patients due to COVID-19” featuring Blake Robbins</p><p><br></p><p>22:05: Discussion about the SCCM Glycemic Control in the ICU featuring Judi Jacobi</p><p><br></p><p>Glycemic control guidelines: <a href="https://journals.lww.com/ccmjournal/fulltext/9900/society_of_critical_care_medicine_guidelines_on.277.aspx">https://journals.lww.com/ccmjournal/fulltext/9900/society_of_critical_care_medicine_guidelines_on.277.aspx</a></p><p>Star research presentation: <a href="https://journals.lww.com/ccmjournal/pages/articleviewer.aspx?year=2024&amp;issue=01001&amp;article=00030&amp;type=Fulltext">https://journals.lww.com/ccmjournal/pages/articleviewer.aspx?year=2024&amp;issue=01001&amp;article=00030&amp;type=Fulltext</a></p><p>PROPHY-VAP: <a href="https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00471-X/fulltext">https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00471-X/fulltext</a></p><p><br></p><p>2024 SCCM Congress website: <a href="https://congress2024.sccm.org/">https://congress2024.sccm.org</a></p><p><br></p><p>﻿PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2685</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d461573e-b8cc-11ee-a21d-d7ee9d7d7ee2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9715461072.mp3?updated=1705890764" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2024 SCCM Congress: Saturday</title>
      <description>2024 SCCM Congress: Saturday

The episode starts out with a preview of the 2024 SCCM Congress schedule as the conference starts Sunday, January 21 in Phoenix, AZ

11:25: Then I highlight 3 presentations with Pharmacist speakers from the SCCM Digital Congress

Fill the Tank or Squeeze the Pipes? Fluid Administration Over Early Vasopressor Therapy for the Management of Shock with Olivia Marchionda, PharmD, BCCCP
Anticoagulation Considerations in Critically Ill Oncology Patients with Heather May, PharmD, MSc, BCCCP, FCCM
Pharmacologic Agents Used in the ICU for Palliation of Symptoms: What’s New? With Nicole Palm, PharmD, BCCCP, FCCM

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sat, 20 Jan 2024 17:59:06 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick previews the 2024 SCCM Congress schedule, highlighting Pharmacist speakers. Then 3 Pharmacist presenters join to discuss their SCCM Digital Congress education and answer a few questions.</itunes:subtitle>
      <itunes:summary>2024 SCCM Congress: Saturday

The episode starts out with a preview of the 2024 SCCM Congress schedule as the conference starts Sunday, January 21 in Phoenix, AZ

11:25: Then I highlight 3 presentations with Pharmacist speakers from the SCCM Digital Congress

Fill the Tank or Squeeze the Pipes? Fluid Administration Over Early Vasopressor Therapy for the Management of Shock with Olivia Marchionda, PharmD, BCCCP
Anticoagulation Considerations in Critically Ill Oncology Patients with Heather May, PharmD, MSc, BCCCP, FCCM
Pharmacologic Agents Used in the ICU for Palliation of Symptoms: What’s New? With Nicole Palm, PharmD, BCCCP, FCCM

2024 SCCM Congress website: https://congress2024.sccm.org

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2024 SCCM Congress: Saturday</p><p><br></p><p>The episode starts out with a preview of the 2024 SCCM Congress schedule as the conference starts Sunday, January 21 in Phoenix, AZ</p><p><br></p><p>11:25: Then I highlight 3 presentations with Pharmacist speakers from the SCCM Digital Congress</p><p><br></p><p>Fill the Tank or Squeeze the Pipes? Fluid Administration Over Early Vasopressor Therapy for the Management of Shock with Olivia Marchionda, PharmD, BCCCP</p><p>Anticoagulation Considerations in Critically Ill Oncology Patients with Heather May, PharmD, MSc, BCCCP, FCCM</p><p>Pharmacologic Agents Used in the ICU for Palliation of Symptoms: What’s New? With Nicole Palm, PharmD, BCCCP, FCCM</p><p><br></p><p>2024 SCCM Congress website: <a href="https://congress2024.sccm.org/">https://congress2024.sccm.org</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2711</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a22a7116-b7bd-11ee-84e6-4f8577cc3561]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5170449843.mp3?updated=1705774577" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: ACORN trial</title>
      <description>ACORN: Rapid Reaction
Special Guests: Michael Behal, PharmD, BCCCP
Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP

Michael Behal joins me to review the recently published ACORN trial from JAMA. We highlight the background of antibiotic-associated AKI, review the trial methodology and results, dive into the supplement and talk about duration of treatment, empiric v. targeted treatment, have definitively answered this question or not, and much more.

Joanna Stollings makes a special appearance highlighting her experience on the research group while also discussing the logistics of this innovative trial design.

Reference List: https://pharmacytodose.files.wordpress.com/2024/01/acorn-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 19 Jan 2024 17:42:15 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Michael Behal and Joanna Stollings join me to discuss the ACORN trial, comparing the safety of cefepime and piperacillin/tazobactam, published in JAMA in October 2023.</itunes:subtitle>
      <itunes:summary>ACORN: Rapid Reaction
Special Guests: Michael Behal, PharmD, BCCCP
Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP

Michael Behal joins me to review the recently published ACORN trial from JAMA. We highlight the background of antibiotic-associated AKI, review the trial methodology and results, dive into the supplement and talk about duration of treatment, empiric v. targeted treatment, have definitively answered this question or not, and much more.

Joanna Stollings makes a special appearance highlighting her experience on the research group while also discussing the logistics of this innovative trial design.

Reference List: https://pharmacytodose.files.wordpress.com/2024/01/acorn-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ACORN: Rapid Reaction</p><p>Special Guests: Michael Behal, PharmD, BCCCP</p><p>Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP</p><p><br></p><p>Michael Behal joins me to review the recently published ACORN trial from JAMA. We highlight the background of antibiotic-associated AKI, review the trial methodology and results, dive into the supplement and talk about duration of treatment, empiric v. targeted treatment, have definitively answered this question or not, and much more.</p><p><br></p><p>Joanna Stollings makes a special appearance highlighting her experience on the research group while also discussing the logistics of this innovative trial design.</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2024/01/acorn-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2024/01/acorn-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4315</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1f58bcbe-b6f2-11ee-adf1-3b604049b457]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8024777133.mp3?updated=1705687210" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pharmacy to Eat: Food Recommendations</title>
      <description>Pharmacy to Eat: Food Recommendations and Life Update 

HAPPY THANKSGIVING!

03:19 – Indianapolis: Nick Peters
04:50 – Boston: Grace Erdman
05:55 – New Haven: Steve Lemieux and Kelly Oldziej
08:30 – Buffalo: Nick Servati
10:33 – New York: Karen Berger and Peter Nikolos
12:58 – Philadelphia: Ashley Barlow, Brooke Barlow, Sara Groome, Alyssa Meester, and Todd Miano
19:31 – Maryland: Mojdeh Heavner and Amy Yeung
21:38 – Charleston: Melanie Smith Condeni
24:07 – Memphis: Morgan Jones
26:18 – Cincinnati: Chris Droege
30:00 – Chicago: Matt Rubertus
31:35 – Detroit: Zach Smith
32:57 – Texas: Josiah Smith and Matt Wanat
36:25 – Europe: Philip Jacobson 
38:12 – Favorite meals: Brian Gilbert and Haley Peters
41:02 – Life update

https://pharmacytodose.com/2023/11/23/pharmacy-to-eat-food-recommendations/ 

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com


Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 23 Nov 2023 16:22:12 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Happy Thanksgiving! On the holiday known for food, enjoy recommendations from previous podcast guests on their favorite food and restaurants. </itunes:subtitle>
      <itunes:summary>Pharmacy to Eat: Food Recommendations and Life Update 

HAPPY THANKSGIVING!

03:19 – Indianapolis: Nick Peters
04:50 – Boston: Grace Erdman
05:55 – New Haven: Steve Lemieux and Kelly Oldziej
08:30 – Buffalo: Nick Servati
10:33 – New York: Karen Berger and Peter Nikolos
12:58 – Philadelphia: Ashley Barlow, Brooke Barlow, Sara Groome, Alyssa Meester, and Todd Miano
19:31 – Maryland: Mojdeh Heavner and Amy Yeung
21:38 – Charleston: Melanie Smith Condeni
24:07 – Memphis: Morgan Jones
26:18 – Cincinnati: Chris Droege
30:00 – Chicago: Matt Rubertus
31:35 – Detroit: Zach Smith
32:57 – Texas: Josiah Smith and Matt Wanat
36:25 – Europe: Philip Jacobson 
38:12 – Favorite meals: Brian Gilbert and Haley Peters
41:02 – Life update

https://pharmacytodose.com/2023/11/23/pharmacy-to-eat-food-recommendations/ 

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com


Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Pharmacy to Eat: Food Recommendations and Life Update </p><p><br></p><p>HAPPY THANKSGIVING!</p><p><br></p><p>03:19 – Indianapolis: Nick Peters</p><p>04:50 – Boston: Grace Erdman</p><p>05:55 – New Haven: Steve Lemieux and Kelly Oldziej</p><p>08:30 – Buffalo: Nick Servati</p><p>10:33 – New York: Karen Berger and Peter Nikolos</p><p>12:58 – Philadelphia: Ashley Barlow, Brooke Barlow, Sara Groome, Alyssa Meester, and Todd Miano</p><p>19:31 – Maryland: Mojdeh Heavner and Amy Yeung</p><p>21:38 – Charleston: Melanie Smith Condeni</p><p>24:07 – Memphis: Morgan Jones</p><p>26:18 – Cincinnati: Chris Droege</p><p>30:00 – Chicago: Matt Rubertus</p><p>31:35 – Detroit: Zach Smith</p><p>32:57 – Texas: Josiah Smith and Matt Wanat</p><p>36:25 – Europe: Philip Jacobson </p><p>38:12 – Favorite meals: Brian Gilbert and Haley Peters</p><p>41:02 – Life update</p><p><br></p><p>https://pharmacytodose.com/2023/11/23/pharmacy-to-eat-food-recommendations/ </p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p><br></p><p><br></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2908</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9d127170-8a1c-11ee-89cc-f3f5a4c65986]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3213749106.mp3?updated=1700757378" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 ACCP Annual Meeting Recap</title>
      <description>2023 ACCP Annual Meeting Recap
Conference Correspondent: Anthony Hawkins, PharmD, FCCM, BCCCP

Anthony’s travel day, Dallas airport comparison and city review, poster hall likes/dislikes, unique and notable clinical sessions, favorite titles, Critical Care PRN business meeting highlights, award winners, FCCP awardees, correcting a last name mispronunciation, #MakePharmacyLessFormal and much more. 

https://pharmacytodose.com/2023/11/22/2023-accp-annual-meeting-recap/

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 22 Nov 2023 20:37:54 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Conference correspondent, Anthony Hawkins, joins me to recap our experience at the 2023 ACCP Annual Meeting in Dallas, TX. </itunes:subtitle>
      <itunes:summary>2023 ACCP Annual Meeting Recap
Conference Correspondent: Anthony Hawkins, PharmD, FCCM, BCCCP

Anthony’s travel day, Dallas airport comparison and city review, poster hall likes/dislikes, unique and notable clinical sessions, favorite titles, Critical Care PRN business meeting highlights, award winners, FCCP awardees, correcting a last name mispronunciation, #MakePharmacyLessFormal and much more. 

https://pharmacytodose.com/2023/11/22/2023-accp-annual-meeting-recap/

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 ACCP Annual Meeting Recap</p><p>Conference Correspondent: Anthony Hawkins, PharmD, FCCM, BCCCP</p><p><br></p><p>Anthony’s travel day, Dallas airport comparison and city review, poster hall likes/dislikes, unique and notable clinical sessions, favorite titles, Critical Care PRN business meeting highlights, award winners, FCCP awardees, correcting a last name mispronunciation, #MakePharmacyLessFormal and much more. </p><p><br></p><p><a href="https://pharmacytodose.com/2023/11/22/2023-accp-annual-meeting-recap/">https://pharmacytodose.com/2023/11/22/2023-accp-annual-meeting-recap/</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5071</itunes:duration>
      <guid isPermaLink="false"><![CDATA[60f91b76-8977-11ee-b0b0-b78c16f587ed]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7934410461.mp3?updated=1700686709" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 ACCP Annual Meeting Day 1 &amp; 2 Mini Recap</title>
      <description>2023 ACCP Annual Meeting
Day 1 &amp; 2 Mini Recap

Nick discusses his highlights, thoughts, and even suggestions from Day 1 &amp; 2 of the 2023 ACCP Annual Meeting in Dallas, TX.
https://www.accp.com/meetings/am23/index.aspx

@PharmacyToDose
PharmacyToDose@Gmail.Com
PharmacyToDose.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 13 Nov 2023 01:35:25 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick discusses highlights, thoughts, and questions from the first 2 days of the 2023 ACCP Annual Meeting in Dallas, TX. </itunes:subtitle>
      <itunes:summary>2023 ACCP Annual Meeting
Day 1 &amp; 2 Mini Recap

Nick discusses his highlights, thoughts, and even suggestions from Day 1 &amp; 2 of the 2023 ACCP Annual Meeting in Dallas, TX.
https://www.accp.com/meetings/am23/index.aspx

@PharmacyToDose
PharmacyToDose@Gmail.Com
PharmacyToDose.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 ACCP Annual Meeting</p><p>Day 1 &amp; 2 Mini Recap</p><p><br></p><p>Nick discusses his highlights, thoughts, and even suggestions from Day 1 &amp; 2 of the 2023 ACCP Annual Meeting in Dallas, TX.</p><p><a href="https://www.accp.com/meetings/am23/index.aspx">https://www.accp.com/meetings/am23/index.aspx</a></p><p><br></p><p>@PharmacyToDose</p><p>PharmacyToDose@Gmail.Com</p><p>PharmacyToDose.com </p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1574</itunes:duration>
      <guid isPermaLink="false"><![CDATA[274be8da-81c6-11ee-9b82-c7036af01203]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7628628874.mp3?updated=1699840449" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>AVP: All Vasopressin Podcast</title>
      <description>AVP: All Vasopressin Podcast
Special Guests: Seth Bauer, PharmD, FCCM, FCCP, BCCCP
Gretchen Sacha, PharmD, BCCCP

05:42 – Historical use/mechanism of action
14:00 – Septic shock guideline recommendations
18:45 – When to add vasopressin?
26:55 – Vasopressin dosing
38:52 – Predicting vasopressin response
48:55 – Use in special populations
61:25 – Discontinuation
67:39 – Cost considerations
72:48 – Use in other shock states
77:00 – Future research/Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/11/avp-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 09 Nov 2023 20:06:07 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Gretchen Sacha and Seth Bauer join me to discuss all things related to the use of vasopressin in septic shock.</itunes:subtitle>
      <itunes:summary>AVP: All Vasopressin Podcast
Special Guests: Seth Bauer, PharmD, FCCM, FCCP, BCCCP
Gretchen Sacha, PharmD, BCCCP

05:42 – Historical use/mechanism of action
14:00 – Septic shock guideline recommendations
18:45 – When to add vasopressin?
26:55 – Vasopressin dosing
38:52 – Predicting vasopressin response
48:55 – Use in special populations
61:25 – Discontinuation
67:39 – Cost considerations
72:48 – Use in other shock states
77:00 – Future research/Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/11/avp-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>AVP: All Vasopressin Podcast</p><p>Special Guests: Seth Bauer, PharmD, FCCM, FCCP, BCCCP</p><p>Gretchen Sacha, PharmD, BCCCP</p><p><br></p><p>05:42 – Historical use/mechanism of action</p><p>14:00 – Septic shock guideline recommendations</p><p>18:45 – When to add vasopressin?</p><p>26:55 – Vasopressin dosing</p><p>38:52 – Predicting vasopressin response</p><p>48:55 – Use in special populations</p><p>61:25 – Discontinuation</p><p>67:39 – Cost considerations</p><p>72:48 – Use in other shock states</p><p>77:00 – Future research/Take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/11/avp-references.pdf">https://pharmacytodose.files.wordpress.com/2023/11/avp-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5298</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7c969818-7f3b-11ee-865f-570718148e92]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6074588480.mp3?updated=1699561434" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Rivers EGDT in Sepsis</title>
      <description>Trial of the Week: Rivers EGDT in Sepsis
Special Guest: Rob Maclaren, PharmD, MPH, MCCM, FCCP

I’m joined by Rob Maclaren to discuss the 2001 NEJM study “Early goal-directed therapy in the treatment of severe sepsis and septic shock.”
We discuss the historical care of sepsis, mortality rates prior to this study, and use of critical care bundles before highlighting all the findings from the Rivers EGDT in sepsis trial. Then we review if one component is more important than others, break down the bundle, is EGDT still recommended, and much, much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/11/rivers-egdt-tow-references.pdf

﻿PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 07 Nov 2023 20:19:11 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Rob Maclaren joins us for a November Trial of the Week highlighting the famous critical care study, Rivers EGDT in Sepsis, published in 2001 in NEJM.</itunes:subtitle>
      <itunes:summary>Trial of the Week: Rivers EGDT in Sepsis
Special Guest: Rob Maclaren, PharmD, MPH, MCCM, FCCP

I’m joined by Rob Maclaren to discuss the 2001 NEJM study “Early goal-directed therapy in the treatment of severe sepsis and septic shock.”
We discuss the historical care of sepsis, mortality rates prior to this study, and use of critical care bundles before highlighting all the findings from the Rivers EGDT in sepsis trial. Then we review if one component is more important than others, break down the bundle, is EGDT still recommended, and much, much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/11/rivers-egdt-tow-references.pdf

﻿PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Rivers EGDT in Sepsis</p><p>Special Guest: Rob Maclaren, PharmD, MPH, MCCM, FCCP</p><p><br></p><p>I’m joined by Rob Maclaren to discuss the 2001 NEJM study “Early goal-directed therapy in the treatment of severe sepsis and septic shock.”</p><p>We discuss the historical care of sepsis, mortality rates prior to this study, and use of critical care bundles before highlighting all the findings from the Rivers EGDT in sepsis trial. Then we review if one component is more important than others, break down the bundle, is EGDT still recommended, and much, much more. </p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/11/rivers-egdt-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/11/rivers-egdt-tow-references.pdf</a></p><p><br></p><p>﻿PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2537</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2d915514-7dab-11ee-a4cf-9b1d3764c8bc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4397288700.mp3?updated=1699389117" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 NACCT PharmD Research Highlights</title>
      <description>2023 North American Congress of Clinical Toxicology (NACCT)
Pharmacist-featured Research Highlights

02:36 –  “Association between daily high temperature and copperhead envenomations reported to a regional poison center” ft. Jimmy Leonard, PharmD, DABAT

18:22 – “Persistent complications following snake envenomation: results of a specialized snake post-discharge clinic” ft. Erin Ryan, PharmD

31:56 – “Evaluation of large-scale, interactive simulation in poison management &amp; drug abuse course” ft. Kristin Reinaker, PharmD, DABAT

44:43 – “A systematic review of phenibut withdrawal with a focus on complications, treatment strategies, and phenibut alone or polysubstance withdrawal” ft. Ryan Feldman, PharmD, BCPS, DABAT

61:33 – “Evaluation of the carbapenem-valproate interaction” ft. Nick Petrucelli, PharmD

70:40 – “The use of ertapenem for reducing toxic valproic acid concentrations” ft. Patrick Dougherty, PharmD, BCPS, BCEMP

Link to view research poster PDFs: https://pharmacytodose.com/2023/11/03/2023-nacct-pharmd-research-highlights/

@PharmacyToDose
PharmacyToDose.com
PharmacyToDose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 03 Nov 2023 16:07:44 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>I'm joined by 6 Pharmacists highlighting their research presented at the 2023 North American Congress of Clinical Toxicology (NACCT). </itunes:subtitle>
      <itunes:summary>2023 North American Congress of Clinical Toxicology (NACCT)
Pharmacist-featured Research Highlights

02:36 –  “Association between daily high temperature and copperhead envenomations reported to a regional poison center” ft. Jimmy Leonard, PharmD, DABAT

18:22 – “Persistent complications following snake envenomation: results of a specialized snake post-discharge clinic” ft. Erin Ryan, PharmD

31:56 – “Evaluation of large-scale, interactive simulation in poison management &amp; drug abuse course” ft. Kristin Reinaker, PharmD, DABAT

44:43 – “A systematic review of phenibut withdrawal with a focus on complications, treatment strategies, and phenibut alone or polysubstance withdrawal” ft. Ryan Feldman, PharmD, BCPS, DABAT

61:33 – “Evaluation of the carbapenem-valproate interaction” ft. Nick Petrucelli, PharmD

70:40 – “The use of ertapenem for reducing toxic valproic acid concentrations” ft. Patrick Dougherty, PharmD, BCPS, BCEMP

Link to view research poster PDFs: https://pharmacytodose.com/2023/11/03/2023-nacct-pharmd-research-highlights/

@PharmacyToDose
PharmacyToDose.com
PharmacyToDose@gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 North American Congress of Clinical Toxicology (NACCT)</p><p>Pharmacist-featured Research Highlights</p><p><br></p><p>02:36 –  “Association between daily high temperature and copperhead envenomations reported to a regional poison center” ft. Jimmy Leonard, PharmD, DABAT</p><p><br></p><p>18:22 – “Persistent complications following snake envenomation: results of a specialized snake post-discharge clinic” ft. Erin Ryan, PharmD</p><p><br></p><p>31:56 – “Evaluation of large-scale, interactive simulation in poison management &amp; drug abuse course” ft. Kristin Reinaker, PharmD, DABAT</p><p><br></p><p>44:43 – “A systematic review of phenibut withdrawal with a focus on complications, treatment strategies, and phenibut alone or polysubstance withdrawal” ft. Ryan Feldman, PharmD, BCPS, DABAT</p><p><br></p><p>61:33 – “Evaluation of the carbapenem-valproate interaction” ft. Nick Petrucelli, PharmD</p><p><br></p><p>70:40 – “The use of ertapenem for reducing toxic valproic acid concentrations” ft. Patrick Dougherty, PharmD, BCPS, BCEMP</p><p><br></p><p>Link to view research poster PDFs: <a href="https://pharmacytodose.com/2023/11/03/2023-nacct-pharmd-research-highlights/">https://pharmacytodose.com/2023/11/03/2023-nacct-pharmd-research-highlights/</a></p><p><br></p><p>@PharmacyToDose</p><p>PharmacyToDose.com</p><p><a href="mailto:PharmacyToDose@gmail.com">PharmacyToDose@gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5364</itunes:duration>
      <guid isPermaLink="false"><![CDATA[40aac27a-7a63-11ee-b051-f389ef4002d4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3082424720.mp3?updated=1699028807" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>CRRT Trials of the Week: RENAL &amp; IDEAL-ICU</title>
      <description>CRRT Trials of the Week: RENAL &amp; IDEAL-ICU 
Special Guest: Linda Awdishu, PharmD, MAS

Linda Awdishu joins me to highlight two landmark studies related to the use of continuous renal replacement therapy (CRRT) in the critically ill.

We discuss renal replacement therapy, compare modalities, and review the history of CRRT as an introduction. Then we review two studies: “Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients: RENAL study” published in 2009 and “Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis: IDEAL-ICU study” published in 2018, both in the New England Journal of Medicine. 

Would these findings be replicated in other populations, do we have answers about the most appropriate effluent rate and when to initiate CRRT in the critically ill, findings from both studies, future research priorities, and much, much more!

References list: https://pharmacytodose.files.wordpress.com/2023/10/crrt-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 31 Oct 2023 22:23:43 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Linda Awdishu joins to highlight not one, but two CRRT-themed landmark research articles: RENAL and the IDEAL-ICU trials published in NEJM. </itunes:subtitle>
      <itunes:summary>CRRT Trials of the Week: RENAL &amp; IDEAL-ICU 
Special Guest: Linda Awdishu, PharmD, MAS

Linda Awdishu joins me to highlight two landmark studies related to the use of continuous renal replacement therapy (CRRT) in the critically ill.

We discuss renal replacement therapy, compare modalities, and review the history of CRRT as an introduction. Then we review two studies: “Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients: RENAL study” published in 2009 and “Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis: IDEAL-ICU study” published in 2018, both in the New England Journal of Medicine. 

Would these findings be replicated in other populations, do we have answers about the most appropriate effluent rate and when to initiate CRRT in the critically ill, findings from both studies, future research priorities, and much, much more!

References list: https://pharmacytodose.files.wordpress.com/2023/10/crrt-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>CRRT Trials of the Week: RENAL &amp; IDEAL-ICU </p><p>Special Guest: Linda Awdishu, PharmD, MAS</p><p><br></p><p>Linda Awdishu joins me to highlight two landmark studies related to the use of continuous renal replacement therapy (CRRT) in the critically ill.</p><p><br></p><p>We discuss renal replacement therapy, compare modalities, and review the history of CRRT as an introduction. Then we review two studies: “Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients: RENAL study” published in 2009 and “Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis: IDEAL-ICU study” published in 2018, both in the New England Journal of Medicine. </p><p><br></p><p>Would these findings be replicated in other populations, do we have answers about the most appropriate effluent rate and when to initiate CRRT in the critically ill, findings from both studies, future research priorities, and much, much more!</p><p><br></p><p>References list: <a href="https://pharmacytodose.files.wordpress.com/2023/10/crrt-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/10/crrt-tow-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3169</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7e8844ce-783c-11ee-8d28-8359e5cd3e40]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1883897149.mp3?updated=1698792029" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pulmonary Hypertension Part II</title>
      <description>Pulmonary Hypertension Part II
Special Guest: Zach Smith, PharmD, BCPS, BCCCP, FCCP

04:03 – Intro/Diagnosis/Classification
14:30 – Treatment overview
24:00 – CCB
30:30 – PDE5i/ERA/GCS
40:00 – Prostacyclins 
46:40 – RV failure in the ICU
64:30 – Role of PharmD/Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/10/pulmonary-hypertension-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 31 Oct 2023 04:38:27 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Zach Smith joins me for an updated overview on the management of pulmonary hypertension in the critically ill as well as a discussion into the management of RV failure.</itunes:subtitle>
      <itunes:summary>Pulmonary Hypertension Part II
Special Guest: Zach Smith, PharmD, BCPS, BCCCP, FCCP

04:03 – Intro/Diagnosis/Classification
14:30 – Treatment overview
24:00 – CCB
30:30 – PDE5i/ERA/GCS
40:00 – Prostacyclins 
46:40 – RV failure in the ICU
64:30 – Role of PharmD/Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/10/pulmonary-hypertension-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Pulmonary Hypertension Part II</p><p>Special Guest: Zach Smith, PharmD, BCPS, BCCCP, FCCP</p><p><br></p><p>04:03 – Intro/Diagnosis/Classification</p><p>14:30 – Treatment overview</p><p>24:00 – CCB</p><p>30:30 – PDE5i/ERA/GCS</p><p>40:00 – Prostacyclins </p><p>46:40 – RV failure in the ICU</p><p>64:30 – Role of PharmD/Take-home points</p><p><br></p><p>Reference List: https://pharmacytodose.files.wordpress.com/2023/10/pulmonary-hypertension-part-ii-references.pdf</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a> </p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4884</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9751ef04-77a7-11ee-a0aa-878cfb16ec85]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8495197909.mp3?updated=1698728099" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: AID-ICU</title>
      <description>Trial of the Week: AID-ICU
Special Guest: Grace Erdman, PharmD

Grace Erdman, 2023 Pharmacy to Dose Award Winner, joins to discuss “Haloperidol for the treatment of delirium in ICU patients: AID-ICU trial” published in NEJM in 2022.
We review studies that led to the AID-ICU study, discuss difficulties with delirium research, deep-dive into the AID-ICU trial, compare treatment in hyper-, and hypoactive delirium, research priorities moving forward, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/10/aid-icu-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 20 Oct 2023 19:13:20 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Grace Erdman joins the podcast to highlight the 2022 NEJM research study, AID-ICU, researching the effect of haloperidol on critically ill patient outcomes. </itunes:subtitle>
      <itunes:summary>Trial of the Week: AID-ICU
Special Guest: Grace Erdman, PharmD

Grace Erdman, 2023 Pharmacy to Dose Award Winner, joins to discuss “Haloperidol for the treatment of delirium in ICU patients: AID-ICU trial” published in NEJM in 2022.
We review studies that led to the AID-ICU study, discuss difficulties with delirium research, deep-dive into the AID-ICU trial, compare treatment in hyper-, and hypoactive delirium, research priorities moving forward, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/10/aid-icu-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: AID-ICU</p><p>Special Guest: Grace Erdman, PharmD</p><p><br></p><p>Grace Erdman, 2023 Pharmacy to Dose Award Winner, joins to discuss “Haloperidol for the treatment of delirium in ICU patients: AID-ICU trial” published in NEJM in 2022.</p><p>We review studies that led to the AID-ICU study, discuss difficulties with delirium research, deep-dive into the AID-ICU trial, compare treatment in hyper-, and hypoactive delirium, research priorities moving forward, and much more. </p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/10/aid-icu-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/10/aid-icu-tow-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1868</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1a801690-6f7d-11ee-9c4d-ebc62cf5844f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7818831338.mp3?updated=1697829940" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: SPLIT</title>
      <description>Trial of the Week: SPLIT
Special Guest: Anthony Hawkins, PharmD, FCCM, BCCCP

Anthony Hawkins joins me to highlight the “Effect of a Buffered Crystalloid Solution vs. Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial” published in JAMA. 
We compare the composition of different crystalloids, review pertinent trials published prior to this study, discuss the findings from the SPLIT RCT, what is the best primary outcome in these studies, research on the horizon, questions to be answered, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/10/split-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 20 Oct 2023 14:10:41 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Anthony Hawkins, our fluid steward, joins the podcast to highlight findings from the landmark SPLIT trial, a study researching the ideal crystalloid in the critically ill. </itunes:subtitle>
      <itunes:summary>Trial of the Week: SPLIT
Special Guest: Anthony Hawkins, PharmD, FCCM, BCCCP

Anthony Hawkins joins me to highlight the “Effect of a Buffered Crystalloid Solution vs. Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial” published in JAMA. 
We compare the composition of different crystalloids, review pertinent trials published prior to this study, discuss the findings from the SPLIT RCT, what is the best primary outcome in these studies, research on the horizon, questions to be answered, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/10/split-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: SPLIT</p><p>Special Guest: Anthony Hawkins, PharmD, FCCM, BCCCP</p><p><br></p><p>Anthony Hawkins joins me to highlight the “Effect of a Buffered Crystalloid Solution vs. Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial” published in JAMA. </p><p>We compare the composition of different crystalloids, review pertinent trials published prior to this study, discuss the findings from the SPLIT RCT, what is the best primary outcome in these studies, research on the horizon, questions to be answered, and much more. </p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/10/split-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/10/split-tow-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2704</itunes:duration>
      <guid isPermaLink="false"><![CDATA[771f8f14-6f52-11ee-b9d7-6b1119bcbff3]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2078182580.mp3?updated=1697812003" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: CRASH-3</title>
      <description>Trial of the Week: CRASH-3
Special Guest: Ruben Santiago, PharmD, BCPS, BCCCP

Ruben Santiago joins me to discuss the landmark article “Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with
acute traumatic brain injury (CRASH-3)” published in Lancet.
We review the history of TXA use in trauma, what the CRASH-3 study ultimately found, how does this compare to previous studies, what are guideline recommendations, applying this info in the viscoelastic testing era, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/10/crash3-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 06 Oct 2023 10:38:13 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Ruben Santiago joins me to highlight the landmark Emergency Medicine article researching tranexamic acid in TBI patients, the CRASH-3 trial</itunes:subtitle>
      <itunes:summary>Trial of the Week: CRASH-3
Special Guest: Ruben Santiago, PharmD, BCPS, BCCCP

Ruben Santiago joins me to discuss the landmark article “Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with
acute traumatic brain injury (CRASH-3)” published in Lancet.
We review the history of TXA use in trauma, what the CRASH-3 study ultimately found, how does this compare to previous studies, what are guideline recommendations, applying this info in the viscoelastic testing era, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/10/crash3-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: CRASH-3</p><p>Special Guest: Ruben Santiago, PharmD, BCPS, BCCCP</p><p><br></p><p>Ruben Santiago joins me to discuss the landmark article “Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with</p><p>acute traumatic brain injury (CRASH-3)” published in Lancet.</p><p>We review the history of TXA use in trauma, what the CRASH-3 study ultimately found, how does this compare to previous studies, what are guideline recommendations, applying this info in the viscoelastic testing era, and much more.</p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/10/crash3-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/10/crash3-tow-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1971</itunes:duration>
      <guid isPermaLink="false"><![CDATA[770386bc-6434-11ee-acd5-6bf8e4d90e7e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9937272854.mp3?updated=1696589284" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>July 2023 Literature Review Series</title>
      <description>Literature Review Series
July 2023
Special Guests: Chris Bollinger, PharmD, MBA
Hannah Davis, PharmD

04:05 – Featured Articles
44:35 – Cardiology
60:30 – Hematology
65:20 – Pulmonary
76:00 – PharmD
82:27 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/10/july-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 05 Oct 2023 17:13:30 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Hannah Davis and Chris Bollinger join me to highlight note-worthy articles from July 2023. We discuss featured articles, as well as those with a cardiology, hematology, and pulmonary focus, before closing the episode with Pharmacist-featured articles and non-clinical articles. </itunes:subtitle>
      <itunes:summary>Literature Review Series
July 2023
Special Guests: Chris Bollinger, PharmD, MBA
Hannah Davis, PharmD

04:05 – Featured Articles
44:35 – Cardiology
60:30 – Hematology
65:20 – Pulmonary
76:00 – PharmD
82:27 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/10/july-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>July 2023</p><p>Special Guests: Chris Bollinger, PharmD, MBA</p><p>Hannah Davis, PharmD</p><p><br></p><p>04:05 – Featured Articles</p><p>44:35 – Cardiology</p><p>60:30 – Hematology</p><p>65:20 – Pulmonary</p><p>76:00 – PharmD</p><p>82:27 – Grab Bag</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/10/july-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2023/10/july-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5415</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a7bbaba0-63a2-11ee-88ee-b3fb81455756]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1792539789.mp3?updated=1696526993" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: UFH v. LMWH for Trauma VTE Prophylaxis</title>
      <description>Trial of the Week: UFH v. LMWH for Trauma VTE Prophylaxis
Special Guest: Brandon Hobbs, PharmD, BCPS, BCCCP, FCCM

Brandon Hobbs joins to discuss the landmark article “A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma” published in the New England Journal of Medicine. 
We review the history of VTE prophylaxis in trauma, what this study ultimately found, how long did it impact practice, what regimen is guideline-recommended today, practices from other centers across the country, and much, more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/vte-ppx-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 29 Sep 2023 15:04:30 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brandon Hobbs joins me to highlight the landmark NEJM article comparing UFH v. LMWH for VTE prophylaxis in trauma patients. </itunes:subtitle>
      <itunes:summary>Trial of the Week: UFH v. LMWH for Trauma VTE Prophylaxis
Special Guest: Brandon Hobbs, PharmD, BCPS, BCCCP, FCCM

Brandon Hobbs joins to discuss the landmark article “A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma” published in the New England Journal of Medicine. 
We review the history of VTE prophylaxis in trauma, what this study ultimately found, how long did it impact practice, what regimen is guideline-recommended today, practices from other centers across the country, and much, more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/vte-ppx-tow-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: UFH v. LMWH for Trauma VTE Prophylaxis</p><p>Special Guest: Brandon Hobbs, PharmD, BCPS, BCCCP, FCCM</p><p><br></p><p>Brandon Hobbs joins to discuss the landmark article “A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma” published in the New England Journal of Medicine. </p><p>We review the history of VTE prophylaxis in trauma, what this study ultimately found, how long did it impact practice, what regimen is guideline-recommended today, practices from other centers across the country, and much, more.</p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/09/vte-ppx-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/vte-ppx-tow-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2724</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9efd852e-5ed9-11ee-801d-c7ed9083742f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5956491957.mp3?updated=1696002146" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ECPR</title>
      <description>Extracorporeal Cardiopulmonary Resuscitation (ECPR) 
Special Guests: Caitlin Brown, PharmD, BCCCP, FCCM
Patrick Wieruszewski, PharmD, BCCCP

04:22 – Definition/History of use
06:48 – ECPR vs. ACLS
11:40 – ECPR research
22:00 –VA ECMO overview
24:02 – Ideal patients/Contraindications
30:52 – ECPR overview from presentation to cannulation
41:15 – Pharmacotherapy in longer ECPR cardiac arrests
49:00 – ECPR post-resuscitation care
50:42 – Guideline recommendations
52:50 – Post-cannulation acute complications
56:10 – ECMO-induced PK/PD changes
59:07 – Advice for new ECPR programs
62:20 – Pharmacist’s role/Take-home points

ECPR: A Primer for Pharmacists https://pubmed.ncbi.nlm.nih.gov/37070401/

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/ecpr-references.pdf

Curious Boxwood Etsy Shop: https://www.etsy.com/shop/curiousboxwood

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 29 Sep 2023 01:01:08 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Patrick Wieruszewski &amp; Caitlin Brown join me to highlight their AJHP article, ECPR: A Primer for Pharmacists, while providing tips/tricks from their experience caring for ECPR patients</itunes:subtitle>
      <itunes:summary>Extracorporeal Cardiopulmonary Resuscitation (ECPR) 
Special Guests: Caitlin Brown, PharmD, BCCCP, FCCM
Patrick Wieruszewski, PharmD, BCCCP

04:22 – Definition/History of use
06:48 – ECPR vs. ACLS
11:40 – ECPR research
22:00 –VA ECMO overview
24:02 – Ideal patients/Contraindications
30:52 – ECPR overview from presentation to cannulation
41:15 – Pharmacotherapy in longer ECPR cardiac arrests
49:00 – ECPR post-resuscitation care
50:42 – Guideline recommendations
52:50 – Post-cannulation acute complications
56:10 – ECMO-induced PK/PD changes
59:07 – Advice for new ECPR programs
62:20 – Pharmacist’s role/Take-home points

ECPR: A Primer for Pharmacists https://pubmed.ncbi.nlm.nih.gov/37070401/

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/ecpr-references.pdf

Curious Boxwood Etsy Shop: https://www.etsy.com/shop/curiousboxwood

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Extracorporeal Cardiopulmonary Resuscitation (ECPR) </p><p>Special Guests: Caitlin Brown, PharmD, BCCCP, FCCM</p><p>Patrick Wieruszewski, PharmD, BCCCP</p><p><br></p><p>04:22 – Definition/History of use</p><p>06:48 – ECPR vs. ACLS</p><p>11:40 – ECPR research</p><p>22:00 –VA ECMO overview</p><p>24:02 – Ideal patients/Contraindications</p><p>30:52 – ECPR overview from presentation to cannulation</p><p>41:15 – Pharmacotherapy in longer ECPR cardiac arrests</p><p>49:00 – ECPR post-resuscitation care</p><p>50:42 – Guideline recommendations</p><p>52:50 – Post-cannulation acute complications</p><p>56:10 – ECMO-induced PK/PD changes</p><p>59:07 – Advice for new ECPR programs</p><p>62:20 – Pharmacist’s role/Take-home points</p><p><br></p><p>ECPR: A Primer for Pharmacists <a href="https://pubmed.ncbi.nlm.nih.gov/37070401/">https://pubmed.ncbi.nlm.nih.gov/37070401/</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/09/ecpr-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/ecpr-references.pdf</a></p><p><br></p><p>Curious Boxwood Etsy Shop: <a href="https://www.etsy.com/shop/curiousboxwood">https://www.etsy.com/shop/curiousboxwood</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4337</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c25b92de-5e63-11ee-b07c-4b1fa3a1c722]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7400114237.mp3?updated=1695950160" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Pharmacist Impact and MRC-ICU Score</title>
      <description>Trial of the Week: Impact of Pharmacists &amp; MRC-ICU Score
Special Guest: Andrea Sikora, PharmD, MSCR, BCCCP, FCCM

Andrea Sikora joins me to discuss her study “Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics with the MRC-ICU Score” published in Critical Care Medicine. 
We review what the MRC-ICU scoring tool is, evidence up to this point, where it’s been implemented, what did this study show, where do we go from here, how to join the MRC-ICU investigator team, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/mrc-icu-tow-references.pdf
Andrea’s book: “Pay It Forward: A Map to Mentorship in Medicine”  https://www.amazon.com/Pay-Forward-Map-Mentorship-Medicine/dp/1946665649

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 22 Sep 2023 15:22:46 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Andrea Sikora joins to highlight the MRC-ICU and the September Trial of the Week, her first author research looking at the use of MRC-ICU score and the impact on Pharmacists.</itunes:subtitle>
      <itunes:summary>Trial of the Week: Impact of Pharmacists &amp; MRC-ICU Score
Special Guest: Andrea Sikora, PharmD, MSCR, BCCCP, FCCM

Andrea Sikora joins me to discuss her study “Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics with the MRC-ICU Score” published in Critical Care Medicine. 
We review what the MRC-ICU scoring tool is, evidence up to this point, where it’s been implemented, what did this study show, where do we go from here, how to join the MRC-ICU investigator team, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/mrc-icu-tow-references.pdf
Andrea’s book: “Pay It Forward: A Map to Mentorship in Medicine”  https://www.amazon.com/Pay-Forward-Map-Mentorship-Medicine/dp/1946665649

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Impact of Pharmacists &amp; MRC-ICU Score</p><p>Special Guest: Andrea Sikora, PharmD, MSCR, BCCCP, FCCM</p><p><br></p><p>Andrea Sikora joins me to discuss her study “Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics with the MRC-ICU Score” published in Critical Care Medicine. </p><p>We review what the MRC-ICU scoring tool is, evidence up to this point, where it’s been implemented, what did this study show, where do we go from here, how to join the MRC-ICU investigator team, and much more. </p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/09/mrc-icu-tow-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/mrc-icu-tow-references.pdf</a></p><p>Andrea’s book: “Pay It Forward: A Map to Mentorship in Medicine”  <a href="https://www.amazon.com/Pay-Forward-Map-Mentorship-Medicine/dp/1946665649">https://www.amazon.com/Pay-Forward-Map-Mentorship-Medicine/dp/1946665649</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2247</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2c6bb530-595c-11ee-92e7-cb8adfe778d2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1268734956.mp3?updated=1695396922" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Acute Coronary Syndromes</title>
      <description>Acute Coronary Syndromes (ACS)
Special Guest: Nick Servati, PharmD, BCCP

04:55 – Pathophysiology/Clinical presentation
12:40 – “MONA” myths
20:05 – P2Y12 pretreatment
24:25 – Thrombolytics in ACS
30:35 – Anticoagulation
38:55 – Vasopressors/Inotropes
49:50 – IV antiplatelet agents
60:10 – STEMI pharmacotherapy checklist
66:00 – Future research/Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/acute-coronary-syndromes-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 21 Sep 2023 21:48:33 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick Servati joins me to do a deep-dive into ACS and its pharmacotherapy in the critically ill. </itunes:subtitle>
      <itunes:summary>Acute Coronary Syndromes (ACS)
Special Guest: Nick Servati, PharmD, BCCP

04:55 – Pathophysiology/Clinical presentation
12:40 – “MONA” myths
20:05 – P2Y12 pretreatment
24:25 – Thrombolytics in ACS
30:35 – Anticoagulation
38:55 – Vasopressors/Inotropes
49:50 – IV antiplatelet agents
60:10 – STEMI pharmacotherapy checklist
66:00 – Future research/Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/acute-coronary-syndromes-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Acute Coronary Syndromes (ACS)</p><p>Special Guest: Nick Servati, PharmD, BCCP</p><p><br></p><p>04:55 – Pathophysiology/Clinical presentation</p><p>12:40 – “MONA” myths</p><p>20:05 – P2Y12 pretreatment</p><p>24:25 – Thrombolytics in ACS</p><p>30:35 – Anticoagulation</p><p>38:55 – Vasopressors/Inotropes</p><p>49:50 – IV antiplatelet agents</p><p>60:10 – STEMI pharmacotherapy checklist</p><p>66:00 – Future research/Take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/09/acute-coronary-syndromes-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/acute-coronary-syndromes-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4602</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ae9c57c4-58c8-11ee-8a33-eb4cfc51e56a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7434837646.mp3?updated=1695333723" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>June 2023 Literature Review Series</title>
      <description>Literature Review Series
June 2023
Special Guest: Beau Blake, PharmD

03:50 – Featured Articles
30:40 – Cardiology
43:10 – PADIS
48:15 – Prostacyclins
51:20 – Infectious Diseases 
63:10 – PharmD
70:15 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/june-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 21 Sep 2023 00:27:44 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Beau Blake joins me to highlight articles that were published in June 2023 including Featured, CV, PADIS, ID, and PharmD featured articles.</itunes:subtitle>
      <itunes:summary>Literature Review Series
June 2023
Special Guest: Beau Blake, PharmD

03:50 – Featured Articles
30:40 – Cardiology
43:10 – PADIS
48:15 – Prostacyclins
51:20 – Infectious Diseases 
63:10 – PharmD
70:15 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/june-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>June 2023</p><p>Special Guest: Beau Blake, PharmD</p><p><br></p><p>03:50 – Featured Articles</p><p>30:40 – Cardiology</p><p>43:10 – PADIS</p><p>48:15 – Prostacyclins</p><p>51:20 – Infectious Diseases </p><p>63:10 – PharmD</p><p>70:15 – Grab Bag</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/09/june-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/june-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4774</itunes:duration>
      <guid isPermaLink="false"><![CDATA[bd8e0c9a-5815-11ee-ba8f-73534a8d8f0b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1787854977.mp3?updated=1695257145" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Linezolid v Daptomycin in VRE BSI</title>
      <description>Trial of the Week: Linezolid v Daptomycin in VRE BSI
Special Guest: Nick Britt, PharmD, MS, BCPS, BCIDP

Nick Britt joins to highlight his first-author research comparing the use of linezolid v. daptomycin for treatment of vancomycin-resistant Enterococcus bloodstream infection (VRE BSI) published in Clinical Infectious Diseases in 2015. We review what the standard of care was for treatment at this time, how this study became to be, covering this featured article and discussing outcomes/results, then reviewing studies published since, how we still use results from this study, and much, much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/dapto-v-linez-vre-bsi-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 20 Sep 2023 00:15:02 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick Britt joins to highlight his first author research comparing antibiotics for the treatment of vancoymycin-resistant Enterococcus bloodstream infections. </itunes:subtitle>
      <itunes:summary>Trial of the Week: Linezolid v Daptomycin in VRE BSI
Special Guest: Nick Britt, PharmD, MS, BCPS, BCIDP

Nick Britt joins to highlight his first-author research comparing the use of linezolid v. daptomycin for treatment of vancomycin-resistant Enterococcus bloodstream infection (VRE BSI) published in Clinical Infectious Diseases in 2015. We review what the standard of care was for treatment at this time, how this study became to be, covering this featured article and discussing outcomes/results, then reviewing studies published since, how we still use results from this study, and much, much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/dapto-v-linez-vre-bsi-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Linezolid v Daptomycin in VRE BSI</p><p>Special Guest: Nick Britt, PharmD, MS, BCPS, BCIDP</p><p><br></p><p>Nick Britt joins to highlight his first-author research comparing the use of linezolid v. daptomycin for treatment of vancomycin-resistant <em>Enterococcus</em> bloodstream infection (VRE BSI) published in Clinical Infectious Diseases in 2015. We review what the standard of care was for treatment at this time, how this study became to be, covering this featured article and discussing outcomes/results, then reviewing studies published since, how we still use results from this study, and much, much more.</p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/09/dapto-v-linez-vre-bsi-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/dapto-v-linez-vre-bsi-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1946</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c57126fc-574a-11ee-b0f4-3fecae54975a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8114809685.mp3?updated=1695169483" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 NCS PharmD Research</title>
      <description>2023 Neurocritical Care Society Annual Meeting Pharmacist-featured research

02:24 – Multicenter comparison of the safety and efficacy of clopidogrel versus ticagrelor for neuroendovascular stents featuring Casey May, PharmD, BCCCP, FNCS
15:24 – Prevalence of augmented renal clearance in neurocritical care population: a prospective multicenter study (Neuro-ARC study) featuring Sherif Mahmoud, BSc (Pharm), MSc, PhD, FNCS
24:41 – Derivation and validation of an equation to predict free valproate concentration in intensive care patients featuring Ji Liu, PharmD, BCCCP
43:05 – Effect of IV push levetiracetam and lacosamide implementation on turn-around times and cost featuring Veronica Bonderski, PharmD, BCCCP
53:25 – Neurostimulant prescription rates in patients with neurologic injuries AND 
Statin effects on inflammatory biomarker concentrations in patients with mild traumatic brain injury: a potential target for intervention featuring Sulaiman Almohaish, PharmD, BCPS and Gretchen Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM
66:20 – Effect of melatonin on the use of antipsychotic medications in the intensive care unit featuring Madeline Mitchell, PharmD, BCPS
77:10 – Pharmacists decrease number of protocol discordant four-factor prothrombin complex concentrate orders for oral anticoagulant-associated intracranial hemorrhage in a community emergency department featuring Ifoma Ofoegbuna, PharmD, BCCCP
84:12 – Clinical pharmacist-driven electronic data capture of medication administration records in the ELECTRO-BOOST multicenter study featuring Andy Webb, PharmD, BCCCP

Link to research poster PDFs: https://pharmacytodose.com/2023/09/13/2023-ncs-pharmd-research-highlights/

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 13 Sep 2023 19:09:32 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Highlighting research presented by Pharmacists at the 2023 Neurocritical Care Society Annual Meeting </itunes:subtitle>
      <itunes:summary>2023 Neurocritical Care Society Annual Meeting Pharmacist-featured research

02:24 – Multicenter comparison of the safety and efficacy of clopidogrel versus ticagrelor for neuroendovascular stents featuring Casey May, PharmD, BCCCP, FNCS
15:24 – Prevalence of augmented renal clearance in neurocritical care population: a prospective multicenter study (Neuro-ARC study) featuring Sherif Mahmoud, BSc (Pharm), MSc, PhD, FNCS
24:41 – Derivation and validation of an equation to predict free valproate concentration in intensive care patients featuring Ji Liu, PharmD, BCCCP
43:05 – Effect of IV push levetiracetam and lacosamide implementation on turn-around times and cost featuring Veronica Bonderski, PharmD, BCCCP
53:25 – Neurostimulant prescription rates in patients with neurologic injuries AND 
Statin effects on inflammatory biomarker concentrations in patients with mild traumatic brain injury: a potential target for intervention featuring Sulaiman Almohaish, PharmD, BCPS and Gretchen Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM
66:20 – Effect of melatonin on the use of antipsychotic medications in the intensive care unit featuring Madeline Mitchell, PharmD, BCPS
77:10 – Pharmacists decrease number of protocol discordant four-factor prothrombin complex concentrate orders for oral anticoagulant-associated intracranial hemorrhage in a community emergency department featuring Ifoma Ofoegbuna, PharmD, BCCCP
84:12 – Clinical pharmacist-driven electronic data capture of medication administration records in the ELECTRO-BOOST multicenter study featuring Andy Webb, PharmD, BCCCP

Link to research poster PDFs: https://pharmacytodose.com/2023/09/13/2023-ncs-pharmd-research-highlights/

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 Neurocritical Care Society Annual Meeting Pharmacist-featured research</p><p><br></p><p>02:24 – Multicenter comparison of the safety and efficacy of clopidogrel versus ticagrelor for neuroendovascular stents featuring Casey May, PharmD, BCCCP, FNCS</p><p>15:24 – Prevalence of augmented renal clearance in neurocritical care population: a prospective multicenter study (Neuro-ARC study) featuring Sherif Mahmoud, BSc (Pharm), MSc, PhD, FNCS</p><p>24:41 – Derivation and validation of an equation to predict free valproate concentration in intensive care patients featuring Ji Liu, PharmD, BCCCP</p><p>43:05 – Effect of IV push levetiracetam and lacosamide implementation on turn-around times and cost featuring Veronica Bonderski, PharmD, BCCCP</p><p>53:25 – Neurostimulant prescription rates in patients with neurologic injuries AND </p><p>Statin effects on inflammatory biomarker concentrations in patients with mild traumatic brain injury: a potential target for intervention featuring Sulaiman Almohaish, PharmD, BCPS and Gretchen Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM</p><p>66:20 – Effect of melatonin on the use of antipsychotic medications in the intensive care unit featuring Madeline Mitchell, PharmD, BCPS</p><p>77:10 – Pharmacists decrease number of protocol discordant four-factor prothrombin complex concentrate orders for oral anticoagulant-associated intracranial hemorrhage in a community emergency department featuring Ifoma Ofoegbuna, PharmD, BCCCP</p><p>84:12 – Clinical pharmacist-driven electronic data capture of medication administration records in the ELECTRO-BOOST multicenter study featuring Andy Webb, PharmD, BCCCP</p><p><br></p><p>Link to research poster PDFs: <a href="https://pharmacytodose.com/2023/09/13/2023-ncs-pharmd-research-highlights/">https://pharmacytodose.com/2023/09/13/2023-ncs-pharmd-research-highlights/</a></p><p><br></p><p>PharmacyToDose.Com</p><p>@PharmacyToDose</p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>6140</itunes:duration>
      <guid isPermaLink="false"><![CDATA[04548b66-5269-11ee-b1d9-834d66baf083]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3668703455.mp3?updated=1694633591" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 Pharmacy to Dose Award Winner Celebration</title>
      <description>2023 Pharmacy to Dose Award Winner Celebration

08:04 – Deborah Wagner, Publication of the year winner
11:35 – Megan Rech, Mentor of the year winner
13:32 – Brian Gilbert, Conference speaker of the year winner
15:45 – Melissa Thompson Bastin, Preceptor of the year winner
18:14 – Alyssa Meester and Adam Smith, Tag Team Tandem of the year winner
21:54 – Grace Erdman, PGY2 resident of the year winner
24:45 – Ruben Santiago and Andy Webb, Co-Social media star winners
28:17 – Carolyn Bell, People’s Choice award winner
30:56 – Mojdeh Heavner, MVP award winner
34:06 – Rob Maclaren, Living legend award winner

2023 Award Winners: https://pharmacytodose.files.wordpress.com/2023/09/the-2023-pharmacy-to-dose-award-winners.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 13 Sep 2023 05:58:30 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick celebrates the 100th episode of the podcast before switching gears and celebrating the 11 winners of the 10 award categories from the First Annual Pharmacy to Dose Awards.</itunes:subtitle>
      <itunes:summary>2023 Pharmacy to Dose Award Winner Celebration

08:04 – Deborah Wagner, Publication of the year winner
11:35 – Megan Rech, Mentor of the year winner
13:32 – Brian Gilbert, Conference speaker of the year winner
15:45 – Melissa Thompson Bastin, Preceptor of the year winner
18:14 – Alyssa Meester and Adam Smith, Tag Team Tandem of the year winner
21:54 – Grace Erdman, PGY2 resident of the year winner
24:45 – Ruben Santiago and Andy Webb, Co-Social media star winners
28:17 – Carolyn Bell, People’s Choice award winner
30:56 – Mojdeh Heavner, MVP award winner
34:06 – Rob Maclaren, Living legend award winner

2023 Award Winners: https://pharmacytodose.files.wordpress.com/2023/09/the-2023-pharmacy-to-dose-award-winners.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 Pharmacy to Dose Award Winner Celebration</p><p><br></p><p>08:04 – Deborah Wagner, Publication of the year winner</p><p>11:35 – Megan Rech, Mentor of the year winner</p><p>13:32 – Brian Gilbert, Conference speaker of the year winner</p><p>15:45 – Melissa Thompson Bastin, Preceptor of the year winner</p><p>18:14 – Alyssa Meester and Adam Smith, Tag Team Tandem of the year winner</p><p>21:54 – Grace Erdman, PGY2 resident of the year winner</p><p>24:45 – Ruben Santiago and Andy Webb, Co-Social media star winners</p><p>28:17 – Carolyn Bell, People’s Choice award winner</p><p>30:56 – Mojdeh Heavner, MVP award winner</p><p>34:06 – Rob Maclaren, Living legend award winner</p><p><br></p><p>2023 Award Winners: <a href="https://pharmacytodose.files.wordpress.com/2023/09/the-2023-pharmacy-to-dose-award-winners.pdf">https://pharmacytodose.files.wordpress.com/2023/09/the-2023-pharmacy-to-dose-award-winners.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2549</itunes:duration>
      <guid isPermaLink="false"><![CDATA[aa948338-51fa-11ee-8732-87d8f14e2a89]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1464684335.mp3?updated=1694585488" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Phenobarbital for Acute Alcohol Withdrawal</title>
      <description>Trial of the Week: Phenobarbital for Acute Alcohol Withdrawal
Special Guest: Joseph Lam, PharmD

Joseph Lam joins me to highlight the 2013 trial published in the Journal of Emergency: Phenobarbital for acute alcohol withdrawal: a prospective, randomized, double-blind, placebo-controlled study. Joe shares his experience in the trial and all he did behind the scenes. Plus, we discuss the role of phenobarbital at that time, what this study found, what do we still need to know on this topic, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/phb-in-aws-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 08 Sep 2023 20:33:36 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Joseph Lam joins me to highlight his research team's study, Phenobarbital for acute alcohol withdrawal: a prospective, randomized, double-blind, placebo-controlled study published in the Journal of Emergency Medicine in 2013. </itunes:subtitle>
      <itunes:summary>Trial of the Week: Phenobarbital for Acute Alcohol Withdrawal
Special Guest: Joseph Lam, PharmD

Joseph Lam joins me to highlight the 2013 trial published in the Journal of Emergency: Phenobarbital for acute alcohol withdrawal: a prospective, randomized, double-blind, placebo-controlled study. Joe shares his experience in the trial and all he did behind the scenes. Plus, we discuss the role of phenobarbital at that time, what this study found, what do we still need to know on this topic, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/phb-in-aws-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Phenobarbital for Acute Alcohol Withdrawal</p><p>Special Guest: Joseph Lam, PharmD</p><p><br></p><p>Joseph Lam joins me to highlight the 2013 trial published in the Journal of Emergency: Phenobarbital for acute alcohol withdrawal: a prospective, randomized, double-blind, placebo-controlled study. Joe shares his experience in the trial and all he did behind the scenes. Plus, we discuss the role of phenobarbital at that time, what this study found, what do we still need to know on this topic, and much more. </p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/09/phb-in-aws-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/phb-in-aws-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1822</itunes:duration>
      <guid isPermaLink="false"><![CDATA[014f0ef4-4e87-11ee-abb0-7b404f5a6bef]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3266887138.mp3?updated=1694205777" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Arrhythmias in the Emergency Department</title>
      <description>Arrhythmias in the Emergency Department
Special Guests: Kyle DeWitt, PharmD, BCPS
Lance Ray, PharmD, BCPS, BCEMP

05:30 – Intro/background
10:10 – Atrial arrhythmias
56:40 – EKGs/Ventricular arrhythmias
72:35 – Bradyarrhythmias/take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/arrhythmias-in-the-ed-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 08 Sep 2023 17:09:48 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Lance Ray and Kyle DeWitt join me to give an overview on the management of arrhythmias in the Emergency Department, highlighting their 2-part review on this same topic published in AJHP</itunes:subtitle>
      <itunes:summary>Arrhythmias in the Emergency Department
Special Guests: Kyle DeWitt, PharmD, BCPS
Lance Ray, PharmD, BCPS, BCEMP

05:30 – Intro/background
10:10 – Atrial arrhythmias
56:40 – EKGs/Ventricular arrhythmias
72:35 – Bradyarrhythmias/take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/09/arrhythmias-in-the-ed-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Arrhythmias in the Emergency Department</p><p>Special Guests: Kyle DeWitt, PharmD, BCPS</p><p>Lance Ray, PharmD, BCPS, BCEMP</p><p><br></p><p>05:30 – Intro/background</p><p>10:10 – Atrial arrhythmias</p><p>56:40 – EKGs/Ventricular arrhythmias</p><p>72:35 – Bradyarrhythmias/take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/09/arrhythmias-in-the-ed-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/arrhythmias-in-the-ed-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5200</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b332c7a4-4e6a-11ee-81cd-1bd205ff16fa]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9193768393.mp3?updated=1694193961" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: ATHOS-3</title>
      <description>Trial of the Week: ATHOS-3 Angiotensin II for the Treatment of Vasodilatory Shock
Special Guest: Dr. Ashish Khanna, MD, MS, FCCP, FCCM, FASA

Dr. Ashish Khanna joins me to highlight the ATHOS-3 trial, where Dr. Khanna is the principal investigator and first author of the NEJM publication.
We discuss the history of angiogensin II, research prior to ATHOS-3, highlight findings from the ATHOS-3 trial, writing for NEJM, experience leading a large prospective RCT in the critically ill, what research do we have since this landmark publication, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/athos3-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 06 Sep 2023 02:21:13 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Dr. Ashish Khanna, principal investigator of the ATHOS-3 research team, joins me to highlight the landmark ATHOS-3 trial as the Trial of the Week. </itunes:subtitle>
      <itunes:summary>Trial of the Week: ATHOS-3 Angiotensin II for the Treatment of Vasodilatory Shock
Special Guest: Dr. Ashish Khanna, MD, MS, FCCP, FCCM, FASA

Dr. Ashish Khanna joins me to highlight the ATHOS-3 trial, where Dr. Khanna is the principal investigator and first author of the NEJM publication.
We discuss the history of angiogensin II, research prior to ATHOS-3, highlight findings from the ATHOS-3 trial, writing for NEJM, experience leading a large prospective RCT in the critically ill, what research do we have since this landmark publication, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/09/athos3-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: ATHOS-3 Angiotensin II for the Treatment of Vasodilatory Shock</p><p>Special Guest: Dr. Ashish Khanna, MD, MS, FCCP, FCCM, FASA</p><p><br></p><p>Dr. Ashish Khanna joins me to highlight the ATHOS-3 trial, where Dr. Khanna is the principal investigator and first author of the NEJM publication.</p><p>We discuss the history of angiogensin II, research prior to ATHOS-3, highlight findings from the ATHOS-3 trial, writing for NEJM, experience leading a large prospective RCT in the critically ill, what research do we have since this landmark publication, and much more.</p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/09/athos3-references.pdf">https://pharmacytodose.files.wordpress.com/2023/09/athos3-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2394</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2024b6bc-4c5c-11ee-858e-2379011ac2be]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9511260870.mp3?updated=1693967556" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Insidious Harm of Medication Diluents</title>
      <description>Trial of the Week: Insidious Harm of Medication Diluents

Special Guest: Carolyn Magee Bell, PharmD, BCCCP

Carolyn Bell joins me to discuss her first author research study, the Insidious Harm of Medication Diluents. We review what the perception around balanced fluids was in 2016, advice for prospective research, ultimate trial take-aways, things she would do different, bribing other Pharmacists, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/08/medication-diluent-trial-of-week-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 25 Aug 2023 20:04:18 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Carolyn Bell joins me to discuss her first author research study, the Insidious Harm of Medication Diluents, published in August 2018 in Critical Care Medicine. </itunes:subtitle>
      <itunes:summary>Trial of the Week: Insidious Harm of Medication Diluents

Special Guest: Carolyn Magee Bell, PharmD, BCCCP

Carolyn Bell joins me to discuss her first author research study, the Insidious Harm of Medication Diluents. We review what the perception around balanced fluids was in 2016, advice for prospective research, ultimate trial take-aways, things she would do different, bribing other Pharmacists, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2023/08/medication-diluent-trial-of-week-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Insidious Harm of Medication Diluents</p><p><br></p><p>Special Guest: Carolyn Magee Bell, PharmD, BCCCP</p><p><br></p><p>Carolyn Bell joins me to discuss her first author research study, the Insidious Harm of Medication Diluents. We review what the perception around balanced fluids was in 2016, advice for prospective research, ultimate trial take-aways, things she would do different, bribing other Pharmacists, and much more.</p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/08/medication-diluent-trial-of-week-references.pdf">https://pharmacytodose.files.wordpress.com/2023/08/medication-diluent-trial-of-week-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1973</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9dc71c6e-4382-11ee-88a9-9b8b558ef449]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9452562764.mp3?updated=1692994857" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>aSAH Part II</title>
      <description>Aneurysmal Subarachnoid Hemorrhage (aSAH) Part II
Special Guest: Casey May, PharmD, BCCCP, FNCS

04:24 – Guideline overview
09:15 – Blood pressure management
22:03 – Nimodipine
31:15 – Antifibrinolytics
36:58 – Hyponatremia and adjunctive treatments
46:20 – Seizure prophylaxis
49:10 -- Cerebral vasospasm/DCI treatment
52:46 -- Gaps in guidelines, future trials, ideas for future studies
60:25 – Take-home points 

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/asah-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 24 Aug 2023 15:14:13 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Casey May joins me to highlight 2 recent guideline statements on the management of aSAH patients. We review guideline recommendations, what's missing, pertinent pharmacotherapy, future research ideas, and much, much more. </itunes:subtitle>
      <itunes:summary>Aneurysmal Subarachnoid Hemorrhage (aSAH) Part II
Special Guest: Casey May, PharmD, BCCCP, FNCS

04:24 – Guideline overview
09:15 – Blood pressure management
22:03 – Nimodipine
31:15 – Antifibrinolytics
36:58 – Hyponatremia and adjunctive treatments
46:20 – Seizure prophylaxis
49:10 -- Cerebral vasospasm/DCI treatment
52:46 -- Gaps in guidelines, future trials, ideas for future studies
60:25 – Take-home points 

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/asah-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Aneurysmal Subarachnoid Hemorrhage (aSAH) Part II</p><p>Special Guest: Casey May, PharmD, BCCCP, FNCS</p><p><br></p><p>04:24 – Guideline overview</p><p>09:15 – Blood pressure management</p><p>22:03 – Nimodipine</p><p>31:15 – Antifibrinolytics</p><p>36:58 – Hyponatremia and adjunctive treatments</p><p>46:20 – Seizure prophylaxis</p><p>49:10 -- Cerebral vasospasm/DCI treatment</p><p>52:46 -- Gaps in guidelines, future trials, ideas for future studies</p><p>60:25 – Take-home points </p><p><br></p><p>Reference List: https://pharmacytodose.files.wordpress.com/2023/08/asah-part-ii-references.pdf</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4148</itunes:duration>
      <guid isPermaLink="false"><![CDATA[e6351c6e-4290-11ee-a4cc-13453b72f2ef]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3013038018.mp3?updated=1692890694" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Tamiflu Dosing Review</title>
      <description>Trial of the Week: Tamiflu Dosing Review
Special Guest: Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM

Melissa Thompson Bastin joins me to discuss her review on oseltamivir dosing in the critically ill. We give an overview of the H1N1 pandemic, treatment regimens we used in the past, findings from this review, present-day oseltamivir dosing, applying lessons learned from H1N1 pandemic to the COVID-19 pandemic, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/08/tamiflu-dosing-trial-of-week-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 18 Aug 2023 21:43:36 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Melissa Thompson Bastin joins me to discuss her review on oseltamivir dosing in the critically ill, published in 2014 in the Annals of Pharmacotherapy. </itunes:subtitle>
      <itunes:summary>Trial of the Week: Tamiflu Dosing Review
Special Guest: Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM

Melissa Thompson Bastin joins me to discuss her review on oseltamivir dosing in the critically ill. We give an overview of the H1N1 pandemic, treatment regimens we used in the past, findings from this review, present-day oseltamivir dosing, applying lessons learned from H1N1 pandemic to the COVID-19 pandemic, and much more. 

Reference list: https://pharmacytodose.files.wordpress.com/2023/08/tamiflu-dosing-trial-of-week-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Tamiflu Dosing Review</p><p>Special Guest: Melissa Thompson Bastin, PharmD, PhD, BCCCP, FCCM</p><p><br></p><p>Melissa Thompson Bastin joins me to discuss her review on oseltamivir dosing in the critically ill. We give an overview of the H1N1 pandemic, treatment regimens we used in the past, findings from this review, present-day oseltamivir dosing, applying lessons learned from H1N1 pandemic to the COVID-19 pandemic, and much more. </p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/08/tamiflu-dosing-trial-of-week-references.pdf">https://pharmacytodose.files.wordpress.com/2023/08/tamiflu-dosing-trial-of-week-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1823</itunes:duration>
      <guid isPermaLink="false"><![CDATA[94d4e59a-3e10-11ee-9c13-d39990b81d44]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4237775659.mp3?updated=1692395642" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>HFpEF and Guideline/Consensus Document Writing</title>
      <description>Heart Failure with Preserved Ejection Fraction (HFpEF) and Guideline/Consensus Document Writing
Special Guest: Dave Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS

02:57 – Experience and advice with guideline/consensus document writing 
19:40 – HFpEF definition, complications, acute presentation, and HFpEF mimics
36:17 – HFpEF GDMT treatment
61:50 – Future directions and take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/hfpef-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 17 Aug 2023 04:52:06 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Dave Dixon joins me to highlight his experience on the heart failure with preserved ejection fraction (HFpEF) consensus decision pathway, before diving into all things HFpEF and its pharmacotherapy. </itunes:subtitle>
      <itunes:summary>Heart Failure with Preserved Ejection Fraction (HFpEF) and Guideline/Consensus Document Writing
Special Guest: Dave Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS

02:57 – Experience and advice with guideline/consensus document writing 
19:40 – HFpEF definition, complications, acute presentation, and HFpEF mimics
36:17 – HFpEF GDMT treatment
61:50 – Future directions and take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/hfpef-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Heart Failure with Preserved Ejection Fraction (HFpEF) and Guideline/Consensus Document Writing</p><p>Special Guest: Dave Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS</p><p><br></p><p>02:57 – Experience and advice with guideline/consensus document writing </p><p>19:40 – HFpEF definition, complications, acute presentation, and HFpEF mimics</p><p>36:17 – HFpEF GDMT treatment</p><p>61:50 – Future directions and take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/08/hfpef-references.pdf">https://pharmacytodose.files.wordpress.com/2023/08/hfpef-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4475</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d4ddcbb4-3cb9-11ee-a7d3-3fbf95681074]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5957274722.mp3?updated=1692248787" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ARDS Part II</title>
      <description>ARDS Part II
Special Guest: Steven Lemieux, PharmD, BCPS, BCCCP

03:45 – ESICM guidelines and ARDS definition
11:50 – Phenotypes and respiratory support
23:50 – Corticosteroids
34:40 – NMBA, pulmonary vasodilators, and VV ECMO
44:00 - Fun facts and take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/ards-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 11 Aug 2023 16:01:27 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Steven Lemieux joins me to discuss ARDS, specifically highlighting the 2023 ESICM guidelines while also discussing severe ARDS pharmacotherapy </itunes:subtitle>
      <itunes:summary>ARDS Part II
Special Guest: Steven Lemieux, PharmD, BCPS, BCCCP

03:45 – ESICM guidelines and ARDS definition
11:50 – Phenotypes and respiratory support
23:50 – Corticosteroids
34:40 – NMBA, pulmonary vasodilators, and VV ECMO
44:00 - Fun facts and take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/ards-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ARDS Part II</p><p>Special Guest: Steven Lemieux, PharmD, BCPS, BCCCP</p><p><br></p><p>03:45 – ESICM guidelines and ARDS definition</p><p>11:50 – Phenotypes and respiratory support</p><p>23:50 – Corticosteroids</p><p>34:40 – NMBA, pulmonary vasodilators, and VV ECMO</p><p>44:00 - Fun facts and take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/08/ards-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2023/08/ards-part-ii-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3310</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9704afea-3860-11ee-bd1f-ef66ebd37453]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9658228107.mp3?updated=1691770398" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: CATS</title>
      <description>Trial of the Week: CATS

Special Guest: Scott Benken, PharmD, MHPE, BCPS-AQ Cardiology, FCCM, FCCP

Scott Benken joins me to discuss the upcoming 2023 Chicagoland Critical Care Conference before reviewing the 2007 CATS study which compares catecholamine vasopressors and inotropes in septic shock. We cover the history of septic shock treatment, review the study results, current guideline recommendations, and much more.

2023 Chicagoland Critical Care Conference registration link:https://appserv7.admin.uillinois.edu/FormBuilderSurvey/Survey/uic_college_of_pharmacy/continuing_education/critical_care_2023/Survey

Reference list: https://pharmacytodose.files.wordpress.com/2023/08/cats-trial-of-week-references.pdf


PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 11 Aug 2023 14:01:45 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Scott Benken joins me to promote the C4 conference and review the landmark CATS trial, researching norepinephrine and dobutamine compared to epinephrine in septic shock</itunes:subtitle>
      <itunes:summary>Trial of the Week: CATS

Special Guest: Scott Benken, PharmD, MHPE, BCPS-AQ Cardiology, FCCM, FCCP

Scott Benken joins me to discuss the upcoming 2023 Chicagoland Critical Care Conference before reviewing the 2007 CATS study which compares catecholamine vasopressors and inotropes in septic shock. We cover the history of septic shock treatment, review the study results, current guideline recommendations, and much more.

2023 Chicagoland Critical Care Conference registration link:https://appserv7.admin.uillinois.edu/FormBuilderSurvey/Survey/uic_college_of_pharmacy/continuing_education/critical_care_2023/Survey

Reference list: https://pharmacytodose.files.wordpress.com/2023/08/cats-trial-of-week-references.pdf


PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: CATS</p><p><br></p><p>Special Guest: Scott Benken, PharmD, MHPE, BCPS-AQ Cardiology, FCCM, FCCP</p><p><br></p><p>Scott Benken joins me to discuss the upcoming 2023 Chicagoland Critical Care Conference before reviewing the 2007 CATS study which compares catecholamine vasopressors and inotropes in septic shock. We cover the history of septic shock treatment, review the study results, current guideline recommendations, and much more.</p><p><br></p><p>2023 Chicagoland Critical Care Conference registration link:<a href="https://appserv7.admin.uillinois.edu/FormBuilderSurvey/Survey/uic_college_of_pharmacy/continuing_education/critical_care_2023/Survey">https://appserv7.admin.uillinois.edu/FormBuilderSurvey/Survey/uic_college_of_pharmacy/continuing_education/critical_care_2023/Survey</a></p><p><br></p><p>Reference list: <a href="https://pharmacytodose.files.wordpress.com/2023/08/cats-trial-of-week-references.pdf">https://pharmacytodose.files.wordpress.com/2023/08/cats-trial-of-week-references.pdf</a></p><p><br></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1934</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d09ce01c-384f-11ee-bbfe-efa6cef6827e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7614106113.mp3?updated=1691763319" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trial of the Week: Unpeeling the Banana Bag</title>
      <description>Trial of the Week: Unpeeling the Banana Bag

Special Guests: Aaron Cook, PharmD, FCCP, FNCS, FKSHP, BCCCP, BCPS
Alex Flannery, PharmD, PhD, FCCM, BCCCP, BCPS

Listen to Aaron and Alex go into the history of this famous article, discuss how this paper, and how they still feel the impact years after publication.

Flannery AH, Adkins DA, Cook AM. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU. Crit Care Med. 2016 Aug;44(8):1545-52. https://pubmed.ncbi.nlm.nih.gov/27002274/

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 04 Aug 2023 10:31:29 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Aaron Cook and Alex Flannery join me for the inaugural Trial of the Week to discuss one of their most recognized publications</itunes:subtitle>
      <itunes:summary>Trial of the Week: Unpeeling the Banana Bag

Special Guests: Aaron Cook, PharmD, FCCP, FNCS, FKSHP, BCCCP, BCPS
Alex Flannery, PharmD, PhD, FCCM, BCCCP, BCPS

Listen to Aaron and Alex go into the history of this famous article, discuss how this paper, and how they still feel the impact years after publication.

Flannery AH, Adkins DA, Cook AM. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU. Crit Care Med. 2016 Aug;44(8):1545-52. https://pubmed.ncbi.nlm.nih.gov/27002274/

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trial of the Week: Unpeeling the Banana Bag</p><p><br></p><p>Special Guests: Aaron Cook, PharmD, FCCP, FNCS, FKSHP, BCCCP, BCPS</p><p>Alex Flannery, PharmD, PhD, FCCM, BCCCP, BCPS</p><p><br></p><p>Listen to Aaron and Alex go into the history of this famous article, discuss how this paper, and how they still feel the impact years after publication.</p><p><br></p><p>Flannery AH, Adkins DA, Cook AM. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU. <em>Crit Care Med</em>. 2016 Aug;44(8):1545-52. <a href="https://pubmed.ncbi.nlm.nih.gov/27002274/">https://pubmed.ncbi.nlm.nih.gov/27002274/</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>1456</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2e0d86d2-32b2-11ee-8602-87116039766b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8305764492.mp3?updated=1691145678" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: MERCY</title>
      <description>Rapid Reaction: MERCY

Special Guests: Erin McCreary, PharmD, BCPS, BCIDP
Jason Pogue, PharmD, BCPS, BCIDP

11:00 – Background, study methodology, and results
23:00 – MERCY deep-dive, discussion, and future considerations

MERCY: https://pubmed.ncbi.nlm.nih.gov/37326473/

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/mercy-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 02 Aug 2023 21:06:12 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Erin McCreary and Jason Pogue join me to break down the MERCY trial, published in JAMA in July 2023, comparing continuous v intermittent administration of meropenem in sepsis</itunes:subtitle>
      <itunes:summary>Rapid Reaction: MERCY

Special Guests: Erin McCreary, PharmD, BCPS, BCIDP
Jason Pogue, PharmD, BCPS, BCIDP

11:00 – Background, study methodology, and results
23:00 – MERCY deep-dive, discussion, and future considerations

MERCY: https://pubmed.ncbi.nlm.nih.gov/37326473/

Reference List: https://pharmacytodose.files.wordpress.com/2023/08/mercy-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: MERCY</p><p><br></p><p>Special Guests: Erin McCreary, PharmD, BCPS, BCIDP</p><p>Jason Pogue, PharmD, BCPS, BCIDP</p><p><br></p><p>11:00 – Background, study methodology, and results</p><p>23:00 – MERCY deep-dive, discussion, and future considerations</p><p><br></p><p>MERCY: <a href="https://pubmed.ncbi.nlm.nih.gov/37326473/">https://pubmed.ncbi.nlm.nih.gov/37326473/</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/08/mercy-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2023/08/mercy-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4307</itunes:duration>
      <guid isPermaLink="false"><![CDATA[78147ba4-3178-11ee-ab27-77c919f382c1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2911663327.mp3?updated=1691011106" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>May 2023 Literature Review Series</title>
      <description>Literature Review Series
May 2023
Special Guest: Kelly Oldziej, PharmD

05:00 – Featured Articles
36:20 – Cardiology
47:20 – Infectious Diseases
51:00 – Emergency Medicine
59:22 – PharmD
66:15 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/may-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sat, 29 Jul 2023 00:15:41 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Kelly Oldziej, PharmD joins me to highlight the notable articles from May 2023. </itunes:subtitle>
      <itunes:summary>Literature Review Series
May 2023
Special Guest: Kelly Oldziej, PharmD

05:00 – Featured Articles
36:20 – Cardiology
47:20 – Infectious Diseases
51:00 – Emergency Medicine
59:22 – PharmD
66:15 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/may-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>May 2023</p><p>Special Guest: Kelly Oldziej, PharmD</p><p><br></p><p>05:00 – Featured Articles</p><p>36:20 – Cardiology</p><p>47:20 – Infectious Diseases</p><p>51:00 – Emergency Medicine</p><p>59:22 – PharmD</p><p>66:15 – Grab Bag</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/07/may-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2023/07/may-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4540</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3999e19c-2da5-11ee-9a9a-074c62fb048d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4600792779.mp3?updated=1690591041" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Amiodarone v Lidocaine: Versus Series</title>
      <description>Amiodarone v. Lidocaine: Versus Series
Special Guest: Matt Wanat, PharmD, BCPS, BCCCP, FCCM

05:50 – Out-of-hospital cardiac arrest
19:15 – In-hospital cardiac arrest
32:04 – Refractory ventricular arrhythmias
47:08 – Potpourri
52:26 – Closing statements

2023 Pharmacy to Dose Awards Ballot: https://forms.gle/9y2wTM8y8tgodvYUA

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/amiodarone-vs-lidocaine-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 20 Jul 2023 13:30:27 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Matt Wanat joins me in the first ever Pharmacy to Dose: Versus Series, where 2 critical care pharmacotherapy agents square off to determine a champion. Matt is defending amiodarone, and Nick is defending lidocaine. </itunes:subtitle>
      <itunes:summary>Amiodarone v. Lidocaine: Versus Series
Special Guest: Matt Wanat, PharmD, BCPS, BCCCP, FCCM

05:50 – Out-of-hospital cardiac arrest
19:15 – In-hospital cardiac arrest
32:04 – Refractory ventricular arrhythmias
47:08 – Potpourri
52:26 – Closing statements

2023 Pharmacy to Dose Awards Ballot: https://forms.gle/9y2wTM8y8tgodvYUA

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/amiodarone-vs-lidocaine-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Amiodarone v. Lidocaine: Versus Series</p><p>Special Guest: Matt Wanat, PharmD, BCPS, BCCCP, FCCM</p><p><br></p><p>05:50 – Out-of-hospital cardiac arrest</p><p>19:15 – In-hospital cardiac arrest</p><p>32:04 – Refractory ventricular arrhythmias</p><p>47:08 – Potpourri</p><p>52:26 – Closing statements</p><p><br></p><p>2023 Pharmacy to Dose Awards Ballot: <a href="https://forms.gle/9y2wTM8y8tgodvYUA">https://forms.gle/9y2wTM8y8tgodvYUA</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/07/amiodarone-vs-lidocaine-references.pdf">https://pharmacytodose.files.wordpress.com/2023/07/amiodarone-vs-lidocaine-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3886</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9c9e5480-2701-11ee-8f59-774f91b3fc92]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1733516363.mp3?updated=1689860541" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>COPD</title>
      <description>COPD
Special Guest: Ty Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS

03:15 – Background &amp; classification
07:10 – AECOPD
13:00 – Pharmacotherapy in AECOPD
32:40 – Maintenance medications
41:55 – Future research / wrap-up 

2023 Pharmacy to Dose Awards Ballot: https://forms.gle/9y2wTM8y8tgodvYUA

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/copd-references-1.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 18 Jul 2023 01:59:32 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>COPD Discussion with Ty Kiser where we dive into the new 2023 GOLD Report, discuss pharmacotherapy in AECOPD, considerations for maintenance medications, future research, and much more. </itunes:subtitle>
      <itunes:summary>COPD
Special Guest: Ty Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS

03:15 – Background &amp; classification
07:10 – AECOPD
13:00 – Pharmacotherapy in AECOPD
32:40 – Maintenance medications
41:55 – Future research / wrap-up 

2023 Pharmacy to Dose Awards Ballot: https://forms.gle/9y2wTM8y8tgodvYUA

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/copd-references-1.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>COPD</p><p>Special Guest: Ty Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS</p><p><br></p><p>03:15 – Background &amp; classification</p><p>07:10 – AECOPD</p><p>13:00 – Pharmacotherapy in AECOPD</p><p>32:40 – Maintenance medications</p><p>41:55 – Future research / wrap-up </p><p><br></p><p>2023 Pharmacy to Dose Awards Ballot: <a href="https://forms.gle/9y2wTM8y8tgodvYUA">https://forms.gle/9y2wTM8y8tgodvYUA</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/07/copd-references-1.pdf">https://pharmacytodose.files.wordpress.com/2023/07/copd-references-1.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3146</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b71dea7c-250e-11ee-89a4-f3ecacbae548]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2636471902.mp3?updated=1689646266" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>BP Control in Neurologic Emergencies Part II</title>
      <description>BP Control in Neurologic Emergencies Part II
Special Guest: Andrew Webb, PharmD, BCCCP
https://www.neurowiserx.com

02:25 – Antihypertensive treatment overview
10:02 – IV push agents
17:47 – Continuous IV agents
34:00 – Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/bp-in-neurologic-emergencies-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 06 Jul 2023 21:46:22 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Andy Webb joins me for Part II of BP Control in Neurologic Emergencies, focusing on antihypertensive pharmacotherapy and treatment considerations for the neurocritical care patient </itunes:subtitle>
      <itunes:summary>BP Control in Neurologic Emergencies Part II
Special Guest: Andrew Webb, PharmD, BCCCP
https://www.neurowiserx.com

02:25 – Antihypertensive treatment overview
10:02 – IV push agents
17:47 – Continuous IV agents
34:00 – Take-home points

Reference List: https://pharmacytodose.files.wordpress.com/2023/07/bp-in-neurologic-emergencies-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>BP Control in Neurologic Emergencies Part II</p><p>Special Guest: Andrew Webb, PharmD, BCCCP</p><p><a href="https://www.neurowiserx.com/">https://www.neurowiserx.com</a></p><p><br></p><p>02:25 – Antihypertensive treatment overview</p><p>10:02 – IV push agents</p><p>17:47 – Continuous IV agents</p><p>34:00 – Take-home points</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/07/bp-in-neurologic-emergencies-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2023/07/bp-in-neurologic-emergencies-part-ii-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2610</itunes:duration>
      <guid isPermaLink="false"><![CDATA[99d974b6-1c46-11ee-9c26-fb5ba0095769]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3445061133.mp3?updated=1688680639" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>BP Control in Neurologic Emergencies Part I</title>
      <description>Blood Pressure Control in Neurologic Emergencies Part I
Special Guest: Andrew Webb, PharmD, BCCCP
https://www.neurowiserx.com

03:50 – Background/pathophysiology
11:30 – AIS &amp; thrombolysis
20:10 – AIS &amp; thrombectomy
39:35 – Spontaneous intracerebral hemorrhage

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/bp-in-neurologic-emergencies-part-i-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 29 Jun 2023 16:59:58 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Andy Webb joins me in Part I of Blood Pressure Control in Neurologic Emergencies, focusing on the individual emergencies themselves with specific BP goals, landmark trials, and other considerations.</itunes:subtitle>
      <itunes:summary>Blood Pressure Control in Neurologic Emergencies Part I
Special Guest: Andrew Webb, PharmD, BCCCP
https://www.neurowiserx.com

03:50 – Background/pathophysiology
11:30 – AIS &amp; thrombolysis
20:10 – AIS &amp; thrombectomy
39:35 – Spontaneous intracerebral hemorrhage

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/bp-in-neurologic-emergencies-part-i-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Blood Pressure Control in Neurologic Emergencies Part I</p><p>Special Guest: Andrew Webb, PharmD, BCCCP</p><p><a href="https://www.neurowiserx.com/">https://www.neurowiserx.com</a></p><p><br></p><p>03:50 – Background/pathophysiology</p><p>11:30 – AIS &amp; thrombolysis</p><p>20:10 – AIS &amp; thrombectomy</p><p>39:35 – Spontaneous intracerebral hemorrhage</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/06/bp-in-neurologic-emergencies-part-i-references.pdf">https://pharmacytodose.files.wordpress.com/2023/06/bp-in-neurologic-emergencies-part-i-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3901</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6bad3cd8-169e-11ee-ba35-33d3e6f6b425]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7864690376.mp3?updated=1688058648" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ESOC 2023 Rapid Reactions: TIMELESS &amp; OPTIMAL-BP</title>
      <description>ESOC 2023 Rapid Reactions: TIMELESS and OPTIMAL-BP

Special Guest: Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP 

04:15 – TIMELESS trial
21:20 – OPTIMAL-BP trial

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/esoc-2023-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 26 Jun 2023 20:07:17 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Leslie Hamilton joins me to highlight 2 studies that were discussed at ESOC 2023, but haven't been published yet.</itunes:subtitle>
      <itunes:summary>ESOC 2023 Rapid Reactions: TIMELESS and OPTIMAL-BP

Special Guest: Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP 

04:15 – TIMELESS trial
21:20 – OPTIMAL-BP trial

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/esoc-2023-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ESOC 2023 Rapid Reactions: TIMELESS and OPTIMAL-BP</p><p><br></p><p>Special Guest: Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP </p><p><br></p><p>04:15 – TIMELESS trial</p><p>21:20 – OPTIMAL-BP trial</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/06/esoc-2023-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2023/06/esoc-2023-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2515</itunes:duration>
      <guid isPermaLink="false"><![CDATA[208ca380-145d-11ee-9e32-df5758a5c495]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7351189859.mp3?updated=1687810772" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 SAEM PharmD Research</title>
      <description>2023 SAEM PharmD Research 

02:10 – Emergency Medicine Resident Perceptions of the Educational Impact of Emergency Medicine Clinical Pharmacists with Francisco Ibarra, PharmD, BCCCP

12:10 – Impact of Emergency Medicine Pharmacists on Anticoagulation Reversal with Jaclyn Scalgione, PharmD, BCPS

24:25 – Incidence of Postintubation Hypotension after Rapid Sequence Intubation in Full vs. Reduced Dose Induction Agent with Alicia Mattson, PharmD, BCCCP

35:12 – Phenobarbital as an Adjunct to Benzodiazepines in the Setting of Alcohol Withdrawal with Amelia Slane, PharmD, BCPS

48:19 – Single Dose Aminoglycosides for Complicated Urinary Tract Infections in the Emergency Department with Jordan Jenrette, PharmD

61:53 – Effect of Intravenous vs. Oral First Dose Antibiotics in the Emergency Department on Hospital Admission with Jessica Pham, PharmD

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 22 Jun 2023 18:04:24 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>6 Pharmacists highlight their research presented at the 2023 SAEM Annual Meeting with Nick</itunes:subtitle>
      <itunes:summary>2023 SAEM PharmD Research 

02:10 – Emergency Medicine Resident Perceptions of the Educational Impact of Emergency Medicine Clinical Pharmacists with Francisco Ibarra, PharmD, BCCCP

12:10 – Impact of Emergency Medicine Pharmacists on Anticoagulation Reversal with Jaclyn Scalgione, PharmD, BCPS

24:25 – Incidence of Postintubation Hypotension after Rapid Sequence Intubation in Full vs. Reduced Dose Induction Agent with Alicia Mattson, PharmD, BCCCP

35:12 – Phenobarbital as an Adjunct to Benzodiazepines in the Setting of Alcohol Withdrawal with Amelia Slane, PharmD, BCPS

48:19 – Single Dose Aminoglycosides for Complicated Urinary Tract Infections in the Emergency Department with Jordan Jenrette, PharmD

61:53 – Effect of Intravenous vs. Oral First Dose Antibiotics in the Emergency Department on Hospital Admission with Jessica Pham, PharmD

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 SAEM PharmD Research </p><p><br></p><p>02:10 – Emergency Medicine Resident Perceptions of the Educational Impact of Emergency Medicine Clinical Pharmacists with Francisco Ibarra, PharmD, BCCCP</p><p><br></p><p>12:10 – Impact of Emergency Medicine Pharmacists on Anticoagulation Reversal with Jaclyn Scalgione, PharmD, BCPS</p><p><br></p><p>24:25 – Incidence of Postintubation Hypotension after Rapid Sequence Intubation in Full vs. Reduced Dose Induction Agent with Alicia Mattson, PharmD, BCCCP</p><p><br></p><p>35:12 – Phenobarbital as an Adjunct to Benzodiazepines in the Setting of Alcohol Withdrawal with Amelia Slane, PharmD, BCPS</p><p><br></p><p>48:19 – Single Dose Aminoglycosides for Complicated Urinary Tract Infections in the Emergency Department with Jordan Jenrette, PharmD</p><p><br></p><p>61:53 – Effect of Intravenous vs. Oral First Dose Antibiotics in the Emergency Department on Hospital Admission with Jessica Pham, PharmD</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4571</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6663635a-1127-11ee-86c6-1ba7ae4a6900]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5064453380.mp3?updated=1687457870" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: INTERACT3</title>
      <description>Rapid Reaction: INTERACT3

Special Guests: Keaton Smetana, PharmD, MBA, BCCCP, FNCS
Todd Miano, PharmD, PhD, FCCM

04:05 – Background, methodology, and results
17:35 – Statistics consideration and breakdown
31:10 – Deep-dive and future considerations

2023 Award Nomination Link: https://t.co/G4NfEEBFaS

INTERACT3: https://pubmed.ncbi.nlm.nih.gov/37245517/

Todd Miano Figures: https://pharmacytodose.files.wordpress.com/2023/06/interact3_slides.pdf

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/interact3-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 20 Jun 2023 16:59:26 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Keaton Smetana and Todd Miano join Nick to dive into the INTERACT3 results, statistics, ultimate take-aways, and much more. </itunes:subtitle>
      <itunes:summary>Rapid Reaction: INTERACT3

Special Guests: Keaton Smetana, PharmD, MBA, BCCCP, FNCS
Todd Miano, PharmD, PhD, FCCM

04:05 – Background, methodology, and results
17:35 – Statistics consideration and breakdown
31:10 – Deep-dive and future considerations

2023 Award Nomination Link: https://t.co/G4NfEEBFaS

INTERACT3: https://pubmed.ncbi.nlm.nih.gov/37245517/

Todd Miano Figures: https://pharmacytodose.files.wordpress.com/2023/06/interact3_slides.pdf

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/interact3-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: INTERACT3</p><p><br></p><p>Special Guests: Keaton Smetana, PharmD, MBA, BCCCP, FNCS</p><p>Todd Miano, PharmD, PhD, FCCM</p><p><br></p><p>04:05 – Background, methodology, and results</p><p>17:35 – Statistics consideration and breakdown</p><p>31:10 – Deep-dive and future considerations</p><p><br></p><p>2023 Award Nomination Link: <a href="https://t.co/G4NfEEBFaS">https://t.co/G4NfEEBFaS</a></p><p><br></p><p>INTERACT3: <a href="https://pubmed.ncbi.nlm.nih.gov/37245517/"><strong>https://pubmed.ncbi.nlm.nih.gov/37245517/</strong></a></p><p><br></p><p>Todd Miano Figures: <a href="https://pharmacytodose.files.wordpress.com/2023/06/interact3_slides.pdf">https://pharmacytodose.files.wordpress.com/2023/06/interact3_slides.pdf</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/06/interact3-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2023/06/interact3-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3844</itunes:duration>
      <guid isPermaLink="false"><![CDATA[60fb630a-0f8c-11ee-af8a-bb4044b7788f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9504681181.mp3?updated=1687281375" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>April 2023 Literature Review Series</title>
      <description>Literature Review Series
Apr 2023

02:45 – 6-pack of studies
18:16 – Neuro
23:06 – Heme
27:55 – Infectious Diseases
31:20 – PharmD
36:44 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/apr-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 16 Jun 2023 19:22:03 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Nick reviews some of the most notable articles from April 2023</itunes:subtitle>
      <itunes:summary>Literature Review Series
Apr 2023

02:45 – 6-pack of studies
18:16 – Neuro
23:06 – Heme
27:55 – Infectious Diseases
31:20 – PharmD
36:44 – Grab Bag

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/apr-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>Apr 2023</p><p><br></p><p>02:45 – 6-pack of studies</p><p>18:16 – Neuro</p><p>23:06 – Heme</p><p>27:55 – Infectious Diseases</p><p>31:20 – PharmD</p><p>36:44 – Grab Bag</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/06/apr-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2023/06/apr-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2593</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1527c662-0c7b-11ee-b4dd-b7ba6b6822f3]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9879433428.mp3?updated=1686944012" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Perioperative Emergencies: Part II</title>
      <description>Perioperative Emergencies: Part II
Special Guests: Sara J. Hyland, PharmD, BCCCP
Eric Johnson, PharmD, BCCCP
Gourang Patel, PharmD, MSc, BCPS, BCCCP, FCCP, FCCM
Rachel Wolfe, PharmD, MHA, BCCCP

2023 Award Nomination Form: https://forms.gle/5oRzFYoVyJdPNCDA6

04:10 – LAST
24:05 – Dantrolene
37:45 – Advice and Future Vision

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/perioperative-emergencies-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 06 Jun 2023 17:41:49 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Part II in the series discussing perioperative emergencies and perioperative clinical pharmacy services</itunes:subtitle>
      <itunes:summary>Perioperative Emergencies: Part II
Special Guests: Sara J. Hyland, PharmD, BCCCP
Eric Johnson, PharmD, BCCCP
Gourang Patel, PharmD, MSc, BCPS, BCCCP, FCCP, FCCM
Rachel Wolfe, PharmD, MHA, BCCCP

2023 Award Nomination Form: https://forms.gle/5oRzFYoVyJdPNCDA6

04:10 – LAST
24:05 – Dantrolene
37:45 – Advice and Future Vision

Reference List: https://pharmacytodose.files.wordpress.com/2023/06/perioperative-emergencies-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Perioperative Emergencies: Part II</p><p>Special Guests: Sara J. Hyland, PharmD, BCCCP</p><p>Eric Johnson, PharmD, BCCCP</p><p>Gourang Patel, PharmD, MSc, BCPS, BCCCP, FCCP, FCCM</p><p>Rachel Wolfe, PharmD, MHA, BCCCP</p><p><br></p><p>2023 Award Nomination Form: <a href="https://forms.gle/5oRzFYoVyJdPNCDA6">https://forms.gle/5oRzFYoVyJdPNCDA6</a></p><p><br></p><p>04:10 – LAST</p><p>24:05 – Dantrolene</p><p>37:45 – Advice and Future Vision</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/06/perioperative-emergencies-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2023/06/perioperative-emergencies-part-ii-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3562</itunes:duration>
      <guid isPermaLink="false"><![CDATA[737d000c-0491-11ee-a349-0beb4b6e99b0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1410445903.mp3?updated=1686073951" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Clinical Pearls with the Partners and Awards!</title>
      <description>Special Guests and Podcast Partners: 
Tori Arsenault, PharmD
Brooke Barlow, PharmD
Anthony Hawkins, PharmD, FCCM
Sylvia Stefanos, PharmD

2023 Pharmacy to Dose Award Nomination Form: https://t.co/G4NfEEBFaS

03:30 – 2023 Pharmacy to Dose Awards Info
18:35 – Medical Social Media Tips/Tricks
43:55 – Picking a Topic for Residency Research Projects
69:30 – Teaching and Precepting at the Bedside

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 02 Jun 2023 05:38:13 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Official announcement of the Podcast Partnership as well as the 2023 Pharmacy to Dose Awards nomination information</itunes:subtitle>
      <itunes:summary>Special Guests and Podcast Partners: 
Tori Arsenault, PharmD
Brooke Barlow, PharmD
Anthony Hawkins, PharmD, FCCM
Sylvia Stefanos, PharmD

2023 Pharmacy to Dose Award Nomination Form: https://t.co/G4NfEEBFaS

03:30 – 2023 Pharmacy to Dose Awards Info
18:35 – Medical Social Media Tips/Tricks
43:55 – Picking a Topic for Residency Research Projects
69:30 – Teaching and Precepting at the Bedside

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Special Guests and Podcast Partners: </p><p>Tori Arsenault, PharmD</p><p>Brooke Barlow, PharmD</p><p>Anthony Hawkins, PharmD, FCCM</p><p>Sylvia Stefanos, PharmD</p><p><br></p><p>2023 Pharmacy to Dose Award Nomination Form: <a href="https://t.co/G4NfEEBFaS">https://t.co/G4NfEEBFaS</a></p><p><br></p><p>03:30 – 2023 Pharmacy to Dose Awards Info</p><p>18:35 – Medical Social Media Tips/Tricks</p><p>43:55 – Picking a Topic for Residency Research Projects</p><p>69:30 – Teaching and Precepting at the Bedside</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>6070</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b0e2caa4-0107-11ee-87fa-63094b312c0d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1999424047.mp3?updated=1685685168" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Perioperative Emergencies: Part I</title>
      <description>Perioperative Emergencies: Part I
Special Guests: Sara J. Hyland, PharmD, BCCCP
Eric Johnson, PharmD, BCCCP
Gourang Patel, PharmD, MSc, BCPS, BCCCP, FCCP, FCCM
Rachel Wolfe, PharmD, MHA, BCCCP


05:55 – Perioperative Pharmacist Background/Roles &amp; Responsibilities
34:30 – Cardiac Arrest in the OR
52:43 – Sugammadex

Reference List: https://pharmacytodose.files.wordpress.com/2023/05/perioperative-emergencies-part-i-references.pdf

﻿PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 30 May 2023 20:37:12 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Joined by 4 Perioperative Clinical Pharmacists to discuss a general overview into the roles/responsibilities before reviewing the management of cardiac arrests in the OR and sugammadex.</itunes:subtitle>
      <itunes:summary>Perioperative Emergencies: Part I
Special Guests: Sara J. Hyland, PharmD, BCCCP
Eric Johnson, PharmD, BCCCP
Gourang Patel, PharmD, MSc, BCPS, BCCCP, FCCP, FCCM
Rachel Wolfe, PharmD, MHA, BCCCP


05:55 – Perioperative Pharmacist Background/Roles &amp; Responsibilities
34:30 – Cardiac Arrest in the OR
52:43 – Sugammadex

Reference List: https://pharmacytodose.files.wordpress.com/2023/05/perioperative-emergencies-part-i-references.pdf

﻿PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Perioperative Emergencies: Part I</p><p>Special Guests: Sara J. Hyland, PharmD, BCCCP</p><p>Eric Johnson, PharmD, BCCCP</p><p>Gourang Patel, PharmD, MSc, BCPS, BCCCP, FCCP, FCCM</p><p>Rachel Wolfe, PharmD, MHA, BCCCP</p><p><br></p><p><br></p><p>05:55 – Perioperative Pharmacist Background/Roles &amp; Responsibilities</p><p>34:30 – Cardiac Arrest in the OR</p><p>52:43 – Sugammadex</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/05/perioperative-emergencies-part-i-references.pdf">https://pharmacytodose.files.wordpress.com/2023/05/perioperative-emergencies-part-i-references.pdf</a></p><p><br></p><p>﻿PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4433</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f82620bc-ff29-11ed-a018-ab8a3225c0d6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6703759326.mp3?updated=1685480005" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 EMPoweRx Conference Recap</title>
      <description>Recap of 2023 EMPoweRx Conference 
Special guest: Jimmy Pruitt, PharmD, BCPS, BCCCP

First, a behind the scenes discussion with Jimmy Pruitt on all that went into EMPoweRx 23 (03:36). 
Followed by a recap of the conference itself including: an Austin city review, discussion on the educational sessions, highlighting the virtual side of the conference, favorite slide of the day, and more (24:48).  

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 18 May 2023 05:39:32 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>A recap of the 2023 Emergency Medicine Pharmacotherapy with Resuscitation Conference including a discussion with the creator Jimmy Pruitt, PharmD, BCPS, BCCCP</itunes:subtitle>
      <itunes:summary>Recap of 2023 EMPoweRx Conference 
Special guest: Jimmy Pruitt, PharmD, BCPS, BCCCP

First, a behind the scenes discussion with Jimmy Pruitt on all that went into EMPoweRx 23 (03:36). 
Followed by a recap of the conference itself including: an Austin city review, discussion on the educational sessions, highlighting the virtual side of the conference, favorite slide of the day, and more (24:48).  

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Recap of 2023 EMPoweRx Conference </p><p>Special guest: Jimmy Pruitt, PharmD, BCPS, BCCCP</p><p><br></p><p>First, a behind the scenes discussion with Jimmy Pruitt on all that went into EMPoweRx 23 (03:36). </p><p>Followed by a recap of the conference itself including: an Austin city review, discussion on the educational sessions, highlighting the virtual side of the conference, favorite slide of the day, and more (24:48).  </p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3671</itunes:duration>
      <guid isPermaLink="false"><![CDATA[82a71e94-f53e-11ed-86ac-b3ca854b2be0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9277775458.mp3?updated=1684389044" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>March 2023 Literature Review Series</title>
      <description>Literature Review Series
Mar 2023
Special Guest: Brent Tucker, PharmD

06:00 – Featured Articles
35:30 – Sepsis
42:15 – Heme
46:35 – Infectious Diseases
56:40 – PharmD
63:30 – Fun Article of the Month

Reference List: https://pharmacytodose.files.wordpress.com/2023/05/mar-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 11 May 2023 16:31:24 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Brent Tucker joins me to highlight the best articles from March 2023</itunes:subtitle>
      <itunes:summary>Literature Review Series
Mar 2023
Special Guest: Brent Tucker, PharmD

06:00 – Featured Articles
35:30 – Sepsis
42:15 – Heme
46:35 – Infectious Diseases
56:40 – PharmD
63:30 – Fun Article of the Month

Reference List: https://pharmacytodose.files.wordpress.com/2023/05/mar-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>Mar 2023</p><p>Special Guest: Brent Tucker, PharmD</p><p><br></p><p>06:00 – Featured Articles</p><p>35:30 – Sepsis</p><p>42:15 – Heme</p><p>46:35 – Infectious Diseases</p><p>56:40 – PharmD</p><p>63:30 – Fun Article of the Month</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/05/mar-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2023/05/mar-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4118</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7d497be2-f019-11ed-b9be-a7e6c6656879]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2418941871.mp3?updated=1683823548" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Diabetic Ketoacidosis</title>
      <description>Diabetic Ketoacidosis and Medicine in the Media
Special Guest: Janice Tsui, PharmD, BCCCP, MS

05:00 – DKA guidelines and consensus statements
13:05 – IV fluids
19:45 – Insulin
27:40 – Treatment goals and transition
31:20 – Hypoglycemia prevention
35:00 – Electrolytes and acidosis
41:05 – Euglycemic DKA
43:40 – Role of Pharmacist and ultimate take-aways
48:47 – Medicine in the Media featuring Jimmy Leonard, PharmD, DABAT

Reference List: https://pharmacytodose.files.wordpress.com/2023/05/diabetic-ketoacidosis-references-1.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 02 May 2023 22:20:26 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Janice Tsui joins me to discuss DKA and then Medicine in the Media returns with Jimmy Leonard</itunes:subtitle>
      <itunes:summary>Diabetic Ketoacidosis and Medicine in the Media
Special Guest: Janice Tsui, PharmD, BCCCP, MS

05:00 – DKA guidelines and consensus statements
13:05 – IV fluids
19:45 – Insulin
27:40 – Treatment goals and transition
31:20 – Hypoglycemia prevention
35:00 – Electrolytes and acidosis
41:05 – Euglycemic DKA
43:40 – Role of Pharmacist and ultimate take-aways
48:47 – Medicine in the Media featuring Jimmy Leonard, PharmD, DABAT

Reference List: https://pharmacytodose.files.wordpress.com/2023/05/diabetic-ketoacidosis-references-1.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Diabetic Ketoacidosis and Medicine in the Media</p><p>Special Guest: Janice Tsui, PharmD, BCCCP, MS</p><p><br></p><p>05:00 – DKA guidelines and consensus statements</p><p>13:05 – IV fluids</p><p>19:45 – Insulin</p><p>27:40 – Treatment goals and transition</p><p>31:20 – Hypoglycemia prevention</p><p>35:00 – Electrolytes and acidosis</p><p>41:05 – Euglycemic DKA</p><p>43:40 – Role of Pharmacist and ultimate take-aways</p><p>48:47 – Medicine in the Media featuring Jimmy Leonard, PharmD, DABAT</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/05/diabetic-ketoacidosis-references-1.pdf">https://pharmacytodose.files.wordpress.com/2023/05/diabetic-ketoacidosis-references-1.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4212</itunes:duration>
      <guid isPermaLink="false"><![CDATA[5c21564e-e937-11ed-984a-c3d01a2ffc21]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9408591652.mp3?updated=1683067035" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Tenecteplase in Acute Ischemic Stroke</title>
      <description>Tenecteplase in Acute Ischemic Stroke 
Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS

07:45 – Alteplase history and comparison
14:20 – Thrombolysis guidelines in AIS
19:15 – Tips for reading stroke literature
21:00 – Tenecteplase literature review 
39:45 – Tenecteplase research-in-progress
42:30 – Thrombolytic-induced ICH management
46:25 – Arguments for and against Tenecteplase
51:30 – Advice when switching thrombolytics
58:20 – Ultimate take-aways

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/tenecteplase-in-acute-ischemic-stroke-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 25 Apr 2023 09:03:18 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Clinical and practical review on the use of tenecteplase in acute ischemic stroke with Salia Farrokh, PharmD, BCCCP, FNCS</itunes:subtitle>
      <itunes:summary>Tenecteplase in Acute Ischemic Stroke 
Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS

07:45 – Alteplase history and comparison
14:20 – Thrombolysis guidelines in AIS
19:15 – Tips for reading stroke literature
21:00 – Tenecteplase literature review 
39:45 – Tenecteplase research-in-progress
42:30 – Thrombolytic-induced ICH management
46:25 – Arguments for and against Tenecteplase
51:30 – Advice when switching thrombolytics
58:20 – Ultimate take-aways

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/tenecteplase-in-acute-ischemic-stroke-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Tenecteplase in Acute Ischemic Stroke </p><p>Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS</p><p><br></p><p>07:45 – Alteplase history and comparison</p><p>14:20 – Thrombolysis guidelines in AIS</p><p>19:15 – Tips for reading stroke literature</p><p>21:00 – Tenecteplase literature review </p><p>39:45 – Tenecteplase research-in-progress</p><p>42:30 – Thrombolytic-induced ICH management</p><p>46:25 – Arguments for and against Tenecteplase</p><p>51:30 – Advice when switching thrombolytics</p><p>58:20 – Ultimate take-aways</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/04/tenecteplase-in-acute-ischemic-stroke-references.pdf">https://pharmacytodose.files.wordpress.com/2023/04/tenecteplase-in-acute-ischemic-stroke-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3851</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fe5e4534-e347-11ed-be71-e7153f230ee3]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4743175497.mp3?updated=1682414120" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Acetaminophen Overdose</title>
      <description>Acetaminophen Overdose
Special Guest: Jimmy Leonard, PharmD, DABAT

Poison Center: 1-800-222-1222

05:11 – Patient Case Intro
06:46 – Pathophysiology and Nomogram
21:55 – GI Decontamination
29:10 – Labs &amp; Signs/Symptoms
35:55 – Historical Treatments
37:10 – N-acetylcysteine (NAC)
66:30 – Adjunctive Treatments
77:50 – Ultimate Take-Away 

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/acetaminophen-overdose-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 19 Apr 2023 10:00:42 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Jimmy Leonard, PharmD, DABAT joins to discuss all things related to acetaminophen overdose</itunes:subtitle>
      <itunes:summary>Acetaminophen Overdose
Special Guest: Jimmy Leonard, PharmD, DABAT

Poison Center: 1-800-222-1222

05:11 – Patient Case Intro
06:46 – Pathophysiology and Nomogram
21:55 – GI Decontamination
29:10 – Labs &amp; Signs/Symptoms
35:55 – Historical Treatments
37:10 – N-acetylcysteine (NAC)
66:30 – Adjunctive Treatments
77:50 – Ultimate Take-Away 

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/acetaminophen-overdose-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Acetaminophen Overdose</p><p>Special Guest: Jimmy Leonard, PharmD, DABAT</p><p><br></p><p>Poison Center: 1-800-222-1222</p><p><br></p><p>05:11 – Patient Case Intro</p><p>06:46 – Pathophysiology and Nomogram</p><p>21:55 – GI Decontamination</p><p>29:10 – Labs &amp; Signs/Symptoms</p><p>35:55 – Historical Treatments</p><p>37:10 – N-acetylcysteine (NAC)</p><p>66:30 – Adjunctive Treatments</p><p>77:50 – Ultimate Take-Away </p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/04/acetaminophen-overdose-references.pdf">https://pharmacytodose.files.wordpress.com/2023/04/acetaminophen-overdose-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4988</itunes:duration>
      <guid isPermaLink="false"><![CDATA[230d8132-de99-11ed-bbe0-4b60517cf43a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4324013815.mp3?updated=1681899497" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>February 2023 Literature Review Series</title>
      <description>Literature Review Series
Feb 2023
Special Guest: Rhea Soltau, PharmD

04:10 – Featured Articles
34:50 – Cardiovascular
51:32 – Neurology
55:00 – PharmD
74:10 – Fun Article of the Month

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/feb-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 13 Apr 2023 19:56:54 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Highlighting notable articles from February 2023 with Rhea Soltau, PharmD</itunes:subtitle>
      <itunes:summary>Literature Review Series
Feb 2023
Special Guest: Rhea Soltau, PharmD

04:10 – Featured Articles
34:50 – Cardiovascular
51:32 – Neurology
55:00 – PharmD
74:10 – Fun Article of the Month

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/feb-lrs-2023-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>Feb 2023</p><p>Special Guest: Rhea Soltau, PharmD</p><p><br></p><p>04:10 – Featured Articles</p><p>34:50 – Cardiovascular</p><p>51:32 – Neurology</p><p>55:00 – PharmD</p><p>74:10 – Fun Article of the Month</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/04/feb-lrs-2023-references.pdf">https://pharmacytodose.files.wordpress.com/2023/04/feb-lrs-2023-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4691</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7fbeca98-da35-11ed-9e86-c310dc0c0842]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9526789684.mp3?updated=1681416773" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: PROCOAG</title>
      <description>Rapid Reaction: PROCOAG trial

Special Guest: Scott Dietrich, PharmD, BCCCP 

Rapid reaction episode discussing the PROCOAG study looking at 4-factor prothrombin complex concentrate (PCC) use in trauma patients at risk of massive transfusion published in JAMA. We go into the outcomes, European v. American trauma management, PCC dosing, effect of viscoelastic testing, and much more.  

PROCOAG trial: https://pubmed.ncbi.nlm.nih.gov/36942533/

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/procoag-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 13 Apr 2023 00:13:33 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Rapid reaction episode discussing the PROCOAG study published in JAMA looking at PCC use in trauma</itunes:subtitle>
      <itunes:summary>Rapid Reaction: PROCOAG trial

Special Guest: Scott Dietrich, PharmD, BCCCP 

Rapid reaction episode discussing the PROCOAG study looking at 4-factor prothrombin complex concentrate (PCC) use in trauma patients at risk of massive transfusion published in JAMA. We go into the outcomes, European v. American trauma management, PCC dosing, effect of viscoelastic testing, and much more.  

PROCOAG trial: https://pubmed.ncbi.nlm.nih.gov/36942533/

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/procoag-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: PROCOAG trial</p><p><br></p><p>Special Guest: Scott Dietrich, PharmD, BCCCP </p><p><br></p><p>Rapid reaction episode discussing the PROCOAG study looking at 4-factor prothrombin complex concentrate (PCC) use in trauma patients at risk of massive transfusion published in JAMA. We go into the outcomes, European v. American trauma management, PCC dosing, effect of viscoelastic testing, and much more.  </p><p><br></p><p>PROCOAG trial: <a href="https://pubmed.ncbi.nlm.nih.gov/36942533/">https://pubmed.ncbi.nlm.nih.gov/36942533/</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/04/procoag-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2023/04/procoag-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2553</itunes:duration>
      <guid isPermaLink="false"><![CDATA[01cd0c26-d990-11ed-a77c-a73b7aa85051]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9487273718.mp3?updated=1681345441" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: CAPE COD</title>
      <description>Rapid Reaction: CAPE COD trial

Special Guest: Carolyn Magee Bell, PharmD, BCCCP, FCCM 

Rapid reaction episode covering the CAPE COD trial which looked at the use of hydrocortisone in ICU CAP patients published in NEJM. We discuss outcomes, pertinent findings, questions remaining, ultimate take-aways, fun facts, and much more.

CAPE COD trial: https://pubmed.ncbi.nlm.nih.gov/36942789/

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/cape-cod-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 06 Apr 2023 20:34:05 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Rapid reaction episode covering the CAPE COD trial which looked at the use of hydrocortisone in ICU CAP patients published in NEJM. I discuss outcomes, pertinent findings, questions remaining, ultimate take-aways, fun facts, and much more with Carolyn Magee Bell, PharmD, BCCCP, FCCM.</itunes:subtitle>
      <itunes:summary>Rapid Reaction: CAPE COD trial

Special Guest: Carolyn Magee Bell, PharmD, BCCCP, FCCM 

Rapid reaction episode covering the CAPE COD trial which looked at the use of hydrocortisone in ICU CAP patients published in NEJM. We discuss outcomes, pertinent findings, questions remaining, ultimate take-aways, fun facts, and much more.

CAPE COD trial: https://pubmed.ncbi.nlm.nih.gov/36942789/

Reference List: https://pharmacytodose.files.wordpress.com/2023/04/cape-cod-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: CAPE COD trial</p><p><br></p><p>Special Guest: Carolyn Magee Bell, PharmD, BCCCP, FCCM </p><p><br></p><p>Rapid reaction episode covering the CAPE COD trial which looked at the use of hydrocortisone in ICU CAP patients published in NEJM. We discuss outcomes, pertinent findings, questions remaining, ultimate take-aways, fun facts, and much more.</p><p><br></p><p>CAPE COD trial: <a href="https://pubmed.ncbi.nlm.nih.gov/36942789/">https://pubmed.ncbi.nlm.nih.gov/36942789/</a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/04/cape-cod-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2023/04/cape-cod-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2210</itunes:duration>
      <guid isPermaLink="false"><![CDATA[36f8c9e6-d4bb-11ed-bc37-abbab7fde805]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3709805114.mp3?updated=1680814316" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Emergency Medicine Clinical Pearls and EMPoweRx Conference</title>
      <description>Emergency Medicine Clinical Pearls and EMPoweRx Conference 
Special Guest: Megan Rech, PharmD, MS, BCCCP, FCCM, FCCP
 
https://empowerx-conference.com

https://rutgers.cloud-cme.com/course/courseoverview?P=0&amp;EID=17157&amp;formid=2931

https://empharmnet.org/

03:35 – EMPoweRx Conference 
12:28 – TXA in Epistaxis
21:40 – DDAVP in Antiplatelet-Associated ICH
34:47 – Awareness with Paralysis

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/em-pearls-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 29 Mar 2023 21:30:45 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Megan Rech joins me to highlight the upcoming EMPoweRx Conference and then discuss 3 Emergency Medicine clinical pearls</itunes:subtitle>
      <itunes:summary>Emergency Medicine Clinical Pearls and EMPoweRx Conference 
Special Guest: Megan Rech, PharmD, MS, BCCCP, FCCM, FCCP
 
https://empowerx-conference.com

https://rutgers.cloud-cme.com/course/courseoverview?P=0&amp;EID=17157&amp;formid=2931

https://empharmnet.org/

03:35 – EMPoweRx Conference 
12:28 – TXA in Epistaxis
21:40 – DDAVP in Antiplatelet-Associated ICH
34:47 – Awareness with Paralysis

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/em-pearls-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Emergency Medicine Clinical Pearls and EMPoweRx Conference </p><p>Special Guest: Megan Rech, PharmD, MS, BCCCP, FCCM, FCCP</p><p> </p><p><a href="https://empowerx-conference.com/">https://empowerx-conference.com</a></p><p><br></p><p><a href="https://rutgers.cloud-cme.com/course/courseoverview?P=0&amp;EID=17157&amp;formid=2931">https://rutgers.cloud-cme.com/course/courseoverview?P=0&amp;EID=17157&amp;formid=2931</a></p><p><br></p><p><a href="https://empharmnet.org/">https://empharmnet.org/</a></p><p><br></p><p>03:35 – EMPoweRx Conference </p><p>12:28 – TXA in Epistaxis</p><p>21:40 – DDAVP in Antiplatelet-Associated ICH</p><p>34:47 – Awareness with Paralysis</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/03/em-pearls-references.pdf">https://pharmacytodose.files.wordpress.com/2023/03/em-pearls-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2965</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1565e162-ce79-11ed-b775-a33263b0e511]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7480480802.mp3?updated=1680126177" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Heart Failure: Part II</title>
      <description>Heart Failure: Part II
Special Guest: Cait Kulig, PharmD 
https://cards.rxexplained.com/


07:55 – Transitions of Care
17:35 – HFrEF GDMT
48:35 – HFpEF GDMT

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 17 Mar 2023 13:37:45 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Part II of my discussion with Cait Kulig on Heart Failure focusing on transitions of care, GDMT, HFrEF v. HFpEF, and much more. </itunes:subtitle>
      <itunes:summary>Heart Failure: Part II
Special Guest: Cait Kulig, PharmD 
https://cards.rxexplained.com/


07:55 – Transitions of Care
17:35 – HFrEF GDMT
48:35 – HFpEF GDMT

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-ii-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Heart Failure: Part II</p><p>Special Guest: Cait Kulig, PharmD </p><p>https://cards.rxexplained.com/</p><p><br></p><p><br></p><p>07:55 – Transitions of Care</p><p>17:35 – HFrEF GDMT</p><p>48:35 – HFpEF GDMT</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-ii-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p>PharmacyToDose@Gmail.com</p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3905</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ec60a324-c4c8-11ed-9818-1b96966c70df]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3864317701.mp3?updated=1679061251" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>January 2023 Literature Review Series</title>
      <description>Literature Review Series
Jan 2023
Special Guest: Austin Roe, PharmD

04:15 – Featured Articles
40:18 – Cardiovascular
53:05 – Neurology
57:45 – Infectious Diseases
71:12 – PharmD


Reference List: https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf

Full article list: https://docs.google.com/document/d/1ZDGStSjlCWg8eCCCrIHQlChyI2Y5Jrwr8cRNYIzFeIc/edit?usp=sharing

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 15 Mar 2023 05:06:09 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>Highlighting published research and medical articles from January 2023 with special guest Austin Roe, PharmD</itunes:subtitle>
      <itunes:summary>Literature Review Series
Jan 2023
Special Guest: Austin Roe, PharmD

04:15 – Featured Articles
40:18 – Cardiovascular
53:05 – Neurology
57:45 – Infectious Diseases
71:12 – PharmD


Reference List: https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf

Full article list: https://docs.google.com/document/d/1ZDGStSjlCWg8eCCCrIHQlChyI2Y5Jrwr8cRNYIzFeIc/edit?usp=sharing

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p><p>Jan 2023</p><p>Special Guest: Austin Roe, PharmD</p><p><br></p><p>04:15 – Featured Articles</p><p>40:18 – Cardiovascular</p><p>53:05 – Neurology</p><p>57:45 – Infectious Diseases</p><p>71:12 – PharmD</p><p><br></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf">https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf</a></p><p><br></p><p>Full article list: <a href="https://docs.google.com/document/d/1ZDGStSjlCWg8eCCCrIHQlChyI2Y5Jrwr8cRNYIzFeIc/edit?usp=sharing">https://docs.google.com/document/d/1ZDGStSjlCWg8eCCCrIHQlChyI2Y5Jrwr8cRNYIzFeIc/edit?usp=sharing</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4912</itunes:duration>
      <guid isPermaLink="false"><![CDATA[264ac21c-c2ef-11ed-9f22-032a9d58bf6a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6215418515.mp3?updated=1678857852" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Reaction: ANNEXA-4</title>
      <description>Rapid Reaction: ANNEXA-4

Special Guest: Brian Gilbert, PharmD, MBA, BCCCP, BCPS, FCCM

Discussion about the ANNEXA-4 final study results including some of our biggest takeaways, future directions, and more.

ANNEXA-4: https://pubmed.ncbi.nlm.nih.gov/36802876/

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/annexa-4-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 09 Mar 2023 18:31:51 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>ANNEXA-4 study discussion </itunes:subtitle>
      <itunes:summary>Rapid Reaction: ANNEXA-4

Special Guest: Brian Gilbert, PharmD, MBA, BCCCP, BCPS, FCCM

Discussion about the ANNEXA-4 final study results including some of our biggest takeaways, future directions, and more.

ANNEXA-4: https://pubmed.ncbi.nlm.nih.gov/36802876/

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/annexa-4-rapid-reaction-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Reaction: ANNEXA-4</p><p><br></p><p>Special Guest: Brian Gilbert, PharmD, MBA, BCCCP, BCPS, FCCM</p><p><br></p><p>Discussion about the ANNEXA-4 final study results including some of our biggest takeaways, future directions, and more.</p><p><br></p><p>ANNEXA-4: <a href="https://pubmed.ncbi.nlm.nih.gov/36802876/"><strong>https://pubmed.ncbi.nlm.nih.gov/36802876/</strong></a></p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/03/annexa-4-rapid-reaction-references.pdf">https://pharmacytodose.files.wordpress.com/2023/03/annexa-4-rapid-reaction-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3250</itunes:duration>
      <guid isPermaLink="false"><![CDATA[0b5f8d4c-bea9-11ed-8f94-53ba93f50fbf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2292898389.mp3?updated=1678387888" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Heart Failure: Part I</title>
      <description>Heart Failure: Part I

Special Guest: Cait Kulig, PharmD 
https://cards.rxexplained.com/

06:15 – Definitions
13:48 – ADHF
29:50 – Diuresis and Diuretic Resistance
52:45 – IV Vasoactives

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-i-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 08 Mar 2023 08:32:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>1st part in a 2-episode series talking all things heart failure.</itunes:subtitle>
      <itunes:summary>Heart Failure: Part I

Special Guest: Cait Kulig, PharmD 
https://cards.rxexplained.com/

06:15 – Definitions
13:48 – ADHF
29:50 – Diuresis and Diuretic Resistance
52:45 – IV Vasoactives

Reference List: https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-i-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Heart Failure: Part I</p><p><br></p><p>Special Guest: Cait Kulig, PharmD </p><p><a href="https://cards.rxexplained.com/">https://cards.rxexplained.com/</a></p><p><br></p><p>06:15 – Definitions</p><p>13:48 – ADHF</p><p>29:50 – Diuresis and Diuretic Resistance</p><p>52:45 – IV Vasoactives</p><p><br></p><p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-i-references.pdf">https://pharmacytodose.files.wordpress.com/2023/03/heart-failure-part-i-references.pdf</a></p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4298</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c92df792-bd8b-11ed-be16-d7a703dff492]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7319872973.mp3?updated=1678265522" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Top Cardiology Trials with Cardioscripts</title>
      <description>Top Cardiology Trials with Cardioscripts

Special Guests:
Tracy Macaulay, PharmD, BCCP, FACC, FCCP @SchwietTMax
Elisabeth Wang, PharmD, BCCP @Val_Smartan
Nathan Wayne, PharmD, BCPS, BCCP @TweetlessNathan

13:45 – Top Landmark Trials
32:50 – Top New Trials
50:00 – Top Grab Bag/Random Trials

Reference list: https://pharmacytodose.files.wordpress.com/2023/03/top-cardiology-trials-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 01 Mar 2023 16:28:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>The Cardioscripts podcast team joins me to discuss our favorite landmark, new, and random trials in cardiology. </itunes:subtitle>
      <itunes:summary>Top Cardiology Trials with Cardioscripts

Special Guests:
Tracy Macaulay, PharmD, BCCP, FACC, FCCP @SchwietTMax
Elisabeth Wang, PharmD, BCCP @Val_Smartan
Nathan Wayne, PharmD, BCPS, BCCP @TweetlessNathan

13:45 – Top Landmark Trials
32:50 – Top New Trials
50:00 – Top Grab Bag/Random Trials

Reference list: https://pharmacytodose.files.wordpress.com/2023/03/top-cardiology-trials-references.pdf

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Top Cardiology Trials with Cardioscripts</p><p><br></p><p>Special Guests:</p><p>Tracy Macaulay, PharmD, BCCP, FACC, FCCP @SchwietTMax</p><p>Elisabeth Wang, PharmD, BCCP @Val_Smartan</p><p>Nathan Wayne, PharmD, BCPS, BCCP @TweetlessNathan</p><p><br></p><p>13:45 – Top Landmark Trials</p><p>32:50 – Top New Trials</p><p>50:00 – Top Grab Bag/Random Trials</p><p><br></p><p>Reference list: https://pharmacytodose.files.wordpress.com/2023/03/top-cardiology-trials-references.pdf</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4451</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2796ad76-b84e-11ed-bf67-0f38a8d6e209]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9705632739.mp3?updated=1677689148" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>SCCM PharmD Star Research</title>
      <description>2023 SCCM PharmD Star Researchers

03:10 – Restrictive Resuscitation in Patients with Sepsis: A Systematic Review with Trial Sequential analysis with Sylvia Stefanos, PharmD 
10:50 – Incidence of Acute Kidney Injury in Traumatic Brain Injury Patients Treated with Hypertonic Saline with Jesse Briscoe, PharmD
19:42 – Comparison of Factor Products for Uncontrolled Bleeding Related to Cardiac Surgery with Lauren Caldwell, PharmD, BCCCP
28:00 – Validation of Heparin-Induced Thrombocytopenia Risk Stratification Tools in Post-Surgical Cardiovascular Patients with Shahristan Kokoy, PharmD, BCPS
39:16 – Naloxone Co-prescribing for Emergency Medicine and Trauma Patients at High-risk for Opioid Overdose with William Peppard, PharmD, BCPS, FCCM
52:20 – Incidence of Detectable Drug Levels with Inhaled Aminoglycoside Therapy in Critically Ill Adults with Jenny Schultheis, PharmD, BCPS, BCCCP
63:28 – Evaluation of Achieving Targeted Vancomycin Levels in Augmented Renal Clearance with Sydney Wilson, PharmD
73:30 – Vancomycin and Piperacillin/tazobactam or Cefepime and Sepsis-Associated AKI Trajectory with Michael Behal, PharmD, BCCCP

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 13 Feb 2023 18:26:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>2023 SCCM PharmD Star Researchers

03:10 – Restrictive Resuscitation in Patients with Sepsis: A Systematic Review with Trial Sequential analysis with Sylvia Stefanos, PharmD 
10:50 – Incidence of Acute Kidney Injury in Traumatic Brain Injury Patients Treated with Hypertonic Saline with Jesse Briscoe, PharmD
19:42 – Comparison of Factor Products for Uncontrolled Bleeding Related to Cardiac Surgery with Lauren Caldwell, PharmD, BCCCP
28:00 – Validation of Heparin-Induced Thrombocytopenia Risk Stratification Tools in Post-Surgical Cardiovascular Patients with Shahristan Kokoy, PharmD, BCPS
39:16 – Naloxone Co-prescribing for Emergency Medicine and Trauma Patients at High-risk for Opioid Overdose with William Peppard, PharmD, BCPS, FCCM
52:20 – Incidence of Detectable Drug Levels with Inhaled Aminoglycoside Therapy in Critically Ill Adults with Jenny Schultheis, PharmD, BCPS, BCCCP
63:28 – Evaluation of Achieving Targeted Vancomycin Levels in Augmented Renal Clearance with Sydney Wilson, PharmD
73:30 – Vancomycin and Piperacillin/tazobactam or Cefepime and Sepsis-Associated AKI Trajectory with Michael Behal, PharmD, BCCCP

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 SCCM PharmD Star Researchers</p><p><br></p><p>03:10 – Restrictive Resuscitation in Patients with Sepsis: A Systematic Review with Trial Sequential analysis with Sylvia Stefanos, PharmD </p><p>10:50 – Incidence of Acute Kidney Injury in Traumatic Brain Injury Patients Treated with Hypertonic Saline with Jesse Briscoe, PharmD</p><p>19:42 – Comparison of Factor Products for Uncontrolled Bleeding Related to Cardiac Surgery with Lauren Caldwell, PharmD, BCCCP</p><p>28:00 – Validation of Heparin-Induced Thrombocytopenia Risk Stratification Tools in Post-Surgical Cardiovascular Patients with Shahristan Kokoy, PharmD, BCPS</p><p>39:16 – Naloxone Co-prescribing for Emergency Medicine and Trauma Patients at High-risk for Opioid Overdose with William Peppard, PharmD, BCPS, FCCM</p><p>52:20 – Incidence of Detectable Drug Levels with Inhaled Aminoglycoside Therapy in Critically Ill Adults with Jenny Schultheis, PharmD, BCPS, BCCCP</p><p>63:28 – Evaluation of Achieving Targeted Vancomycin Levels in Augmented Renal Clearance with Sydney Wilson, PharmD</p><p>73:30 – Vancomycin and Piperacillin/tazobactam or Cefepime and Sepsis-Associated AKI Trajectory with Michael Behal, PharmD, BCCCP</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5297</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f5308340-abcb-11ed-846d-9f2872541b32]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7108545309.mp3?updated=1676313808" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>SCCM PharmD Speakers Part II</title>
      <description>2023 SCCM PharmD Speakers Part II

02:18 – Acute Ischemic Stroke Mgmt Updates with Salia Farrokh, PharmD, BCCCP, FNCS
13:30 – Ketamine’s Role in Opioid-Sparing Analgesia with Luma Succar, PharmD, BCCCP
24:00 – Incorporating Lidocaine in Multimodal Pain Regimens with Chelsea Lopez, PharmD, BCCCP
43:19 – Choice of Analgesic/Sedatives in ABCDEF bundle with Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP
58:54 – Constipation in the Critically Ill with Melissa Santibañez, PharmD, BCCCP
74:40 – Practical Aspects of Immunotherapy in the ICU Heather May, PharmD, FCCM, BCPS, BCCCP
92:27 – Updates on CAR-T Products and Toxicity Management with Anne Rain Brown, PharmD, BCCCP, FCCM
103:37 – Immunomodulator Drug Highlights with Tuqa Alkhateeb, PharmD, PhD
118:18 - Empiric Anerobic Antibiotics in the ICU with Kevin Betthauser, PharmD, BCCCP
134:37 – Pharmacotherapy Adjustments in Obesity with Bethany Shoulders, PharmD, BCCCP

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 10 Feb 2023 16:31:03 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>10 Pharmacist speakers from the 2023 SCCM Congress join to highlight their talk and answer some questions</itunes:subtitle>
      <itunes:summary>2023 SCCM PharmD Speakers Part II

02:18 – Acute Ischemic Stroke Mgmt Updates with Salia Farrokh, PharmD, BCCCP, FNCS
13:30 – Ketamine’s Role in Opioid-Sparing Analgesia with Luma Succar, PharmD, BCCCP
24:00 – Incorporating Lidocaine in Multimodal Pain Regimens with Chelsea Lopez, PharmD, BCCCP
43:19 – Choice of Analgesic/Sedatives in ABCDEF bundle with Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP
58:54 – Constipation in the Critically Ill with Melissa Santibañez, PharmD, BCCCP
74:40 – Practical Aspects of Immunotherapy in the ICU Heather May, PharmD, FCCM, BCPS, BCCCP
92:27 – Updates on CAR-T Products and Toxicity Management with Anne Rain Brown, PharmD, BCCCP, FCCM
103:37 – Immunomodulator Drug Highlights with Tuqa Alkhateeb, PharmD, PhD
118:18 - Empiric Anerobic Antibiotics in the ICU with Kevin Betthauser, PharmD, BCCCP
134:37 – Pharmacotherapy Adjustments in Obesity with Bethany Shoulders, PharmD, BCCCP

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 SCCM PharmD Speakers Part II</p><p><br></p><p>02:18 – Acute Ischemic Stroke Mgmt Updates with Salia Farrokh, PharmD, BCCCP, FNCS</p><p>13:30 – Ketamine’s Role in Opioid-Sparing Analgesia with Luma Succar, PharmD, BCCCP</p><p>24:00 – Incorporating Lidocaine in Multimodal Pain Regimens with Chelsea Lopez, PharmD, BCCCP</p><p>43:19 – Choice of Analgesic/Sedatives in ABCDEF bundle with Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP</p><p>58:54 – Constipation in the Critically Ill with Melissa Santibañez, PharmD, BCCCP</p><p>74:40 – Practical Aspects of Immunotherapy in the ICU Heather May, PharmD, FCCM, BCPS, BCCCP</p><p>92:27 – Updates on CAR-T Products and Toxicity Management with Anne Rain Brown, PharmD, BCCCP, FCCM</p><p>103:37 – Immunomodulator Drug Highlights with Tuqa Alkhateeb, PharmD, PhD</p><p>118:18 - Empiric Anerobic Antibiotics in the ICU with Kevin Betthauser, PharmD, BCCCP</p><p>134:37 – Pharmacotherapy Adjustments in Obesity with Bethany Shoulders, PharmD, BCCCP</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>9147</itunes:duration>
      <guid isPermaLink="false"><![CDATA[82e986c8-a960-11ed-a165-2f91e82626ad]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6263405399.mp3?updated=1676048085" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>SCCM PharmD Speakers Part I</title>
      <description>2023 SCCM PharmD Speakers Part I

03:46 – PAH Pharmacotherapy with Diana Lemieux, PharmD, BCCCP
17:01 – USA v. EU AF Mgmt. with Cait Kulig, PharmD
30:25 – Caring for Special Populations in the ED with Erin Wieruszewski, PharmD, BCCCP
42:26 – Medical Treatments to Consider with RV Failure in VV ECMO with Patrick Wieruszewski, PharmD, BCCCP
57:30 – Toxicology Year in Review with Rachel Wein, PharmD, BCPS
65:40 – Effect of IV Fluids on Microcirculation with Susan Smith, PharmD, BCPS, BCCCP, FCCM
75:15 – Finding Fluid Stewardship in the ICU &amp; Phases of Fluid Management in the ICU with Anthony Hawkins, PharmD, FCCM

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 10 Feb 2023 15:30:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:subtitle>8 Pharmacist speakers from the 2023 SCCM Congress join to highlight their presentations and answer some questions</itunes:subtitle>
      <itunes:summary>2023 SCCM PharmD Speakers Part I

03:46 – PAH Pharmacotherapy with Diana Lemieux, PharmD, BCCCP
17:01 – USA v. EU AF Mgmt. with Cait Kulig, PharmD
30:25 – Caring for Special Populations in the ED with Erin Wieruszewski, PharmD, BCCCP
42:26 – Medical Treatments to Consider with RV Failure in VV ECMO with Patrick Wieruszewski, PharmD, BCCCP
57:30 – Toxicology Year in Review with Rachel Wein, PharmD, BCPS
65:40 – Effect of IV Fluids on Microcirculation with Susan Smith, PharmD, BCPS, BCCCP, FCCM
75:15 – Finding Fluid Stewardship in the ICU &amp; Phases of Fluid Management in the ICU with Anthony Hawkins, PharmD, FCCM

PharmacyToDose.Com 
@PharmacyToDose 
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2023 SCCM PharmD Speakers Part I</p><p><br></p><p>03:46 – PAH Pharmacotherapy with Diana Lemieux, PharmD, BCCCP</p><p>17:01 – USA v. EU AF Mgmt. with Cait Kulig, PharmD</p><p>30:25 – Caring for Special Populations in the ED with Erin Wieruszewski, PharmD, BCCCP</p><p>42:26 – Medical Treatments to Consider with RV Failure in VV ECMO with Patrick Wieruszewski, PharmD, BCCCP</p><p>57:30 – Toxicology Year in Review with Rachel Wein, PharmD, BCPS</p><p>65:40 – Effect of IV Fluids on Microcirculation with Susan Smith, PharmD, BCPS, BCCCP, FCCM</p><p>75:15 – Finding Fluid Stewardship in the ICU &amp; Phases of Fluid Management in the ICU with Anthony Hawkins, PharmD, FCCM</p><p><br></p><p>PharmacyToDose.Com </p><p>@PharmacyToDose </p><p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5732</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3a5a526c-a950-11ed-ae62-5f72931e7b05]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9926323475.mp3?updated=1676044631" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2023 SCCM Congress Recap</title>
      <link>https://pharmacytodose.podbean.com/e/2023-sccm-congress-recap/</link>
      <description>Recap of 2023 SCCM Congress

Special guest: W. Anthony Hawkins, PharmD, FCCM, BCCCP

 

SF review, unique sessions, speaker perspective, FCCM/awards, Dr. Glaucomflocken, late-breaking studies, exhibit hall, receptions, our favorite sessions and more.

 

 

PharmacyToDose.Com

@PharmacyToDose

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 24 Jan 2023 04:29:19 -0000</pubDate>
      <itunes:title>2023 SCCM Congress Recap</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>59</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/aeaf04dc-a883-11ed-9652-2b73fc0998a0/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Recap of 2023 SCCM Congress
Special guest: W. Anthony Hawkins, PharmD, FCCM, BCCCP
 
SF review, unique sessions, speaker perspective, FCCM/awards, Dr. Glaucomflocken, late-breaking studies, exhibit hall, receptions, our favorite sessions and more.
 
...</itunes:subtitle>
      <itunes:summary>Recap of 2023 SCCM Congress

Special guest: W. Anthony Hawkins, PharmD, FCCM, BCCCP

 

SF review, unique sessions, speaker perspective, FCCM/awards, Dr. Glaucomflocken, late-breaking studies, exhibit hall, receptions, our favorite sessions and more.

 

 

PharmacyToDose.Com

@PharmacyToDose

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Recap of 2023 SCCM Congress</p>
<p>Special guest: W. Anthony Hawkins, PharmD, FCCM, BCCCP</p>
<p> </p>
<p>SF review, unique sessions, speaker perspective, FCCM/awards, Dr. Glaucomflocken, late-breaking studies, exhibit hall, receptions, our favorite sessions and more.</p>
<p> </p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>7219</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/115bb47d-6587-3ca3-a451-cdb098eccf6b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7530988818.mp3?updated=1679327482" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>December 2022 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/december-2022-literature-review-series/</link>
      <description>Literature Review Series

Dec 2022

 

00:26 – Life/podcast update; 08:40 – Top 5; 24:50 – BP management; 28:55 – IV fluids; 31:40 – Lost in my mind; 39:28 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf

 

 

PharmacyToDose.Com

@PharmacyToDose

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sun, 15 Jan 2023 20:46:38 -0000</pubDate>
      <itunes:title>December 2022 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>58</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/aec3bfb2-a883-11ed-9652-8fe233853e7b/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Dec 2022
 
00:26 – Life/podcast update; 08:40 – Top 5; 24:50 – BP management; 28:55 – IV fluids; 31:40 – Lost in my mind; 39:28 – Front of the fridge
 
Reference List: https://pharmacytodose.files.wordpress.com/2023/01/lrs-de...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Dec 2022

 

00:26 – Life/podcast update; 08:40 – Top 5; 24:50 – BP management; 28:55 – IV fluids; 31:40 – Lost in my mind; 39:28 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf

 

 

PharmacyToDose.Com

@PharmacyToDose

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Dec 2022</p>
<p> </p>
<p>00:26 – Life/podcast update; 08:40 – Top 5; 24:50 – BP management; 28:55 – IV fluids; 31:40 – Lost in my mind; 39:28 – Front of the fridge</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf">https://pharmacytodose.files.wordpress.com/2023/01/lrs-dec-2022-references.pdf</a></p>
<p> </p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2840</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/ec4242a2-cb70-3187-933f-043a2dbbda0b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5797988447.mp3?updated=1679335831" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>April 2022 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/april-2022-literature-review-series/</link>
      <description>Literature Review Series

Apr 2022

Special Guests: Philip Jacobson, PharmD and Andi Ray, PharmD

 

07:10 – 6-pack of studies; 45:20 – Don’t go breaking my heart; 55:20 – Ventilator blues; 65:00 – Front of the fridge Pt I and II

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/10/lrs-apr-2022-references.pdf

 

 

Full Article List: https://docs.google.com/document/d/1EcldymfgaszAcKmYlr6wYt4XRI5_GFhQo4DeqrGAfAE/edit?usp=sharing

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 13 Oct 2022 23:46:17 -0000</pubDate>
      <itunes:title>April 2022 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>57</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/aed5b9e2-a883-11ed-9652-1fd548fea95a/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Apr 2022
Special Guests: Philip Jacobson, PharmD and Andi Ray, PharmD
 
07:10 – 6-pack of studies; 45:20 – Don’t go breaking my heart; 55:20 – Ventilator blues; 65:00 – Front of the fridge Pt I and II
 
Reference List: https:...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Apr 2022

Special Guests: Philip Jacobson, PharmD and Andi Ray, PharmD

 

07:10 – 6-pack of studies; 45:20 – Don’t go breaking my heart; 55:20 – Ventilator blues; 65:00 – Front of the fridge Pt I and II

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/10/lrs-apr-2022-references.pdf

 

 

Full Article List: https://docs.google.com/document/d/1EcldymfgaszAcKmYlr6wYt4XRI5_GFhQo4DeqrGAfAE/edit?usp=sharing

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Apr 2022</p>
<p>Special Guests: Philip Jacobson, PharmD and Andi Ray, PharmD</p>
<p> </p>
<p>07:10 – 6-pack of studies; 45:20 – Don’t go breaking my heart; 55:20 – Ventilator blues; 65:00 – Front of the fridge Pt I and II</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/10/lrs-apr-2022-references.pdf">https://pharmacytodose.files.wordpress.com/2022/10/lrs-apr-2022-references.pdf</a></p>
<p> </p>
<p> </p>
<p>Full Article List: <a href="https://docs.google.com/document/d/1EcldymfgaszAcKmYlr6wYt4XRI5_GFhQo4DeqrGAfAE/edit?usp=sharing">https://docs.google.com/document/d/1EcldymfgaszAcKmYlr6wYt4XRI5_GFhQo4DeqrGAfAE/edit?usp=sharing</a></p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5321</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/7ab98ef1-f676-327d-8988-8e663f718d15]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9920545898.mp3?updated=1679335731" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>March 2022 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/march-2022-literature-review-series/</link>
      <description>Literature Review Series

Mar 2022

Special Guests: Paige Miller, PharmD and Jontae Warren, PharmD

 

05:00 – 6-pack of studies; 45:00 – Lost in my mind; 55:20 – When we were young; 66:50 – Don’t go breaking my heart; 79:40 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/09/lrs-mar-2022-references.pdf

 

Full Article List: https://docs.google.com/document/d/1X43sqQX9IYRKJ2hGSp5gneqzL0OQcxeGJMGgKs2Bu54/edit?usp=sharing

 

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 13 Sep 2022 09:48:34 -0000</pubDate>
      <itunes:title>March 2022 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>56</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/aee758c8-a883-11ed-9652-d3e7e7fcc916/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Mar 2022
Special Guests: Paige Miller, PharmD and Jontae Warren, PharmD
 
05:00 – 6-pack of studies; 45:00 – Lost in my mind; 55:20 – When we were young; 66:50 – Don’t go breaking my heart; 79:40 – Front of the fridge
 
Refer...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Mar 2022

Special Guests: Paige Miller, PharmD and Jontae Warren, PharmD

 

05:00 – 6-pack of studies; 45:00 – Lost in my mind; 55:20 – When we were young; 66:50 – Don’t go breaking my heart; 79:40 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/09/lrs-mar-2022-references.pdf

 

Full Article List: https://docs.google.com/document/d/1X43sqQX9IYRKJ2hGSp5gneqzL0OQcxeGJMGgKs2Bu54/edit?usp=sharing

 

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Mar 2022</p>
<p>Special Guests: Paige Miller, PharmD and Jontae Warren, PharmD</p>
<p> </p>
<p>05:00 – 6-pack of studies; 45:00 – Lost in my mind; 55:20 – When we were young; 66:50 – Don’t go breaking my heart; 79:40 – Front of the fridge</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/09/lrs-mar-2022-references.pdf">https://pharmacytodose.files.wordpress.com/2022/09/lrs-mar-2022-references.pdf</a></p>
<p> </p>
<p>Full Article List: <a href="https://docs.google.com/document/d/1X43sqQX9IYRKJ2hGSp5gneqzL0OQcxeGJMGgKs2Bu54/edit?usp=sharing">https://docs.google.com/document/d/1X43sqQX9IYRKJ2hGSp5gneqzL0OQcxeGJMGgKs2Bu54/edit?usp=sharing</a></p>
<p> </p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5617</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/d29ffeb5-494b-34b8-855d-ca640719c86e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4583114882.mp3?updated=1679335598" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>PCCs for PharmD Part II</title>
      <link>https://pharmacytodose.podbean.com/e/pccs-for-pharmd-part-ii/</link>
      <description>PCCs for PharmDs Part II

Special Guest: Scott Dietrich, PharmD, BCCCP

@PCC_PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/08/pccs-for-pharmds-part-ii-references.pdf

 

04:45 – Fixed dose PCC; 11:58 – Time to administration; 15:00 – 3-factor v. 4-factor PCC; 19:12 – 4-factor PCC v. 4-factor aPCC; 30:36 – No anticoagulation reversal; 33:36 – PCC in surgery; 37:40 – PCC in trauma; 40:51 – PCC v. andexanet alfa; 54:10 – Guideline recommendations; 62:00 – Future studies; 69:10 – Take home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Tue, 30 Aug 2022 15:27:14 -0000</pubDate>
      <itunes:title>PCCs for PharmD Part II</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>55</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/aef8a18c-a883-11ed-9652-337d927e27b8/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>PCCs for PharmDs Part II
Special Guest: Scott Dietrich, PharmD, BCCCP
@PCC_PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2022/08/pccs-for-pharmds-part-ii-references.pdf
 
04:45 – Fixed dose PCC; 11:58 – Time to administration; 1...</itunes:subtitle>
      <itunes:summary>PCCs for PharmDs Part II

Special Guest: Scott Dietrich, PharmD, BCCCP

@PCC_PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/08/pccs-for-pharmds-part-ii-references.pdf

 

04:45 – Fixed dose PCC; 11:58 – Time to administration; 15:00 – 3-factor v. 4-factor PCC; 19:12 – 4-factor PCC v. 4-factor aPCC; 30:36 – No anticoagulation reversal; 33:36 – PCC in surgery; 37:40 – PCC in trauma; 40:51 – PCC v. andexanet alfa; 54:10 – Guideline recommendations; 62:00 – Future studies; 69:10 – Take home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>PCCs for PharmDs Part II</p>
<p>Special Guest: Scott Dietrich, PharmD, BCCCP</p>
<p>@PCC_PharmD</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/08/pccs-for-pharmds-part-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2022/08/pccs-for-pharmds-part-ii-references.pdf</a></p>
<p> </p>
<p>04:45 – Fixed dose PCC; 11:58 – Time to administration; 15:00 – 3-factor v. 4-factor PCC; 19:12 – 4-factor PCC v. 4-factor aPCC; 30:36 – No anticoagulation reversal; 33:36 – PCC in surgery; 37:40 – PCC in trauma; 40:51 – PCC v. andexanet alfa; 54:10 – Guideline recommendations; 62:00 – Future studies; 69:10 – Take home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4497</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/31d56f5a-e703-3e30-9479-bbbfce1da1cf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9984468038.mp3?updated=1679335474" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Things We Wish We Knew During Residency</title>
      <link>https://pharmacytodose.podbean.com/e/things-we-wish-we-knew-during-residency/</link>
      <description>Things We Wish We Knew During Residency

 

Special Guests: ACCP Critical Care PRN Officers

Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP;  Mojdeh Heavner, PharmD, BCPS, BCCCP, FCCM;  Susan Smith, PharmD, BCCCP, BCPS

 

03:25 – ACCP Critical Care PRN discussion

28:35 – Residency roundtable

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 21 Jul 2022 07:38:31 -0000</pubDate>
      <itunes:title>Things We Wish We Knew During Residency</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>54</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af09eeb0-a883-11ed-9652-97cc1f801643/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Things We Wish We Knew During Residency
 
Special Guests: ACCP Critical Care PRN Officers
Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP;  Mojdeh Heavner, PharmD, BCPS, BCCCP, FCCM;  Susan Smith, PharmD, BCCCP, BCPS
 
03:25 – ACCP Critical Ca...</itunes:subtitle>
      <itunes:summary>Things We Wish We Knew During Residency

 

Special Guests: ACCP Critical Care PRN Officers

Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP;  Mojdeh Heavner, PharmD, BCPS, BCCCP, FCCM;  Susan Smith, PharmD, BCCCP, BCPS

 

03:25 – ACCP Critical Care PRN discussion

28:35 – Residency roundtable

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Things We Wish We Knew During Residency</p>
<p> </p>
<p>Special Guests: ACCP Critical Care PRN Officers</p>
<p>Leslie Hamilton, PharmD, FCCP, FCCM, FNCS, BCPS, BCCCP;  Mojdeh Heavner, PharmD, BCPS, BCCCP, FCCM;  Susan Smith, PharmD, BCCCP, BCPS</p>
<p> </p>
<p>03:25 – ACCP Critical Care PRN discussion</p>
<p>28:35 – Residency roundtable</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3143</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/f2be8581-0b7b-36ff-a315-6c1624a330d2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6269421500.mp3?updated=1679335345" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>February 2022 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/february-2022-literature-review-series/</link>
      <description>Literature Review Series

Feb 2022

Special Guests: Aaron Hunsaker, PharmD and Kelsey Rhoten, PharmD

 

05:41 – 6-pack of studies; 46:09 – Dust in the wind; 55:20 – Under pressure; 65:04 – Lost in my mind; 74:54 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/06/lrs-feb-2022-references.pdf

 

Full Article List: https://docs.google.com/document/d/18g5UqJqMGvm_q9qfTiEuETV34TMaWRWbQbKzfi_vbDA/edit?usp=sharing

 

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 29 Jun 2022 23:17:06 -0000</pubDate>
      <itunes:title>February 2022 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>53</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af1b568c-a883-11ed-9652-4f233e8e5699/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Feb 2022
Special Guests: Aaron Hunsaker, PharmD and Kelsey Rhoten, PharmD
 
05:41 – 6-pack of studies; 46:09 – Dust in the wind; 55:20 – Under pressure; 65:04 – Lost in my mind; 74:54 – Front of the fridge
 
Reference List: h...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Feb 2022

Special Guests: Aaron Hunsaker, PharmD and Kelsey Rhoten, PharmD

 

05:41 – 6-pack of studies; 46:09 – Dust in the wind; 55:20 – Under pressure; 65:04 – Lost in my mind; 74:54 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/06/lrs-feb-2022-references.pdf

 

Full Article List: https://docs.google.com/document/d/18g5UqJqMGvm_q9qfTiEuETV34TMaWRWbQbKzfi_vbDA/edit?usp=sharing

 

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Feb 2022</p>
<p>Special Guests: Aaron Hunsaker, PharmD and Kelsey Rhoten, PharmD</p>
<p> </p>
<p>05:41 – 6-pack of studies; 46:09 – Dust in the wind; 55:20 – Under pressure; 65:04 – Lost in my mind; 74:54 – Front of the fridge</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/06/lrs-feb-2022-references.pdf">https://pharmacytodose.files.wordpress.com/2022/06/lrs-feb-2022-references.pdf</a></p>
<p> </p>
<p>Full Article List: <a href="https://docs.google.com/document/d/18g5UqJqMGvm_q9qfTiEuETV34TMaWRWbQbKzfi_vbDA/edit?usp=sharing">https://docs.google.com/document/d/18g5UqJqMGvm_q9qfTiEuETV34TMaWRWbQbKzfi_vbDA/edit?usp=sharing</a></p>
<p> </p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5140</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/d137a211-9dd4-3c68-93c0-e84fc6777ea6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7034822689.mp3?updated=1679335226" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Jan 22 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/jan-22-literature-review-series/</link>
      <description>Literature Review Series

Jan 2022

Special Guests: Michael Behal, PharmD and CJ Wilson, PharmD

 

08:13 – 6-pack of studies; 60:20 – Every breath you take; 68:35 – Under pressure; 76:43 – Lost in my mind; 84:10 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/06/lrs-jan-2022-references.pdf

 

Full Article List: https://docs.google.com/document/d/1Z2FDNWO6uhJjYINdnTn_ruBJHOT9s-etPyNFYmJokD0/edit?usp=sharing

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 02 Jun 2022 15:11:37 -0000</pubDate>
      <itunes:title>Jan 22 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>52</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af2cee92-a883-11ed-9652-3782277fe00a/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Jan 2022
Special Guests: Michael Behal, PharmD and CJ Wilson, PharmD
 
08:13 – 6-pack of studies; 60:20 – Every breath you take; 68:35 – Under pressure; 76:43 – Lost in my mind; 84:10 – Front of the fridge
 
Reference List: h...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Jan 2022

Special Guests: Michael Behal, PharmD and CJ Wilson, PharmD

 

08:13 – 6-pack of studies; 60:20 – Every breath you take; 68:35 – Under pressure; 76:43 – Lost in my mind; 84:10 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/06/lrs-jan-2022-references.pdf

 

Full Article List: https://docs.google.com/document/d/1Z2FDNWO6uhJjYINdnTn_ruBJHOT9s-etPyNFYmJokD0/edit?usp=sharing

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Jan 2022</p>
<p>Special Guests: Michael Behal, PharmD and CJ Wilson, PharmD</p>
<p> </p>
<p>08:13 – 6-pack of studies; 60:20 – Every breath you take; 68:35 – Under pressure; 76:43 – Lost in my mind; 84:10 – Front of the fridge</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/06/lrs-jan-2022-references.pdf">https://pharmacytodose.files.wordpress.com/2022/06/lrs-jan-2022-references.pdf</a></p>
<p> </p>
<p>Full Article List: <a href="https://docs.google.com/document/d/1Z2FDNWO6uhJjYINdnTn_ruBJHOT9s-etPyNFYmJokD0/edit?usp=sharing">https://docs.google.com/document/d/1Z2FDNWO6uhJjYINdnTn_ruBJHOT9s-etPyNFYmJokD0/edit?usp=sharing</a></p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5744</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/031c75b0-2452-3b71-bc50-6a3cdd0fcebc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9179761635.mp3?updated=1679335134" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Nov Dec 2021 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/nov-dec-2021-literature-review-series/</link>
      <description>Literature Review Series

Nov/Dec 2021

Special Guests: Callee Brooks, PharmD and Andy Jatis, PharmD

 

05:00 – 6-pack of studies; 48:25 – Ventilator blues; 60:10 – Lost in my mind; 72:38 – Don’t go breaking my heart; 81:42 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/05/nov_dec-2021-references.pdf

 

Full Article List: https://docs.google.com/document/d/1E-inQwnlcNqkvq6q657UdFEZ4x9Zd_Bi_ii0iOALS3Q/edit?usp=sharing

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 04 May 2022 09:56:41 -0000</pubDate>
      <itunes:title>Nov Dec 2021 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>51</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af3dfc50-a883-11ed-9652-23636eb14530/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Nov/Dec 2021
Special Guests: Callee Brooks, PharmD and Andy Jatis, PharmD
 
05:00 – 6-pack of studies; 48:25 – Ventilator blues; 60:10 – Lost in my mind; 72:38 – Don’t go breaking my heart; 81:42 – Front of the fridge
 
Refer...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Nov/Dec 2021

Special Guests: Callee Brooks, PharmD and Andy Jatis, PharmD

 

05:00 – 6-pack of studies; 48:25 – Ventilator blues; 60:10 – Lost in my mind; 72:38 – Don’t go breaking my heart; 81:42 – Front of the fridge

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/05/nov_dec-2021-references.pdf

 

Full Article List: https://docs.google.com/document/d/1E-inQwnlcNqkvq6q657UdFEZ4x9Zd_Bi_ii0iOALS3Q/edit?usp=sharing

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Nov/Dec 2021</p>
<p>Special Guests: Callee Brooks, PharmD and Andy Jatis, PharmD</p>
<p> </p>
<p>05:00 – 6-pack of studies; 48:25 – Ventilator blues; 60:10 – Lost in my mind; 72:38 – Don’t go breaking my heart; 81:42 – Front of the fridge</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/05/nov_dec-2021-references.pdf">https://pharmacytodose.files.wordpress.com/2022/05/nov_dec-2021-references.pdf</a></p>
<p> </p>
<p>Full Article List: <a href="https://docs.google.com/document/d/1E-inQwnlcNqkvq6q657UdFEZ4x9Zd_Bi_ii0iOALS3Q/edit?usp=sharing">https://docs.google.com/document/d/1E-inQwnlcNqkvq6q657UdFEZ4x9Zd_Bi_ii0iOALS3Q/edit?usp=sharing</a></p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5962</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/24184bdf-4416-342f-987e-adb3aaaa3943]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5174720786.mp3?updated=1679334981" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Management of Beta Blocker and Calcium Channel Blocker Overdose</title>
      <link>https://pharmacytodose.podbean.com/e/management-of-beta-blocker-and-calcium-channel-blocker-overdose/</link>
      <description>Management of Beta Blocker and Calcium Channel Overdose

Special Guest: James Leonard, PharmD, DABAT

@leonardjbrx

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/04/bb-and-ccb-overdose-references.pdf

 

Topics covered: Activated charcoal, Hemodynamics, Calcium, High dose insulin, Lipid emulsion therapy, Glucagon, Pharmacotherapy for refractory cases, Advanced therapies

 

“What would really happen: Medicine in the movies”


Old School

Knives Out

Wedding Crashers

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 01 Apr 2022 04:35:36 -0000</pubDate>
      <itunes:title>Management of Beta Blocker and Calcium Channel Blocker Overdose</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>50</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af4e459c-a883-11ed-9652-ebeb53b11aa5/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Management of Beta Blocker and Calcium Channel Overdose
Special Guest: James Leonard, PharmD, DABAT
@leonardjbrx
 
Reference List: https://pharmacytodose.files.wordpress.com/2022/04/bb-and-ccb-overdose-references.pdf
 
Topics covered: Activated charc...</itunes:subtitle>
      <itunes:summary>Management of Beta Blocker and Calcium Channel Overdose

Special Guest: James Leonard, PharmD, DABAT

@leonardjbrx

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/04/bb-and-ccb-overdose-references.pdf

 

Topics covered: Activated charcoal, Hemodynamics, Calcium, High dose insulin, Lipid emulsion therapy, Glucagon, Pharmacotherapy for refractory cases, Advanced therapies

 

“What would really happen: Medicine in the movies”


Old School

Knives Out

Wedding Crashers

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Management of Beta Blocker and Calcium Channel Overdose</p>
<p>Special Guest: James Leonard, PharmD, DABAT</p>
<p>@leonardjbrx</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/04/bb-and-ccb-overdose-references.pdf">https://pharmacytodose.files.wordpress.com/2022/04/bb-and-ccb-overdose-references.pdf</a></p>
<p> </p>
<p>Topics covered: Activated charcoal, Hemodynamics, Calcium, High dose insulin, Lipid emulsion therapy, Glucagon, Pharmacotherapy for refractory cases, Advanced therapies</p>
<p> </p>
<p>“What would really happen: Medicine in the movies”</p>
<ol>
<li>Old School</li>
<li>Knives Out</li>
<li>Wedding Crashers</li>
</ol><p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5297</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/25b84c7d-2393-34ae-98a5-54fb28b5fe15]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4080691783.mp3?updated=1679334916" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Quick Updates and Future Directions</title>
      <link>https://pharmacytodose.podbean.com/e/quick-updates-and-future-directions/</link>
      <description>I wanted to talk to the Friends of the Pod about what's been going on behind the scenes and what to expect in the future.

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

 

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 01 Apr 2022 03:55:19 -0000</pubDate>
      <itunes:title>Quick Updates and Future Directions</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>49</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af5f16ce-a883-11ed-9652-4f5cf51c8594/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>I wanted to talk to the Friends of the Pod about what's been going on behind the scenes and what to expect in the future.
PharmacyToDose.Com
@PharmacyToDose on Twitter
PharmacyToDose@Gmail.com
 </itunes:subtitle>
      <itunes:summary>I wanted to talk to the Friends of the Pod about what's been going on behind the scenes and what to expect in the future.

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

 

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>I wanted to talk to the Friends of the Pod about what's been going on behind the scenes and what to expect in the future.</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>584</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/fda52dbd-b388-327b-bfbc-7966d52dc0a4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3538032695.mp3?updated=1675952211" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Surviving Sepsis Campaign Guideline Updates</title>
      <link>https://pharmacytodose.podbean.com/e/surviving-sepsis-campaign-guideline-updates/</link>
      <description>2021 Surviving Sepsis Campaign Guideline Updates

Special Guests: Carolyn Bell PharmD, BCCCP and Brittany Bissell, PharmD, PhD, BCCCP, FCCM

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/02/2021-sepsis-guideline-updates-references.pdf

 

05:00 – General thoughts and historical perspective; 12:10 – qSOFA; 14:44 – Author diversity; 19:10 – IV fluids; 27:15 – Vasopressors; 33:12 – Antibiotics (and antifungals); 46:10 – Adjunctive treatments; 57:40 – Hopes for future guidelines; 61:35 – Gender inequity and sexual harassment in pharmacy

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 16 Feb 2022 15:22:55 -0000</pubDate>
      <itunes:title>Surviving Sepsis Campaign Guideline Updates</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>48</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af7b7026-a883-11ed-9652-ff6e888d360c/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>2021 Surviving Sepsis Campaign Guideline Updates
Special Guests: Carolyn Bell PharmD, BCCCP and Brittany Bissell, PharmD, PhD, BCCCP, FCCM
 
Reference List: https://pharmacytodose.files.wordpress.com/2022/02/2021-sepsis-guideline-updates-references.p...</itunes:subtitle>
      <itunes:summary>2021 Surviving Sepsis Campaign Guideline Updates

Special Guests: Carolyn Bell PharmD, BCCCP and Brittany Bissell, PharmD, PhD, BCCCP, FCCM

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/02/2021-sepsis-guideline-updates-references.pdf

 

05:00 – General thoughts and historical perspective; 12:10 – qSOFA; 14:44 – Author diversity; 19:10 – IV fluids; 27:15 – Vasopressors; 33:12 – Antibiotics (and antifungals); 46:10 – Adjunctive treatments; 57:40 – Hopes for future guidelines; 61:35 – Gender inequity and sexual harassment in pharmacy

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2021 Surviving Sepsis Campaign Guideline Updates</p>
<p>Special Guests: Carolyn Bell PharmD, BCCCP and Brittany Bissell, PharmD, PhD, BCCCP, FCCM</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2022/02/2021-sepsis-guideline-updates-references.pdf</p>
<p> </p>
<p>05:00 – General thoughts and historical perspective; 12:10 – qSOFA; 14:44 – Author diversity; 19:10 – IV fluids; 27:15 – Vasopressors; 33:12 – Antibiotics (and antifungals); 46:10 – Adjunctive treatments; 57:40 – Hopes for future guidelines; 61:35 – Gender inequity and sexual harassment in pharmacy</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4322</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/8d7f931c-e669-3607-a0c5-722481b5447a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2094428517.mp3?updated=1679334786" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Sept Oct 2021 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/sept-oct-2021-literature-review-series/</link>
      <description>Literature Review Series

Sept/Oct 2021

Special Guests: Sara Groome, PharmD, BCIDP and Alyssa Sykuta, PharmD, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/02/sept_oct-2021-references.pdf

 

06:10 – Sepsis 6-pack; 47:55 – In my blood; 59:55 – Ventilator blues; 72:00 – Review Room; 82:38 – Front of the Fridge

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 02 Feb 2022 22:25:16 -0000</pubDate>
      <itunes:title>Sept Oct 2021 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>47</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af8c9f68-a883-11ed-9652-abd505db5e29/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Sept/Oct 2021
Special Guests: Sara Groome, PharmD, BCIDP and Alyssa Sykuta, PharmD, BCCCP
 
Reference List: https://pharmacytodose.files.wordpress.com/2022/02/sept_oct-2021-references.pdf
 
06:10 – Sepsis 6-pack; 47:55 – In m...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Sept/Oct 2021

Special Guests: Sara Groome, PharmD, BCIDP and Alyssa Sykuta, PharmD, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/02/sept_oct-2021-references.pdf

 

06:10 – Sepsis 6-pack; 47:55 – In my blood; 59:55 – Ventilator blues; 72:00 – Review Room; 82:38 – Front of the Fridge

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Sept/Oct 2021</p>
<p>Special Guests: Sara Groome, PharmD, BCIDP and Alyssa Sykuta, PharmD, BCCCP</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2022/02/sept_oct-2021-references.pdf</p>
<p> </p>
<p>06:10 – Sepsis 6-pack; 47:55 – In my blood; 59:55 – Ventilator blues; 72:00 – Review Room; 82:38 – Front of the Fridge</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>6114</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/59c90be5-31d5-3859-b975-e03916880149]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3192923261.mp3?updated=1679334737" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>July Aug 2021 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/july-aug-2021-literature-review-series/</link>
      <description>Literature Review Series

July/August 2021

Special Guests: Hannah Brokmeier, PharmD and Natalie Haddad, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/01/july_aug-2021-references.pdf

 

06:45 – 6-pack of studies; 46:20 – Ventilator blues; 57:30 – Don’t go breaking my heart; 68:30 – Front of the fridge

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 05 Jan 2022 01:31:28 -0000</pubDate>
      <itunes:title>July Aug 2021 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>46</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/af9e1bda-a883-11ed-9652-0728e19cba1e/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
July/August 2021
Special Guests: Hannah Brokmeier, PharmD and Natalie Haddad, PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2022/01/july_aug-2021-references.pdf
 
06:45 – 6-pack of studies; 46:20 – Venti...</itunes:subtitle>
      <itunes:summary>Literature Review Series

July/August 2021

Special Guests: Hannah Brokmeier, PharmD and Natalie Haddad, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2022/01/july_aug-2021-references.pdf

 

06:45 – 6-pack of studies; 46:20 – Ventilator blues; 57:30 – Don’t go breaking my heart; 68:30 – Front of the fridge

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>July/August 2021</p>
<p>Special Guests: Hannah Brokmeier, PharmD and Natalie Haddad, PharmD</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2022/01/july_aug-2021-references.pdf">https://pharmacytodose.files.wordpress.com/2022/01/july_aug-2021-references.pdf</a></p>
<p> </p>
<p>06:45 – 6-pack of studies; 46:20 – Ventilator blues; 57:30 – Don’t go breaking my heart; 68:30 – Front of the fridge</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5696</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/2bdaac8f-a156-383d-94e3-a3dc8ff4dfbd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2250405356.mp3?updated=1679334668" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Vasoactives in Septic Shock Part II</title>
      <link>https://pharmacytodose.podbean.com/e/vasoactives-in-septic-shock-part-ii/</link>
      <description>Vasoactives in Septic Shock Part II

Special Guest: Patrick M. Wieruszewski, Pharm.D., BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/12/vasoactives-in-septic-shock-ii-references.pdf

 

02:51 – Background into vasodilatory shock and its outcomes; 04:14 – Signs/symptoms of septic shock; 05:09 – Norepinephrine as first-line vasopressor; 09:05 – Using second-line vasopressors; 17:04 – Human physiology and hemodynamics; 21:02 – More important: time to treatment or vasopressor choice; 22:16 – Taking biomarkers/genetic markers from the research lab to clinical practice; 28:22 – Vasopressin use in septic shock; 43:14 – Angiotensin II updates; 66:00 – Epinephrine in septic shock; 69:32 – Vasopressor stewardship; 72:40 – One wish for septic shock management

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 16 Dec 2021 01:46:55 -0000</pubDate>
      <itunes:title>Vasoactives in Septic Shock Part II</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>45</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/afaf61ec-a883-11ed-9652-7ffc1a589124/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Vasoactives in Septic Shock Part II
Special Guest: Patrick M. Wieruszewski, Pharm.D., BCCCP
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/12/vasoactives-in-septic-shock-ii-references.pdf
 
02:51 – Background into vasodilatory shoc...</itunes:subtitle>
      <itunes:summary>Vasoactives in Septic Shock Part II

Special Guest: Patrick M. Wieruszewski, Pharm.D., BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/12/vasoactives-in-septic-shock-ii-references.pdf

 

02:51 – Background into vasodilatory shock and its outcomes; 04:14 – Signs/symptoms of septic shock; 05:09 – Norepinephrine as first-line vasopressor; 09:05 – Using second-line vasopressors; 17:04 – Human physiology and hemodynamics; 21:02 – More important: time to treatment or vasopressor choice; 22:16 – Taking biomarkers/genetic markers from the research lab to clinical practice; 28:22 – Vasopressin use in septic shock; 43:14 – Angiotensin II updates; 66:00 – Epinephrine in septic shock; 69:32 – Vasopressor stewardship; 72:40 – One wish for septic shock management

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Vasoactives in Septic Shock Part II</p>
<p>Special Guest: Patrick M. Wieruszewski, Pharm.D., BCCCP</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/12/vasoactives-in-septic-shock-ii-references.pdf">https://pharmacytodose.files.wordpress.com/2021/12/vasoactives-in-septic-shock-ii-references.pdf</a></p>
<p> </p>
<p>02:51 – Background into vasodilatory shock and its outcomes; 04:14 – Signs/symptoms of septic shock; 05:09 – Norepinephrine as first-line vasopressor; 09:05 – Using second-line vasopressors; 17:04 – Human physiology and hemodynamics; 21:02 – More important: time to treatment or vasopressor choice; 22:16 – Taking biomarkers/genetic markers from the research lab to clinical practice; 28:22 – Vasopressin use in septic shock; 43:14 – Angiotensin II updates; 66:00 – Epinephrine in septic shock; 69:32 – Vasopressor stewardship; 72:40 – One wish for septic shock management</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4883</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/b3eb5809-68be-3f0e-82a9-c692e95e88bd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3844702867.mp3?updated=1679334569" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Intro to Mechanical Ventilation</title>
      <link>https://pharmacytodose.podbean.com/e/intro-to-mechanical-ventilation/</link>
      <description>Introduction to Mechanical Ventilation

Special Guests: Andrea Sikora Newsome, PharmD, BCPS, BCCCP, FCCM

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/11/mechanical-ventilation-references.pdf

 

05:49 – Indications for mechanical ventilation; 12:45 – Principles of critical care; 16:40 – Review of respiratory cycle; 20:04 – Common terminology (Tidal volume, FiO2, PEEP); 32:01 – Ventilator modes; 39:15 – Pressure v. volume control; 47:00 – Inspiratory pressure, plateau pressure, and autoPEEP; 51:50 – Ventilator weaning; 61:00 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 15 Nov 2021 19:09:26 -0000</pubDate>
      <itunes:title>Intro to Mechanical Ventilation</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>44</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/afc196b4-a883-11ed-9652-833cc6302963/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Introduction to Mechanical Ventilation
Special Guests: Andrea Sikora Newsome, PharmD, BCPS, BCCCP, FCCM
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/11/mechanical-ventilation-references.pdf
 
05:49 – Indications for mechanical ve...</itunes:subtitle>
      <itunes:summary>Introduction to Mechanical Ventilation

Special Guests: Andrea Sikora Newsome, PharmD, BCPS, BCCCP, FCCM

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/11/mechanical-ventilation-references.pdf

 

05:49 – Indications for mechanical ventilation; 12:45 – Principles of critical care; 16:40 – Review of respiratory cycle; 20:04 – Common terminology (Tidal volume, FiO2, PEEP); 32:01 – Ventilator modes; 39:15 – Pressure v. volume control; 47:00 – Inspiratory pressure, plateau pressure, and autoPEEP; 51:50 – Ventilator weaning; 61:00 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Introduction to Mechanical Ventilation</p>
<p>Special Guests: Andrea Sikora Newsome, PharmD, BCPS, BCCCP, FCCM</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2021/11/mechanical-ventilation-references.pdf</p>
<p> </p>
<p>05:49 – Indications for mechanical ventilation; 12:45 – Principles of critical care; 16:40 – Review of respiratory cycle; 20:04 – Common terminology (Tidal volume, FiO2, PEEP); 32:01 – Ventilator modes; 39:15 – Pressure v. volume control; 47:00 – Inspiratory pressure, plateau pressure, and autoPEEP; 51:50 – Ventilator weaning; 61:00 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4456</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/9a32680a-a6ac-3bdd-beb6-e5e1b82986d1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6677919334.mp3?updated=1679334451" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>May June 2021 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/may-june-2021-literature-review-series/</link>
      <description>Literature Review Series

May/June 2021

Special Guests: Nikko Bonavoglia, PharmD and Alyssa White, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/09/may_june-2021-references.pdf

 

06:40 – Six pack of studies; 41:00 – Anticoagulation/Reversal “Let it Bleed”; 55:40 – Sepsis with a sprinkle of random “Start Me Up”; 69:35 – PADIS “Ventilator Blues”; 78:50 – Pharmacist-driven studies “Front of the Fridge”

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 30 Sep 2021 13:19:49 -0000</pubDate>
      <itunes:title>May June 2021 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>43</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/afd37bd6-a883-11ed-9652-d3efc3f40c93/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
May/June 2021
Special Guests: Nikko Bonavoglia, PharmD and Alyssa White, PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/09/may_june-2021-references.pdf
 
06:40 – Six pack of studies; 41:00 – Anticoag...</itunes:subtitle>
      <itunes:summary>Literature Review Series

May/June 2021

Special Guests: Nikko Bonavoglia, PharmD and Alyssa White, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/09/may_june-2021-references.pdf

 

06:40 – Six pack of studies; 41:00 – Anticoagulation/Reversal “Let it Bleed”; 55:40 – Sepsis with a sprinkle of random “Start Me Up”; 69:35 – PADIS “Ventilator Blues”; 78:50 – Pharmacist-driven studies “Front of the Fridge”

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>May/June 2021</p>
<p>Special Guests: Nikko Bonavoglia, PharmD and Alyssa White, PharmD</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/09/may_june-2021-references.pdf">https://pharmacytodose.files.wordpress.com/2021/09/may_june-2021-references.pdf</a></p>
<p> </p>
<p>06:40 – Six pack of studies; 41:00 – Anticoagulation/Reversal “Let it Bleed”; 55:40 – Sepsis with a sprinkle of random “Start Me Up”; 69:35 – PADIS “Ventilator Blues”; 78:50 – Pharmacist-driven studies “Front of the Fridge”</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5589</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/7a0cfc9c-de3a-308d-b575-f30e24ce11a9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2370111725.mp3?updated=1679333618" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Targeted Temperature Management (TTM)</title>
      <link>https://pharmacytodose.podbean.com/e/targeted-temperature-management-ttm/</link>
      <description>Targeted Temperature Management (TTM)

Special Guests: Scott Benken, PharmD, BCPS-AQ Cardiology, FCCM

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/08/ttm-references.pdf

 

08:05 – Preferred nomenclature; 09:20 – TTM history; 11:30 – Optimal temperature; 14:45 – Ways to lower temperature; 17:20 – Guideline recommendations; 20:50 – TTM2 trial; 28:05 – Future areas of research; 33:05 – TTM PK/PD changes; 39:50 – Shivering; 45:10 – Rapid-fire questions; 58:30 – Creating electronic TTM protocols; 61:15 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 27 Aug 2021 14:43:37 -0000</pubDate>
      <itunes:title>Targeted Temperature Management (TTM)</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>42</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/afe5629c-a883-11ed-9652-ffd11e9271e1/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Targeted Temperature Management (TTM)
Special Guests: Scott Benken, PharmD, BCPS-AQ Cardiology, FCCM
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/08/ttm-references.pdf
 
08:05 – Preferred nomenclature; 09:20 – TTM history; 11:30 ...</itunes:subtitle>
      <itunes:summary>Targeted Temperature Management (TTM)

Special Guests: Scott Benken, PharmD, BCPS-AQ Cardiology, FCCM

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/08/ttm-references.pdf

 

08:05 – Preferred nomenclature; 09:20 – TTM history; 11:30 – Optimal temperature; 14:45 – Ways to lower temperature; 17:20 – Guideline recommendations; 20:50 – TTM2 trial; 28:05 – Future areas of research; 33:05 – TTM PK/PD changes; 39:50 – Shivering; 45:10 – Rapid-fire questions; 58:30 – Creating electronic TTM protocols; 61:15 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Targeted Temperature Management (TTM)</p>
<p>Special Guests: Scott Benken, PharmD, BCPS-AQ Cardiology, FCCM</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/08/ttm-references.pdf">https://pharmacytodose.files.wordpress.com/2021/08/ttm-references.pdf</a></p>
<p> </p>
<p>08:05 – Preferred nomenclature; 09:20 – TTM history; 11:30 – Optimal temperature; 14:45 – Ways to lower temperature; 17:20 – Guideline recommendations; 20:50 – TTM2 trial; 28:05 – Future areas of research; 33:05 – TTM PK/PD changes; 39:50 – Shivering; 45:10 – Rapid-fire questions; 58:30 – Creating electronic TTM protocols; 61:15 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4131</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/50251ba9-8915-3092-ba61-6b30c43e4acc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6487943155.mp3?updated=1679333518" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Mar Apr 2021 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/mar-apr-2021-literature-review-series/</link>
      <description>Literature Review Series

Mar/Apr 2021

Special Guests: Ashley Barlow, PharmD and Brooke Barlow, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/07/mar_apr2021-references.pdf

 

07:19 – Six-pack of studies; 48:15 – Sepsis; 59:14 – Pain, agitation, delirium, and neuromuscular blockade; 73:50 – Infectious diseases and pharmacokinetics; 82:36 – Pharmacist-driven studies

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 30 Jul 2021 17:47:44 -0000</pubDate>
      <itunes:title>Mar Apr 2021 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>41</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/aff754fc-a883-11ed-9652-97df925d8b97/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Mar/Apr 2021
Special Guests: Ashley Barlow, PharmD and Brooke Barlow, PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/07/mar_apr2021-references.pdf
 
07:19 – Six-pack of studies; 48:15 – Sepsis; 59:14...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Mar/Apr 2021

Special Guests: Ashley Barlow, PharmD and Brooke Barlow, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/07/mar_apr2021-references.pdf

 

07:19 – Six-pack of studies; 48:15 – Sepsis; 59:14 – Pain, agitation, delirium, and neuromuscular blockade; 73:50 – Infectious diseases and pharmacokinetics; 82:36 – Pharmacist-driven studies

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Mar/Apr 2021</p>
<p>Special Guests: Ashley Barlow, PharmD and Brooke Barlow, PharmD</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/07/mar_apr2021-references.pdf">https://pharmacytodose.files.wordpress.com/2021/07/mar_apr2021-references.pdf</a></p>
<p> </p>
<p>07:19 – Six-pack of studies; 48:15 – Sepsis; 59:14 – Pain, agitation, delirium, and neuromuscular blockade; 73:50 – Infectious diseases and pharmacokinetics; 82:36 – Pharmacist-driven studies</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5522</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/ff0ef4fd-7316-37fa-b83b-d52d5cbadde4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2711085356.mp3?updated=1679333957" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Rapid Sequence Intubation</title>
      <link>https://pharmacytodose.podbean.com/e/rapid-sequence-intubation/</link>
      <description>Rapid Sequence Intubation (RSI)

Special Guests: Haley Peters, PharmD, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/06/rsi-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/06/rsi-references.pdf

 

05:05 – Over-arching considerations; 09:45 – Neuromuscular blockers; 31:35 – Pre-induction agents; 46:46 – Induction agents; 72:23 – Obesity dosing considerations; 81:21 – Difficult airways; 84:30 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 16 Jun 2021 21:07:39 -0000</pubDate>
      <itunes:title>Rapid Sequence Intubation</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>40</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0098320-a883-11ed-9652-e3456f4309c0/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Rapid Sequence Intubation (RSI)
Special Guests: Haley Peters, PharmD, BCCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/06/rsi-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/06/rsi-references.pdf
 
...</itunes:subtitle>
      <itunes:summary>Rapid Sequence Intubation (RSI)

Special Guests: Haley Peters, PharmD, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/06/rsi-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/06/rsi-references.pdf

 

05:05 – Over-arching considerations; 09:45 – Neuromuscular blockers; 31:35 – Pre-induction agents; 46:46 – Induction agents; 72:23 – Obesity dosing considerations; 81:21 – Difficult airways; 84:30 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rapid Sequence Intubation (RSI)</p>
<p>Special Guests: Haley Peters, PharmD, BCCCP</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2021/06/rsi-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2021/06/rsi-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/06/rsi-references.pdf">https://pharmacytodose.files.wordpress.com/2021/06/rsi-references.pdf</a></p>
<p> </p>
<p>05:05 – Over-arching considerations; 09:45 – Neuromuscular blockers; 31:35 – Pre-induction agents; 46:46 – Induction agents; 72:23 – Obesity dosing considerations; 81:21 – Difficult airways; 84:30 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5814</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/df9ed56b-5e72-3692-8980-9f39a56e1978]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6208342077.mp3?updated=1679333543" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Jan Feb 2021 Literature Review Series</title>
      <link>https://pharmacytodose.podbean.com/e/jan-feb-2021-literature-review-series/</link>
      <description>Literature Review Series

Jan/Feb 2021

Special Guests: Abagail Kirwen, PharmD and Paige Morgan, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/05/jan_feb2021-references.pdf

 

07:13 – Six-pack of Studies; 39:06 – Review Room; 52:20 – Glance at the Guidelines; 61:58 – Kinetics Corner; 73:37 – Front of the Fridge

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 20 May 2021 22:54:57 -0000</pubDate>
      <itunes:title>Jan Feb 2021 Literature Review Series</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>39</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b01b3db8-a883-11ed-9652-bf7f22e955d3/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Literature Review Series
Jan/Feb 2021
Special Guests: Abagail Kirwen, PharmD and Paige Morgan, PharmD
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/05/jan_feb2021-references.pdf
 
07:13 – Six-pack of Studies; 39:06 – Review Room; ...</itunes:subtitle>
      <itunes:summary>Literature Review Series

Jan/Feb 2021

Special Guests: Abagail Kirwen, PharmD and Paige Morgan, PharmD

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/05/jan_feb2021-references.pdf

 

07:13 – Six-pack of Studies; 39:06 – Review Room; 52:20 – Glance at the Guidelines; 61:58 – Kinetics Corner; 73:37 – Front of the Fridge

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Literature Review Series</p>
<p>Jan/Feb 2021</p>
<p>Special Guests: Abagail Kirwen, PharmD and Paige Morgan, PharmD</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/05/jan_feb2021-references.pdf">https://pharmacytodose.files.wordpress.com/2021/05/jan_feb2021-references.pdf</a></p>
<p> </p>
<p>07:13 – Six-pack of Studies; 39:06 – Review Room; 52:20 – Glance at the Guidelines; 61:58 – Kinetics Corner; 73:37 – Front of the Fridge</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5674</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/b92256bb-1147-3c91-b604-ada0dc0e81a4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4730092023.mp3?updated=1679332719" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Updates in COVID-19 Pharmacotherapy</title>
      <link>https://pharmacytodose.podbean.com/e/updates-in-covid-19-pharmacotherapy/</link>
      <description>Updates in COVID-19 Pharmacotherapy

Special Guests: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP

Mitchell Buckley, PharmD, FASHP, FCCM, FCCP, BCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/covid19-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/04/covid19-references.pdf

 

03:25 – Tocilizumab; 22:21 – Corticosteroids; 37:50 – Anticoagulation; 72:50 – Potpourri/Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 28 Apr 2021 13:55:31 -0000</pubDate>
      <itunes:title>Updates in COVID-19 Pharmacotherapy</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>38</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b02c6f2a-a883-11ed-9652-3f92e2f39d2f/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Updates in COVID-19 Pharmacotherapy
Special Guests: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP
Mitchell Buckley, PharmD, FASHP, FCCM, FCCP, BCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/covid19-show-notes.pdf
 
Reference List: htt...</itunes:subtitle>
      <itunes:summary>Updates in COVID-19 Pharmacotherapy

Special Guests: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP

Mitchell Buckley, PharmD, FASHP, FCCM, FCCP, BCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/covid19-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/04/covid19-references.pdf

 

03:25 – Tocilizumab; 22:21 – Corticosteroids; 37:50 – Anticoagulation; 72:50 – Potpourri/Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Updates in COVID-19 Pharmacotherapy</p>
<p>Special Guests: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP</p>
<p>Mitchell Buckley, PharmD, FASHP, FCCM, FCCP, BCCP</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2021/04/covid19-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2021/04/covid19-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/04/covid19-references.pdf">https://pharmacytodose.files.wordpress.com/2021/04/covid19-references.pdf</a></p>
<p> </p>
<p>03:25 – Tocilizumab; 22:21 – Corticosteroids; 37:50 – Anticoagulation; 72:50 – Potpourri/Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5498</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/a85a84c6-ac58-35a3-9c3d-995aeab65a63]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5182880378.mp3?updated=1679332542" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ICU Liberation (ABCDEF) Bundle</title>
      <link>https://pharmacytodose.podbean.com/e/icu-liberation-abcdef-bundle/</link>
      <description>ICU Liberation (ABCDEF) Bundle

Special Guest: Joanna Stollings, PharmD, FCCM, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-references-ii.pdf 

 

03:48 – What is the ABCDEF bundle?; 08:35 – Barriers to bundle implementation; 12:14 – Excluding patients; 14:18 – A: Assessing/preventing/treating pain; 20:27 – B: Spontaneous awakening/breathing trials; 26:27 – C: Choice of sedation; 38:40 – D: Assessing/prevention/treating delirium; 42:09 – E: Early mobility/exercise; 45:40 – F: Family engagement and involvement; 49:16 – Importance of multidisciplinary involvement; 52:58 – Bundle implementation with COVID-19; 60:21 – Advice for those looking to implement the ICU Liberation Bundle; 64:30 – Pharmacist’s role in successful bundle implementation

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

 

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 12 Apr 2021 13:42:00 -0000</pubDate>
      <itunes:title>ICU Liberation (ABCDEF) Bundle</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>37</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b03e2008-a883-11ed-9652-d30be9009e45/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>ICU Liberation (ABCDEF) Bundle
Special Guest: Joanna Stollings, PharmD, FCCM, BCPS, BCCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.c...</itunes:subtitle>
      <itunes:summary>ICU Liberation (ABCDEF) Bundle

Special Guest: Joanna Stollings, PharmD, FCCM, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-references-ii.pdf 

 

03:48 – What is the ABCDEF bundle?; 08:35 – Barriers to bundle implementation; 12:14 – Excluding patients; 14:18 – A: Assessing/preventing/treating pain; 20:27 – B: Spontaneous awakening/breathing trials; 26:27 – C: Choice of sedation; 38:40 – D: Assessing/prevention/treating delirium; 42:09 – E: Early mobility/exercise; 45:40 – F: Family engagement and involvement; 49:16 – Importance of multidisciplinary involvement; 52:58 – Bundle implementation with COVID-19; 60:21 – Advice for those looking to implement the ICU Liberation Bundle; 64:30 – Pharmacist’s role in successful bundle implementation

 

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

 

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>ICU Liberation (ABCDEF) Bundle</p>
<p>Special Guest: Joanna Stollings, PharmD, FCCM, BCPS, BCCCP</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-references-ii.pdf">https://pharmacytodose.files.wordpress.com/2021/04/icu-liberation-bundle-references-ii.pdf</a> </p>
<p> </p>
<p>03:48 – What is the ABCDEF bundle?; 08:35 – Barriers to bundle implementation; 12:14 – Excluding patients; 14:18 – A: Assessing/preventing/treating pain; 20:27 – B: Spontaneous awakening/breathing trials; 26:27 – C: Choice of sedation; 38:40 – D: Assessing/prevention/treating delirium; 42:09 – E: Early mobility/exercise; 45:40 – F: Family engagement and involvement; 49:16 – Importance of multidisciplinary involvement; 52:58 – Bundle implementation with COVID-19; 60:21 – Advice for those looking to implement the ICU Liberation Bundle; 64:30 – Pharmacist’s role in successful bundle implementation</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4675</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/830861b7-ca19-33b6-8563-6e884111d923]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3272255954.mp3?updated=1679332386" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>HTN Crises (Emergency/Urgency)</title>
      <link>https://pharmacytodose.podbean.com/e/htn-crises-emergencyurgency/</link>
      <description>Hypertensive Crises (Emergency/Urgency)

Special Guest: Deepali Dixit, PharmD, BCPS, BCCCP, FCCM

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-references.pdf 

 

06:50 – Diagnosis; 09:17 – Clinical presentation; 11:14 – Common causes; 13:36 – HTN urgency management; 17:50 – HTN emergency BP goal; 23:26 - IV push v. continuous IV infusions; 28:30 – Aortic dissection/Esmolol; 34:10 – Acute ischemic stroke/Hydralazine; 40:25 – Intracranial hemorrhage/Nicardipine; 44:48 – ACS/Labetalol; 49:20 – ADHF/Nitrates; 56:08 – Miscellaneous medication pearls; 59:33 – Pregnancy treatment; 64:10 – Take-home points

 

4th Annual Multidisciplinary Tri-State Critical Care Virtual Symposium

Details: https://rutgers.cloud-cme.com/course/courseoverview?P=5&amp;EID=8158

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 24 Feb 2021 11:42:36 -0000</pubDate>
      <itunes:title>HTN Crises (Emergency/Urgency)</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>36</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b04ffa80-a883-11ed-9652-6fe66520ee56/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Hypertensive Crises (Emergency/Urgency)
Special Guest: Deepali Dixit, PharmD, BCPS, BCCCP, FCCM
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/20...</itunes:subtitle>
      <itunes:summary>Hypertensive Crises (Emergency/Urgency)

Special Guest: Deepali Dixit, PharmD, BCPS, BCCCP, FCCM

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-references.pdf 

 

06:50 – Diagnosis; 09:17 – Clinical presentation; 11:14 – Common causes; 13:36 – HTN urgency management; 17:50 – HTN emergency BP goal; 23:26 - IV push v. continuous IV infusions; 28:30 – Aortic dissection/Esmolol; 34:10 – Acute ischemic stroke/Hydralazine; 40:25 – Intracranial hemorrhage/Nicardipine; 44:48 – ACS/Labetalol; 49:20 – ADHF/Nitrates; 56:08 – Miscellaneous medication pearls; 59:33 – Pregnancy treatment; 64:10 – Take-home points

 

4th Annual Multidisciplinary Tri-State Critical Care Virtual Symposium

Details: https://rutgers.cloud-cme.com/course/courseoverview?P=5&amp;EID=8158

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Hypertensive Crises (Emergency/Urgency)</p>
<p>Special Guest: Deepali Dixit, PharmD, BCPS, BCCCP, FCCM</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-references.pdf">https://pharmacytodose.files.wordpress.com/2021/02/htn-crises-references.pdf</a> </p>
<p> </p>
<p>06:50 – Diagnosis; 09:17 – Clinical presentation; 11:14 – Common causes; 13:36 – HTN urgency management; 17:50 – HTN emergency BP goal; 23:26 - IV push v. continuous IV infusions; 28:30 – Aortic dissection/Esmolol; 34:10 – Acute ischemic stroke/Hydralazine; 40:25 – Intracranial hemorrhage/Nicardipine; 44:48 – ACS/Labetalol; 49:20 – ADHF/Nitrates; 56:08 – Miscellaneous medication pearls; 59:33 – Pregnancy treatment; 64:10 – Take-home points</p>
<p> </p>
<p>4th Annual Multidisciplinary Tri-State Critical Care Virtual Symposium</p>
<p>Details: https://rutgers.cloud-cme.com/course/courseoverview?P=5&amp;EID=8158</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4168</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/956b5449-501f-3792-a497-7590f60e3f7a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7808399017.mp3?updated=1679332160" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Oncologic Emergencies</title>
      <link>https://pharmacytodose.podbean.com/e/oncologic-emergencies/</link>
      <description>Oncologic Emergencies

Special Guest: Siu Yan Amy Yeung, PharmD, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-show-notes-1.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-references.pdf

 

06:00 – Oncologic emergency overview; 10:12 – Tumor lysis syndrome; 46:40 – Hypercalcemia of malignancy; 67:12 – Superior vena cava syndrome; 75:05 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 19 Feb 2021 21:03:34 -0000</pubDate>
      <itunes:title>Oncologic Emergencies</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>35</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b061aba4-a883-11ed-9652-07463f776744/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Oncologic Emergencies
Special Guest: Siu Yan Amy Yeung, PharmD, BCPS, BCCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-show-notes-1.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2021/02/o...</itunes:subtitle>
      <itunes:summary>Oncologic Emergencies

Special Guest: Siu Yan Amy Yeung, PharmD, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-show-notes-1.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-references.pdf

 

06:00 – Oncologic emergency overview; 10:12 – Tumor lysis syndrome; 46:40 – Hypercalcemia of malignancy; 67:12 – Superior vena cava syndrome; 75:05 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Oncologic Emergencies</p>
<p>Special Guest: Siu Yan Amy Yeung, PharmD, BCPS, BCCCP</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-show-notes-1.pdf">https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-show-notes-1.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-references.pdf">https://pharmacytodose.files.wordpress.com/2021/02/oncologic-emergencies-references.pdf</a></p>
<p> </p>
<p>06:00 – Oncologic emergency overview; 10:12 – Tumor lysis syndrome; 46:40 – Hypercalcemia of malignancy; 67:12 – Superior vena cava syndrome; 75:05 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5001</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/b7a0cc6b-3828-322f-9133-3c30927142b4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6809038717.mp3?updated=1679332094" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trauma Alert Part II: ICU Management</title>
      <link>https://pharmacytodose.podbean.com/e/trauma-alert-part-ii-icu-management/</link>
      <description>Trauma Alert Part II: ICU Management

Special Guest: Melanie Smith Condeni, PharmD, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-references.pdf

 

05:25 – Pain, agitation, and delirium management; 24:30 – VTE prophylaxis; 48:47 – Open fracture antibiotics; 52:16 – Identifying infections; 57:03 – Neurostorming; 66:42 – TBI clinical pearls; 82:34 – Bowel regimens; 87:14 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 28 Jan 2021 03:37:06 -0000</pubDate>
      <itunes:title>Trauma Alert Part II: ICU Management</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>34</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b07374e2-a883-11ed-9652-075217067b5f/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Trauma Alert Part II: ICU Management
Special Guest: Melanie Smith Condeni, PharmD, BCPS, BCCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-show-notes.pdf
 
Reference List: https://pharmacytodose.files....</itunes:subtitle>
      <itunes:summary>Trauma Alert Part II: ICU Management

Special Guest: Melanie Smith Condeni, PharmD, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-references.pdf

 

05:25 – Pain, agitation, and delirium management; 24:30 – VTE prophylaxis; 48:47 – Open fracture antibiotics; 52:16 – Identifying infections; 57:03 – Neurostorming; 66:42 – TBI clinical pearls; 82:34 – Bowel regimens; 87:14 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trauma Alert Part II: ICU Management</p>
<p>Special Guest: Melanie Smith Condeni, PharmD, BCPS, BCCCP</p>
<p> </p>
<p>Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-show-notes.pdf</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2021/01/trauma-alert-icu-management-references.pdf</p>
<p> </p>
<p>05:25 – Pain, agitation, and delirium management; 24:30 – VTE prophylaxis; 48:47 – Open fracture antibiotics; 52:16 – Identifying infections; 57:03 – Neurostorming; 66:42 – TBI clinical pearls; 82:34 – Bowel regimens; 87:14 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5584</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/c8edd687-1d93-328f-9fb9-63f8f193c225]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1673006203.mp3?updated=1679332705" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Practice-Based Research</title>
      <link>https://pharmacytodose.podbean.com/e/practice-based-research/</link>
      <description>Practice-Based Research

Special Guest: Alex Flannery, PharmD, FCCM, BCCCP, BCPS

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-show-notes-1.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-references-1.pdf

 

04:17 – Defining practice-based research; 06:02 – Importance of research; 12:38 – Developing infrastructure that supports research; 18:59 – Finding a good research idea; 22:15 – Research v. MUE; 25:48 – Reducing duplicate research studies; 28:00 – Developing an idea into a study; 31:52 – Study design resources; 35:23 – Research funding; 43:12 – Statistics; 47:05 – Manuscript publishing; 52:15 – Implementing results from practice-based research; 55:00 – Most common research pitfalls; 59:04 – Student/resident research mentorship; 62:00 – Practice-based research networks; 64:40 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 06 Jan 2021 12:53:47 -0000</pubDate>
      <itunes:title>Practice-Based Research</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>33</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0863ffa-a883-11ed-9652-53458d4bc004/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Practice-Based Research
Special Guest: Alex Flannery, PharmD, FCCM, BCCCP, BCPS
 
Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-show-notes-1.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/202...</itunes:subtitle>
      <itunes:summary>Practice-Based Research

Special Guest: Alex Flannery, PharmD, FCCM, BCCCP, BCPS

 

Show Notes: https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-show-notes-1.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-references-1.pdf

 

04:17 – Defining practice-based research; 06:02 – Importance of research; 12:38 – Developing infrastructure that supports research; 18:59 – Finding a good research idea; 22:15 – Research v. MUE; 25:48 – Reducing duplicate research studies; 28:00 – Developing an idea into a study; 31:52 – Study design resources; 35:23 – Research funding; 43:12 – Statistics; 47:05 – Manuscript publishing; 52:15 – Implementing results from practice-based research; 55:00 – Most common research pitfalls; 59:04 – Student/resident research mentorship; 62:00 – Practice-based research networks; 64:40 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Practice-Based Research</p>
<p>Special Guest: Alex Flannery, PharmD, FCCM, BCCCP, BCPS</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-show-notes-1.pdf">https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-show-notes-1.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-references-1.pdf">https://pharmacytodose.files.wordpress.com/2021/01/practice-based-research-references-1.pdf</a></p>
<p> </p>
<p>04:17 – Defining practice-based research; 06:02 – Importance of research; 12:38 – Developing infrastructure that supports research; 18:59 – Finding a good research idea; 22:15 – Research v. MUE; 25:48 – Reducing duplicate research studies; 28:00 – Developing an idea into a study; 31:52 – Study design resources; 35:23 – Research funding; 43:12 – Statistics; 47:05 – Manuscript publishing; 52:15 – Implementing results from practice-based research; 55:00 – Most common research pitfalls; 59:04 – Student/resident research mentorship; 62:00 – Practice-based research networks; 64:40 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4307</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/12538bea-aa51-3660-a841-a76b56bcd2b9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6858544551.mp3?updated=1679330525" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Alcohol Withdrawal Disorder</title>
      <link>https://pharmacytodose.podbean.com/e/alcohol-withdrawal-disorder/</link>
      <description>Alcohol Withdrawal Disorder

Special Guest: Kent Owusu, PharmD, BCCCP, BCPS

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-references.pdf

 

05:50 – Consequences of alcohol withdrawal; 06:56 – Diagnosis/Pathophysiology; 11:15 – Treatment goal; 12:20 – Alcohol for withdrawal prevention; 15:30 – Benzodiazepine treatment considerations; 25:45 – Monitoring tools; 30:40 – Phenobarbital; 38:50 – Dexmedetomidine; 43:20 – Ketamine; 47:40 – Propofol; 51:43 – Valproic Acid and Gabapentin; 58:25 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 11 Dec 2020 20:56:05 -0000</pubDate>
      <itunes:title>Alcohol Withdrawal Disorder</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>32</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0984b8c-a883-11ed-9652-a70d6ee5fce0/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Alcohol Withdrawal Disorder
Special Guest: Kent Owusu, PharmD, BCCCP, BCPS
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/12/alcohol...</itunes:subtitle>
      <itunes:summary>Alcohol Withdrawal Disorder

Special Guest: Kent Owusu, PharmD, BCCCP, BCPS

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-references.pdf

 

05:50 – Consequences of alcohol withdrawal; 06:56 – Diagnosis/Pathophysiology; 11:15 – Treatment goal; 12:20 – Alcohol for withdrawal prevention; 15:30 – Benzodiazepine treatment considerations; 25:45 – Monitoring tools; 30:40 – Phenobarbital; 38:50 – Dexmedetomidine; 43:20 – Ketamine; 47:40 – Propofol; 51:43 – Valproic Acid and Gabapentin; 58:25 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Alcohol Withdrawal Disorder</p>
<p>Special Guest: Kent Owusu, PharmD, BCCCP, BCPS</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-references.pdf">https://pharmacytodose.files.wordpress.com/2020/12/alcohol-withdrawal-references.pdf</a></p>
<p> </p>
<p>05:50 – Consequences of alcohol withdrawal; 06:56 – Diagnosis/Pathophysiology; 11:15 – Treatment goal; 12:20 – Alcohol for withdrawal prevention; 15:30 – Benzodiazepine treatment considerations; 25:45 – Monitoring tools; 30:40 – Phenobarbital; 38:50 – Dexmedetomidine; 43:20 – Ketamine; 47:40 – Propofol; 51:43 – Valproic Acid and Gabapentin; 58:25 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4107</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/3416964e-042f-3cff-a0a0-8b008d053730]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4592509914.mp3?updated=1679329590" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Trauma Alert Part 1 Acute Management</title>
      <link>https://pharmacytodose.podbean.com/e/trauma-alert-part-1-acute-management/</link>
      <description>Trauma Alert Part I: Acute Management

Special Guest: Brian Gilbert, PharmD, BCCCP, BCPS

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-references.pdf

 

05:12 – Pre-arrival preparation; 14:19 – Pharmacist role on trauma team; 15:40 – Primary survey; 23:37 – Massive transfusion protocol; 27:00 – Viscoelastography; 40:34 – PCC administration and dosage; 44:40 – Calcium; 51:00 – RSI/PAD considerations; 56:10 – Open fractures and antibiotics; 58:37 – Elevated ICP management; 62:37 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 27 Nov 2020 21:19:42 -0000</pubDate>
      <itunes:title>Trauma Alert Part 1 Acute Management</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>31</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0a9eedc-a883-11ed-9652-17edaee77f78/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Trauma Alert Part I: Acute Management
Special Guest: Brian Gilbert, PharmD, BCCCP, BCPS
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/11...</itunes:subtitle>
      <itunes:summary>Trauma Alert Part I: Acute Management

Special Guest: Brian Gilbert, PharmD, BCCCP, BCPS

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-references.pdf

 

05:12 – Pre-arrival preparation; 14:19 – Pharmacist role on trauma team; 15:40 – Primary survey; 23:37 – Massive transfusion protocol; 27:00 – Viscoelastography; 40:34 – PCC administration and dosage; 44:40 – Calcium; 51:00 – RSI/PAD considerations; 56:10 – Open fractures and antibiotics; 58:37 – Elevated ICP management; 62:37 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Trauma Alert Part I: Acute Management</p>
<p>Special Guest: Brian Gilbert, PharmD, BCCCP, BCPS</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-references.pdf">https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-references.pdf</a></p>
<p> </p>
<p>05:12 – Pre-arrival preparation; 14:19 – Pharmacist role on trauma team; 15:40 – Primary survey; 23:37 – Massive transfusion protocol; 27:00 – Viscoelastography; 40:34 – PCC administration and dosage; 44:40 – Calcium; 51:00 – RSI/PAD considerations; 56:10 – Open fractures and antibiotics; 58:37 – Elevated ICP management; 62:37 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4332</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/2fb444c1-e32a-3371-ae7a-9a6196d2450b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6556225738.mp3?updated=1679328957" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2020 ACCP Annual Meeting Recap</title>
      <link>https://pharmacytodose.podbean.com/e/2020-accp-annual-meeting-recap/</link>
      <description>2020 ACCP Annual Meeting Recap

Special Guest: Anthony Hawkins, PharmD, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/11/2020-accp-annual-meeting-references.pdf

 

06:30 – Virtual v. in-person meetings; 30:35 – BIG announcement!; 34:15 – Poster sessions; 47:00 – Scientific sessions

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sat, 07 Nov 2020 00:35:04 -0000</pubDate>
      <itunes:title>2020 ACCP Annual Meeting Recap</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>30</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0bafb14-a883-11ed-9652-479a679fbfcf/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>2020 ACCP Annual Meeting Recap
Special Guest: Anthony Hawkins, PharmD, BCCCP
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/11/2020-accp-annual-meeting-references.pdf
 
06:30 – Virtual v. in-person meetings; 30:35 – BIG announcemen...</itunes:subtitle>
      <itunes:summary>2020 ACCP Annual Meeting Recap

Special Guest: Anthony Hawkins, PharmD, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/11/2020-accp-annual-meeting-references.pdf

 

06:30 – Virtual v. in-person meetings; 30:35 – BIG announcement!; 34:15 – Poster sessions; 47:00 – Scientific sessions

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2020 ACCP Annual Meeting Recap</p>
<p>Special Guest: Anthony Hawkins, PharmD, BCCCP</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2020/11/2020-accp-annual-meeting-references.pdf</p>
<p> </p>
<p>06:30 – Virtual v. in-person meetings; 30:35 – BIG announcement!; 34:15 – Poster sessions; 47:00 – Scientific sessions</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>6644</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/8549851c-c61e-3e31-a1e9-4d16504281a2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5062283526.mp3?updated=1679328845" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pulmonary Hypertension</title>
      <link>https://pharmacytodose.podbean.com/e/pulmonary-hypertension/</link>
      <description>Pulmonary Hypertension

Special Guest: Brian Murray, PharmD, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/09/ph-references.pdf

 

03:38 – Recent changes in PH management; 05:05 – PH classification; 10:22 – PH functional classification; 13:15 – PH diagnosis; 16:00 – Vasoreactivity challenge; 18:51 – Drug-induced PH; 21:08 – Short- and long-term PAH treatment goals; 23:50 – PH risk factors; 26:00 – Modifying outpatient PH medications/medication regimens; 33:03 – Fluid management in PH; 35:37 – VTE prophylaxis/treatment in PAH; 38:32 – Management of arrhythmias in PAH; 41:35 – CCB for PH treatment; 46:24 – Comparative studies in PH; 47:37 – Prostacyclins; 71:30 – Endothelin receptor antagonists; 76:04 – Phosphodiesterase inhibitors; 77:00 – sGC stimulator; 80:00 – Preferred treatment of PAH?; 84:53 – Vasopressors in patients with PH; 88:50 – Acute RV decompensation; 92:32 – Effect of positive pressure ventilation on PH; 94:55 – Management of outpatient PH infusion pumps; 97:22 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 14 Sep 2020 14:37:31 -0000</pubDate>
      <itunes:title>Pulmonary Hypertension</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>29</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0cc2dee-a883-11ed-9652-4b2c9d248987/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Pulmonary Hypertension
Special Guest: Brian Murray, PharmD, BCCCP
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/09/ph-references.pdf
 
03:38 – Recent changes in PH management; 05:05 – PH classification; 10:22 – PH functional class...</itunes:subtitle>
      <itunes:summary>Pulmonary Hypertension

Special Guest: Brian Murray, PharmD, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/09/ph-references.pdf

 

03:38 – Recent changes in PH management; 05:05 – PH classification; 10:22 – PH functional classification; 13:15 – PH diagnosis; 16:00 – Vasoreactivity challenge; 18:51 – Drug-induced PH; 21:08 – Short- and long-term PAH treatment goals; 23:50 – PH risk factors; 26:00 – Modifying outpatient PH medications/medication regimens; 33:03 – Fluid management in PH; 35:37 – VTE prophylaxis/treatment in PAH; 38:32 – Management of arrhythmias in PAH; 41:35 – CCB for PH treatment; 46:24 – Comparative studies in PH; 47:37 – Prostacyclins; 71:30 – Endothelin receptor antagonists; 76:04 – Phosphodiesterase inhibitors; 77:00 – sGC stimulator; 80:00 – Preferred treatment of PAH?; 84:53 – Vasopressors in patients with PH; 88:50 – Acute RV decompensation; 92:32 – Effect of positive pressure ventilation on PH; 94:55 – Management of outpatient PH infusion pumps; 97:22 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Pulmonary Hypertension</p>
<p>Special Guest: Brian Murray, PharmD, BCCCP</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2020/09/ph-references.pdf</p>
<p> </p>
<p>03:38 – Recent changes in PH management; 05:05 – PH classification; 10:22 – PH functional classification; 13:15 – PH diagnosis; 16:00 – Vasoreactivity challenge; 18:51 – Drug-induced PH; 21:08 – Short- and long-term PAH treatment goals; 23:50 – PH risk factors; 26:00 – Modifying outpatient PH medications/medication regimens; 33:03 – Fluid management in PH; 35:37 – VTE prophylaxis/treatment in PAH; 38:32 – Management of arrhythmias in PAH; 41:35 – CCB for PH treatment; 46:24 – Comparative studies in PH; 47:37 – Prostacyclins; 71:30 – Endothelin receptor antagonists; 76:04 – Phosphodiesterase inhibitors; 77:00 – sGC stimulator; 80:00 – Preferred treatment of PAH?; 84:53 – Vasopressors in patients with PH; 88:50 – Acute RV decompensation; 92:32 – Effect of positive pressure ventilation on PH; 94:55 – Management of outpatient PH infusion pumps; 97:22 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>6328</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/2d40b6cd-d10f-3a3d-aff1-722cb834a99e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2424188393.mp3?updated=1679328776" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Antithrombotic &amp; Anticoagulant Therapy with Cardiac Devices</title>
      <link>https://pharmacytodose.podbean.com/e/antithrombotic-anticoagulant-therapy-with-cardiac-devices/</link>
      <description>Antithrombotic and Anticoagulant Therapy with Cardiac Devices

Special Guest: Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-references.pdf

 

04:35 – MCS Overview; Case I; 07:45 – IABP Overview; Case I Continued; 17:17 – IABP Anticoagulation; Case I Continued; 24:03 – Impella Overview; Case IIl; 31:50 – Impella Anticoagulation; Case II Continued; 52:00 – LVAD thrombosis/bleeding management; Case III; 62:47 – Anticoagulation with Watchmen device; Case IV; 72:20 – TAVR overview; Case V; 80:45 – IV cangrelor; 82:37 – Does MCS reduce mortality?; 84:28 – Future research; 85:25 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 26 Aug 2020 21:37:28 -0000</pubDate>
      <itunes:title>Antithrombotic &amp; Anticoagulant Therapy with Cardiac Devices</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>28</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0ddaba0-a883-11ed-9652-9f9aa8a58524/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Antithrombotic and Anticoagulant Therapy with Cardiac Devices
Special Guest: Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-sho...</itunes:subtitle>
      <itunes:summary>Antithrombotic and Anticoagulant Therapy with Cardiac Devices

Special Guest: Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-references.pdf

 

04:35 – MCS Overview; Case I; 07:45 – IABP Overview; Case I Continued; 17:17 – IABP Anticoagulation; Case I Continued; 24:03 – Impella Overview; Case IIl; 31:50 – Impella Anticoagulation; Case II Continued; 52:00 – LVAD thrombosis/bleeding management; Case III; 62:47 – Anticoagulation with Watchmen device; Case IV; 72:20 – TAVR overview; Case V; 80:45 – IV cangrelor; 82:37 – Does MCS reduce mortality?; 84:28 – Future research; 85:25 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Antithrombotic and Anticoagulant Therapy with Cardiac Devices</p>
<p>Special Guest: Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP</p>
<p> </p>
<p>Show Notes: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-show-notes.pdf</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-references.pdf</p>
<p> </p>
<p>04:35 – MCS Overview; Case I; 07:45 – IABP Overview; Case I Continued; 17:17 – IABP Anticoagulation; Case I Continued; 24:03 – Impella Overview; Case IIl; 31:50 – Impella Anticoagulation; Case II Continued; 52:00 – LVAD thrombosis/bleeding management; Case III; 62:47 – Anticoagulation with Watchmen device; Case IV; 72:20 – TAVR overview; Case V; 80:45 – IV cangrelor; 82:37 – Does MCS reduce mortality?; 84:28 – Future research; 85:25 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5650</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/55ccdb87-fa50-3b3d-8306-4587b9710222]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5735117464.mp3?updated=1679328566" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pediatric Critical Care Part I</title>
      <link>https://pharmacytodose.podbean.com/e/pediatric-critical-care-part-i/</link>
      <description>Pediatric Critical Care Part I

Special Guest: Joseph LaRochelle, PharmD, BCPPS, FCCP

 

Resource List: https://pharmacytodose.files.wordpress.com/2020/08/pediatric-critical-care-part-i-resources.pdf

 

04:22 – Applying adult principles to kids?; 06:01 – Neonatal/pediatric vital signs; 10:25 – Pediatric/neonatal PK changes; 20:34 – Cytochrome P450 metabolism; 31:20 – Pediatric renal function/elimination; 44:22 – Pediatric v. adult dosing; 51:10 – Pediatric medication safety principles; 60:45 – Memorizing pediatric dosing; 70:13 – Pediatric weights; 74:26 – Pediatric Pharmacist training; 84:20 – Advice for Pharmacists; 86:43 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 13 Aug 2020 11:15:21 -0000</pubDate>
      <itunes:title>Pediatric Critical Care Part I</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>27</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b0efa6d4-a883-11ed-9652-1bca51329ce1/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Pediatric Critical Care Part I
Special Guest: Joseph LaRochelle, PharmD, BCPPS, FCCP
 
Resource List: https://pharmacytodose.files.wordpress.com/2020/08/pediatric-critical-care-part-i-resources.pdf
 
04:22 – Applying adult principles to kids?; 06:01 ...</itunes:subtitle>
      <itunes:summary>Pediatric Critical Care Part I

Special Guest: Joseph LaRochelle, PharmD, BCPPS, FCCP

 

Resource List: https://pharmacytodose.files.wordpress.com/2020/08/pediatric-critical-care-part-i-resources.pdf

 

04:22 – Applying adult principles to kids?; 06:01 – Neonatal/pediatric vital signs; 10:25 – Pediatric/neonatal PK changes; 20:34 – Cytochrome P450 metabolism; 31:20 – Pediatric renal function/elimination; 44:22 – Pediatric v. adult dosing; 51:10 – Pediatric medication safety principles; 60:45 – Memorizing pediatric dosing; 70:13 – Pediatric weights; 74:26 – Pediatric Pharmacist training; 84:20 – Advice for Pharmacists; 86:43 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Pediatric Critical Care Part I</p>
<p>Special Guest: Joseph LaRochelle, PharmD, BCPPS, FCCP</p>
<p> </p>
<p>Resource List: https://pharmacytodose.files.wordpress.com/2020/08/pediatric-critical-care-part-i-resources.pdf</p>
<p> </p>
<p>04:22 – Applying adult principles to kids?; 06:01 – Neonatal/pediatric vital signs; 10:25 – Pediatric/neonatal PK changes; 20:34 – Cytochrome P450 metabolism; 31:20 – Pediatric renal function/elimination; 44:22 – Pediatric v. adult dosing; 51:10 – Pediatric medication safety principles; 60:45 – Memorizing pediatric dosing; 70:13 – Pediatric weights; 74:26 – Pediatric Pharmacist training; 84:20 – Advice for Pharmacists; 86:43 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5999</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/0cdd76b8-f57b-3cfc-b472-07b7a6212e19]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7116476973.mp3?updated=1679328451" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Ventricular Arrhythmias</title>
      <link>https://pharmacytodose.podbean.com/e/ventricular-arrhythmias/</link>
      <description>Ventricular Arrhythmias

Special Guest: Matthew Wanat, PharmD, BCPS, BCCCP, FCCM

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-references.pdf

 

04:00 – What are arrhythmias?; 05:30 – Why are arrhythmias harmful/dangerous?; 06:58 – Risk factors; 09:12 – Common atrial arrhythmias; 10:19 – General arrhythmia treatment principles; 12:45 – When to use rhythm control for AF; 14:37 – Adenosine; 22:04 – Non-sustained VT/PVCs; 27:00 – Monomorphic v. Polymorphic VT; 30:53 – Torsades de Pointes; 34:16 – QTc prolongation; 42:18 – VF v. VT; 43:29 – Pulseless VT/VF; 49:30 – Amiodarone; 54:55 – Lidocaine/Mextiletine; 64:10 – Sotalol; 67:40 – Sodium channel blockers; 70:25 – Isoproterenol; 73:43 – BB/CCB; 78:29 – Long-term management; 80:34 – Stroke risk with ventricular arrhythmias; 82:20 – Prevention; 83:40 – EKG Interpretation; 86:48 – Step-wise approach; 88:13 – Take-home points; 90:00 – Small talk

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sun, 26 Jul 2020 23:52:30 -0000</pubDate>
      <itunes:title>Ventricular Arrhythmias</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>26</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b100e3ae-a883-11ed-9652-6bb954f1b94a/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Ventricular Arrhythmias
Special Guest: Matthew Wanat, PharmD, BCPS, BCCCP, FCCM
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/...</itunes:subtitle>
      <itunes:summary>Ventricular Arrhythmias

Special Guest: Matthew Wanat, PharmD, BCPS, BCCCP, FCCM

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-references.pdf

 

04:00 – What are arrhythmias?; 05:30 – Why are arrhythmias harmful/dangerous?; 06:58 – Risk factors; 09:12 – Common atrial arrhythmias; 10:19 – General arrhythmia treatment principles; 12:45 – When to use rhythm control for AF; 14:37 – Adenosine; 22:04 – Non-sustained VT/PVCs; 27:00 – Monomorphic v. Polymorphic VT; 30:53 – Torsades de Pointes; 34:16 – QTc prolongation; 42:18 – VF v. VT; 43:29 – Pulseless VT/VF; 49:30 – Amiodarone; 54:55 – Lidocaine/Mextiletine; 64:10 – Sotalol; 67:40 – Sodium channel blockers; 70:25 – Isoproterenol; 73:43 – BB/CCB; 78:29 – Long-term management; 80:34 – Stroke risk with ventricular arrhythmias; 82:20 – Prevention; 83:40 – EKG Interpretation; 86:48 – Step-wise approach; 88:13 – Take-home points; 90:00 – Small talk

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Ventricular Arrhythmias</p>
<p>Special Guest: Matthew Wanat, PharmD, BCPS, BCCCP, FCCM</p>
<p> </p>
<p>Show Notes: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-show-notes.pdf</p>
<p> </p>
<p>Reference List: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-references.pdf</p>
<p> </p>
<p>04:00 – What are arrhythmias?; 05:30 – Why are arrhythmias harmful/dangerous?; 06:58 – Risk factors; 09:12 – Common atrial arrhythmias; 10:19 – General arrhythmia treatment principles; 12:45 – When to use rhythm control for AF; 14:37 – Adenosine; 22:04 – Non-sustained VT/PVCs; 27:00 – Monomorphic v. Polymorphic VT; 30:53 – Torsades de Pointes; 34:16 – QTc prolongation; 42:18 – VF v. VT; 43:29 – Pulseless VT/VF; 49:30 – Amiodarone; 54:55 – Lidocaine/Mextiletine; 64:10 – Sotalol; 67:40 – Sodium channel blockers; 70:25 – Isoproterenol; 73:43 – BB/CCB; 78:29 – Long-term management; 80:34 – Stroke risk with ventricular arrhythmias; 82:20 – Prevention; 83:40 – EKG Interpretation; 86:48 – Step-wise approach; 88:13 – Take-home points; 90:00 – Small talk</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>6067</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/bbfda361-2ac4-3992-ba2f-5fe6e8822a16]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC2166746723.mp3?updated=1679328320" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>White Coats for Black Lives</title>
      <link>https://pharmacytodose.podbean.com/e/white-coats-for-black-lives/</link>
      <description>White Coats for Black Lives

 

Special Guests:

Earnest Alexander, PharmD, BCCCP, FCCM

 

Sheriff Gbadamosi, PharmD

 

Jason Jones, PharmD, BCPS, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/07/white-coats-for-black-lives-references.pdf

 

05:01 – How did we get here?; 27:16 – What emotions have you felt over recent events?; 45:40 – Why is this movement different?; 51:30 – Are these protests necessary/effective to enact change?; 59:20 – Inequality within the criminal justice system; 71:50 – Differences in treatment/outcomes for black patients; 83:43 – Systemic racism within US healthcare system; 87:09 – Is this a public health issue?; 91:55 – Importance of the diversity on the healthcare team; 95:35 – Increased pressure/stress being a black team member; 100:20 – Being an anti-racist; 104:40 – “All Lives Matter”; 109:55 – Powerful/Impactful media recommendations or further reading; 118:37 – Being a productive ally to the Black Lives Matter movement; 123:38 – Final thoughts

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 03 Jul 2020 16:07:27 -0000</pubDate>
      <itunes:title>White Coats for Black Lives</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>25</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b112b110-a883-11ed-9652-ebfe66f59348/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>White Coats for Black Lives
 
Special Guests:
Earnest Alexander, PharmD, BCCCP, FCCM
 
Sheriff Gbadamosi, PharmD
 
Jason Jones, PharmD, BCPS, BCCCP
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/07/white-coats-for-black-lives-refer...</itunes:subtitle>
      <itunes:summary>White Coats for Black Lives

 

Special Guests:

Earnest Alexander, PharmD, BCCCP, FCCM

 

Sheriff Gbadamosi, PharmD

 

Jason Jones, PharmD, BCPS, BCCCP

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/07/white-coats-for-black-lives-references.pdf

 

05:01 – How did we get here?; 27:16 – What emotions have you felt over recent events?; 45:40 – Why is this movement different?; 51:30 – Are these protests necessary/effective to enact change?; 59:20 – Inequality within the criminal justice system; 71:50 – Differences in treatment/outcomes for black patients; 83:43 – Systemic racism within US healthcare system; 87:09 – Is this a public health issue?; 91:55 – Importance of the diversity on the healthcare team; 95:35 – Increased pressure/stress being a black team member; 100:20 – Being an anti-racist; 104:40 – “All Lives Matter”; 109:55 – Powerful/Impactful media recommendations or further reading; 118:37 – Being a productive ally to the Black Lives Matter movement; 123:38 – Final thoughts

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>White Coats for Black Lives</p>
<p> </p>
<p>Special Guests:</p>
<p>Earnest Alexander, PharmD, BCCCP, FCCM</p>
<p> </p>
<p>Sheriff Gbadamosi, PharmD</p>
<p> </p>
<p>Jason Jones, PharmD, BCPS, BCCCP</p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2020/07/white-coats-for-black-lives-references.pdf">https://pharmacytodose.files.wordpress.com/2020/07/white-coats-for-black-lives-references.pdf</a></p>
<p> </p>
<p>05:01 – How did we get here?; 27:16 – What emotions have you felt over recent events?; 45:40 – Why is this movement different?; 51:30 – Are these protests necessary/effective to enact change?; 59:20 – Inequality within the criminal justice system; 71:50 – Differences in treatment/outcomes for black patients; 83:43 – Systemic racism within US healthcare system; 87:09 – Is this a public health issue?; 91:55 – Importance of the diversity on the healthcare team; 95:35 – Increased pressure/stress being a black team member; 100:20 – Being an anti-racist; 104:40 – “All Lives Matter”; 109:55 – Powerful/Impactful media recommendations or further reading; 118:37 – Being a productive ally to the Black Lives Matter movement; 123:38 – Final thoughts</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>8028</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/e63a723a-64f7-535e-9432-880417622097]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4614303595.mp3?updated=1679328259" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Medication Dosing in CRRT</title>
      <link>https://pharmacytodose.podbean.com/e/medication-dosing-in-crrt/</link>
      <description>CRRT Medication Dosing

Special Guest: Bruce Mueller, PharmD, FCCP, FASN, FNKF

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-show-notes.pdf

Reference List: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-references.pdf

 

04:05 – Effect of AKI on patient outcomes; 08:40 – Different RRT modalities; 13:56 – How long has CRRT been used?; 17:35 – CRRT for all ICU patients?; 22:06 – When to avoid CRRT; 23:28 – CRRT definitions; 43:20 – Medication underdosing on CRRT; 51:27 – Older CRRT dosing studies v. newer studies; 54:29 – Drug properties that increase CRRT clearance; 58:36 – Does CRRT modality affect medication clearance?; 60:02 – Antibiotic retiming; 61:20 – Drug reference dosing recommendations; 64:20 – Dosing when patient is on CRRT and not in AKI; 66:40 – Anticoagulation for CRRT; 75:13 – Hybrid CRRT modalities; 81:45 – General dosing considerations; 83:23 – CRRT dosing drug references

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 18 Jun 2020 14:28:24 -0000</pubDate>
      <itunes:title>Medication Dosing in CRRT</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>24</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1243d18-a883-11ed-9652-431547fcf6f5/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>CRRT Medication Dosing
Special Guest: Bruce Mueller, PharmD, FCCP, FASN, FNKF
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-show-notes.pdf
Reference List: https://pharmacytodose.files.wordpress.com/2020/06...</itunes:subtitle>
      <itunes:summary>CRRT Medication Dosing

Special Guest: Bruce Mueller, PharmD, FCCP, FASN, FNKF

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-show-notes.pdf

Reference List: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-references.pdf

 

04:05 – Effect of AKI on patient outcomes; 08:40 – Different RRT modalities; 13:56 – How long has CRRT been used?; 17:35 – CRRT for all ICU patients?; 22:06 – When to avoid CRRT; 23:28 – CRRT definitions; 43:20 – Medication underdosing on CRRT; 51:27 – Older CRRT dosing studies v. newer studies; 54:29 – Drug properties that increase CRRT clearance; 58:36 – Does CRRT modality affect medication clearance?; 60:02 – Antibiotic retiming; 61:20 – Drug reference dosing recommendations; 64:20 – Dosing when patient is on CRRT and not in AKI; 66:40 – Anticoagulation for CRRT; 75:13 – Hybrid CRRT modalities; 81:45 – General dosing considerations; 83:23 – CRRT dosing drug references

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>CRRT Medication Dosing</p>
<p>Special Guest: Bruce Mueller, PharmD, FCCP, FASN, FNKF</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-show-notes.pdf</a></p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-references.pdf">https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-references.pdf</a></p>
<p> </p>
<p>04:05 – Effect of AKI on patient outcomes; 08:40 – Different RRT modalities; 13:56 – How long has CRRT been used?; 17:35 – CRRT for all ICU patients?; 22:06 – When to avoid CRRT; 23:28 – CRRT definitions; 43:20 – Medication underdosing on CRRT; 51:27 – Older CRRT dosing studies v. newer studies; 54:29 – Drug properties that increase CRRT clearance; 58:36 – Does CRRT modality affect medication clearance?; 60:02 – Antibiotic retiming; 61:20 – Drug reference dosing recommendations; 64:20 – Dosing when patient is on CRRT and not in AKI; 66:40 – Anticoagulation for CRRT; 75:13 – Hybrid CRRT modalities; 81:45 – General dosing considerations; 83:23 – CRRT dosing drug references</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5643</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/278c818f-b495-5fa9-b05a-0658d10f239f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1065587932.mp3?updated=1679328145" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Aneurysmal Subarachnoid Hemorrhage</title>
      <link>https://pharmacytodose.podbean.com/e/aneurysmal-subarachnoid-hemorrhage/</link>
      <description>Aneurysmal Subarachnoid Hemorrhage

Special Guest: Casey May, PharmD, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf

 

02:51 – Types of intracerebral bleeds; 06:19 – Types of subarachnoid hemorrhage; 08:25 – Pathophysiology of aSAH; 10:45 – Risk factors; 12:48 – Classic aSAH presentation; 16:36 – Classificiation systems; 22:25 – Prioritizating acute management of aSAH; 25:15 – Blood pressure goals; 26:21 – Preferred anti-HTN agent?; 28:25 – Biggest concerns with anti-HTN agents; 31:08 – ICP management; 35:40 – Surgical clipping v. Endovascular coiling; 42:51 – Cerebral vasospasms and delayed cerebral ischemia; 55:07 – Nimodipine in aSAH; 68:20 – DVT prophylaxis; 73:48 – Seizure prophylaxis; 76:30 – Augmented renal clearance; 83:56 – Take-home points

  

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 03 Jun 2020 23:40:51 -0000</pubDate>
      <itunes:title>Aneurysmal Subarachnoid Hemorrhage</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>23</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b135ce52-a883-11ed-9652-477bd703262b/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Aneurysmal Subarachnoid Hemorrhage
Special Guest: Casey May, PharmD, BCCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf
 ...</itunes:subtitle>
      <itunes:summary>Aneurysmal Subarachnoid Hemorrhage

Special Guest: Casey May, PharmD, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf

 

02:51 – Types of intracerebral bleeds; 06:19 – Types of subarachnoid hemorrhage; 08:25 – Pathophysiology of aSAH; 10:45 – Risk factors; 12:48 – Classic aSAH presentation; 16:36 – Classificiation systems; 22:25 – Prioritizating acute management of aSAH; 25:15 – Blood pressure goals; 26:21 – Preferred anti-HTN agent?; 28:25 – Biggest concerns with anti-HTN agents; 31:08 – ICP management; 35:40 – Surgical clipping v. Endovascular coiling; 42:51 – Cerebral vasospasms and delayed cerebral ischemia; 55:07 – Nimodipine in aSAH; 68:20 – DVT prophylaxis; 73:48 – Seizure prophylaxis; 76:30 – Augmented renal clearance; 83:56 – Take-home points

  

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Aneurysmal Subarachnoid Hemorrhage</p>
<p>Special Guest: Casey May, PharmD, BCCCP</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf">https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf</a></p>
<p> </p>
<p>02:51 – Types of intracerebral bleeds; 06:19 – Types of subarachnoid hemorrhage; 08:25 – Pathophysiology of aSAH; 10:45 – Risk factors; 12:48 – Classic aSAH presentation; 16:36 – Classificiation systems; 22:25 – Prioritizating acute management of aSAH; 25:15 – Blood pressure goals; 26:21 – Preferred anti-HTN agent?; 28:25 – Biggest concerns with anti-HTN agents; 31:08 – ICP management; 35:40 – Surgical clipping v. Endovascular coiling; 42:51 – Cerebral vasospasms and delayed cerebral ischemia; 55:07 – Nimodipine in aSAH; 68:20 – DVT prophylaxis; 73:48 – Seizure prophylaxis; 76:30 – Augmented renal clearance; 83:56 – Take-home points</p>
<p>  </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5794</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/a83787b2-e01b-5a62-b897-87814d9f6063]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3312378351.mp3?updated=1679328039" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Acute Liver Failure</title>
      <link>https://pharmacytodose.podbean.com/e/acute-liver-failure/</link>
      <description>Acute Liver Failure

Special Guest: Stephanie Bass, PharmD, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-references.pdf

 

03:05 – Stephanie’s interest in the liver; 05:54 – Diagnosing ALF; 07:20 – Does having liver disease increase ALF risk?; 09:00 – Ultimate goal when treating ALF; 10:07 – Patient presentation; 11:58 – Common causes of ALF; 13:30 – ICP and cerebral edema management in ALF; 15:50 – PAD management in ALF; 18:55 – Acute hepatic encephalopathy management; 21:00 – Trending ammonia levels?; 22:25 – NAC for APAP overdose ALF; 27:11 – NAC for non-APAP overdose ALF; 30:23 – Albumin for ALF fluid resuscitation; 34:33 – Vasopressor use; 36:53 – Blood pressure goals; 40:00 – TEG for bleeding risk assessment; 43:45 – Hemostatic agents for coagulopathy; 46:18 – Anticoagulant of choice; 47:59 – Hepatic dose adjustments; 52:12 – Medication dosing with MARS/RRT; 54:00 – Medications to avoid; 56:02 – Transplant considerations; 58:24 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 20 May 2020 02:18:59 -0000</pubDate>
      <itunes:title>Acute Liver Failure</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>22</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1474966-a883-11ed-9652-5bd88fe972a8/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Acute Liver Failure
Special Guest: Stephanie Bass, PharmD, BCPS, BCCCP
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-show-notes.pdf
 
Reference List: https://pharmacytodose.files.wordpress.com/2020/05/acute-live...</itunes:subtitle>
      <itunes:summary>Acute Liver Failure

Special Guest: Stephanie Bass, PharmD, BCPS, BCCCP

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-show-notes.pdf

 

Reference List: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-references.pdf

 

03:05 – Stephanie’s interest in the liver; 05:54 – Diagnosing ALF; 07:20 – Does having liver disease increase ALF risk?; 09:00 – Ultimate goal when treating ALF; 10:07 – Patient presentation; 11:58 – Common causes of ALF; 13:30 – ICP and cerebral edema management in ALF; 15:50 – PAD management in ALF; 18:55 – Acute hepatic encephalopathy management; 21:00 – Trending ammonia levels?; 22:25 – NAC for APAP overdose ALF; 27:11 – NAC for non-APAP overdose ALF; 30:23 – Albumin for ALF fluid resuscitation; 34:33 – Vasopressor use; 36:53 – Blood pressure goals; 40:00 – TEG for bleeding risk assessment; 43:45 – Hemostatic agents for coagulopathy; 46:18 – Anticoagulant of choice; 47:59 – Hepatic dose adjustments; 52:12 – Medication dosing with MARS/RRT; 54:00 – Medications to avoid; 56:02 – Transplant considerations; 58:24 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Acute Liver Failure</p>
<p>Special Guest: Stephanie Bass, PharmD, BCPS, BCCCP</p>
<p> </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-show-notes.pdf</a></p>
<p> </p>
<p>Reference List: <a href="https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-references.pdf">https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-references.pdf</a></p>
<p> </p>
<p>03:05 – Stephanie’s interest in the liver; 05:54 – Diagnosing ALF; 07:20 – Does having liver disease increase ALF risk?; 09:00 – Ultimate goal when treating ALF; 10:07 – Patient presentation; 11:58 – Common causes of ALF; 13:30 – ICP and cerebral edema management in ALF; 15:50 – PAD management in ALF; 18:55 – Acute hepatic encephalopathy management; 21:00 – Trending ammonia levels?; 22:25 – NAC for APAP overdose ALF; 27:11 – NAC for non-APAP overdose ALF; 30:23 – Albumin for ALF fluid resuscitation; 34:33 – Vasopressor use; 36:53 – Blood pressure goals; 40:00 – TEG for bleeding risk assessment; 43:45 – Hemostatic agents for coagulopathy; 46:18 – Anticoagulant of choice; 47:59 – Hepatic dose adjustments; 52:12 – Medication dosing with MARS/RRT; 54:00 – Medications to avoid; 56:02 – Transplant considerations; 58:24 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4127</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/43a86c13-94e1-5e55-a19b-0c44bbc05c0f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6999179032.mp3?updated=1679327782" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Critical Care Management of COVID-19</title>
      <link>https://pharmacytodose.podbean.com/e/critical-care-management-of-covid-19/</link>
      <description>Critical Care Management of COVID-19

Special Guests: Drayton Hammond, PharmD, MBA, MSc, BCPS, BCCCP, FCCM

Peter Nikolos, PharmD

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/covid-19-complications-show-notes.pdf

 

Mechanical Ventilation (Drayton)

08:00 – Non-COVID-19 PAD management; 11:16 – COVID-19 PAD management; 18:22 – Managing PAD drug shortages; 22:38 – Opioid conservation strategies; 26:08 – Propofol conservation strategies; 29:08 – Hypertriglyceridemia with propofol; 32:10 – Risk of PRIS; 34:30 – Ketamine; 41:05 – NMBA use and shortage; 46:00 – PPE conservation; 49:00 – Bronchodilator use for COVID-19; 50:28 – Inhaled anticoagulants; 52:46 – Inhaled pulmonary vasodilators; 54:17 – Advice for COVID-19 management

 

Cardiovascular (Peter)

67:20 – Current shortages; 71:05 – First-line vasopressor; 73:25 – Vasopressor compounding and utilization changes; 74:50 – Smart pump management; 77:15 – Vasopressor shortage management; 79:45 – Anticoagulation treatment strategy; 85:30 – Anticoagulation monitoring; 86:28 – Anticoagulation in ECMO/CRRT; 88:20 – PE causing rapid decompensation?; 90:25 – Alternate anticoagulants; 92:52 – Thrombolytics in ACS; 98:13 – Code response changes; 100:05 – ACE-I/ARB use in COVID-19; 103:41 – NSAID use in COVID-19; 105:15 – Statin use in COVID-19; 107:25 – Challenges from virtual rounding; 110:20 – Key points on COVID-19 management

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 27 Apr 2020 08:48:41 -0000</pubDate>
      <itunes:title>Critical Care Management of COVID-19</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>21</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1585e5e-a883-11ed-9652-d703aa84cc59/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Critical Care Management of COVID-19
Special Guests: Drayton Hammond, PharmD, MBA, MSc, BCPS, BCCCP, FCCM
Peter Nikolos, PharmD
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/covid-19-complications-show-notes.pdf
 
Mechanical Ventil...</itunes:subtitle>
      <itunes:summary>Critical Care Management of COVID-19

Special Guests: Drayton Hammond, PharmD, MBA, MSc, BCPS, BCCCP, FCCM

Peter Nikolos, PharmD

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/covid-19-complications-show-notes.pdf

 

Mechanical Ventilation (Drayton)

08:00 – Non-COVID-19 PAD management; 11:16 – COVID-19 PAD management; 18:22 – Managing PAD drug shortages; 22:38 – Opioid conservation strategies; 26:08 – Propofol conservation strategies; 29:08 – Hypertriglyceridemia with propofol; 32:10 – Risk of PRIS; 34:30 – Ketamine; 41:05 – NMBA use and shortage; 46:00 – PPE conservation; 49:00 – Bronchodilator use for COVID-19; 50:28 – Inhaled anticoagulants; 52:46 – Inhaled pulmonary vasodilators; 54:17 – Advice for COVID-19 management

 

Cardiovascular (Peter)

67:20 – Current shortages; 71:05 – First-line vasopressor; 73:25 – Vasopressor compounding and utilization changes; 74:50 – Smart pump management; 77:15 – Vasopressor shortage management; 79:45 – Anticoagulation treatment strategy; 85:30 – Anticoagulation monitoring; 86:28 – Anticoagulation in ECMO/CRRT; 88:20 – PE causing rapid decompensation?; 90:25 – Alternate anticoagulants; 92:52 – Thrombolytics in ACS; 98:13 – Code response changes; 100:05 – ACE-I/ARB use in COVID-19; 103:41 – NSAID use in COVID-19; 105:15 – Statin use in COVID-19; 107:25 – Challenges from virtual rounding; 110:20 – Key points on COVID-19 management

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Critical Care Management of COVID-19</p>
<p>Special Guests: Drayton Hammond, PharmD, MBA, MSc, BCPS, BCCCP, FCCM</p>
<p>Peter Nikolos, PharmD</p>
<p> </p>
<p>Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/covid-19-complications-show-notes.pdf</p>
<p> </p>
<p>Mechanical Ventilation (Drayton)</p>
<p>08:00 – Non-COVID-19 PAD management; 11:16 – COVID-19 PAD management; 18:22 – Managing PAD drug shortages; 22:38 – Opioid conservation strategies; 26:08 – Propofol conservation strategies; 29:08 – Hypertriglyceridemia with propofol; 32:10 – Risk of PRIS; 34:30 – Ketamine; 41:05 – NMBA use and shortage; 46:00 – PPE conservation; 49:00 – Bronchodilator use for COVID-19; 50:28 – Inhaled anticoagulants; 52:46 – Inhaled pulmonary vasodilators; 54:17 – Advice for COVID-19 management</p>
<p> </p>
<p>Cardiovascular (Peter)</p>
<p>67:20 – Current shortages; 71:05 – First-line vasopressor; 73:25 – Vasopressor compounding and utilization changes; 74:50 – Smart pump management; 77:15 – Vasopressor shortage management; 79:45 – Anticoagulation treatment strategy; 85:30 – Anticoagulation monitoring; 86:28 – Anticoagulation in ECMO/CRRT; 88:20 – PE causing rapid decompensation?; 90:25 – Alternate anticoagulants; 92:52 – Thrombolytics in ACS; 98:13 – Code response changes; 100:05 – ACE-I/ARB use in COVID-19; 103:41 – NSAID use in COVID-19; 105:15 – Statin use in COVID-19; 107:25 – Challenges from virtual rounding; 110:20 – Key points on COVID-19 management</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>7315</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/67e3bd06-2135-51fa-ab3f-ae7ac80d2241]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9495131503.mp3?updated=1679327639" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Research Principles for COVID-19</title>
      <link>https://pharmacytodose.podbean.com/e/research-principles-for-covid-19/</link>
      <description>Research Principles for COVID-19

Special Guest: Todd Miano, PharmD, PhD

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/research-principles-show-notes.pdf

 

05:19 – Todd’s interest in research/statistics; 09:18 – How Todd analyzes a research article; 24:22 – Why so much low-quality research for COVID-19?; 28:18 – In vitro v. in vivo; 32:34 – Risk of study errors in low-quality research; 45:43 – Publication bias; 51:50 – Interpreting outcome-based studies when patients are still critically ill; 54:46 – Ideal primary outcome for COVID-19 trials; 57:50 – Applying information from international data to US patients; 61:02 – What is the risk of using experimental drug treatments?; 68:54 – Effect of COVID-19 on non-COVID research; 70:33 – Advice for starting COVID-19 research; 73:43 – Research red flags; 75:46 – Keeping up with COVID-19 literature; 79:09 – Quarantine entertainment recommendations

 

PharmacyToDose.Com

 

@PharmacyToDose on Twitter/Instagram

 

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 22 Apr 2020 20:57:39 -0000</pubDate>
      <itunes:title>Research Principles for COVID-19</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>20</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b16a3b56-a883-11ed-9652-af5e15ed654d/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Research Principles for COVID-19
Special Guest: Todd Miano, PharmD, PhD
 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/research-principles-show-notes.pdf
 
05:19 – Todd’s interest in research/statistics; 09:18 – How Todd analyzes a ...</itunes:subtitle>
      <itunes:summary>Research Principles for COVID-19

Special Guest: Todd Miano, PharmD, PhD

 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/research-principles-show-notes.pdf

 

05:19 – Todd’s interest in research/statistics; 09:18 – How Todd analyzes a research article; 24:22 – Why so much low-quality research for COVID-19?; 28:18 – In vitro v. in vivo; 32:34 – Risk of study errors in low-quality research; 45:43 – Publication bias; 51:50 – Interpreting outcome-based studies when patients are still critically ill; 54:46 – Ideal primary outcome for COVID-19 trials; 57:50 – Applying information from international data to US patients; 61:02 – What is the risk of using experimental drug treatments?; 68:54 – Effect of COVID-19 on non-COVID research; 70:33 – Advice for starting COVID-19 research; 73:43 – Research red flags; 75:46 – Keeping up with COVID-19 literature; 79:09 – Quarantine entertainment recommendations

 

PharmacyToDose.Com

 

@PharmacyToDose on Twitter/Instagram

 

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Research Principles for COVID-19</p>
<p>Special Guest: Todd Miano, PharmD, PhD</p>
<p> </p>
<p>Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/research-principles-show-notes.pdf</p>
<p> </p>
<p>05:19 – Todd’s interest in research/statistics; 09:18 – How Todd analyzes a research article; 24:22 – Why so much low-quality research for COVID-19?; 28:18 – In vitro v. in vivo; 32:34 – Risk of study errors in low-quality research; 45:43 – Publication bias; 51:50 – Interpreting outcome-based studies when patients are still critically ill; 54:46 – Ideal primary outcome for COVID-19 trials; 57:50 – Applying information from international data to US patients; 61:02 – What is the risk of using experimental drug treatments?; 68:54 – Effect of COVID-19 on non-COVID research; 70:33 – Advice for starting COVID-19 research; 73:43 – Research red flags; 75:46 – Keeping up with COVID-19 literature; 79:09 – Quarantine entertainment recommendations</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p> </p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p> </p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5258</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/37a6fbf5-d5ea-5297-9fa0-110086ef6a5d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4173244281.mp3?updated=1676478080" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Cerebral Edema Treatment</title>
      <link>https://pharmacytodose.podbean.com/e/cerebral-edema-treatment/</link>
      <description>Cerebral Edema Treatment

Special Guest: Aaron Cook, PharmD, BCCCP, BCPS, FCCP, FKSHP, FNCS 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/treatment-of-cerebral-edema-show-notes.pdf

 

Guideline Development

06:18 – How did the content and the chairs for this guideline get chosen?; 08:40 – How long were you working on these guidelines?; 09:40 – How are panel members chosen for the guidelines?; 11:20 – Is the research librarian underrated?; 13:31 – GRADE methodology and PICO formatting; 17:24 – Has this changed your research habits or ideas?; 21:40 – Challenges from meeting virtually when developing the guidelines; 23:53 – How were disagreements settled within the working group?

Management of Cerebral Edema 

27:45 – Cerebral edema and elevated ICP; 29:22 – Refractory cerebral edema management; 31:59 – How long was the initial question list?; 35:03 – Quality of evidence; 37:58 – Patient subgroup with the most evidence; 40:10 – Should we be driving up patients’ sodium levels?; 44:56 – Is there a preferred hyperosmolar agent?; 47:45 – Mannitol in acute ischemic stroke; 49:00 – Osmolar therapy and neurologic outcomes; 51:16 – HTS administration; 54:30 – HTS ADE and monitoring; 57:10 – Mannitol osmolality monitoring; 58:20 – Hyperosmolar therapy ADE prevention; 61:00 – Guideline key take-aways; 62:20 – Common research issues

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 15 Apr 2020 17:03:02 -0000</pubDate>
      <itunes:title>Cerebral Edema Treatment</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>19</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b17b6d22-a883-11ed-9652-37377b47f234/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Cerebral Edema Treatment
Special Guest: Aaron Cook, PharmD, BCCCP, BCPS, FCCP, FKSHP, FNCS 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/treatment-of-cerebral-edema-show-notes.pdf
 
Guideline Development
06:18 – How did the content ...</itunes:subtitle>
      <itunes:summary>Cerebral Edema Treatment

Special Guest: Aaron Cook, PharmD, BCCCP, BCPS, FCCP, FKSHP, FNCS 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/treatment-of-cerebral-edema-show-notes.pdf

 

Guideline Development

06:18 – How did the content and the chairs for this guideline get chosen?; 08:40 – How long were you working on these guidelines?; 09:40 – How are panel members chosen for the guidelines?; 11:20 – Is the research librarian underrated?; 13:31 – GRADE methodology and PICO formatting; 17:24 – Has this changed your research habits or ideas?; 21:40 – Challenges from meeting virtually when developing the guidelines; 23:53 – How were disagreements settled within the working group?

Management of Cerebral Edema 

27:45 – Cerebral edema and elevated ICP; 29:22 – Refractory cerebral edema management; 31:59 – How long was the initial question list?; 35:03 – Quality of evidence; 37:58 – Patient subgroup with the most evidence; 40:10 – Should we be driving up patients’ sodium levels?; 44:56 – Is there a preferred hyperosmolar agent?; 47:45 – Mannitol in acute ischemic stroke; 49:00 – Osmolar therapy and neurologic outcomes; 51:16 – HTS administration; 54:30 – HTS ADE and monitoring; 57:10 – Mannitol osmolality monitoring; 58:20 – Hyperosmolar therapy ADE prevention; 61:00 – Guideline key take-aways; 62:20 – Common research issues

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Cerebral Edema Treatment</p>
<p>Special Guest: Aaron Cook, PharmD, BCCCP, BCPS, FCCP, FKSHP, FNCS </p>
<p>Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/treatment-of-cerebral-edema-show-notes.pdf</p>
<p> </p>
<p>Guideline Development</p>
<p>06:18 – How did the content and the chairs for this guideline get chosen?; 08:40 – How long were you working on these guidelines?; 09:40 – How are panel members chosen for the guidelines?; 11:20 – Is the research librarian underrated?; 13:31 – GRADE methodology and PICO formatting; 17:24 – Has this changed your research habits or ideas?; 21:40 – Challenges from meeting virtually when developing the guidelines; 23:53 – How were disagreements settled within the working group?</p>
<p>Management of Cerebral Edema </p>
<p>27:45 – Cerebral edema and elevated ICP; 29:22 – Refractory cerebral edema management; 31:59 – How long was the initial question list?; 35:03 – Quality of evidence; 37:58 – Patient subgroup with the most evidence; 40:10 – Should we be driving up patients’ sodium levels?; 44:56 – Is there a preferred hyperosmolar agent?; 47:45 – Mannitol in acute ischemic stroke; 49:00 – Osmolar therapy and neurologic outcomes; 51:16 – HTS administration; 54:30 – HTS ADE and monitoring; 57:10 – Mannitol osmolality monitoring; 58:20 – Hyperosmolar therapy ADE prevention; 61:00 – Guideline key take-aways; 62:20 – Common research issues</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4418</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/f39b9138-2d3f-5ccb-a41a-dc6e8a7317bb]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7494122433.mp3?updated=1676477863" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>COVID-19</title>
      <link>https://pharmacytodose.podbean.com/e/covid-19-1585155792/</link>
      <description>COVID-19 

Special Guest: Andrew Barnes, PharmD

Dr. Andrew Barnes joins the podcast to discuss the effects of COVID-19. We talk about what Seattle and the University of Washington are doing to help treat this national pandemic. Plus there are plenty of tips throughout the episode for ways you can adapt to COVID-19 in your hospital or health system.

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 25 Mar 2020 17:03:12 -0000</pubDate>
      <itunes:title>COVID-19</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>18</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b18c68f2-a883-11ed-9652-6f8c70118295/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>COVID-19 
Special Guest: Andrew Barnes, PharmD
Dr. Andrew Barnes joins the podcast to discuss the effects of COVID-19. We talk about what Seattle and the University of Washington are doing to help treat this national pandemic. Plus there are plenty o...</itunes:subtitle>
      <itunes:summary>COVID-19 

Special Guest: Andrew Barnes, PharmD

Dr. Andrew Barnes joins the podcast to discuss the effects of COVID-19. We talk about what Seattle and the University of Washington are doing to help treat this national pandemic. Plus there are plenty of tips throughout the episode for ways you can adapt to COVID-19 in your hospital or health system.

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>COVID-19 </p>
<p>Special Guest: Andrew Barnes, PharmD</p>
<p>Dr. Andrew Barnes joins the podcast to discuss the effects of COVID-19. We talk about what Seattle and the University of Washington are doing to help treat this national pandemic. Plus there are plenty of tips throughout the episode for ways you can adapt to COVID-19 in your hospital or health system.</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3413</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/76c41817-4dd5-505b-89a8-80676a9ba9d5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7036831500.mp3?updated=1676477733" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Part 3: Critical Care Medication March Madness Bracket</title>
      <link>https://pharmacytodose.podbean.com/e/part-3-critical-care-medication-march-madness-bracket/</link>
      <description>Part 3 Critical Care Medication March Madness Bracket

Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/

 

03:01 – Final Four analysis with Matt Rubertus, PharmD, BCCCP

09:11 – Final Four analysis with Josiah Smith, PharmD, BCCCP

17:35 – Final Four analysis with Brian Gilbert, PharmD, BCPS, BCCCP

29:18 – Final Four analysis with Melanie Smith, PharmD, BCPS, BCCCP

 

Email: PharmacyToDose@Gmail.com

Social Media: @PharmacyToDose

Website: PharmacyToDose.Com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Mon, 23 Mar 2020 01:05:15 -0000</pubDate>
      <itunes:title>Part 3: Critical Care Medication March Madness Bracket</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>17</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b19d269c-a883-11ed-9652-57599448c126/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Part 3 Critical Care Medication March Madness Bracket
Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/
 
03:01 – Final Four analysis with Matt Rubertus, ...</itunes:subtitle>
      <itunes:summary>Part 3 Critical Care Medication March Madness Bracket

Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/

 

03:01 – Final Four analysis with Matt Rubertus, PharmD, BCCCP

09:11 – Final Four analysis with Josiah Smith, PharmD, BCCCP

17:35 – Final Four analysis with Brian Gilbert, PharmD, BCPS, BCCCP

29:18 – Final Four analysis with Melanie Smith, PharmD, BCPS, BCCCP

 

Email: PharmacyToDose@Gmail.com

Social Media: @PharmacyToDose

Website: PharmacyToDose.Com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Part 3 Critical Care Medication March Madness Bracket</p>
<p>Downloadable bracket and more available here: <a href="https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/">https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/</a></p>
<p> </p>
<p>03:01 – Final Four analysis with Matt Rubertus, PharmD, BCCCP</p>
<p>09:11 – Final Four analysis with Josiah Smith, PharmD, BCCCP</p>
<p>17:35 – Final Four analysis with Brian Gilbert, PharmD, BCPS, BCCCP</p>
<p>29:18 – Final Four analysis with Melanie Smith, PharmD, BCPS, BCCCP</p>
<p> </p>
<p>Email: <a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p>Social Media: @PharmacyToDose</p>
<p>Website: PharmacyToDose.Com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>2486</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/9388004a-385d-596a-903f-20dd71ad175c]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7743420177.mp3?updated=1676477535" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Part 2: Critical Care Medication March Madness Bracket</title>
      <link>https://pharmacytodose.podbean.com/e/part-2-critical-care-medication-march-madness-bracket/</link>
      <description>Part 2 Critical Care Medication March Madness Bracket

 Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/  

00:50 – Introduction; 03:23 – Potpourri region analysis with Brian Gilbert, PharmD, BCPS, BCCCP; 43:43 – PAD region analysis with Melanie Smith, PharmD, BCPS, BCCCP 

Email: PharmacyToDose@Gmail.com

Social Media: @PharmacyToDose 

Website: PharmacyToDose.Com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 20 Mar 2020 20:12:57 -0000</pubDate>
      <itunes:title>Part 2: Critical Care Medication March Madness Bracket</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>16</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1ae6628-a883-11ed-9652-4f81ba1e9b48/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Part 2 Critical Care Medication March Madness Bracket
 Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/  
00:50 – Introduction; 03:23 – Potpourri region ...</itunes:subtitle>
      <itunes:summary>Part 2 Critical Care Medication March Madness Bracket

 Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/  

00:50 – Introduction; 03:23 – Potpourri region analysis with Brian Gilbert, PharmD, BCPS, BCCCP; 43:43 – PAD region analysis with Melanie Smith, PharmD, BCPS, BCCCP 

Email: PharmacyToDose@Gmail.com

Social Media: @PharmacyToDose 

Website: PharmacyToDose.Com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Part 2 Critical Care Medication March Madness Bracket</p>
<p> Downloadable bracket and more available here: <a href="https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/">https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/</a>  </p>
<p>00:50 – Introduction; 03:23 – Potpourri region analysis with Brian Gilbert, PharmD, BCPS, BCCCP; 43:43 – PAD region analysis with Melanie Smith, PharmD, BCPS, BCCCP </p>
<p>Email: <a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p>Social Media: @PharmacyToDose </p>
<p>Website: PharmacyToDose.Com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5358</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/05fba913-de83-5cfa-ad76-f684b723943e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3908834747.mp3?updated=1676477695" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Part 1: Critical Care Medication March Madness Bracket</title>
      <link>https://pharmacytodose.podbean.com/e/part-1-critical-care-medication-march-madness-bracket/</link>
      <description>Part 1: Critical Care Medication March Madness Bracket 

Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/

00:58 – Bracket announcement, background, rules, and how you can participate!; 10:15 – Cardiac region analysis with Matt Rubertus, PharmD, BCCCP; 40:37 – Infectious Diseases region analysis with Josiah Smith, PharmD, BCCCP

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 19 Mar 2020 20:30:35 -0000</pubDate>
      <itunes:title>Part 1: Critical Care Medication March Madness Bracket</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>15</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1bfd26e-a883-11ed-9652-c3067acd5748/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Part 1: Critical Care Medication March Madness Bracket 
Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/
00:58 – Bracket announcement, background, rules,...</itunes:subtitle>
      <itunes:summary>Part 1: Critical Care Medication March Madness Bracket 

Downloadable bracket and more available here: https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/

00:58 – Bracket announcement, background, rules, and how you can participate!; 10:15 – Cardiac region analysis with Matt Rubertus, PharmD, BCCCP; 40:37 – Infectious Diseases region analysis with Josiah Smith, PharmD, BCCCP

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Part 1: Critical Care Medication March Madness Bracket </p>
<p>Downloadable bracket and more available here: <a href="https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/">https://pharmacytodose.com/2020/03/15/2020-critical-care-medication-march-madness-bracket-and-info/</a></p>
<p>00:58 – Bracket announcement, background, rules, and how you can participate!; 10:15 – Cardiac region analysis with Matt Rubertus, PharmD, BCCCP; 40:37 – Infectious Diseases region analysis with Josiah Smith, PharmD, BCCCP</p>
<p>PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5166</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/aa1f0c06-e4e8-5b7a-bb91-7a9221e6f879]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC8734737273.mp3?updated=1676477412" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Immunotherapy Toxicity in the ICU</title>
      <link>https://pharmacytodose.podbean.com/e/immunotherapy-toxicity-in-the-icu/</link>
      <description>Immunotherapy Toxicity in the ICU
Special Guest: Heather May, PharmD, FCCM, BCPS, BCCCP 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-toxicity-in-the-icu-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-references.pdf

00:52 – Show updates!; 10:50 – Immune system primer; 13:30 – How does CART therapy work?; 16:35 – CART Side effects that lead to the ICU; 17:40 – When does CRS occur and how acute is the presentation?; 20:50 – CRS risk factors; 23:26 – Biomarkers for CRS identification; 25:25 – CRS treatment; 32:30 – CART neurotoxicity; 37:00 – Mechanism of ICANS; 38:00 – ICANS risk factors; 39:30 – ICANS treatment; 42:45 – Where do patients go post-CART?; 47:15 – Examples of immune checkpoint inhibitors; 49:27 – ICI mechanism of action; 51:05 – Immune-related adverse events (irAEs); 55:20 – Which irAEs grades will present to the hospital/ICU?; 57:30 – When do irAEs occur?; 59:28 – irAEs treatment; 64:55 – Downside to treating irAEs?; 68:22 – Do irAEs mean the treatment is working?; 73:12 – Take-home points for immunotherapy toxicity

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 11 Mar 2020 08:28:14 -0000</pubDate>
      <itunes:title>Immunotherapy Toxicity in the ICU</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>14</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1d0f8c8-a883-11ed-9652-5f9205cdda26/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Immunotherapy Toxicity in the ICUSpecial Guest: Heather May, PharmD, FCCM, BCPS, BCCCP 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-toxicity-in-the-icu-show-notes.pdf
Show References: https://pharmacytodose.files.word...</itunes:subtitle>
      <itunes:summary>Immunotherapy Toxicity in the ICU
Special Guest: Heather May, PharmD, FCCM, BCPS, BCCCP 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-toxicity-in-the-icu-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-references.pdf

00:52 – Show updates!; 10:50 – Immune system primer; 13:30 – How does CART therapy work?; 16:35 – CART Side effects that lead to the ICU; 17:40 – When does CRS occur and how acute is the presentation?; 20:50 – CRS risk factors; 23:26 – Biomarkers for CRS identification; 25:25 – CRS treatment; 32:30 – CART neurotoxicity; 37:00 – Mechanism of ICANS; 38:00 – ICANS risk factors; 39:30 – ICANS treatment; 42:45 – Where do patients go post-CART?; 47:15 – Examples of immune checkpoint inhibitors; 49:27 – ICI mechanism of action; 51:05 – Immune-related adverse events (irAEs); 55:20 – Which irAEs grades will present to the hospital/ICU?; 57:30 – When do irAEs occur?; 59:28 – irAEs treatment; 64:55 – Downside to treating irAEs?; 68:22 – Do irAEs mean the treatment is working?; 73:12 – Take-home points for immunotherapy toxicity

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Immunotherapy Toxicity in the ICU
Special Guest: Heather May, PharmD, FCCM, BCPS, BCCCP </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-toxicity-in-the-icu-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-toxicity-in-the-icu-show-notes.pdf</a></p>
<p>Show References: <a href="https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-references.pdf">https://pharmacytodose.files.wordpress.com/2020/03/immunotherapy-references.pdf</a></p>
<p>00:52 – Show updates!; 10:50 – Immune system primer; 13:30 – How does CART therapy work?; 16:35 – CART Side effects that lead to the ICU; 17:40 – When does CRS occur and how acute is the presentation?; 20:50 – CRS risk factors; 23:26 – Biomarkers for CRS identification; 25:25 – CRS treatment; 32:30 – CART neurotoxicity; 37:00 – Mechanism of ICANS; 38:00 – ICANS risk factors; 39:30 – ICANS treatment; 42:45 – Where do patients go post-CART?; 47:15 – Examples of immune checkpoint inhibitors; 49:27 – ICI mechanism of action; 51:05 – Immune-related adverse events (irAEs); 55:20 – Which irAEs grades will present to the hospital/ICU?; 57:30 – When do irAEs occur?; 59:28 – irAEs treatment; 64:55 – Downside to treating irAEs?; 68:22 – Do irAEs mean the treatment is working?; 73:12 – Take-home points for immunotherapy toxicity</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5007</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/4bc3b160-4e56-5a88-89ed-fdaf6981dae4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4682135832.mp3?updated=1676477173" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>2020 SCCM Congress Recap</title>
      <link>https://pharmacytodose.podbean.com/e/2020-sccm-congress-recap/</link>
      <description>2020 SCCM Congress Recap

Special Guest and Official Conference Correspondent: Anthony Hawkins, PharmD, BCCCP

Anthony and I recap the 2020 SCCM Congress discussing everything from the convention center, research presentations, educational sessions, receptions, things we would change, and much more! This episode was recorded live in Orlando, FL.

Show references: https://pharmacytodose.files.wordpress.com/2020/02/2020-sccm-congress-references.pdf

PharmacyToDose.Com 
@PharmacyToDose on Twitter/Instagram 
PharmacyToDose@Gmail.com

 

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 20 Feb 2020 00:23:42 -0000</pubDate>
      <itunes:title>2020 SCCM Congress Recap</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>13</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1e2c832-a883-11ed-9652-4f1b83a8de1f/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>2020 SCCM Congress Recap
Special Guest and Official Conference Correspondent: Anthony Hawkins, PharmD, BCCCP
Anthony and I recap the 2020 SCCM Congress discussing everything from the convention center, research presentations, educational sessions, re...</itunes:subtitle>
      <itunes:summary>2020 SCCM Congress Recap

Special Guest and Official Conference Correspondent: Anthony Hawkins, PharmD, BCCCP

Anthony and I recap the 2020 SCCM Congress discussing everything from the convention center, research presentations, educational sessions, receptions, things we would change, and much more! This episode was recorded live in Orlando, FL.

Show references: https://pharmacytodose.files.wordpress.com/2020/02/2020-sccm-congress-references.pdf

PharmacyToDose.Com 
@PharmacyToDose on Twitter/Instagram 
PharmacyToDose@Gmail.com

 

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>2020 SCCM Congress Recap</p>
<p>Special Guest and Official Conference Correspondent: Anthony Hawkins, PharmD, BCCCP</p>
<p>Anthony and I recap the 2020 SCCM Congress discussing everything from the convention center, research presentations, educational sessions, receptions, things we would change, and much more! This episode was recorded live in Orlando, FL.</p>
<p>Show references: <a href="https://pharmacytodose.files.wordpress.com/2020/02/2020-sccm-congress-references.pdf">https://pharmacytodose.files.wordpress.com/2020/02/2020-sccm-congress-references.pdf</a></p>
<p>PharmacyToDose.Com 
@PharmacyToDose on Twitter/Instagram 
PharmacyToDose@Gmail.com</p>
<p> </p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5291</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/17d841a8-a79a-50e0-b1c5-c3c4aefb8dd9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC5860843773.mp3?updated=1676476745" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Acute Kidney Injury</title>
      <link>https://pharmacytodose.podbean.com/e/acute-kidney-injury/</link>
      <description>Acute Kidney Injury (AKI)
Special Guest: Erin Barreto, PharmD, MSc, BCPS, BCCCP, FCCM

Show Notes: https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2020/02/aki-references.pdf

1:10 – Show updates!; 9:15 – Define and classify AKI; 14:45 – Subspecifying the type of AKI; 18:22 – Prevalence of AKI in the ICU; 20:45 – Identification of high-risk patients; 24:43 – Preferred risk prediction tools; 26:12 – Ideal kidney biomarker; 28:28 – Ideal v. current biomarkers; 32:13 – Structural biomarkers; 39:40 – AKI prevention; 44:08 – Kidney/drug dosing equations; 53:49 – Equations in AKI/renal recovery; 56:43 – Cystatin C; 72:19 – What if you don’t use novel biomarkers?; 75:33 – Favorite calculator for AKI clinical risk predictor tool; 77:43 – AKI potpourri; 85:05 – Take-home points

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 12 Feb 2020 17:28:54 -0000</pubDate>
      <itunes:title>Acute Kidney Injury</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>12</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b1f409a8-a883-11ed-9652-5b217d42e057/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Acute Kidney Injury (AKI)Special Guest: Erin Barreto, PharmD, MSc, BCPS, BCCCP, FCCM
Show Notes: https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com/2020/02/aki-references....</itunes:subtitle>
      <itunes:summary>Acute Kidney Injury (AKI)
Special Guest: Erin Barreto, PharmD, MSc, BCPS, BCCCP, FCCM

Show Notes: https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2020/02/aki-references.pdf

1:10 – Show updates!; 9:15 – Define and classify AKI; 14:45 – Subspecifying the type of AKI; 18:22 – Prevalence of AKI in the ICU; 20:45 – Identification of high-risk patients; 24:43 – Preferred risk prediction tools; 26:12 – Ideal kidney biomarker; 28:28 – Ideal v. current biomarkers; 32:13 – Structural biomarkers; 39:40 – AKI prevention; 44:08 – Kidney/drug dosing equations; 53:49 – Equations in AKI/renal recovery; 56:43 – Cystatin C; 72:19 – What if you don’t use novel biomarkers?; 75:33 – Favorite calculator for AKI clinical risk predictor tool; 77:43 – AKI potpourri; 85:05 – Take-home points

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Acute Kidney Injury (AKI)
Special Guest: Erin Barreto, PharmD, MSc, BCPS, BCCCP, FCCM</p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf</a></p>
<p>Show References: <a href="https://pharmacytodose.files.wordpress.com/2020/02/aki-references.pdf">https://pharmacytodose.files.wordpress.com/2020/02/aki-references.pdf</a></p>
<p>1:10 – Show updates!; 9:15 – Define and classify AKI; 14:45 – Subspecifying the type of AKI; 18:22 – Prevalence of AKI in the ICU; 20:45 – Identification of high-risk patients; 24:43 – Preferred risk prediction tools; 26:12 – Ideal kidney biomarker; 28:28 – Ideal v. current biomarkers; 32:13 – Structural biomarkers; 39:40 – AKI prevention; 44:08 – Kidney/drug dosing equations; 53:49 – Equations in AKI/renal recovery; 56:43 – Cystatin C; 72:19 – What if you don’t use novel biomarkers?; 75:33 – Favorite calculator for AKI clinical risk predictor tool; 77:43 – AKI potpourri; 85:05 – Take-home points</p>
<p>PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
<a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5584</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/c6534bc0-fd8b-553d-89cf-0f443b966b5f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3758944973.mp3?updated=1676476348" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Life After the ICU: A Personal Experience</title>
      <link>https://pharmacytodose.podbean.com/e/life-after-the-icu-a-personal-experience/</link>
      <description>Life After the ICU: A Personal Experience
Special Guest: G. Morgan Jones, PharmD, BCCCP, FCCM

Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/life-after-the-icu-show-notes.pdf

Morgan details his incredible journey after a personal experience with PICS and PICS-F.

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 29 Jan 2020 04:36:49 -0000</pubDate>
      <itunes:title>Life After the ICU: A Personal Experience</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>11</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b20555be-a883-11ed-9652-dfec57216016/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Life After the ICU: A Personal ExperienceSpecial Guest: G. Morgan Jones, PharmD, BCCCP, FCCM
Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/life-after-the-icu-show-notes.pdf
Morgan details his incredible journey after a personal exper...</itunes:subtitle>
      <itunes:summary>Life After the ICU: A Personal Experience
Special Guest: G. Morgan Jones, PharmD, BCCCP, FCCM

Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/life-after-the-icu-show-notes.pdf

Morgan details his incredible journey after a personal experience with PICS and PICS-F.

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Life After the ICU: A Personal Experience
Special Guest: G. Morgan Jones, PharmD, BCCCP, FCCM</p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/01/life-after-the-icu-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/01/life-after-the-icu-show-notes.pdf</a></p>
<p>Morgan details his incredible journey after a personal experience with PICS and PICS-F.</p>
<p>PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
<a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>5047</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/28da652e-47cc-58c5-a5ef-65941bad7b32]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7545184020.mp3?updated=1676476163" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>PICS </title>
      <link>https://pharmacytodose.podbean.com/e/pics-1579123375/</link>
      <description>Post-Intensive Care Syndrome (PICS)
Special Guest: Jimmi Hatton Kolpek, PharmD, BSPharm, FCCP, FCCM, FNAP

Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/pics-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2020/01/pics-references.pdf

00:25 - #PharmacyToRead Update; 10:07 – Why Jimmi is interested in PICS; 12:36 – When did PICS become an ICU focus?; 13:56 – How did PICS get thrust into the spotlight?; 15:40 – Definition of PICS; 16:27 – When does PICS occur?; 19:38 – How common is PICS?; 21:30 – PICS risk factors; 25:35 – How long does PICS last and how does it affect recovery?; 28:55 – Role of peer support; 31:20 – PICS prevention; 38:17 – Medications that can treat/prevent PICS; 41:50 – When to seek help for PICS?; 44:25 – Process for patients being referred to ICU Recovery Clinic; 48:12 – Who makes up the team and what problems are addressed?; 51:18 – What PICS resources are available for patients/families?; 54:35 – Do we prepare patients for what happens after the ICU?; 56:58 – How can we improve?; 59:53 – Take-home points on PICS

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 15 Jan 2020 21:22:55 -0000</pubDate>
      <itunes:title>PICS </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>10</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b2179bb6-a883-11ed-9652-8fe82a0661f0/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Post-Intensive Care Syndrome (PICS)Special Guest: Jimmi Hatton Kolpek, PharmD, BSPharm, FCCP, FCCM, FNAP
Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/pics-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com/20...</itunes:subtitle>
      <itunes:summary>Post-Intensive Care Syndrome (PICS)
Special Guest: Jimmi Hatton Kolpek, PharmD, BSPharm, FCCP, FCCM, FNAP

Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/pics-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2020/01/pics-references.pdf

00:25 - #PharmacyToRead Update; 10:07 – Why Jimmi is interested in PICS; 12:36 – When did PICS become an ICU focus?; 13:56 – How did PICS get thrust into the spotlight?; 15:40 – Definition of PICS; 16:27 – When does PICS occur?; 19:38 – How common is PICS?; 21:30 – PICS risk factors; 25:35 – How long does PICS last and how does it affect recovery?; 28:55 – Role of peer support; 31:20 – PICS prevention; 38:17 – Medications that can treat/prevent PICS; 41:50 – When to seek help for PICS?; 44:25 – Process for patients being referred to ICU Recovery Clinic; 48:12 – Who makes up the team and what problems are addressed?; 51:18 – What PICS resources are available for patients/families?; 54:35 – Do we prepare patients for what happens after the ICU?; 56:58 – How can we improve?; 59:53 – Take-home points on PICS

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Post-Intensive Care Syndrome (PICS)
Special Guest: Jimmi Hatton Kolpek, PharmD, BSPharm, FCCP, FCCM, FNAP</p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/01/pics-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/01/pics-show-notes.pdf</a></p>
<p>Show References: <a href="https://pharmacytodose.files.wordpress.com/2020/01/pics-references.pdf">https://pharmacytodose.files.wordpress.com/2020/01/pics-references.pdf</a></p>
<p>00:25 - #PharmacyToRead Update; 10:07 – Why Jimmi is interested in PICS; 12:36 – When did PICS become an ICU focus?; 13:56 – How did PICS get thrust into the spotlight?; 15:40 – Definition of PICS; 16:27 – When does PICS occur?; 19:38 – How common is PICS?; 21:30 – PICS risk factors; 25:35 – How long does PICS last and how does it affect recovery?; 28:55 – Role of peer support; 31:20 – PICS prevention; 38:17 – Medications that can treat/prevent PICS; 41:50 – When to seek help for PICS?; 44:25 – Process for patients being referred to ICU Recovery Clinic; 48:12 – Who makes up the team and what problems are addressed?; 51:18 – What PICS resources are available for patients/families?; 54:35 – Do we prepare patients for what happens after the ICU?; 56:58 – How can we improve?; 59:53 – Take-home points on PICS</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4067</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/8e0d6891-fae4-52d0-bd91-3fa8ed12a476]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9151691441.mp3?updated=1676476085" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ECMO </title>
      <link>https://pharmacytodose.podbean.com/e/ecmo/</link>
      <description>Extracorporeal Membrane Oxygenation (ECMO)
Special Guest: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/ecmo-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com/2020/01/ecmo-references.pdf 

00:25 - #PharmacyToRead Announcement!; 07:50 – Why is Amy interested in ECMO?; 11:48 – What is ECMO and when did we start using ECMO in the US?; 13:45 – ECLS v. ECMO; 15:52 – Why are we talking about ECMO today?; 19:40– What does ECMO do?; 21:05 – ECMO modalities; 22:59 – ECMO equipment; 27:30 – What should be tried before ECMO?; 30:56 – ECLS effect on PK/PD; 40:05 – Tips/tricks on ECMO anticoagulation, infection, and sedation protocols; 40:45 – Anticoagulation protocols; 47:30 – Infection protocols; 53:15 – Sedation protocols; 58:18 – ECMO complications; 60:40 – Tips when creating or modifying ECMO protocols; 63:27 – Future areas of ECMO research; 65:00 – Take-home points

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Fri, 03 Jan 2020 00:52:05 -0000</pubDate>
      <itunes:title>ECMO </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>9</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b228e646-a883-11ed-9652-bb0a3abd7b87/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Extracorporeal Membrane Oxygenation (ECMO)Special Guest: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP 
Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/ecmo-show-notes.pdfShow References: https://pharmacytodose.files.wordpress.com/2020/01/ecm...</itunes:subtitle>
      <itunes:summary>Extracorporeal Membrane Oxygenation (ECMO)
Special Guest: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP 

Show Notes: https://pharmacytodose.files.wordpress.com/2020/01/ecmo-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com/2020/01/ecmo-references.pdf 

00:25 - #PharmacyToRead Announcement!; 07:50 – Why is Amy interested in ECMO?; 11:48 – What is ECMO and when did we start using ECMO in the US?; 13:45 – ECLS v. ECMO; 15:52 – Why are we talking about ECMO today?; 19:40– What does ECMO do?; 21:05 – ECMO modalities; 22:59 – ECMO equipment; 27:30 – What should be tried before ECMO?; 30:56 – ECLS effect on PK/PD; 40:05 – Tips/tricks on ECMO anticoagulation, infection, and sedation protocols; 40:45 – Anticoagulation protocols; 47:30 – Infection protocols; 53:15 – Sedation protocols; 58:18 – ECMO complications; 60:40 – Tips when creating or modifying ECMO protocols; 63:27 – Future areas of ECMO research; 65:00 – Take-home points

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Extracorporeal Membrane Oxygenation (ECMO)
Special Guest: Amy Dzierba, PharmD, FCCM, FCCP, BCCCP </p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2020/01/ecmo-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2020/01/ecmo-show-notes.pdf</a>
Show References: <a href="https://pharmacytodose.files.wordpress.com/2020/01/ecmo-references.pdf">https://pharmacytodose.files.wordpress.com/2020/01/ecmo-references.pdf</a> </p>
<p>00:25 - #PharmacyToRead Announcement!; 07:50 – Why is Amy interested in ECMO?; 11:48 – What is ECMO and when did we start using ECMO in the US?; 13:45 – ECLS v. ECMO; 15:52 – Why are we talking about ECMO today?; 19:40– What does ECMO do?; 21:05 – ECMO modalities; 22:59 – ECMO equipment; 27:30 – What should be tried before ECMO?; 30:56 – ECLS effect on PK/PD; 40:05 – Tips/tricks on ECMO anticoagulation, infection, and sedation protocols; 40:45 – Anticoagulation protocols; 47:30 – Infection protocols; 53:15 – Sedation protocols; 58:18 – ECMO complications; 60:40 – Tips when creating or modifying ECMO protocols; 63:27 – Future areas of ECMO research; 65:00 – Take-home points</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4370</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/b3c74b76-6f27-5ffe-b6cf-6af723e5480e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC6853928966.mp3?updated=1676475939" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>ARDS </title>
      <link>https://pharmacytodose.podbean.com/e/ards/</link>
      <description>Acute Respiratory Distress Syndrome (ARDS)
Special Guest: Andrea Sikora Newsome, PharmD, BCPS, BCCCP

Show Notes: https://pharmacytodose.files.wordpress.com/2019/12/ards-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com/2019/12/ards-references.pdf

4:42 – #PharmacyToRead Book Club Announcement!; 7:24 – History of ARDS; 10:17 – Current ARDS definition; 11:25 – Criticisms to Berlin definition; 13:54 – ARDS Causes/Risk factors; 15:33 – Typical ARDS time course; 18:58 – ARDS treatment goals; 21:04 – Brief primer on mechanical ventilation; 30:50 – Prone positioning; 35:17 – NMBA for ARDS; 42:15 – Prone, paralyze, or both?; 43:34 – FACTT study and fluid stewardship in ARDS; 46:00 – Corticosteroids in ARDS; 49:45 – ARDS failed drugs; 53:55 – ECMO for severe ARDS; 58:25 – Future research areas; 60:10 – Role of PharmD in ARDS

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 18 Dec 2019 15:03:58 -0000</pubDate>
      <itunes:title>ARDS </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>8</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b23f27d0-a883-11ed-9652-63ef82721eed/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Acute Respiratory Distress Syndrome (ARDS)Special Guest: Andrea Sikora Newsome, PharmD, BCPS, BCCCP
Show Notes: https://pharmacytodose.files.wordpress.com/2019/12/ards-show-notes.pdfShow References: https://pharmacytodose.files.wordpress.com/2019/12/...</itunes:subtitle>
      <itunes:summary>Acute Respiratory Distress Syndrome (ARDS)
Special Guest: Andrea Sikora Newsome, PharmD, BCPS, BCCCP

Show Notes: https://pharmacytodose.files.wordpress.com/2019/12/ards-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com/2019/12/ards-references.pdf

4:42 – #PharmacyToRead Book Club Announcement!; 7:24 – History of ARDS; 10:17 – Current ARDS definition; 11:25 – Criticisms to Berlin definition; 13:54 – ARDS Causes/Risk factors; 15:33 – Typical ARDS time course; 18:58 – ARDS treatment goals; 21:04 – Brief primer on mechanical ventilation; 30:50 – Prone positioning; 35:17 – NMBA for ARDS; 42:15 – Prone, paralyze, or both?; 43:34 – FACTT study and fluid stewardship in ARDS; 46:00 – Corticosteroids in ARDS; 49:45 – ARDS failed drugs; 53:55 – ECMO for severe ARDS; 58:25 – Future research areas; 60:10 – Role of PharmD in ARDS

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Acute Respiratory Distress Syndrome (ARDS)
Special Guest: Andrea Sikora Newsome, PharmD, BCPS, BCCCP</p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2019/12/ards-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2019/12/ards-show-notes.pdf</a>
Show References: <a href="https://pharmacytodose.files.wordpress.com/2019/12/ards-references.pdf">https://pharmacytodose.files.wordpress.com/2019/12/ards-references.pdf</a></p>
<p>4:42 – #PharmacyToRead Book Club Announcement!; 7:24 – History of ARDS; 10:17 – Current ARDS definition; 11:25 – Criticisms to Berlin definition; 13:54 – ARDS Causes/Risk factors; 15:33 – Typical ARDS time course; 18:58 – ARDS treatment goals; 21:04 – Brief primer on mechanical ventilation; 30:50 – Prone positioning; 35:17 – NMBA for ARDS; 42:15 – Prone, paralyze, or both?; 43:34 – FACTT study and fluid stewardship in ARDS; 46:00 – Corticosteroids in ARDS; 49:45 – ARDS failed drugs; 53:55 – ECMO for severe ARDS; 58:25 – Future research areas; 60:10 – Role of PharmD in ARDS</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3989</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/ards-88f6196aeb40461f4987518a4dd3bcaf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1799543452.mp3?updated=1676475828" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>PCCs for PharmDs</title>
      <link>https://pharmacytodose.podbean.com/e/pccs-for-pharmds/</link>
      <description>Prothrombin Complex Concentrates (PCCs) for PharmDs
Special Guest: Scott Dietrich, PharmD, BCCCP

Show Notes: https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-references.pdf

3:05 – Anticoagulation reversal pre-PCC
5:18 – Brief history of PCC
6:45 – Current role for 3-factor PCC
7:56 – When should we be using PCC?
10:00 – Role of PCC for non-reversal indications
13:20 – Weight-based v. Fixed-dose Kcentra
15:39 – Why fixed-dose Kcentra?
17:33 – When to re-dose Kcentra?
18:50 – Kcentra when INR &lt; 2
20:20 – Guideline-recommended anticoagulation reversal
22:30 – How does Kcentra differ from FEIBA?
23:48 – FEIBA dosing strategy
24:15 – Kcentra for DOAC reversal
28:22 – FEIBA for DOAC reversal
30:02 – FEIBA v. Kcentra for DOAC reversal
30:25 – FEIBA v. KCentra for warfarin reversal
33:32 – Should we have Kcentra and FEIBA on formulary?
34:26 – Weight-based v. Fixed-dose FEIBA for DOAC reversal
35:20 – Pros/Cons of Andexxa
37:14 – PCC v. Andexxa
37:45 – Andexxa’s cost
40:10 – How would Scott reverse his AC?
43:20 – Pharmacist’s role
45:54 – PCC take home points 

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 05 Dec 2019 03:48:33 -0000</pubDate>
      <itunes:title>PCCs for PharmDs</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b251505e-a883-11ed-9652-4b28fa46ce04/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Prothrombin Complex Concentrates (PCCs) for PharmDsSpecial Guest: Scott Dietrich, PharmD, BCCCP
Show Notes: https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-show-notes.pdf
Show References: https://pharmacytodose.files.wordpress.com...</itunes:subtitle>
      <itunes:summary>Prothrombin Complex Concentrates (PCCs) for PharmDs
Special Guest: Scott Dietrich, PharmD, BCCCP

Show Notes: https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-show-notes.pdf

Show References: https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-references.pdf

3:05 – Anticoagulation reversal pre-PCC
5:18 – Brief history of PCC
6:45 – Current role for 3-factor PCC
7:56 – When should we be using PCC?
10:00 – Role of PCC for non-reversal indications
13:20 – Weight-based v. Fixed-dose Kcentra
15:39 – Why fixed-dose Kcentra?
17:33 – When to re-dose Kcentra?
18:50 – Kcentra when INR &lt; 2
20:20 – Guideline-recommended anticoagulation reversal
22:30 – How does Kcentra differ from FEIBA?
23:48 – FEIBA dosing strategy
24:15 – Kcentra for DOAC reversal
28:22 – FEIBA for DOAC reversal
30:02 – FEIBA v. Kcentra for DOAC reversal
30:25 – FEIBA v. KCentra for warfarin reversal
33:32 – Should we have Kcentra and FEIBA on formulary?
34:26 – Weight-based v. Fixed-dose FEIBA for DOAC reversal
35:20 – Pros/Cons of Andexxa
37:14 – PCC v. Andexxa
37:45 – Andexxa’s cost
40:10 – How would Scott reverse his AC?
43:20 – Pharmacist’s role
45:54 – PCC take home points 

PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Prothrombin Complex Concentrates (PCCs) for PharmDs
Special Guest: Scott Dietrich, PharmD, BCCCP</p>
<p>Show Notes: <a href="https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-show-notes.pdf</a></p>
<p>Show References: <a href="https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-references.pdf">https://pharmacytodose.files.wordpress.com/2019/12/pccs-for-pharmds-references.pdf</a></p>
<p>3:05 – Anticoagulation reversal pre-PCC
5:18 – Brief history of PCC
6:45 – Current role for 3-factor PCC
7:56 – When should we be using PCC?
10:00 – Role of PCC for non-reversal indications
13:20 – Weight-based v. Fixed-dose Kcentra
15:39 – Why fixed-dose Kcentra?
17:33 – When to re-dose Kcentra?
18:50 – Kcentra when INR &lt; 2
20:20 – Guideline-recommended anticoagulation reversal
22:30 – How does Kcentra differ from FEIBA?
23:48 – FEIBA dosing strategy
24:15 – Kcentra for DOAC reversal
28:22 – FEIBA for DOAC reversal
30:02 – FEIBA v. Kcentra for DOAC reversal
30:25 – FEIBA v. KCentra for warfarin reversal
33:32 – Should we have Kcentra and FEIBA on formulary?
34:26 – Weight-based v. Fixed-dose FEIBA for DOAC reversal
35:20 – Pros/Cons of Andexxa
37:14 – PCC v. Andexxa
37:45 – Andexxa’s cost
40:10 – How would Scott reverse his AC?
43:20 – Pharmacist’s role
45:54 – PCC take home points </p>
<p>PharmacyToDose.Com
@PharmacyToDose on Twitter/Instagram
<a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3192</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/pccs-for-pharmds-8373d7018f773c107c74cd8ff9ad78ed]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4847917749.mp3?updated=1676475719" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Fluid Stewardship</title>
      <link>https://pharmacytodose.podbean.com/e/fluid-stewardship/</link>
      <description>Fluid Stewardship

Special Guest: Anthony Hawkins, PharmD, BCCCP

Show notes: https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-show-notes.pdf

Show references: https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-references.pdf

 

5:45 – Defining fluid overload; 7:12 – Complications of being fluid overloaded; 10:45 – Why does fluid overload still happen?; 13:40 – Solutions to help fix mIVF; 15:30 – Patients at risk of becoming fluid overloaded; 18:28 – Determining if patients are fluid responsive; 24:38 – Does fluid responsiveness mean always give fluid?; 26:40 – What does fluid stewardship mean?; 28:45 – Four D’s; 31:30 – ROSE model; 39:39 – Applying ROSE model to non-sepsis patients; 42:20 – 4 rights of Medication Administration for Fluid Stewardship; 53:48 – Interventions that Pharmacists can make; 59:49 – Questions that still need answered; 61:30 – Future research to watch for; 63:33 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Thu, 21 Nov 2019 04:39:52 -0000</pubDate>
      <itunes:title>Fluid Stewardship</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b2631a28-a883-11ed-9652-57efa6e9fb35/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Fluid Stewardship
Special Guest: Anthony Hawkins, PharmD, BCCCP
Show notes: https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-show-notes.pdf
Show references: https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-refe...</itunes:subtitle>
      <itunes:summary>Fluid Stewardship

Special Guest: Anthony Hawkins, PharmD, BCCCP

Show notes: https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-show-notes.pdf

Show references: https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-references.pdf

 

5:45 – Defining fluid overload; 7:12 – Complications of being fluid overloaded; 10:45 – Why does fluid overload still happen?; 13:40 – Solutions to help fix mIVF; 15:30 – Patients at risk of becoming fluid overloaded; 18:28 – Determining if patients are fluid responsive; 24:38 – Does fluid responsiveness mean always give fluid?; 26:40 – What does fluid stewardship mean?; 28:45 – Four D’s; 31:30 – ROSE model; 39:39 – Applying ROSE model to non-sepsis patients; 42:20 – 4 rights of Medication Administration for Fluid Stewardship; 53:48 – Interventions that Pharmacists can make; 59:49 – Questions that still need answered; 61:30 – Future research to watch for; 63:33 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Fluid Stewardship</p>
<p>Special Guest: Anthony Hawkins, PharmD, BCCCP</p>
<p>Show notes: <a href="https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-show-notes.pdf</a></p>
<p>Show references: <a href="https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-references.pdf">https://pharmacytodose.files.wordpress.com/2019/11/fluid-stewardship-references.pdf</a></p>
<p> </p>
<p>5:45 – Defining fluid overload; 7:12 – Complications of being fluid overloaded; 10:45 – Why does fluid overload still happen?; 13:40 – Solutions to help fix mIVF; 15:30 – Patients at risk of becoming fluid overloaded; 18:28 – Determining if patients are fluid responsive; 24:38 – Does fluid responsiveness mean always give fluid?; 26:40 – What does fluid stewardship mean?; 28:45 – Four D’s; 31:30 – ROSE model; 39:39 – Applying ROSE model to non-sepsis patients; 42:20 – 4 rights of Medication Administration for Fluid Stewardship; 53:48 – Interventions that Pharmacists can make; 59:49 – Questions that still need answered; 61:30 – Future research to watch for; 63:33 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p><a href="mailto:PharmacyToDose@Gmail.com">PharmacyToDose@Gmail.com</a></p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4267</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/fluid-stewardship-729b931d5897c173912e4528b55e2284]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC7751445963.mp3?updated=1676475635" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Value and Importance of ICU Pharmacists</title>
      <link>https://pharmacytodose.podbean.com/e/value-and-importance-of-icu-pharmacists/</link>
      <description>Value &amp; Importance of ICU Pharmacists with Special Guest: Chris Droege, PharmD, BCCCP, FCCM, FASHP

Show notes: https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-show-notes.pdf

References: https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-references-1.pdf

8:02 – History of Critical Care Pharmacy; 13:40 – Why are Pharmacists needed as multidisciplinary team members?; 15:45 – Why do Pharmacists still need to justify our value?; 18:45 – Historical perception of Pharmacists play a part?; 21:51 – Overview of the White Paper; 26:52 – How relevant are most of these recommendations now?; 30:40 – How should time be spent within the different pillars?; 36:49 – Avoiding “The Sheriff” mentality; 41:55 – Examples of Pharmacists demonstrating value; 45:30 – How do we continue creating research studies demonstrating Pharmacists’ value?; 49:50 – The future of Clinical Pharmacy; 55:45 – Tips/Tricks for Pharmacists to demonstrate value to the ICU team

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 30 Oct 2019 12:49:10 -0000</pubDate>
      <itunes:title>Value and Importance of ICU Pharmacists</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b28b4c64-a883-11ed-9652-8f1f7a7f36ed/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Value &amp; Importance of ICU Pharmacists with Special Guest: Chris Droege, PharmD, BCCCP, FCCM, FASHP
Show notes: https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-show-notes.pdf
References: https://pharmacytodose.files.wordpress.com/201...</itunes:subtitle>
      <itunes:summary>Value &amp; Importance of ICU Pharmacists with Special Guest: Chris Droege, PharmD, BCCCP, FCCM, FASHP

Show notes: https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-show-notes.pdf

References: https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-references-1.pdf

8:02 – History of Critical Care Pharmacy; 13:40 – Why are Pharmacists needed as multidisciplinary team members?; 15:45 – Why do Pharmacists still need to justify our value?; 18:45 – Historical perception of Pharmacists play a part?; 21:51 – Overview of the White Paper; 26:52 – How relevant are most of these recommendations now?; 30:40 – How should time be spent within the different pillars?; 36:49 – Avoiding “The Sheriff” mentality; 41:55 – Examples of Pharmacists demonstrating value; 45:30 – How do we continue creating research studies demonstrating Pharmacists’ value?; 49:50 – The future of Clinical Pharmacy; 55:45 – Tips/Tricks for Pharmacists to demonstrate value to the ICU team

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Value &amp; Importance of ICU Pharmacists with Special Guest: Chris Droege, PharmD, BCCCP, FCCM, FASHP</p>
<p>Show notes: <a href="https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-show-notes.pdf">https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-show-notes.pdf</a></p>
<p>References: <a href="https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-references-1.pdf">https://pharmacytodose.files.wordpress.com/2019/10/icu-pharmacist-references-1.pdf</a></p>
<p>8:02 – History of Critical Care Pharmacy; 13:40 – Why are Pharmacists needed as multidisciplinary team members?; 15:45 – Why do Pharmacists still need to justify our value?; 18:45 – Historical perception of Pharmacists play a part?; 21:51 – Overview of the White Paper; 26:52 – How relevant are most of these recommendations now?; 30:40 – How should time be spent within the different pillars?; 36:49 – Avoiding “The Sheriff” mentality; 41:55 – Examples of Pharmacists demonstrating value; 45:30 – How do we continue creating research studies demonstrating Pharmacists’ value?; 49:50 – The future of Clinical Pharmacy; 55:45 – Tips/Tricks for Pharmacists to demonstrate value to the ICU team</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p>PharmacyToDose@Gmail.com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4053</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/value-and-importance-of-icu-pharmacists-cf90845707dee13c9a1300511d186857]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4125755420.mp3?updated=1676475484" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Status Epilepticus</title>
      <link>https://pharmacytodose.podbean.com/e/status-epilepticus-1571229283/</link>
      <description>Status Epilepticus with Special Guest: Karen Berger, PharmD, FCCM, BCPS, BCCCP

Show notes: https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-show-notes-1.pdf

References: https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-references.pdf

6:02 –Karen’s interest in SE; 7:35 – What is SE?; 9:32 – Further classifications of SE?; 10:37 – Patient presentation; 11:27 – Can the presentation change?; 13:35 – Any risk factors for SE?; 14:45 – Medication-induced SE; 15:40 – Prompt non-AED treatment for SE?; 17:06 – Empirically treat Wernicke’s?; 18:35 – Preferred BZD for initial treatment of SE?; 20:44 – If they don’t respond to an AED, do you avoid/discontinue using these agents?; 23:08 – Convincing providers to give larger BZD doses?; 26:53 – BZD dosing if a patient uses alcohol or BZD?; 27:37 – First-line AED for patients in SE?; 30:34 – Difficulty with high quality research in SE?; 31:46 – Are there specific patient populations or disease states where you prefer or avoid a specific AED?; 33:04 – Why is timely treatment so important?; 34:25 – General information on first-line AED agents; 47:20 – Where to find evidence-based dosing recommendations for SE?; 49:49 – Appropriate TDM of AED; 53:55 – Increase dose or add another AED?; 55:53 – How to improve time to AED administration for SE?; 59:04 – Review of IV anesthetic infusions for refractory SE; 64:27 – Tips/Tricks for Pharmacists treating SE; 65:40 – Take-home points

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instragram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 16 Oct 2019 12:34:43 -0000</pubDate>
      <itunes:title>Status Epilepticus</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b29da328-a883-11ed-9652-971cac846e2f/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Status Epilepticus with Special Guest: Karen Berger, PharmD, FCCM, BCPS, BCCCP
Show notes: https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-show-notes-1.pdf
References: https://pharmacytodose.files.wordpress.com/2019/10/status-ep...</itunes:subtitle>
      <itunes:summary>Status Epilepticus with Special Guest: Karen Berger, PharmD, FCCM, BCPS, BCCCP

Show notes: https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-show-notes-1.pdf

References: https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-references.pdf

6:02 –Karen’s interest in SE; 7:35 – What is SE?; 9:32 – Further classifications of SE?; 10:37 – Patient presentation; 11:27 – Can the presentation change?; 13:35 – Any risk factors for SE?; 14:45 – Medication-induced SE; 15:40 – Prompt non-AED treatment for SE?; 17:06 – Empirically treat Wernicke’s?; 18:35 – Preferred BZD for initial treatment of SE?; 20:44 – If they don’t respond to an AED, do you avoid/discontinue using these agents?; 23:08 – Convincing providers to give larger BZD doses?; 26:53 – BZD dosing if a patient uses alcohol or BZD?; 27:37 – First-line AED for patients in SE?; 30:34 – Difficulty with high quality research in SE?; 31:46 – Are there specific patient populations or disease states where you prefer or avoid a specific AED?; 33:04 – Why is timely treatment so important?; 34:25 – General information on first-line AED agents; 47:20 – Where to find evidence-based dosing recommendations for SE?; 49:49 – Appropriate TDM of AED; 53:55 – Increase dose or add another AED?; 55:53 – How to improve time to AED administration for SE?; 59:04 – Review of IV anesthetic infusions for refractory SE; 64:27 – Tips/Tricks for Pharmacists treating SE; 65:40 – Take-home points

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instragram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Status Epilepticus with Special Guest: Karen Berger, PharmD, FCCM, BCPS, BCCCP</p>
<p>Show notes: <a href="https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-show-notes-1.pdf">https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-show-notes-1.pdf</a></p>
<p>References: <a href="https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-references.pdf">https://pharmacytodose.files.wordpress.com/2019/10/status-epilepticus-references.pdf</a></p>
<p>6:02 –Karen’s interest in SE; 7:35 – What is SE?; 9:32 – Further classifications of SE?; 10:37 – Patient presentation; 11:27 – Can the presentation change?; 13:35 – Any risk factors for SE?; 14:45 – Medication-induced SE; 15:40 – Prompt non-AED treatment for SE?; 17:06 – Empirically treat Wernicke’s?; 18:35 – Preferred BZD for initial treatment of SE?; 20:44 – If they don’t respond to an AED, do you avoid/discontinue using these agents?; 23:08 – Convincing providers to give larger BZD doses?; 26:53 – BZD dosing if a patient uses alcohol or BZD?; 27:37 – First-line AED for patients in SE?; 30:34 – Difficulty with high quality research in SE?; 31:46 – Are there specific patient populations or disease states where you prefer or avoid a specific AED?; 33:04 – Why is timely treatment so important?; 34:25 – General information on first-line AED agents; 47:20 – Where to find evidence-based dosing recommendations for SE?; 49:49 – Appropriate TDM of AED; 53:55 – Increase dose or add another AED?; 55:53 – How to improve time to AED administration for SE?; 59:04 – Review of IV anesthetic infusions for refractory SE; 64:27 – Tips/Tricks for Pharmacists treating SE; 65:40 – Take-home points</p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instragram</p>
<p>PharmacyToDose@Gmail.com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4271</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/status-epilepticus-1571229283-e205e49efacbeb468936a38a7d693790]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC3532420689.mp3?updated=1676475355" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Vasoactives in Septic Shock</title>
      <link>https://pharmacytodose.podbean.com/e/vasoactives-in-septic-shock/</link>
      <description>Vasoactives in Septic Shock with Special Guest: Alex Flannery, PharmD, BCCCP, BCPS

3:35 – Why is Alex interested in sepsis?...5:49 – How do you teach sepsis with the recent changes?...8:35 – When to start vasopressors in a hypotensive patient?...11:58 – What do you consider high-dose norepinephrine?...13:40 – How do you add vasopressin and corticosteroids for patients in refractory septic shock?...15:15 – Do you use fludricortisone in combination with hydrocortisone?...16:49 – Utility of cortisol levels or ACTH stimulation testing...18:27 – Cost:benefit analysis of vasopressin...19:21 – Role of epinephrine in septic shock...21:15 – Dobutamine or Epinephrine?...22:57 – HAT cocktail...24:55 – Thiamine supplementation in sepsis and septic shock...28:35 – Use of Angiotensin II and its place in therapy...32:30 – Approach to using methylene blue...34:05 – Modify hemodynamic goals to assist with vasopressor weaning...36:07 – Managing adverse effects due to vasopressors...39:27 – Order of operations in weaning vasopressors and corticosteroids...44:35 – The use of midodrine to wean off IV vasopressors...49:25 – Take-away points for vasoactives and their use in septic shock...51:11– Future areas for research

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instragram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 02 Oct 2019 12:48:14 -0000</pubDate>
      <itunes:title>Vasoactives in Septic Shock</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b2af05d2-a883-11ed-9652-8fdcaf1d21c7/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Vasoactives in Septic Shock with Special Guest: Alex Flannery, PharmD, BCCCP, BCPS
3:35 – Why is Alex interested in sepsis?...5:49 – How do you teach sepsis with the recent changes?...8:35 – When to start vasopressors in a hypotensive patient?...11:5...</itunes:subtitle>
      <itunes:summary>Vasoactives in Septic Shock with Special Guest: Alex Flannery, PharmD, BCCCP, BCPS

3:35 – Why is Alex interested in sepsis?...5:49 – How do you teach sepsis with the recent changes?...8:35 – When to start vasopressors in a hypotensive patient?...11:58 – What do you consider high-dose norepinephrine?...13:40 – How do you add vasopressin and corticosteroids for patients in refractory septic shock?...15:15 – Do you use fludricortisone in combination with hydrocortisone?...16:49 – Utility of cortisol levels or ACTH stimulation testing...18:27 – Cost:benefit analysis of vasopressin...19:21 – Role of epinephrine in septic shock...21:15 – Dobutamine or Epinephrine?...22:57 – HAT cocktail...24:55 – Thiamine supplementation in sepsis and septic shock...28:35 – Use of Angiotensin II and its place in therapy...32:30 – Approach to using methylene blue...34:05 – Modify hemodynamic goals to assist with vasopressor weaning...36:07 – Managing adverse effects due to vasopressors...39:27 – Order of operations in weaning vasopressors and corticosteroids...44:35 – The use of midodrine to wean off IV vasopressors...49:25 – Take-away points for vasoactives and their use in septic shock...51:11– Future areas for research

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instragram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Vasoactives in Septic Shock with Special Guest: Alex Flannery, PharmD, BCCCP, BCPS</p>
<p>3:35 – Why is Alex interested in sepsis?...5:49 – How do you teach sepsis with the recent changes?...8:35 – When to start vasopressors in a hypotensive patient?...11:58 – What do you consider high-dose norepinephrine?...13:40 – How do you add vasopressin and corticosteroids for patients in refractory septic shock?...15:15 – Do you use fludricortisone in combination with hydrocortisone?...16:49 – Utility of cortisol levels or ACTH stimulation testing...18:27 – Cost:benefit analysis of vasopressin...19:21 – Role of epinephrine in septic shock...21:15 – Dobutamine or Epinephrine?...22:57 – HAT cocktail...24:55 – Thiamine supplementation in sepsis and septic shock...28:35 – Use of Angiotensin II and its place in therapy...32:30 – Approach to using methylene blue...34:05 – Modify hemodynamic goals to assist with vasopressor weaning...36:07 – Managing adverse effects due to vasopressors...39:27 – Order of operations in weaning vasopressors and corticosteroids...44:35 – The use of midodrine to wean off IV vasopressors...49:25 – Take-away points for vasoactives and their use in septic shock...51:11– Future areas for research</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instragram</p>
<p>PharmacyToDose@Gmail.com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>3450</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/vasoactives-in-septic-shock-024f9a5a5820f772a7ea2422584d3989]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC4391079480.mp3?updated=1676475267" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Sleep in the ICU</title>
      <link>https://pharmacytodose.podbean.com/e/sleep-in-the-icu/</link>
      <description>Sleep in the ICU with Special Guest: Mojdeh Heavner, PharmD, BCPS, BCCCP

4:55 – 10:00 – How did Mojdeh first become interested in sleep?; 10:00 – 13:40 – Why is sleep disruption so bad for ICU patients?; 14:11 – 15:31 – How does sleep deprivation affect clinical outcomes?; 15:35 – 19:13 – How do we know ICU patients have issues with sleep?; 19:45 – 24:38 – Is there a relationship between sleep deprivation and delirium; 24:50 – 30:30 – Risk factors for sleep deprivation; 30:48 – 32:35 – What do the PAD-IS guidelines recommend regarding sleep assessment?; 32:37 – 34:00 – What do we use for sleep assessment currently?; 34:00 – 37:12 – What options are available to assess sleep in ICU patients?; 37:20 – 38:30 – Can we rely on family to bring up sleep related issues?; 38:45 – 44:15 – Non-pharmacologic management of sleep disruption; 44:20 – 54:21 – Pharmacologic interventions for sleep promotion; 54:30 – 55:45 – What to do with the patient who has taken BZD chronically for sleep at home?; 55:45 – 58:10 – Does your approach for sleep management change for patients with chronic insomnia?; 58:12 – 60:09 – Importance of multi-disciplinary involvement with sleep; 60:10 – 63:20 – Role of Pharmacist in Sleep Promotion; 63:20 – 65:00 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Wed, 18 Sep 2019 04:47:25 -0000</pubDate>
      <itunes:title>Sleep in the ICU</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b2c0eba8-a883-11ed-9652-97c0ec504421/image/iTunes_Podcast_Logo.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Sleep in the ICU with Special Guest: Mojdeh Heavner, PharmD, BCPS, BCCCP
4:55 – 10:00 – How did Mojdeh first become interested in sleep?; 10:00 – 13:40 – Why is sleep disruption so bad for ICU patients?; 14:11 – 15:31 – How does sleep deprivation aff...</itunes:subtitle>
      <itunes:summary>Sleep in the ICU with Special Guest: Mojdeh Heavner, PharmD, BCPS, BCCCP

4:55 – 10:00 – How did Mojdeh first become interested in sleep?; 10:00 – 13:40 – Why is sleep disruption so bad for ICU patients?; 14:11 – 15:31 – How does sleep deprivation affect clinical outcomes?; 15:35 – 19:13 – How do we know ICU patients have issues with sleep?; 19:45 – 24:38 – Is there a relationship between sleep deprivation and delirium; 24:50 – 30:30 – Risk factors for sleep deprivation; 30:48 – 32:35 – What do the PAD-IS guidelines recommend regarding sleep assessment?; 32:37 – 34:00 – What do we use for sleep assessment currently?; 34:00 – 37:12 – What options are available to assess sleep in ICU patients?; 37:20 – 38:30 – Can we rely on family to bring up sleep related issues?; 38:45 – 44:15 – Non-pharmacologic management of sleep disruption; 44:20 – 54:21 – Pharmacologic interventions for sleep promotion; 54:30 – 55:45 – What to do with the patient who has taken BZD chronically for sleep at home?; 55:45 – 58:10 – Does your approach for sleep management change for patients with chronic insomnia?; 58:12 – 60:09 – Importance of multi-disciplinary involvement with sleep; 60:10 – 63:20 – Role of Pharmacist in Sleep Promotion; 63:20 – 65:00 – Take-home points

 

PharmacyToDose.Com

@PharmacyToDose on Twitter/Instagram

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Sleep in the ICU with Special Guest: Mojdeh Heavner, PharmD, BCPS, BCCCP</p>
<p>4:55 – 10:00 – How did Mojdeh first become interested in sleep?; 10:00 – 13:40 – Why is sleep disruption so bad for ICU patients?; 14:11 – 15:31 – How does sleep deprivation affect clinical outcomes?; 15:35 – 19:13 – How do we know ICU patients have issues with sleep?; 19:45 – 24:38 – Is there a relationship between sleep deprivation and delirium; 24:50 – 30:30 – Risk factors for sleep deprivation; 30:48 – 32:35 – What do the PAD-IS guidelines recommend regarding sleep assessment?; 32:37 – 34:00 – What do we use for sleep assessment currently?; 34:00 – 37:12 – What options are available to assess sleep in ICU patients?; 37:20 – 38:30 – Can we rely on family to bring up sleep related issues?; 38:45 – 44:15 – Non-pharmacologic management of sleep disruption; 44:20 – 54:21 – Pharmacologic interventions for sleep promotion; 54:30 – 55:45 – What to do with the patient who has taken BZD chronically for sleep at home?; 55:45 – 58:10 – Does your approach for sleep management change for patients with chronic insomnia?; 58:12 – 60:09 – Importance of multi-disciplinary involvement with sleep; 60:10 – 63:20 – Role of Pharmacist in Sleep Promotion; 63:20 – 65:00 – Take-home points</p>
<p> </p>
<p>PharmacyToDose.Com</p>
<p>@PharmacyToDose on Twitter/Instagram</p>
<p>PharmacyToDose@Gmail.com</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>4171</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/sleep-in-the-icu-1c765935129c7cf7bcd7e73e8a1e454c]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC9364407692.mp3?updated=1676475143" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Introducing Pharmacy to Dose: The Critical Care Podcast</title>
      <link>https://pharmacytodose.podbean.com/e/introducing-pharmacy-to-dose-the-critical-care-podcast/</link>
      <description>Introducing Pharmacy to Dose: The Critical Care Podcast with your host Nick Peters. Learn more about the podcast discussing critical care and its pharmacotherapy in a fun and entertaining manner.

Learn more about your ad choices. Visit megaphone.fm/adchoices</description>
      <pubDate>Sat, 07 Sep 2019 17:30:54 -0000</pubDate>
      <itunes:title>Introducing Pharmacy to Dose: The Critical Care Podcast</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:author>Nick Peters</itunes:author>
      <itunes:image href="https://megaphone.imgix.net/podcasts/b2d2bef0-a883-11ed-9652-b7c27e317e7b/image/IMG_3824.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
      <itunes:subtitle>Introducing Pharmacy to Dose: The Critical Care Podcast with your host Nick Peters. Learn more about the podcast discussing critical care and its pharmacotherapy in a fun and entertaining manner.</itunes:subtitle>
      <itunes:summary>Introducing Pharmacy to Dose: The Critical Care Podcast with your host Nick Peters. Learn more about the podcast discussing critical care and its pharmacotherapy in a fun and entertaining manner.

Learn more about your ad choices. Visit megaphone.fm/adchoices</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Introducing Pharmacy to Dose: The Critical Care Podcast with your host Nick Peters. Learn more about the podcast discussing critical care and its pharmacotherapy in a fun and entertaining manner.</p>
<p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>]]>
      </content:encoded>
      <itunes:duration>215</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[pharmacytodose.podbean.com/introducing-pharmacy-to-dose-the-critical-care-podcast-d3d7ac94baf189df0d950be04de401db]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HRALC1977349142.mp3?updated=1675952214" length="0" type="audio/mpeg"/>
    </item>
  </channel>
</rss>
